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The study of small molecules, while not a new concept, is still at its infancy for both 
detection and structure identification. My work at the University of Tennessee, Knoxville 
has been focused on the advancement of both analytical detection and identification of 
novel compounds as potential small molecule targets. Using in vitro and in vivo 
neurometabolomics on rodents as my foundation, I have been able to identify numerous 
small molecules for further study in the areas of social defeat stress and across various 
states of consciousness. Through untargeted metabolomics via liquid chromatography 
coupled with high-resolution mass spectrometry, this research has provided the additional 
hurdle of identifying novel targets among the unidentified spectral features, or “unknown” 
metabolites. In the final chapter of this dissertation, I emphasize my ability to elucidate 
the structure of a novel cobamide identified as a native prosthetic group in catalytically 
active tetrachloroethene reductive dehalogenases of Desulfobacterium hafniense. 
Utilizing stable isotope labeling of microbial cultures, mass spectrometry confirmed the 
molecular formula, followed by 1D and 2D nuclear magnetic resonance spectroscopy to 
characterize structural connectivity. The research presented in this dissertation advances 
the field of novel compound discovery and characterization for the identification of small 
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-- Muhammad Ali 
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Although the term “metabolome” was not introduced until 1998, the idea of 
analyzing an organism’s fluids or tissue to determine overall health is not a new concept. 
This idea can be dated back as far as ancient China (2000 – 1500 B.C.), where ants were 
used to evaluate glucose concentration in urine for the diagnosis of diabetes mellitus. As 
odd as it sounds, these ancient doctors even relied on tasting the patient’s urine for 
diagnosis; can’t say modern physicians are that committed to their patients’ health these 
days. Moving down the timeline, the Greek physician, Galen of Pergamon developed the 
theory of humorism. This concept, also known as the four humors – black bile, yellow bile, 
blood, and phlegm, provided physicians a simple diagnostic tool that was accepted by 
Western medicine for more than 1,300 years. The scientific revolution of the 17th century 
provided significant strides in the field of metabolomics, which were primarily advanced 
by Santorio Sanctorius. Considered a founding father of the field, Santorio is recognized 
for his work on “insensible perspiration,” where he determined that the amount of excreted 
fluid was less than the fluid ingested. This study is the first documented case of physical 
data collection for the quantitative analysis of pathology. From this research, Thomas 
Willis (1674) was able to confirm that a patient with diabetes had sweet urine and coined 
the term “mellitus”. The sweet smell from the patient’s urine was later identified to be a 
sugar by Matthew Dobson in 1776 but were debated until the work of George Owen Rees 
in the mid-19th century. We have since identified that elevated glucose levels occur due 
to a lack of insulin production in diabetes patients, but this early metabolomics research 
reveals the importance of studying small molecules for disease identification, and the true 
duration of time that research has been focused on the study of the human metabolome. 
 Following the industrial revolution and moving into the modern era, J.J. Thompson 
(1905) of the University of Cambridge must be given an enormous amount of credit for 
where we are today with modern metabolomics research. The development of the first 
mass spectrometer marked a new era of how the molecular space would be studied. 
Although this technology has been refined in the century that has passed, the study of 
molecules using their molecular weight has led to the identification of thousands, if not 
millions, of compounds and has become a staple for the characterization of novel 
compounds. Not to be over looked, the manufacturing of the first nuclear magnetic 
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resonance spectrometer (NMR) is equally as important for the field of metabolomics. In 
1946, Felix Bloch of Stanford and Edward Purcell of Harvard simultaneously published 
work using the first NMR in the same issue of Physical Review. The establishment of 
NMR technologies have allowed researchers to characterize structural components of 
novel compounds. Both analytical tools were further supplemented by the advancement 
of chromatographic separation techniques in the 1960’s and made the analysis of a 
complex metabolome possible. Each of these analytical technologies have made 
significant advancements that have positioned the field of metabolomics as an emerging 
field for drug development. 
 
MODERN METABOLOMICS 
Technological advances allowed for the first mass-based metabolomic 
experiments in 1971 by Orval Mamer (Mamer, O. A., et al., Clin. Chim. Acta 1971), and 
Evan and Majorie Horning (Horning, E. C.; Horning, M. G., J. Chrom. Sci. 1971) using 
gas chromatography-mass spectrometry. These experiments provided evidence that 
metabolic profiles could be generated from blood and urine samples. This was the trigger 
for what is referred to as “modern metabolomics,” which started with research from Arthur 
B. Robinson and Linus Pauling. Later that year, Robinson and Pauling (Pauling, L.; 
Robinson, A. B., et al., PNAS 1971) published the first quantitative metabolomics 
experiment showing biological variability of urine vapor and breath from humans following 
dietary restriction. Now their original claim of the intestinal flora disappearing due to a 
“defined diet” was corrected in 1970 (Winitz et al.), but this research still marks the 
climactic beginning of large-scale, small molecule analysis. The term “metabolomics” was 
first used by Stephen G. Oliver (Oliver, S. G. et al., Trends Biotechnol. 1998) for their 




OPENING THE DOOR FOR UNTARGETED METABOLOMICS 
Targeted metabolomics research was the foundation of quantitative metabolomics 
through 1970’s, 80’s and most of the 90’s until the invention and proof-of-principle of the 
Orbitrap™ by Alexander Makarov (2000). Although, the concept of electrostatically 
trapping ions in an orbit was in first developed almost a century prior by the physicist, K. 
H. Kingdon (1923), the commercialization of this technology transitioned the world of 
metabolomics from a targeted point-of-view to untargeted. See, targeted metabolomics 
had technical limitations due to both hardware and software capabilities. Researchers 
were only able to detect less than one percent of the metabolites present in biological 
samples, which prevented the establishment of a comprehensive look at the entire 
metabolome from a single sample.  Now by generating a mass spectrum using Fourier 
transform of the frequency signal, a high-resolution mass analyzer can detect thousands 
of compounds simultaneously with a large dynamic range. This capability has spring 
boarded the field into the direction of finding novel biomarkers as drug targets. Parallel to 
this effort, the Human Metabolome Project started in 2004 and was led by David Wishart 
of the University of Alberta, Canada. In a collaborative effort, over 50 scientists have 
characterized over 2500 metabolites, 1200 drugs, and 3500 food components, which 
have been compiled into the Human Metabolome Database for open-access. 
 Today, we have met a cross-roads of metabolomics research. The amount of data 
generated presents computational limitations, and the field as a whole is attempting to 
provide common practices for proper publication standards. Yet, as scientist, we strive to 
achieve that next level of discovery in hopes of finding the next, great drug target. To 
achieve this goal, we must continue to expand our technical and analytical tools for the 
discovery and characterization of the undiscovered section of the metabolome.  
 
NEUROMETABOLOMICS 
A trending research topic is the analysis of neurometabolomics. The complexity of 
studying the brain starts with the inherit selectivity of the blood brain barrier. The unique 
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feature of this organ provides additional hurdles when trying to understand its intricacies. 
The specialized endothelial cells that line blood capillaries can selectively filter 
compounds using passive diffusion based on size, polarity, and charge. Meaning that the 
study of neuronal tissue cannot be directly supplemented with metabolic changes 
observed from blood or other internal organs. Not to mention that the brain is arguably 
the most complex organ of the body based on the sheer number of cooperative brain 
regions and intricate arborization of nerve cells within/ across these regions. A major 
emphasis on brain research was initiated by president George H. W. Bush when he 
designated the 1990’s as the “Decade of the Brain” and continued when president Barack 
Obama began the Brain Research through Advancing Innovative Neurotechnologies 
(BRAIN) Initiative in 2013. These executive branch initiatives have increased funding and 
recognition for the required advancement of brain research in hopes of solving problems 
such as neurodegenerative diseases, genetic mutations, and psychological disorders. 
 
THE KNOWLEDGE GAP 
In the field of discovery-based small molecule investigation, we have developed a 
diverse set of methods to determine “known” metabolites with the use of standards or 
confirmation through fragmentation. Yet, it is after the detection where a lack of protocols 
for interpretation exists. Following the integration of ion intensities, statisticians, both 
advanced and novice, are presented with the challenge of authenticating significant 
changes through various statistical routes and biochemists, both advanced and novice, 
with the interpretation of metabolic changes and how those relate back to the 
experimental perturbation. Both scenarios offer unique challenges, and as a field, we are 
still laboring over which methods offer the most conclusive results. These are the current 
state of affairs in the field of understanding known metabolites, a.k.a. metabolites from 
your typical biochemistry textbook. When we move past our comfort zone and begin 
looking into the metabolic space of “unknown” compounds, the field is presented with a 
laundry list of challenges that complicate our ability to confirm molecular structure. 
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Identification of the full de novo structure is referred to as structure elucidation, 
which includes the confirmation of molecular connectivity with correct stereochemical 
assignments. The development of detailed bioanalytical approaches has become an 
essential component for the advancement of novel structure elucidation, and specifically 
relevant within the fields of metabolomics and pharmacology, including both discovery 
and synthesis processing phases. Novel structure elucidation can be easily performed 
using X-ray crystallography, given that you have a pure sample in the form of a crystal 
structure. Since this is generally uncommon, additional analytical techniques have been 
developed to further characterize the unknown biological space. Spectroscopic methods, 
such as NMR, infrared, and UV-Vis, are staples within this field. NMR technologies 
include the use of one- (1D) and two-dimensional (2D) analysis to determine bond 
connectivity and atomic spatial resolution, which makes this technology a critical 
component for compound characterization. Yet, this technique requires a relatively large 
quantity of clean sample to obtain chemical shift information from nuclei other than 
protons due to the low abundance of naturally occurring isotopes and complications 
related to the nuclei’s spin quantum number. 
Advances across mass spectrometry platforms have propelled mass-based 
analysis of novel structures to the forefront of this field. The ability to obtain elemental 
composition information from the parent mass and partial structure information from mass 
fragments provides a unique opportunity to use a highly sensitive instrument that can 
resolve several compounds from a complex mixture in a single sample. Platforms for this 
analysis include time-of-flight, triple quadrupole, ion trap, and Fourier transform 
instruments. Each of these instruments have unique figures of merit associated with their 
mass accuracy, resolution, dynamic range, sensitivity, and robustness, which all 
accompany their specific utility. Additionally, several forms of soft and ionization 
techniques can be used to enhance ion detection. To accompany resolution of molecules 
in the mass domain, chromatographic techniques, primarily liquid and gas, can assist in 
feature identification and detection be resolving compounds in the time domain. 
Currently, the field of discovery-based small molecule identification has an 
abundance of analytical tools available at their disposal. The next major hurdle is the 
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handling of mass spectral data; including the development of mass spectral databases 
and data interpretation (both ion intensities and spectral features), advancement of both 
hardware and software packages, and development of strict protocols for the confirmation 





CHAPTER 1: NEUROMETABOLOMICS PROFILE CLASSIFICATION OF 





With neurometabolomics in its infancy, the first chapter of this dissertation offers 
several key advancements to the field. First, the use of a social defeat model for hamsters 
has been established, but this technique was less commonly used on mice. These 
phenotypic, behavioral studies are important for the analysis of acute/ chronic stress 
leading to depression, or even post-traumatic stress disorders. While this model presents 
its own challenges, the following publication is the first record of neuronal metabolomics 
used to study stress resistance from sub-milligram quantities of brain tissue. This study 
involved the extraction of whole brains that were strategically sliced to expose four 
different brain regions; medial prefrontal cortex, hippocampus, nuclear accumbens, and 
basolateral amygdala from both Syrian hamsters and B6 mice. Following an aqueous 
extraction technique, small molecule analysis was performed using an untargeted 
metabolomics method that facilitated the identification of hundreds of identified 
metabolites, thousands of unidentified spectral features, and the elucidation of several 
novel metabolic targets.  
A total of 54 hamsters and 70 mice were used to produce a total of 166 and 121 
samples, respectively from the above-mentioned brain regions. Initially, the left and right 
brain regions were tested separately, and confirmed to have no statistical differences in 
metabolite levels. This lead to the collection of both the left and right side to produce a 
sample mass ~300 - 400 ng. Samples were extracted in a cold-room (5 °C) using an 
acidic acetonitrile solution with a previous established protocol. Samples were injected at 
10 µL aliquots and chromatographically separated prior to analyte detection. Liquid 
chromatography was performed in reverse phase with step-wise increments of methanol 
and formic acid in water. Mass analysis was conducted on an Exactive Plus Orbitrap and 
metabolite integration was completed using the MAVEN software package. 
Statistical analysis, including ANOVA and PLS-DA, VIP scores, were used to 
reduce the number of unidentified features to a consolidated list that was subject to a 
database search using the Human Metabolome Database (HMDB). These statistical 
approaches are commonly used in metabolomics research and provided sufficient feature 
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reduction. Manual investigation of HMDB metabolite hits resulted in novel experimental 
targets for future studies. Although targets were ambiguously identified, we are still left 
with thousands of unidentified features that were statistically significant to our stress 
model, but whose molecular formula did not equate to a known, biologically active 
compound. 
The discovery-based approach of this study hallmarks a first-pass analysis of 
metabolic profiles related to stress resistance. The known and unknown small molecules 
identified in this study will be used to design future experimental endeavors in the pursuit 
of diagnostic biomarkers. In parallel studies, we can continue to identify the small 
molecule targets and metabolic pathways that have a strong correlation to the reduction 
of long-term effects from trauma. These future analyses could lead to the discovery of 
novel drug targets used in the diagnosis, treatment and/or prevention of depression and 
acute/chronic trauma-related stress, such as post-traumatic stress disorder.  
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Contributions: 
This chapter contains only minor adaptations from the originally submitted manuscript. 
BND, CTC, and MBM performed acute social defeat experiments and behavioral/ 
phenotype evaluations of subjects. AKB performed extractions and metabolomics studies 
using UPLC-HRMS, and sequential statistics on results. AKB and BND equally 







Acute social defeat represents a naturalistic form of conditioned fear and is an 
excellent model in which to investigate the biological basis of stress resilience. While 
there is growing interest in identifying biomarkers of stress resilience, until recently, it has 
not been feasible to associate levels of large numbers of neurochemicals and metabolites 
to stress-related phenotypes. The objective of the present study was to use an untargeted 
metabolomics approach to identify known and unknown neurochemicals in select brain 
regions that distinguish susceptible and resistant individuals in two rodent models of acute 
social defeat. In the first experiment, male mice were first phenotyped as resistant or 
susceptible. Then, mice were subjected to acute social defeat, and tissues were 
immediately collected from the ventral medial prefrontal cortex (vmPFC), 
basolateral/central amygdala (BLA/CeA), nucleus accumbens (NAc), and dorsal 
hippocampus (dHPC). Ultra-high performance liquid chromatography coupled with high 
resolution mass spectrometry (UPLC-HRMS) was used for the detection of water-soluble 
neurochemicals. In the second experiment, male Syrian hamsters were paired in daily 
agonistic encounters for 2 weeks, during which they formed stable dominant-subordinate 
relationships. Then, 24 hours after the last dominance encounter, animals were exposed 
to acute social defeat stress. Immediately after social defeat, tissue was collected from 
the vmPFC, BLA/CeA, NAc, and dHPC for analysis using UPLC-HRMS. Although no 
single biomarker characterized stress-related phenotypes in both species, commonalities 
were found. For instance, in both model systems, animals resistant to social defeat stress 
also show increased concentration of molecules to protect against oxidative stress in the 
NAc and vmPFC. Additionally, in both mice and hamsters, unidentified spectral features 
were preliminarily annotated as potential targets for future experiments. Overall, these 
findings suggest that a metabolomics approach can identify functional groups of 
neurochemicals that may serve as novel targets for the diagnosis, treatment, or 




Stress is a contributing factor in the etiology of several psychiatric conditions 
including depression1, panic disorder2, and post-traumatic stress disorder (PTSD)3. 
Aggression is a particularly salient form of trauma, and people exposed to interpersonal 
violence are at a greater risk for developing PTSD than those exposed to non-personal 
trauma4. However, many individuals who experience stressful events do not develop a 
stress-related psychopathology, and there is a great deal of interest in what makes certain 
individuals resilient. Stress resilience refers to the ability of individuals to maintain normal 
levels of psychological, biological, and social functioning following a traumatic event. 
Importantly, resilience is an active process and not simply the absence of a pathological 
response to stress5-7. 
 Animal models of social defeat stress have been put forth as high validity models 
of stress-related mental illness and, interestingly, individuals exhibit pronounced 
variability to the effects of social defeat8. Genetically identical, inbred mice display a great 
deal of variability in social avoidance following 10 days of chronic social defeat9-10 and 
two days of repeated social defeat11-12. Susceptible mice avoid novel animals in a social 
interaction test following social defeat stress, whereas resilient (or resistant) mice 
investigate novel animals following social defeat stress in a pattern similar to non-
defeated controls13. In the chronic social defeat model, brain-derived neurotrophic factor 
(BDNF) signaling in a neural circuit involving the ventral tegmental area and nucleus 
accumbens (NAc) is critical for the expression of defeat-induced social avoidance in 
susceptible animals10. The ventromedial prefrontal cortex (vmPFC) also provides top-
down inhibitory control of the NAc and amygdala, which promotes a resistant phenotype 
after social defeat stress 14. In a mouse model using a single day of acute social defeat, 
BDNF signaling in the basolateral amygdala (BLA) is necessary for acquisition of defeat-
induced social avoidance15. The development of the susceptible and resistant 
phenotypes is largely unknown, although the epigenetic changes that underlie stress 
vulnerability may be linked to environmental influences during pre-natal and post-natal 
development, including the establishment of early dominance hierarchies16-17. 
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 Syrian hamsters are aggressive and territorial animals that exhibit a striking 
change in behavior following social defeat stress. Following exposure to a single bout of 
social defeat, male hamsters fail to defend their home territory and instead exhibit 
submissive and defensive behavior toward novel non-aggressive intruders for up to one 
month18. This stress-induced change in agonistic behavior is called the conditioned defeat 
response and is similar to the defeat-induced social avoidance shown by rats and mice19-
20. The conditioned defeat response in hamsters is an ethologically relevant form of 
conditioned fear and is regulated by many of the same brain regions, neural circuits, and 
neurochemicals as conditioned fear. Neurotransmission in the central amygdala (CeA) is 
critical for the expression of the conditioned defeat response21. In the BLA, NMDA 
receptors, BDNF, and cAMP response element binding (CREB) protein are each 
necessary for the acquisition of the conditioned defeat response22-24. Neurotransmission 
in several other brain regions is known to modulate the conditioned defeat response, such 
as the NAc, ventral hippocampus (vHPC), and vmPFC25-27. A great deal of variation exists 
in the amount of submissive and defensive behavior exhibited by hamsters following 
social defeat. To investigate vulnerability to the conditioned defeat response, we allowed 
dyads of hamsters to establish and maintain dominance relationships and then tested 
dominant and subordinate animals for their conditioned defeat response. We found that 
dominant hamsters show a reduced conditioned defeat response and increased c-Fos 
immunoreactivity in the vmPFC compared to subordinate and control animals28-29. 
Furthermore, pharmacological blockade of neural activity in the vmPFC reinstated the 
conditioned defeat response in dominant hamsters but did not alter conditioned defeat in 
subordinates or controls30. While a great deal is known about the brain regions and neural 
circuitry that control the conditioned defeat response, relatively little is known about the 
neurochemistry within these structures. 
 There is growing interest in identifying neurochemical biomarkers to aid in the 
diagnosis, risk assessment, and prevention of stress-related mental illnesses such as 
PTSD31-33. Additionally, neurochemicals identified after a stressor can serve as 
mechanistic biomarkers, and such biomarkers can be used to improve the treatment of 
stress-related psychopathologies. While attempts to identify biomarkers continue to be a 
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major focus of biomedical research, at present biomarkers have not made it into clinical 
application for mental illness. Part of the difficulty is that individual neurochemicals are 
unlikely to correlate with diagnosis, risk, or treatment response for complex forms of 
stress-related psychopathology. Taking a multifactorial approach is an essential first step 
toward developing biomarkers for mental illness. Metabolomics is a quantitative analysis 
of small molecules present in biological systems and has been increasingly used for the 
discovery of biomarkers34-36. The use of untargeted metabolomics allows the user to take 
a discovery-based approach, which initially results in a data generating experiment. After 
relative quantitation of known metabolites based on pre-determined retention times and 
accurate mass (< 5 ppm), the user is still left with thousands of unidentified spectral 
features (USFs) that potentially relate to a novel compound. 
 This study focused on characterizing the neurochemical profiles in select brain 
regions that distinguish animals that are susceptible and resistant to the effects of acute 
social defeat stress. In both mice and hamster models, we expected that susceptible and 
resistant animals would differentially express specific neurochemical metabolites in brain 
regions known to modulate defeat-induced changes in behavior. Further, a comparative 
approach is expected to aid in the discovery of biomarkers by identifying similar classes 
of compounds associated with stress susceptibility and resilience in both animal models.  
 
1.3 METHODS 
1.3.1 Animals and Housing Conditions 
Male C57BL/6 mice (7-8 weeks old, 20-27 g) were used as subjects (Envigo, 
Indianapolis, IN). Mice were maintained on a 12:12 light/dark cycle with ad libitum access 
to food and water in a temperature-controlled room (21 ± 2 °C). Animals were housed in 
polycarbonate cages (18.4 cm x 29.2 cm x 12.7 cm) with corncob bedding, cotton nesting 
materials, and wire mesh tops. All behavioral procedures were performed during the first 
three hours of the dark phase of their cycle. Subjects were handled several times one 
week prior to social defeat to habituate them to the stress of human handling. 
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Male Syrian hamsters (3-4 months old, 120-180 g) were obtained from our 
breeding colony that is derived from animals purchased from Charles River Laboratories 
(Wilmington, MA). All animals were housed in polycarbonate cages (12 cm × 27 cm × 16 
cm) with corncob bedding, cotton nesting materials, and wire mesh tops. Food and water 
were available ad libitum. Cages were not changed for one week prior to dominant–
subordinate encounters to allow individuals to scent mark their territory. Subjects were 
handled several times one week prior to dominant–subordinate encounters to habituate 
them to the stress of human handling. Animals were housed in a temperature-controlled 
colony room (21 ± 2 °C) and kept on a 14:10 h light:dark cycle to facilitate reproductive 
maturation. All behavioral protocols were performed during the first 3 h of the dark phase 
of their cycle. Procedures in both mice and hamsters were approved by the University of 
Tennessee Institutional Animal Care and Use Committee and are in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. 
1.3.2 Experimental Procedures 
Social Defeat Stress 
 Mice were subjected to acute social defeat stress using a resident-intruder model 
adapted from the social defeat literature in Syrian hamsters18, 37-38. During social defeat 
stress, subjects were exposed to adult male Hsd:ICR (CD1) mice that were individually 
housed to maintain aggression (35-40 g, Evigo). The CD1 mice were prescreened for 
high levels of aggression, and animals exhibited attack latencies of less than 30 sec. 
Social defeat stress consisted of three, 2-min aggressive encounters in the home cage of 
a novel CD1 resident aggressor mouse with 2-min inter-trial intervals in the subjects’ 
home cage, for a total duration of 10-min. These defeats were evaluated by an observer 
in real time to verify that each subject received multiple attacks from each CD1 mouse. 
An attack was defined as a rapid lunge followed by a bite or bite attempt. To correct for 
potential variation in the amount of aggression subjects received, the first defeat episode 
did not begin until the subject submitted to an attack from the resident aggressor. Non-
defeated control animals were exposed to the empty home cage of three separate CD1 
mice for 2-min with 2-min inter-trial intervals in their home cage.  
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In hamsters, social defeat stress consisted of subjects being placed in the home 
cages of three separate hamsters that were larger, older animals (>6 months, >190 g). 
These larger animals were called resident aggressors, and they were individually housed 
to maximize territorial aggression. Resident aggressors were also prescreened to ensure 
that they reliably attacked and defeated intruders. Subjects were exposed to three 
resident aggressors in consecutive 5-min aggressive encounters, with 5-min inter-trial 
intervals in their own home cage, for a total duration of 25-min.  Similarly to mice, the first 
defeat episode did not begin until the subject submitted to an attack from the resident 
aggressor. Subjects submitted immediately in the second and third defeat episodes. Non-
defeated control animals were placed in the empty home cages of three separate resident 
aggressors for three 5-min exposures to control for the novel environment and olfactory 
cues associated with social defeat stress. Social defeats were digitally recorded for 
behavioral analysis. The frequency of attacks by the resident aggressor was recorded 
and scored by a blind observer. Whether or not subjects fought back against the resident 
aggressor during the first social defeat episode was also recorded.  
In both mice and hamsters, aggressive encounters were carefully monitored for 
wounding and animals that received minor scratches were treated with an antiseptic 
solution. No animal received a wound that resulted in signs of pain or distress and none 
of the animals were removed from the study because of wounding. 
Social Interaction Testing 
Social interaction testing was performed in mice to identify animals that were 
susceptible and resistant to the effects of social defeat stress. Testing was performed in 
an open field arena (43.2 cm x 43.2 cm x 43.2 cm) under dim light conditions. Social 
interaction testing was modeled after conditioned defeat testing in Syrian hamsters18, 37, 
as well as social interaction testing following chronic social defeat in mice13. Social 
interaction testing consisted of two 5-min trials: CD1 mouse target absent and CD1 
mouse target present. During the target absent trial, subjects were habituated to an empty 
perforated plastic box that was positioned against one of the four walls. The target present 
trial occurred immediately following the target absent trial, and a novel CD1 mouse was 
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placed inside the perforated plastic box. The perforated box allowed for sensory 
information, but no physical contact. An observer blind to experimental conditions 
quantified the duration of time the subject spent in the interaction zone. The interaction 
zone was defined as a 3 cm area surrounding the plastic box. Considerable variation 
exists in behavioral responses to social defeat in C57 mice, and an interaction ratio has 
been used to categorize mice as either susceptible or resistant to social defeat9, 13. The 
interaction ratio is calculated as (Time investigating target present) / (Time investigating 
target absent). Defeated mice with interaction ratios of less than 1.0 are defined as 
susceptible and defeated mice with interaction ratios equal to or greater than 1.0 are 
defined as resistant to social defeat. 
Dominant-Subordinate Relationships  
Hamsters were not exposed to social interaction testing because it was not 
necessary to phenotype animals following social defeat stress. Rather, hamsters were 
given the opportunity to establish dominance relationships, and we have previously 
shown that over time dominant animals become resistant to social defeat stress whereas 
subordinates become susceptible29. To establish social status, subjects were weight-
matched into resident-intruder dyads and paired in daily social encounters for 14 days as 
described previously29. Subjects were randomly assigned as a resident or intruder, and 
all social encounters occurred in the resident’s home cage. Encounters were 10-min in 
duration prior to the establishment of dominance relationships, while all subsequent 
encounters were 5-min. Dominant and subordinate animals were identified by the 
direction of agonistic behavior within each dyad. If a dyad did not form a dominance 
relationship after 5 encounters, the animals were excluded from statistical analysis. 
Experimental Design 
 In Experiment 1, 62 mice were exposed to social defeat stress and 12 mice were 
non-defeated controls. Twenty-four hours later, mice received social interaction testing 
and were identified as susceptible (N = 51) or resistant (N = 11). Mice were tested until 
the resistant group reached sufficient statistical power, although brain tissue was 
collected from only the first 11 mice identified as susceptible. It is noteworthy that the 
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percentage of resistant mice observed in this study (about 18%) is less than what has 
been reported elsewhere in chronic social defeat models (about 30%)9.  To investigate 
defeat-induced changes in neurochemical activity, mice received a second bout of social 
defeat stress or empty cage exposure one week following their social interaction test. 
In Experiment 2, 30 hamsters were paired in daily dominant-subordinate 
encounters. Three dyads were excluded from analysis because they failed to establish a 
stable dominance relationship. Twenty-four hours after the final dominance encounter, 12 
dominants and 12 subordinates received social defeat stress. Fourteen control animals 
did not receive dominance encounters and were exposed to empty cages instead of social 
defeat. 
Tissue Collection  
Immediately following the final social defeat encounter, animals were sacrificed 
with isoflurane and rapidly decapitated. A brain matrix was used to generate 1 mm thick 
brain slices that were rapidly frozen on glass slides. Tissue punches (1 mm diameter) 
were collected bilaterally from regions containing the BLA/CeA, dorsal hippocampus 
(dHPC), NAc, and vmPFC. Tissue punches were flash frozen in liquid nitrogen and stored 
at -80 ºC until metabolite extraction. In some brain regions, tissue was not assayed 
because of inaccurate punches. In mice, 3 samples were lost from the BLA/CeA, 4 
samples were lost from the dHPC, 2 samples were lost from the vmPFC, and 1 sample 
was lost from the NAc. In hamsters, due to inaccurate punches, 2 samples were lost from 
the BLA/CeA, 8 samples were lost from the dHPC, 7 samples were lost from the vmPFC, 
and 6 samples were lost from the NAc. 
1.3.3 Untargeted Metabolomics using UPLC-HRMS 
Analysis by UPLC-HRMS was completed in accordance with previously published 
protocols39. Refer to appendix for additional details on the extraction protocol, 
chromatography specifications, and mass spectrometry (MS) parameters. The 
Metabolomic Analysis and Visualization Engine (MAVEN) software package, an open 
source program that reduces the complexity of metabolomics analysis, was used to select 
metabolites from a pre-existing list of over 270 compounds40. Henceforth, identified 
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metabolites are referred to as known metabolites, which were previously validated for 
exact mass and retention time using chemical standards from Fisher Scientific or 
preexisting chromatography39. MAVEN enables the user to directly extract all spectral 
features from a single sample. Any spectral feature that was not confirmed as a known 
metabolite will henceforth be referred to as an unidentified spectral feature (USF). 
Metabolite ion counts were normalized using the ratios of intensities among metabolites 
within a sample to remove errors due to sampling and instrumental variability using a 
modification of known methods41-42. This internal ratio normalization (IRN; additional 
information in appendix) technique provides normalized fold changes for the selected 
array comparisons, as well as p-values from complimentary univariate analysis 
techniques, one-way ANOVA with Tukey post-hocs and two-tailed Student’s t-tests. 
These fold changes were then used to generate heatmaps of known metabolites (for mice 
see Figure 1-1, for hamsters see Figure 1-2).  
Additionally, unnormalized ion intensities of known and unknown metabolites were 
also analyzed using partial least squares discriminant analyses (PLS-DA). PLS-DA is a 
statistical method, similar to principal components regression, which finds a linear 
regression model by projecting predicated variables and the observed variables into a 
new space. From these PLS-DA analyses, variable importance in projection (VIP) score 
plots can be extrapolated. The VIP score is a common feature selection tool that is a 
probability function calculated by totaling the weighted sum of squares of the loading 
vectors43, and this tool enables a matrix reduction of selected metabolites for further 
investigation. A metabolite with a VIP score greater than or equal to 1.0 was considered 
a variable that highly contributed to the observed separation within the PLS-DA plot. 
Further description of the extraction protocol, the UPLC-HRMS procedures, and the data 
processing methods can be found in the appendix. 
1.3.4 Statistical Analysis 
 Data were analyzed using one-way ANOVAs followed by Tukey’s post-hocs, 
Student’s t-tests, and chi-square tests, where appropriate. Statistical significance was set 
at α = 0.05. Data are reported as mean ± SEM, except where noted. Statistical reduction  
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Figure 1.1 Heatmap of all identified metabolites in mice from 4 brain regions 
Array comparisons are labeled at the top of the figure; R/C: resistant/ control, S/C: 
susceptible/ control, and R/S: resistant/ susceptible.  
Saturated colors are displayed on a log-2 scale. A Student’s T-test was used to produce 
the p-values using a two-tail comparison of the arrays. Values were converted to symbols 



























Figure 1.1 Continued  
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Figure 1.2 Heatmap of all identified metabolites in hamsters from 4 brain regions 
Array comparisons are labeled at the top of the figure; D/C: dominant/ control, S/C: 
subordinate/ control, and D/S: dominant/ subordinate.  
Saturated colors are displayed on a log 2 scale. A Student’s t-test was used to produce 
the p-values using a two-tail comparison of the arrays. Values were converted to symbols 



































Figure 1.2 Continued   
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of USFs was accomplished using Student’s t-tests (p ≤ 0.05) and VIP score (≥ 1.0), and 
individual metabolites of interest were confirmed to be significant through one-way 
ANOVA analysis and Tukey’s post hoc tests. 
 
1.4 RESULTS 
1.4.1 Behavioral Data 
 To characterize mice as susceptible or resistant to the effects of acute social defeat 
stress, mice were evaluated in a social interaction test. One-way ANOVA analysis 
revealed significant differences in interaction ratios between non-defeated controls, 
susceptible, and resistant mice (F(2, 30) = 31.11, p < 0.0001). Tukey’s post-hoc 
comparisons demonstrated that susceptible mice had a significantly lower social 
interaction ratio compared with resistant mice and controls (p < 0.001 and p < 0.001, 
respectively), whereas resistant mice and controls did not significantly differ in their social 
interaction ratios (p = 0.70) (Figure 1-3). A subset of the defeats were quantified, and 
there were no significant differences between susceptible (8.81 ± 0.74) and resistant 
(8.22 ± 0.40) mice in the number of attacks received per 2-min e (t = 0.38, df = 13, p = 
0.71). No mouse, resistant or susceptible, fought back against the resident aggressor 
during any of the defeat episodes, and all attacks occurred within the first 30-sec.  
In hamsters, the daily dyadic encounters were videotaped and monitored in real time to 
determine the direction of aggression. On average, dominance relationships were 
established on day 1.07 (SD = 0.26). Dominant animals continued to direct aggression 
towards the subordinate throughout the two-week period. Two pairs were excluded 
because they did not form a dominance relationship after 5 days of dyadic encounters, 
and one pair was excluded because of a switch in dominance status on day 6.  The 
number of attacks received during social defeat stress, as well as the duration of fighting 
back by subjects during the first defeat were scored by an observer blind to treatment 
conditions. There were no significant differences between dominant (5.94 ± 0.86) and 






Figure 1.3 Results of social interaction test for mice 
Mice were tested in a neutral arena for social avoidance 24 hours after their first social 
defeat experience. We segregated defeated mice into two populations, resistant and 
susceptible, based on their social interaction ratios. Mice with a social interaction ratio of 
1 or greater were characterized as resistant, while mice with a social interaction ration of 
less than 1 were characterized as susceptible. All non-defeated control mice always had 
a social interaction ration greater than 1. One-way ANOVA analysis revealed significant 
differences in interaction ratios between non-defeated controls, susceptible, and resistant 
mice (F(2, 30) = 31.11, p < 0.0001). Tukey’s post-hoc comparisons demonstrated that 
susceptible mice had a significantly lower social interaction ratio compared with resistant 
mice and controls (p < 0.001 and p < 0.001, respectively), whereas resistant mice and 
controls did not differ in their social interaction ratios (p = 0.70).  
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p = 0.37). Dominant hamsters (8/12) also fought back significantly more often than 
subordinates (0/12) (χ2 = 12.00, df = 1, p = 0.0005). 
1.4.2 Metabolomics Data 
PLS-DA Reveals Distinct Metabolic Profiles 
 Figures 1.4 and 1.5 represent the PLS-DA plots generated from the four select 
brain regions of both mice and hamsters, respectively. The shaded ellipses represent the 
95% confidence intervals for each treatment condition. Significant separation of 
metabolites was achieved for both mice and hamsters, which suggests that the 
phenotypes exhibit a significantly different metabolic pattern of known and unknown 
metabolites in each brain region. Furthermore, from the VIP scores derived from the PLS-
DA analyses, we extracted variables that differentiated susceptible and resistant mice or 
subordinate and dominant hamsters. Each brain region exhibited a unique set of relevant 
(VIP ≥ 1.0) metabolites (Mice; BLA/CeA: 29, dHPC: 25, vmPFC: 33, NAc: 33 and 
Hamster; BLA/CeA: 48, dHPC: 39, vmPFC: 29, NAc: 29). VIP score plots are available 
for both mice (Figure 1-6) and hamsters (Figure 1-7). 
Identifying Representative Known Metabolites 
 Representative metabolites were chosen based on the following parameters: p ≤ 
0.05 and VIP ≥ 1.0. For mice, one-way ANOVA analyses revealed several significant 
neurochemical metabolites that differentiated resistant and susceptible animals. In the 
dHPC, significant differences were observed in the relative abundance of GABA (F(2, 25 = 
4.360, p = 0.024); specifically, Tukey’s post hoc comparisons demonstrated that 
susceptible mice had elevated levels of GABA compared to resistant mice (Figure 1.8A; 
p = 0.018). In the NAc, significant differences were observed in the relative abundance of 
cystine (F(2, 30) = 9.050, p = 0.001), and resistant mice had significantly higher levels 
compared to subordinates (Figure 1.8B; p = 0.001). In the vmPFC, significant differences 
were seen in the relative abundance of IMP (inosinic acid) (F(2, 28 = 3.487, p = 0.044) and 
AMP (F(2, 28 = 3.334, p = 0.050). For both IMP and AMP, resistant mice had significantly 






Figure 1.4 Metabolite patterns of mice from untargeted metabolomic approach 
Qualitative profiling for control (yellow), resistant (red), and susceptible (blue) mice was 
conducted with PLS-DA. PLS component 1 (X-axis) and PLS component 2 (Y-axis) 
represent the highest two X-scores of dimensions 1 and 2 for matrix X of metabolite ion 
abundances, respectively. Ellipses express a 95% confidence interval. Plots exhibit 
significant separation and clustering of samples across all four brain regions. A) BLA/CeA, 






Figure 1.5 Metabolite patterns of hamsters from untargeted metabolomic approach 
Qualitative profiling for control (yellow), dominant (red), and subordinate 
(blue) hamsters was conducted with PLS-DA. PLS component 1 (X-axis) and PLS 
component 2 (Y-axis) represent the highest two X-scores of dimensions 1 and 2 for 
matrix X of metabolite ion abundances, respectively. Ellipses express a 95% confidence 
interval. Plots exhibit significant separation and clustering of samples across all four brain 






Figure 1.6 VIP score plot from metabolomics of mice 
VIP plots of identified metabolites in mice with a VIP score ≥ 1.0. Labels are provided to 
explain the total number of metabolites within three ranges; VIP ≥ 1.0, 1.0 < VIP ≥ 0.8, 
and VIP < 0.8. These plots are derived from PLS-DA multivariate analysis. A) BLA/CeA, 





Figure 1.7 VIP score plot from metabolomics of hamsters 
VIP plots of identified metabolites in hamsters with a VIP score ≥ 1.0. Labels are provided 
to explain the total number of metabolites within three ranges; VIP ≥ 1.0, 1.0 < VIP ≥ 0.8, 
and VIP < 0.8. These plots are derived from PLS-DA multivariate analysis. A) BLA/CeA, 
B) dHPC, C) NAc, D) vmPFC.  
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0.042, respectively). Surprisingly, no significant differences were observed in the 
BLA/CeA of mice. 
In hamsters, one-way ANOVA analyses also revealed changes in neurochemical 
metabolite expression. In the BLA/CeA, serine differed significantly across conditions (F(2, 
33 = 3.542, p = 0.040); specifically, dominants had significantly lower levels compared to 
controls (Figure 1.9A; p = 0.034). In the NAc of hamsters, a statistical trend was observed 
in the relative abundance of fumarate (F(2, 30 = 2.837, p = 0.074; VIP = 0.831), and 
dominant animals tended to have a higher expression compared to subordinates (Figure 
1.9B; p = 0.063). In the vmPFC, tyrosine differed significantly across animals (F(2, 30 = 
9.096, p = 0.001), and dominant hamsters had a higher relative abundance compared to 
controls and subordinates (Figure 1.9C; p = 0.001 and p = 0.018, respectively). Also in 
the vmPFC, significant differences were observed in the expression of methionine (F(2, 30 
= 8.017, p = 0.002), specifically, dominants had a higher relative abundance compared 
to controls and subordinates (Figure 1.9D; p = 0.001 and p = 0.023, respectively). 
However, in the dHPC, no significant differences were observed across conditions. 
Identifying Representative Unknown Metabolites  
The discovery of thousands of USFs reveals the true complexity of mammalian 
metabolism. In the BLA/CeA, dHPC, NAc, and vmPFC of hamsters, the total USFs 
identified were 6981, 5622, 9565, and 7420, respectively, and 2383, 2457, 1987, and 
2098 in mice (Table 1-1). Following statistical reduction of USFs, we identified a total of 
27, 28, 33, and 28 features in hamsters and 27, 27, 30, and 29 features in mice from the 
BLA/CeA, dHPC, NAc, and vmPFC, respectively. The compilation of USFs represents a 
list of unique parent masses not found in our list of known metabolites. 
Regarding unknown metabolites, only USFs that revealed significant changes 
between dominant and subordinate hamsters, or resistant and susceptible mice, were 
further investigated using the Human Metabolome Database (HMDB)44 to produce a list 
of potential compound matches. Significance was established through the following 






Figure 1.8 Effects of social defeat on the relative abundance of neurochemical 
metabolites in mice 
A) In the dHPC, susceptible mice had a greater relative abundance of GABA. B) In the 
NAc, resistant mice had significantly higher levels of cystine. C) In the vmPFC, resistant 
mice had higher levels of inosinic acid (IMP). D) Finally, also in the vmPFC, resistant mice 
had a greater relative abundance of AMP. Data are shown as mean ± SEM. An asterisk 
indicates a significant difference between groups as determined by a Tukey’s post hoc 







Figure 1.9 Effects of social defeat and dominance status on the relative abundance 
of neurochemical metabolites in hamsters 
A) In the BLA/CeA, dominant hamsters had significantly lower levels of serine compared 
to controls. B) In the NAc, dominant hamsters tended to have higher levels of fumarate. 
C) In the vmPFC, dominant hamsters had a greater relative abundance of tyrosine 
compared to controls and subordinates. D) Finally, also in the vmPFC, dominant 
hamsters had significantly higher levels of methionine compared to controls and 
subordinates. Data are shown as mean ± SEM. An asterisk indicates a significant 




Table 1.1 Total number of USFs 













USFs    
(Res v Ctrl) 
Significant* 
USFs          
(Sus v Ctrl) 
Significant* 
USFs          




BLA/CeA 2383 256 141 105 64 27 
dHPC 2457 165 35 24 132 28 
NAc  1987 586 301 63 471 33 













USFs          
(Res v Ctrl) 
Significant* 
USFs          
(Sus v Ctrl) 
Significant* 
USFs    




BLA/CeA 6981 281 147 72 111 27 
dHPC 5622 541 235 285 114 27 
NAc  9565 421 101 195 194 30 
vmPFC 7420 334 86 203 104 29 
 
*Significant features refer to p-value ≤ 0.05 (in a Student’s t-test), variable importance in 




(top 10%). Since each parent mass could exist as an adduct (i.e. [M+Na-H]), the number 
of matches were anywhere from 0 to 50. Compound matches were screened against 
existing literature to determine biologically relevant matches. 
The following features were selected from both mice and hamsters (Table 1-2). 
Two features from the BLA/CeA, m/z 279.0458 (F(2, 26 = 4.919, p = 0.015) and m/z 
297.0563 (F(2, 26 = 5.2, p = 0.013), were significantly reduced in resistant mice compared 
to controls (p = 0.036 and p = 0.043, respectively) and susceptible mice (p = 0.027 and p 
= 0.017, respectively). These features are believed to be the same compound but 
detected as separate adducts. In the NAc, the m/z 274.1045 feature (F(2, 30 = 242.613, p 
< 0.001) revealed a significant decrease in susceptible mice compared to controls (p < 
0.001) and resistant mice (p < 0.001), while resistant mice were also significantly 
increased compared to controls (p < 0.001). 
In the BLA/CeA of hamsters, the m/z 316.1012 feature (F(2, 33 = 11.073, p < 0.001) 
was significantly increased in subordinates compared to controls (p = 0.001) and 
dominants (p < 0.001). Also, in the BLA/CeA, the m/z 289.0903 feature (F(2, 33 = 3.434, p 
= 0.044) was significantly decreased in subordinates compared to dominants (p = 0.044). 
Two features; m/z 320.0619 (F(2, 29 = 3.163, p = 0.057) and m/z 342.0441 (F(2, 29 = 5.402, 
p = 0.010)  in the NAc were selected as potential adduct masses, which means that they 
are derived from the same compound. These features showed a decreased concentration 





Table 1.2 USFs selected for discussion 
Statistical reduction using Student’s t-tests identified several USFs with Human Metabolome Database (HMDB) matches 












dHPC No statistically and biologically active matches 
vmPFC No statistically and biologically active matches 







Brain Region USF parent mass (Da) Retention time (min) Adduct HMDB match 
BLA/CeA 
316.1012 11.6 [M+TFA-H] L-acetylcarnitine 
289.0903 11.6 [M+Na-2H] N-acetylcarnosine 
dHPC No statistically and biologically active matches 












Table 1.2 Continued 
 







df1 df2 F-test p-value Res/Ctrl Sus/Ctrl Res/Sus Res/Ctrl Sus/Ctrl Res/Sus 
BLA/CeA 
2 26 4.919 0.015 0.036 0.998 0.027 0.012 0.957 0.011 
2 26 5.200 0.013 0.043 0.945 0.017 0.127 0.385 0.013 
dHPC No statistically and biologically active matches 
vmPFC No statistically and biologically active matches 









df1 df2 F-test p-value Dom/Ctrl Sub/Ctrl Dom/Sub Dom/Ctrl Sub/Ctrl Dom/Sub 
BLA/CeA 
2 33 11.073 0.000 0.928 0.001 0.000 0.984 0.009 0.005 
2 33 3.434 0.044 0.814 0.155 0.044 0.353 0.170 0.079 
dHPC No statistically and biologically active matches 
vmPFC No statistically and biologically active matches 
NAc  
2 29 3.163 0.057 0.586 0.288 0.050 0.845 0.041 0.017 




1.5.1 The Characteristic Metabolome Associated with Social Defeat 
For the first time, UPLC-HRMS based metabolomics analyses were used to 
investigate the metabolic fluctuations associated with stress resistance. Metabolomics as 
a field is currently at its infancy. Complications arising from biological diversity and poor 
understanding of how to interpret results defines the current state of the field. There are 
thousands of metabolites within a biological system, not to mention that each metabolite 
can be involved within multiple metabolic pathways. These current issues present an 
opportunity to discover novel aspects of biological systems. An untargeted method was 
used for the current analysis, with the goal of identifying features that could lead to the 
discovery of a novel biomarker. Specifically, we used a comparative approach to identify 
similar metabolites that are associated with stress resistance in both models. The varying 
levels of global metabolites for both mice and hamsters were analyzed using PLS-DA, 
which resulted in significant clustering of subjects and separation of phenotypes. The 
separation of the phenotypes in the PLS-DA plots suggests that stress-induced metabolic 
fluctuations can reliably predict phenotypic responses to social defeat stress. Based on 
VIP scores and Tukey’s post hoc comparisons, significant fluctuations were found in 
amino acid and neurotransmitter metabolism that are associated with stress susceptibility 
and resistance in both mice and hamsters. 
Interestingly, both mice and hamsters that are susceptible and resistant to social 
defeat stress show changes in small molecules in the NAc that modulate oxidative stress. 
The relative abundance of the amino acid cystine was higher in resistant mice compared 
to susceptible mice. Cystine is a critical component of the cystine-glutamate exchange, 
also known as the system xc–. The uptake of cystine that results from a cystine-glutamate 
exchange is important for maintaining the levels of glutathione, a critical antioxidant45-46. 
Furthermore, system xc-dependent glutathione production modulates protection from 
oxidative stress47. Taken together, the upregulation of cystine in resistant mice may help 
protect them against defeat-induced social avoidance. In hamsters, the levels of fumarate 
tended to be higher in the NAc of dominants compared to subordinates. Fumarate is an 
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intermediate in the Krebs cycle used by cells to produce energy in the form of adenosine 
triphosphate (ATP). Not surprisingly, oxidative stress suppresses the Krebs cycle48. 
Esterification of the unsaturated dicarbonic acid, fumarate can be enzymatically catalyzed 
to form fumaric acid esters (FAEs), such as dimethyl fumarate that has been shown to 
exert neuroprotective effects against neuroinflammation via activation of the Nrf2 
antioxidant pathway49. Additionally, research has also shown that dimethyl fumarate 
protects cells from oxidative stress50. In addition to these molecules within the NAc that 
modulate oxidative stress, evidence of protection from oxidative stress was further 
observed in the vmPFC of dominant hamsters. To illustrate, methionine was elevated in 
dominants compared to both controls and subordinates. Methionine is an antioxidant that 
has been shown to reverse the effects of oxidative stress51-53. Overall, subjects resistant 
to acute social defeat had elevated levels of small molecules in the NAc and vmPFC 
following social defeat that protect against oxidative stress, such as cystine, fumarate, 
and methionine. 
This study also revealed significant defeat-induced changes in neurotransmitters 
and their precursors.  In the dHPC, susceptible mice had significantly higher levels of 
GABA compared to both resistant and control mice.  Stress exposure has been shown to 
increase GABA levels in the hippocampus. For instance, mild stressors such as novel 
cage exposure and more intense stressors such as forced swimming both increase 
hippocampal GABA levels54. Furthermore, microdialysis reveals increased extracellular 
levels of GABA in response to novelty stress in the vHPC55. In hamsters, we found that 
dominant animals had increased tyrosine concentrations in the vmPFC compared to 
subordinates. Tyrosine serves as a critical precursor to catecholamines and has 
antioxidant properties56-57. Rats given tyrosine before acute tail-shock displayed neither 
shock induced norepinephrine depletion nor the deficits in exploratory behaviors 
observed in saline-treated animals58. Similarly, pre-treatment with tyrosine not only 
prevented behavioral depression and norepinephrine depletion after acute restraint stress 
and intermittent tail-shock but also suppressed the rise in plasma corticosterone59.  
Additionally, we found that dominant hamsters had lower serine concentrations in 
the BLA/CeA compared to control hamsters. D-serine is an endogenous modulator of the 
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glycine site of NMDA receptors and functions to facilitate memory processes60-61. 
Systemic administration of D-serine has been shown to enhance both object recognition 
and T-maze performance62. While partial agonists at the glycine site on NMDA receptors 
have been proposed as cognitive enhancers to facilitate cognitive behavioral therapy63, 
systemic administration of D-serine induces oxidative stress in the rat brain64. One 
possibility is that dominant animals may have less endogenous serine to bind to the 
glycine site of the NMDA receptor in the BLA, which may also reduce the potential for 
oxidative stress.  
Finally, in the vmPFC of mice, changes were observed in molecules relate to 
cellular energy consumption. More specifically, resistant mice had significantly higher 
levels of IMP (inosinic acid) and AMP (adenosine monophosphate) in the vmPFC 
immediately following social defeat compared to susceptible mice. AMP is produced 
during adenosine triphosphate (ATP) synthesis, while IMP is generated via ATP 
degradation in two metabolic pathways in which AMP is generated and then degraded to 
either IMP or adenosine65. Taken together, these two molecules are indicative of 
increased cellular activity in the vmPFC of resistant mice. 
1.5.2 Unidentified Spectral Features Affected by Social Stress 
The current state of metabolomics research is focused on the structural elucidation 
of USFs from an untargeted experiment. Through this technology, the breadth of the 
metabolome can be revealed but there are many steps involved with confirmation of 
structure. This hypothesis driven experiment has produced thousands of USFs, which are 
potential metabolites that could better explain the entire metabolome of a subject. Here, 
we provided a high-throughput method for the characterization of USFs. In this 
experiment, the aim was to find a reduced list of metabolites that exhibited significant 
metabolic changes associated with social stress defeat and provide possible compound 
matches to be evaluated in future experiments. 
Preliminary annotation of USFs revealed a common trend in which several of the 
compounds were related to oxidative stress. In the NAc of mice, the 274.1945 m/z at 4.7 
min feature was matched to norophthalmic acid. This neurochemical was significantly 
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decreased in susceptible mice and increased in resistant mice. As a tripeptide analogue 
of glutathione, norophthalmic acid has been shown to be an intracellular antioxidant. It is 
known that disturbance of glutathione homeostasis either leads to or results from 
oxidative stress66-67. This was particularly interesting because cystine levels in NAc of 
mice were also elevated in resistant mice after social defeat. As a dimer of cysteine, 
fluctuations in concentrations of this compound have a direct effect on levels of 
glutathione. Because resistant mice show increased concentrations of both compounds, 
it suggests that susceptible mice respond to social defeat stress with fewer essential 
antioxidants which may reduce their coping ability. Also, in the BLA/CeA of hamsters, the 
289.0903 m/z at 11.6 mins feature corresponded to N-acetylcarnosine (NAC). This free-
radical scavenger is a natural N-acetylated dipeptide consisting of alanine and histidine. 
Carnosine derivatives have been shown to act as natural antioxidants with hydroxy 
radical, singlet oxygen scavenging and lipid peroxidase properties68. Although this 
compound hasn’t been associated with stress-related behavior, NAC treatment has been 
shown to reduce the effects of cataracts, which are caused by oxidative stress on the 
lens69. In the present study, NAC was increased in dominant hamsters, again suggesting 
a potential mechanism that protects against oxidative stress. 
In a separate correlation, two USF features from hamsters exhibited effects on the 
efficiency of mitochondrial activity. In mammalian cells, mitochondria have been shown 
to produce reactive oxygen species (ROSs) to reduce oxidative damage and contribute 
to redox signaling to the nucleus70. Acetyl-L-carnitine (ALC) has a known biological 
function of improving the efficiency of mitochondrial function by facilitating the movement 
of acetyl CoA into the matrices71. In our study, the amount of ALC (316.1012 m/z at 11.6 
min) was significantly increased in the BLA/CeA of subordinate hamsters. This 
observation reveals that the cellular mitochondrial activity is being up-regulated in 
subordinate hamsters after social defeat. Additionally, the NAc samples revealed a 
significant decrease of relative concentration in subordinate hamsters for a set of parent 
masses at 15 mins; 320.0619 m/z ([M-H]-) and 342.0441 m/z ([M+Na-2H]-). These 
features both correlated to beta-citryl-L-glutamic acid (BCG), which is a derivative of 
glutamate found in the developing brain of rats72. This metabolite has been shown to be 
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an iron carrier that is used to activate the enzyme aconitase73, which is used to enhance 
cell viability by accelerating mitochondrial activity. Alterations to normal mitochondrial 
function during stress can contribute to cell death through two mechanisms; change in 
production of ROSs and release of death regulatory and signaling molecules from the 
intermembrane space74-75. 
Finally, preliminary annotation of unknown metabolites indicates changes in small 
molecules associated with memory function. For example, in the BLA/CeA of mice, two 
features (m/z, 279.0458 ([M-H]-) and 297.0563 ([M-H2O-H]-)) at 11.5 minutes revealed 
the existence of the same compound, N-acetylserotonin sulfate (NAS). NAS is an 
intermediate in the endogenous production of melatonin from serotonin76, and has been 
shown to act as a classic antioxidant through hydrogen donation77. NAS has also been 
shown to improve cognition78 and increases BDNF levels79. Interestingly, NAS has been 
shown to directly activate the TrkB receptor80. TrkB, as the primary receptor for BDNF, is 
critical for learning and memory related plasticity81. One possibility is that increased NAS 
in susceptible mice is associated with a stronger memory of the defeat experience. This 
possibility is consistent with our previous finding that inhibition of the BDNF synthesis 
pathway in the BLA reduced defeat-induced social avoidance15. 
Some limitations of the present study should be acknowledged. While untargeted 
metabolomics provides opportunity for the discovery of novel biomarkers, large quantities 
of data are produced and an agreed upon high-throughput method for structure 
elucidation has not been validated. We have used statistical significance to reduce the 
number of USF considered for discussion, although additional tandem MS/MS analyses 
should be performed to definitively characterize novel metabolites. Additionally, this study 
is limited in that it only used male subjects, which is particularly concerning given that 
women are more likely to develop a stress-related mental illness82-83. Indeed, a sex bias 
exists in neuroscience research84, especially within the realm of social defeat models. 
One noteworthy exception can be seen in work with the California mouse (Peromyscus 
californicus), a monogamous species in which both males and females aggressively 
defend their home territories85. In this species, females are particularly susceptible to 
social defeat compared to males, and analyses of brain activity immediately following 
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social interaction testing suggested that cellular activity in the NAc may be related to 
social avoidance86. While these data suggest that the NAc may be ideally situated to study 
biomarkers in females, sex-differences in stress-induced social withdrawal in the 
California mouse are also associated with BDNF in the bed nucleus of the stria 
terminalus87. Overall, further research is needed to characterize the stress-induced 
neurochemical profiles of females.  
 
1.6 CONCLUSION 
 We found that 18% of C57 mice show resistance to social avoidance following an 
acute social defeat. Similarly, hamsters that have maintained dominant social status 
exhibit less defeat-induced social avoidance compared to subordinates. While an analysis 
of defeat-induced changes in metabolites within select brain regions indicates that the 
concentrations of many small molecules differ between susceptible and resistant animals, 
no single biomarker was observed in both species. However, both dominant hamsters 
and resistant mice show changes in neurochemicals within similar functional classes. 
Importantly, animals resistant to social defeat stress show an increased concentration of 
molecules to protect against oxidative stress in the NAc and vmPFC. Overall, a 
metabolomics approach to the study of stress resilience can identify functional groups of 
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1.8.1 Supplemental Methods and Materials 
Extraction Protocol 
Samples were transferred from a -80 °C freezer to a 5 °C cold room, where they were left 
to thaw for 20 minutes. The samples were then extracted using a modified acidic 
acetonitrile protocol88. To the tissue punches, 500 μL of extraction solvent (40:40:20 
acetonitrile/methanol/water containing 0.1 M formic acid) was added and the mixture was 
transferred to -20 °C for 20 minutes. The samples were then centrifuged for 5 minutes at 
13,000 rpm and the resulting supernatant was collected. Pellets were washed twice with 
100 μL aliquots of extraction solvent. The combined supernatants were then dried under 
nitrogen, followed by resuspension with 150 μL of Millipore water. 
UPLC-HRMS 
Analysis by UPLC-HRMS was completed using an ultimate 3000 LC pump coupled with 
an Exactive Plus Orbitrap MS (Thermo Fisher Scientific, Waltham, MA). All solvents were 
HPLC grade and purchased from Fisher Scientific (Atlanta, GA). The mobile phases, 
solvent A (97:3 water:methanol containing 10 mM tributylamine, and 15 mM acetic acid) 
and solvent B (methanol), were set to use a multi-step gradient as follows; 0 to 5 min, 0% 
B; 5 to 13 min, 20% B; 13 to 15.5 min, 55% B; 15.5 to 19 min, 95% B; and 19 to 25 min, 
0% B. With a flow rate of 200 μL/min, a 10 μL aliquot of sample was injected through a 
Synergi 2.5 μm Hydro-RP 100, 100 x 2.0 mm LC column (Phenomenex) maintained at 
25 °C. While running full scan in negative mode, the eluent was introduced to the MS by 
an electrospray ionization source39. Samples were analyzed with a resolving power of 
140,000 and a scan window of 72 to 800 m/z from 0 to 9 min, and 100 to 1,000 m/z from 
9 to 25 min. Samples were injected in a randomized order to reduce instrumental error. 
Data Processing 
Raw files generated by the Xcaliber software (Thermo Fisher Scientific) were converted 
to an open source format, mxML89, via the open source MSConvert software, which is 
part of the ProteoWizard package90. The converted files were then uploaded into the 
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Metabolomic Analysis and Visualization Engine (MAVEN) software, which automatically 
adjusts the total ion chromatograms based on retention times for each sample40. Using 
MAVEN40, metabolites were selected from a pre-existing list of 270 known compounds 
with annotated biological activity. All retention times were previously validated for exact 
mass and retention time using chemical standards from Fisher Scientific or preexisting 
chromatography39. Integration of the area under the curve provided each metabolite with 
a total ion count that can be considered the relative concentration of the metabolite within 
a single sample. 
Internal Ratio Normalization (IRN) 
By assuming that intensity ratios within a sample are consistent across all metabolites, 
an internal ratio can be used to normalize the data in an attempt to reduce instrumental 
and technical variability. This technique constructs a correlation type matrix for each 
sample, which is composed of the individual ratios across every metabolite within the 
sample. These generated matrices are then averaged among replicates, followed by 
comparison between treatments. Using the IRN R script (https://irn-
access:bu609campagna@gitlab.com/irn/irn.git), the data were normalized to produce 
fold change and p-values across experimental comparisons. These normalized values 
were used to produce the heatmap figures for known metabolites. The discussed IRN 
script is currently in submission for publication. 
Heatmaps 
The fold-change data, after IRN, were log 2 transformed and clustered by average linkage 
using Cluster software, version 3.0 (Eisen Lab, Berkeley, CA). This data was then 
displayed in a heatmap generated by Java Treeview  software91. Using a saturated color 
scale ranging from +3 (red) to -3 (blue), visual comparison of concentration changes can 
be observed. The two array comparisons are listed above each column on the heatmap. 
Each cell has been overlaid with a symbol representing a specific p-value range (≤ 0.01 
– “***”; ≤ 0.05 – “**”; ≤ 0.1 – “*”). 
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Partial least squares discriminant analysis (PLS-DA) 
Within the field of metabolomics, a widely accepted statistical tool used to confirm 
variation among variables is PLS-DA. As a two-dimensional, multivariate linear regression 
model, PLS-DA finds the direction of maximum covariance between a data set (X) and 
the class (Y)92. The original variables are compressed into fewer variables by using their 
weighted averages, referred to as scores. 
Following compilation of all spectral features detected (includes both identified and 
unidentified spectral features), the grouped data was loaded into RStudio93. To generate 
the PLS-DA data, the DiscriMiner package was utilized and specifically the PLS-DA 
function. All data were normalized by using an auto-scaling method that attempts to scale 
and center the data by dividing each value by the metabolites standard deviation. By 
extracting the PLS-DA scores values, the visualization aid was generated using the ggplot 
package with a 95% confidence interval. Variable importance projection (VIP) score plots 
were also generated from the plsDA function of DiscriMiner. These VIP plots only 
represent the identified spectral features to facilitate interpretation. 
Identification and Statistical Reduction of USFs 
The MAVEN software includes a peak picking algorithm that generates a list of all spectral 
features detected by the HRMS in a single sample. A user generated training model 
establishes a quality score for each peak, which enables the software to identify 
thousands of USFs from each sample. All peaks were confirmed manually to have a 
proper Gaussian curve, 3:1 signal-to-blank, and an ion count greater than 103. 
Next, the lists were reduced using Student’s t-tests for three separate array comparisons; 
resistant vs. control, susceptible vs. control, and resistant vs. susceptible for mice or 
dominant vs. control, subordinate vs. control, and dominant vs. subordinate for hamsters. 
Using this statistical tool dramatically reduces the overall number of identified metabolites, 
which are then manually investigated to remove any “known metabolites” that were 
previously identified, as well as any carbon-13 isomers. 
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Finally, the web-based statistical analysis tools of Metaboanalyst43 were used to focus on 
a small number of these USFs. Through cross comparison of the variable importance 
projection (VIP) score plots generated from the PLS-DA and the mean decrease in 
accuracy (MDA) plots from the random forest classification, a reduced list of ~30 
important USFs were extrapolated and used for additional investigation. By viewing Table 
1-1, the specific quantities of USFs after each step can be observed for each brain region. 
Statistical Analysis 
Data were analyzed using one-way ANOVAs followed by Tukey post-hocs and Student’s 
t-tests, where appropriate. Statistical significance was set at α = 0.05. Data are reported 
as mean ± SEM, except where noted. Statistical reduction of USFs was accomplished 
using Student’s t-tests (p ≤ 0.05) and VIP score (≥ 1.0) and metabolites selected for 
further discussion were confirmed to be significant through one-way ANOVA analysis and 
Tukey’s post hoc tests. 
 
1.8.2 Raw data files 




Table 1.3 Raw Data of Dominant Hamsters from BLA/CeA 
Sample Name H2 H3 H4 H5 H12 H19 H21 H25 H28 H33 H38 H47 
2-Aminoadipate 2.83E+04 3.80E+04 7.77E+04 4.72E+04 7.24E+04 7.44E+03 6.26E+03 6.53E+04 4.32E+04 6.97E+04 9.07E+04 6.60E+04 
2-Hydroxy-2-
methylsuccinate 2.15E+05 4.01E+05 8.34E+05 4.07E+05 7.14E+05 4.01E+05 3.59E+05 5.86E+05 2.58E+05 7.12E+05 8.64E+05 6.60E+05 
3-Methoxytyramine 9.51E+04 1.29E+05 1.15E+05 1.01E+05 1.12E+05 1.41E+05 1.45E+05 1.18E+05 1.32E+05 1.15E+05 1.26E+05 1.11E+05 
3_4-
Dihydroxyphenylacetate 8.78E+04 5.68E+04 6.02E+04 5.89E+04 9.65E+04 7.66E+04 8.87E+04 7.09E+04 1.23E+05 7.88E+04 1.99E+05 3.45E+04 
4-Aminobutyrate 6.48E+05 9.99E+05 8.53E+05 8.59E+05 1.56E+06 1.61E+06 1.64E+06 1.43E+06 1.75E+06 2.00E+06 1.82E+06 1.38E+06 
5-Hydroxyindoleacetic 
acid 4.49E+04 3.20E+04 3.98E+04 1.42E+04 7.29E+04 4.19E+04 4.33E+04 4.34E+04 6.85E+04 9.16E+04 4.21E+04 4.13E+04 
6-Phospho-D-gluconate 1.60E+05 1.74E+05 1.80E+05 1.72E+05 4.67E+03 7.70E+03 7.85E+03 1.17E+05 9.13E+03 3.49E+03 8.78E+04 1.08E+05 
Acadesine 2.99E+03 5.57E+03 9.27E+03 1.09E+04 9.53E+03 1.77E+04 1.64E+04 2.33E+04 1.49E+04 1.01E+04 2.29E+04 1.82E+04 
Aconitate 1.68E+04 1.80E+04 1.35E+04 4.62E+04 1.24E+03 1.27E+03 1.44E+03 1.52E+05 1.62E+03 3.51E+03 8.95E+03 1.10E+04 
Adenine 1.26E+05 3.52E+05 3.66E+04 1.10E+05 1.08E+05 2.15E+04 3.86E+04 1.47E+05 1.05E+05 6.58E+05 2.56E+05 2.49E+05 
Adenosine 2.38E+05 5.83E+05 5.12E+04 2.23E+05 1.76E+05 3.20E+04 6.65E+04 2.76E+05 1.78E+05 8.67E+05 4.63E+05 3.72E+05 
AICAR 1.87E+04 2.23E+04 3.46E+04 2.96E+04 6.86E+04 5.42E+04 4.87E+04 3.77E+04 5.14E+04 1.10E+05 9.13E+04 7.20E+04 
Alanine 1.09E+06 1.67E+06 2.77E+06 2.02E+06 2.69E+06 2.62E+06 2.44E+06 2.92E+06 2.33E+06 2.76E+06 2.95E+06 2.48E+06 
Allantoin 3.45E+03 5.95E+03 9.66E+03 1.57E+04 1.17E+04 6.78E+03 2.13E+04 3.83E+03 7.75E+03 1.12E+04 8.99E+03 7.26E+03 
alpha-Ketoglutarate 7.92E+03 2.88E+04 1.56E+04 2.56E+04 1.32E+04 8.81E+03 8.75E+03 1.76E+04 7.93E+03 1.44E+04 2.42E+04 2.87E+04 
AMP 2.03E+06 2.52E+06 3.70E+06 3.44E+06 3.67E+06 2.77E+06 2.14E+06 3.25E+06 2.68E+06 2.21E+06 3.33E+06 4.27E+06 
Arginine 2.75E+03 2.66E+03 4.35E+03 6.53E+03 1.80E+04 8.12E+03 1.64E+04 1.44E+04 1.63E+04 2.23E+04 1.62E+04 6.36E+03 
Ascorbate 7.39E+06 1.53E+07 2.28E+07 1.94E+07 2.18E+07 8.61E+05 5.63E+06 2.43E+07 1.50E+07 2.38E+07 4.31E+07 3.96E+07 
Asparagine 1.21E+05 9.83E+04 1.00E+05 1.22E+05 1.60E+05 1.43E+05 1.11E+05 1.63E+05 1.54E+05 1.85E+05 1.63E+05 1.70E+05 
Aspartate 4.67E+06 6.22E+06 8.70E+06 9.01E+06 1.04E+07 7.67E+06 6.18E+06 1.07E+07 9.18E+06 1.02E+07 1.07E+07 8.97E+06 
Atrolactic acid 5.94E+04 4.51E+04 8.15E+04 5.25E+04 2.04E+05 1.06E+05 1.97E+05 4.42E+04 1.48E+05 2.82E+04 5.56E+04 4.55E+04 
cAMP 3.46E+04 3.63E+04 3.39E+04 2.77E+04 2.26E+04 2.60E+04 3.06E+04 3.54E+04 1.85E+04 1.95E+04 3.14E+04 3.99E+04 
CDP-ethanolamine 1.00E+05 1.16E+05 1.17E+05 1.14E+05 1.87E+05 8.83E+04 1.11E+05 1.28E+05 1.53E+05 1.71E+05 1.60E+05 1.45E+05 
Citrate/isocitrate 2.26E+04 2.23E+04 3.04E+04 4.47E+04 3.28E+03 7.64E+03 1.06E+04 8.58E+04 7.34E+03 1.58E+04 5.12E+04 9.33E+04 
Citrulline 4.10E+04 4.11E+04 6.30E+04 3.45E+04 1.21E+05 1.34E+05 9.25E+04 8.61E+04 9.72E+04 1.41E+05 1.20E+05 1.21E+05 
CMP 1.94E+04 3.06E+04 6.65E+04 3.43E+04 7.05E+04 3.18E+04 4.58E+04 3.91E+04 4.33E+04 3.37E+04 5.00E+04 4.59E+04 
Creatine 1.30E+06 1.61E+06 3.90E+06 2.44E+06 3.41E+06 3.52E+06 3.20E+06 4.28E+06 2.96E+06 3.74E+06 3.50E+06 3.48E+06 
Creatinine 1.67E+04 1.64E+04 3.58E+04 1.59E+04 2.72E+04 3.20E+04 2.01E+04 4.42E+04 2.59E+04 3.59E+04 3.67E+04 3.03E+04 
Cystathionine 6.98E+04 5.65E+04 1.55E+05 8.88E+04 2.03E+05 1.96E+05 1.75E+05 1.18E+05 1.63E+05 2.47E+05 1.89E+05 2.00E+05 
Cysteine 1.59E+04 4.14E+04 6.78E+04 4.00E+04 1.77E+05 3.77E+04 4.37E+04 8.28E+04 2.27E+05 1.47E+05 1.23E+05 9.88E+04 
Cystine 1.45E+03 4.92E+03 8.69E+03 4.61E+03 2.23E+04 3.35E+05 3.67E+05 4.82E+03 2.94E+04 4.81E+04 3.92E+03 7.50E+03 
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Table 1.3 Continued 
Sample Name H2 H3 H4 H5 H12 H19 H21 H25 H28 H33 H38 H47 
Cytidine 4.26E+04 5.68E+04 6.44E+04 9.74E+04 1.32E+05 1.21E+05 8.80E+04 1.47E+05 7.31E+04 1.34E+05 1.21E+05 1.02E+05 
D-Gluconate 2.13E+05 8.35E+04 1.28E+05 1.51E+05 1.17E+05 1.44E+05 1.18E+05 1.86E+05 8.31E+04 1.42E+05 1.00E+05 1.07E+05 
D-Glyceraldehdye 3-
phosphate 1.74E+05 3.79E+05 2.96E+05 3.17E+05 3.16E+05 3.69E+05 1.46E+05 4.59E+05 2.21E+05 1.09E+05 2.14E+05 4.39E+05 
Diiodothyronine 1.48E+05 1.48E+05 2.89E+05 3.08E+05 7.92E+05 6.14E+05 8.05E+05 2.97E+05 5.80E+05 1.02E+06 8.33E+05 9.21E+05 
Dimethylglycine 6.48E+05 9.99E+05 8.53E+05 8.59E+05 1.56E+06 1.61E+06 1.64E+06 1.43E+06 1.75E+06 2.00E+06 1.82E+06 1.38E+06 
Fumarate 1.07E+05 2.98E+05 4.14E+05 2.92E+05 8.11E+05 3.91E+05 3.46E+05 4.30E+05 5.77E+05 7.55E+05 3.95E+05 4.11E+05 
Glucose 1-phosphate 1.60E+05 1.92E+05 8.57E+04 1.39E+05 2.35E+05 2.14E+05 2.92E+05 2.57E+05 2.71E+05 3.61E+05 2.70E+05 2.41E+05 
Glucose 6-phosphate 2.78E+05 1.46E+05 1.09E+05 1.31E+05 1.63E+05 1.90E+05 1.68E+05 1.40E+05 1.55E+05 1.19E+05 1.85E+05 4.55E+05 
Glutamate 7.71E+07 9.21E+07 1.07E+08 1.19E+08 1.06E+08 3.13E+07 3.37E+07 1.21E+08 8.42E+07 1.10E+08 1.31E+08 1.16E+08 
Glutamine 1.96E+07 2.33E+07 2.32E+07 2.25E+07 3.89E+07 3.54E+07 3.56E+07 2.80E+07 3.20E+07 4.22E+07 3.46E+07 3.88E+07 
Glutathione 8.93E+06 1.35E+07 1.59E+07 1.36E+07 1.39E+07 6.43E+06 7.60E+06 1.53E+07 1.17E+07 1.10E+07 1.94E+07 1.82E+07 
Glutathione disulfide 1.13E+05 8.14E+04 4.27E+04 6.84E+04 2.72E+05 1.97E+05 2.41E+05 9.70E+04 2.30E+05 8.73E+05 8.58E+04 9.24E+04 
Glycerate 3.57E+05 1.08E+05 1.23E+05 1.75E+05 6.78E+04 2.12E+05 1.56E+05 8.01E+05 9.18E+04 8.66E+04 9.98E+04 1.28E+05 
Glycerone phosphate 1.74E+05 3.79E+05 2.96E+05 3.17E+05 3.16E+05 3.69E+05 1.46E+05 4.59E+05 2.21E+05 1.09E+05 2.14E+05 4.39E+05 
GMP 1.31E+05 1.99E+05 2.30E+05 2.33E+05 4.58E+05 3.61E+05 4.16E+05 3.14E+05 3.37E+05 3.73E+05 3.09E+05 3.34E+05 
Guanine 5.83E+03 5.55E+03 1.06E+04 8.05E+03 9.53E+03 1.29E+04 1.06E+04 8.40E+03 1.10E+04 1.62E+04 1.13E+04 1.72E+04 
Guanosine 2.70E+05 4.93E+05 1.26E+05 1.28E+05 4.66E+05 2.31E+05 3.33E+05 3.83E+05 6.79E+05 1.14E+06 5.33E+05 3.30E+05 
Histidine 7.29E+03 5.73E+03 1.29E+04 8.74E+03 3.03E+04 2.61E+04 3.55E+04 8.19E+03 2.93E+04 5.52E+04 2.23E+04 2.35E+04 
Homocysteic acid 1.64E+04 2.56E+04 2.39E+04 1.33E+04 2.29E+04 6.36E+02 6.23E+03 2.35E+04 2.06E+04 2.10E+04 2.39E+04 1.51E+04 
Homoserine 4.27E+05 6.29E+05 6.85E+05 7.64E+05 7.45E+05 1.04E+06 8.91E+05 1.03E+06 1.02E+06 1.13E+06 8.88E+05 1.16E+06 
Homovanillic acid 8.18E+04 7.50E+04 7.80E+04 9.84E+04 8.92E+04 3.76E+04 3.27E+04 8.47E+04 7.56E+04 1.04E+05 1.04E+05 8.62E+04 
Hydroxybenzoate 5.70E+04 2.71E+04 7.98E+04 2.45E+04 2.28E+04 2.35E+04 2.34E+04 2.09E+04 2.69E+04 1.17E+04 1.60E+04 9.24E+03 
Hydroxyisocaproic acid 2.82E+05 2.53E+05 2.85E+05 2.86E+05 2.07E+05 1.50E+05 1.81E+05 4.63E+05 1.69E+05 9.94E+04 4.34E+05 4.62E+05 
Hydroxyphenylpyruvate 4.82E+04 4.84E+04 4.07E+04 4.86E+04 4.46E+04 3.89E+04 9.67E+04 4.65E+04 4.28E+04 5.11E+04 4.57E+04 5.19E+04 
Hypoxanthine 5.52E+05 5.46E+05 6.52E+05 2.44E+05 1.71E+06 1.40E+06 1.18E+06 1.08E+06 1.62E+06 1.70E+06 9.73E+05 9.23E+05 
IMP 1.34E+05 1.13E+05 1.68E+05 1.43E+05 5.77E+05 3.18E+05 4.49E+05 3.20E+05 4.37E+05 4.44E+05 3.10E+05 1.78E+05 
Indole-3-carboxylate 4.25E+03 2.32E+03 4.11E+03 2.34E+03 2.61E+03 3.20E+03 2.05E+03 2.67E+04 1.73E+03 4.16E+03 5.31E+03 1.83E+03 
Inosine 2.67E+06 2.18E+06 2.31E+06 1.39E+06 4.81E+06 4.59E+06 5.53E+06 3.36E+06 5.56E+06 6.45E+06 4.06E+06 2.93E+06 
Lactate 5.79E+07 6.38E+07 8.31E+07 6.99E+07 9.54E+07 2.45E+07 2.17E+07 8.24E+07 7.15E+07 9.03E+07 9.28E+07 1.00E+08 
Leucine/Isoleucine 1.95E+05 3.10E+05 5.08E+05 3.51E+05 5.42E+05 5.69E+05 8.20E+05 5.80E+05 5.25E+05 6.17E+05 5.25E+05 6.38E+05 
Malate 8.27E+05 1.21E+06 1.47E+06 1.19E+06 4.50E+04 3.97E+04 3.71E+04 1.04E+06 2.68E+04 3.19E+04 1.00E+06 1.07E+06 
Mandelate 7.08E+05 6.53E+05 7.45E+05 5.79E+05 3.31E+05 2.34E+05 2.13E+05 7.26E+05 3.60E+05 1.46E+05 3.35E+05 4.81E+05 
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Table 1.3 Continued 
Sample Name H2 H3 H4 H5 H12 H19 H21 H25 H28 H33 H38 H47 
Methionine 4.61E+05 3.85E+05 5.97E+05 6.15E+05 7.32E+05 7.02E+05 6.28E+05 7.37E+05 6.70E+05 9.01E+05 9.24E+05 8.00E+05 
Methionine sulfoxide 2.48E+05 1.66E+05 2.69E+05 2.59E+05 9.19E+04 7.29E+04 8.04E+04 3.53E+05 8.88E+04 7.34E+04 9.20E+04 1.45E+05 
Methylmalonate 6.69E+06 1.30E+07 1.31E+07 1.51E+07 2.44E+06 1.60E+06 1.59E+06 1.27E+07 2.16E+06 2.60E+06 1.61E+07 1.61E+07 
myo-Inositol 6.51E+05 6.12E+05 7.91E+05 6.51E+05 8.53E+05 6.76E+04 5.66E+04 8.19E+05 7.51E+05 8.52E+05 1.02E+06 7.93E+05 
N-Acetyl-beta-alanine 1.93E+04 2.24E+04 2.72E+04 2.13E+04 2.73E+04 1.95E+04 1.63E+04 3.59E+04 2.69E+04 3.33E+04 3.10E+04 3.65E+04 
N-Acetylglucosamine 4.35E+03 3.11E+03 4.38E+03 2.82E+03 3.93E+03 1.18E+03 5.04E+03 7.07E+03 1.91E+03 7.44E+03 5.90E+03 7.98E+03 
N-Acetylglucosamine 
1/6-phosphate 5.63E+03 5.94E+03 8.90E+03 5.83E+03 1.26E+04 1.05E+04 4.85E+03 8.83E+03 8.28E+03 1.27E+04 9.04E+03 1.52E+04 
N-Acetylglutamate 4.15E+05 5.01E+05 6.78E+05 5.39E+05 5.65E+05 5.04E+05 3.72E+05 6.98E+05 5.68E+05 7.77E+05 8.40E+05 8.02E+05 
N-Acetylglutamine 1.52E+05 2.23E+05 2.91E+05 3.43E+05 4.52E+05 2.36E+05 2.17E+05 3.82E+05 2.60E+05 4.95E+05 4.52E+05 5.43E+05 
N-Acetylornithine 5.70E+03 8.67E+03 9.76E+03 6.62E+03 1.01E+04 7.98E+03 1.22E+04 1.34E+04 8.69E+03 1.98E+04 1.81E+04 1.25E+04 
N-Carbamoyl-L-
aspartate 2.31E+05 2.92E+05 3.46E+05 2.10E+05 4.04E+05 2.63E+05 2.53E+05 3.26E+05 2.02E+05 1.31E+05 3.71E+05 3.16E+05 
NAD+ 5.46E+04 1.41E+05 7.50E+04 1.87E+05 8.56E+03 3.21E+04 4.36E+04 1.30E+05 5.61E+03 1.04E+04 1.58E+05 1.83E+05 
Nicotinate 4.35E+04 7.27E+03 6.10E+03 7.80E+03 2.67E+03 7.33E+03 5.78E+03 3.11E+03 1.11E+04 3.81E+03 5.31E+03 4.67E+03 
Orotate 4.51E+04 5.91E+04 4.70E+04 4.33E+04 5.62E+04 4.19E+04 3.46E+04 6.02E+04 4.60E+04 8.82E+04 1.13E+05 9.59E+04 
Pantothenate 1.66E+06 2.07E+06 2.06E+06 1.92E+06 2.53E+06 2.52E+06 3.04E+06 2.94E+06 2.03E+06 2.52E+06 2.84E+06 2.63E+06 
Phenylalanine 2.22E+05 1.89E+05 2.23E+05 2.54E+05 2.54E+05 4.69E+05 5.26E+05 2.62E+05 2.79E+05 3.61E+05 2.37E+05 2.89E+05 
Phenylpyruvate 6.22E+03 2.79E+04 1.11E+04 4.60E+04 2.67E+03 1.00E+02 1.00E+02 2.29E+04 2.56E+03 2.74E+03 1.02E+05 8.24E+04 
Phosphorylcholine 4.55E+04 5.26E+04 4.65E+04 4.74E+04 4.66E+05 1.18E+05 5.33E+04 2.49E+05 8.77E+04 5.74E+04 4.60E+05 1.75E+05 
Prephenate 9.51E+04 1.08E+05 1.14E+05 9.21E+04 9.36E+05 5.57E+05 5.37E+05 1.01E+05 8.45E+05 9.06E+05 1.59E+05 1.64E+05 
Proline 1.12E+05 1.21E+05 1.79E+05 1.30E+05 1.92E+05 1.74E+05 2.14E+05 2.03E+05 1.56E+05 2.57E+05 1.65E+05 2.13E+05 
Pyroglutamic acid 2.04E+06 1.82E+06 1.59E+06 1.87E+06 2.88E+06 1.15E+06 1.46E+06 2.46E+06 3.00E+06 3.74E+06 1.75E+06 2.52E+06 
Pyruvate 1.15E+06 1.34E+06 1.56E+06 1.47E+06 1.13E+06 1.22E+06 1.06E+06 8.30E+05 1.25E+06 1.45E+06 7.50E+05 1.05E+06 
Ribose phosphate 1.29E+05 1.22E+05 1.08E+05 6.16E+04 4.84E+05 1.80E+05 2.23E+05 2.15E+05 4.05E+05 5.21E+05 2.65E+05 1.80E+05 
S-Adenosyl-L-
homocysteine 2.07E+03 1.14E+03 4.30E+03 7.23E+02 3.04E+03 4.76E+03 4.70E+03 3.46E+03 8.85E+03 6.51E+03 4.19E+03 3.13E+03 
Sarcosine 1.09E+06 1.67E+06 2.77E+06 2.02E+06 2.69E+06 2.62E+06 2.44E+06 2.92E+06 2.33E+06 2.76E+06 2.95E+06 2.48E+06 
Sedoheptulose 1/7-
phosphate 1.95E+04 1.55E+04 1.60E+04 1.09E+04 1.17E+04 4.97E+03 4.68E+03 2.46E+04 2.62E+04 6.13E+03 2.29E+04 2.69E+04 
Serine 1.48E+06 1.96E+06 2.59E+06 2.46E+06 3.42E+06 3.27E+06 3.28E+06 3.43E+06 2.72E+06 4.07E+06 3.36E+06 3.45E+06 
sn-Glycerol 3-
phosphate 1.12E+05 1.42E+05 4.89E+04 1.49E+05 3.14E+04 7.33E+04 3.57E+04 1.17E+05 2.00E+04 3.29E+04 7.63E+04 7.40E+04 
Succinate 6.69E+06 1.30E+07 1.31E+07 1.51E+07 2.44E+06 1.60E+06 1.59E+06 1.27E+07 2.16E+06 2.60E+06 1.61E+07 1.61E+07 
Sulfolactate 1.46E+04 1.93E+04 1.28E+04 3.71E+04 2.46E+03 1.96E+03 2.39E+03 1.18E+05 2.23E+03 2.29E+03 2.65E+03 1.38E+04 
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Table 1.3 Continued 
Sample Name H2 H3 H4 H5 H12 H19 H21 H25 H28 H33 H38 H47 
Taurine 1.78E+07 2.00E+07 2.20E+07 2.25E+07 2.92E+07 2.13E+07 3.04E+07 2.52E+07 2.72E+07 2.94E+07 3.35E+07 3.33E+07 
Threonine 4.27E+05 6.29E+05 6.85E+05 7.64E+05 7.45E+05 1.04E+06 8.91E+05 1.03E+06 1.02E+06 1.13E+06 8.88E+05 1.16E+06 
Thymidine 3.42E+03 2.48E+03 4.64E+03 4.57E+03 5.46E+03 1.00E+02 1.00E+02 3.68E+03 2.57E+03 9.90E+03 6.88E+03 8.69E+03 
Trehalose/sucrose 9.91E+04 7.43E+04 7.47E+04 2.12E+05 4.53E+04 7.22E+04 6.26E+04 3.80E+04 3.43E+04 4.77E+04 2.27E+04 5.56E+04 
Tryptophan 2.19E+05 2.94E+05 3.71E+05 3.46E+05 4.40E+05 2.20E+05 2.41E+05 4.11E+05 2.63E+05 3.96E+05 4.06E+05 5.33E+05 
Tyrosine 1.02E+06 1.43E+06 1.75E+06 2.00E+06 1.76E+06 1.27E+06 1.42E+06 1.82E+06 1.50E+06 2.20E+06 1.88E+06 2.24E+06 
UDP-glucose 2.15E+05 2.23E+05 3.71E+05 3.36E+05 5.98E+05 3.59E+05 7.08E+05 3.98E+05 5.34E+05 5.17E+05 4.71E+05 3.58E+05 
UDP-N-
acetylglucosamine 2.22E+05 2.18E+05 3.22E+05 3.37E+05 5.29E+05 3.71E+05 4.88E+05 4.02E+05 5.07E+05 5.36E+05 4.10E+05 3.57E+05 
UMP 2.37E+05 3.40E+05 4.73E+05 4.19E+05 5.44E+05 3.09E+05 3.06E+05 5.07E+05 3.47E+05 4.20E+05 6.48E+05 5.91E+05 
Uracil 8.50E+04 9.47E+04 1.11E+05 5.48E+04 4.70E+05 5.44E+05 4.78E+05 5.12E+05 4.67E+05 6.22E+05 3.22E+05 2.51E+05 
Uric acid 1.26E+05 8.92E+04 1.32E+05 1.32E+05 8.04E+04 4.55E+04 9.07E+04 5.56E+04 3.87E+04 7.18E+04 6.85E+04 8.35E+04 
Uridine 3.88E+04 3.51E+04 4.67E+04 4.43E+04 6.31E+04 4.88E+04 5.54E+04 5.61E+04 6.29E+04 7.63E+04 6.22E+04 6.04E+04 
Valine 4.08E+05 5.10E+05 6.20E+05 6.00E+05 7.29E+05 5.57E+05 7.61E+05 8.38E+05 6.93E+05 8.01E+05 7.75E+05 8.91E+05 
Xanthine 1.48E+03 4.10E+03 4.38E+03 2.97E+03 1.01E+04 2.56E+03 1.07E+04 4.23E+03 1.59E+03 1.43E+03 6.69E+03 2.94E+03 





Table 1.4 Raw Data of Handled Control Hamsters from BLA 
Sample Name H1 H10 H11 H18 H26 H31 H32 H34 H43 H44 H49 H53 
2-Aminoadipate 2.75E+04 4.90E+04 2.87E+04 4.42E+04 3.83E+04 1.37E+04 2.34E+04 6.01E+04 1.69E+03 4.39E+04 5.63E+04 5.31E+04 
2-Hydroxy-2-methylsuccinate 1.42E+05 2.87E+05 1.71E+05 2.60E+05 6.65E+05 2.91E+05 3.12E+05 4.40E+05 1.08E+05 3.51E+05 6.62E+05 4.51E+05 
3-Methoxytyramine 8.94E+04 8.65E+04 9.49E+04 1.36E+05 1.14E+05 1.18E+05 1.24E+05 1.32E+05 1.34E+05 1.18E+05 1.27E+05 1.18E+05 
3_4-Dihydroxyphenylacetate 6.24E+04 4.35E+04 3.83E+04 5.44E+04 1.10E+05 1.17E+05 1.32E+05 1.20E+05 1.05E+05 5.28E+04 6.14E+04 4.98E+04 
4-Aminobutyrate 1.09E+06 9.78E+05 1.18E+06 8.43E+05 1.27E+06 1.81E+06 2.15E+06 1.81E+06 1.48E+06 1.18E+06 1.23E+06 1.26E+06 
5-Hydroxyindoleacetic acid 2.49E+04 1.68E+04 2.21E+04 2.05E+04 4.98E+04 6.40E+04 6.91E+04 1.01E+05 3.56E+04 1.39E+04 1.52E+04 2.84E+04 
6-Phospho-D-gluconate 7.09E+04 1.20E+05 1.30E+05 1.93E+05 1.89E+05 5.39E+03 1.41E+04 1.06E+04 7.64E+03 1.18E+05 1.46E+05 7.94E+04 
Acadesine 9.61E+03 1.72E+04 2.41E+04 7.74E+03 1.57E+04 1.28E+04 1.99E+04 1.13E+04 1.74E+04 1.54E+04 2.04E+04 2.88E+04 
Aconitate 5.74E+03 8.70E+03 1.54E+04 4.33E+04 3.57E+04 1.31E+03 1.41E+03 2.62E+03 1.43E+03 1.17E+04 1.65E+04 6.48E+03 
Adenine 2.37E+05 1.70E+05 1.47E+05 1.51E+05 2.09E+05 1.18E+05 4.96E+05 4.78E+05 6.99E+04 1.01E+05 1.36E+05 9.15E+04 
Adenosine 4.52E+05 3.31E+05 2.85E+05 2.73E+05 4.25E+05 2.01E+05 7.10E+05 7.83E+05 1.04E+05 1.95E+05 2.92E+05 1.61E+05 
AICAR 6.14E+04 5.24E+04 5.24E+04 1.82E+04 4.65E+04 6.61E+04 6.33E+04 8.45E+04 3.71E+04 7.67E+04 7.98E+04 6.90E+04 
Alanine 2.10E+06 2.40E+06 2.23E+06 1.90E+06 2.31E+06 2.47E+06 2.50E+06 3.25E+06 2.07E+06 2.70E+06 2.73E+06 3.27E+06 
Allantoin 7.79E+03 1.98E+03 4.00E+03 3.93E+03 1.18E+04 1.36E+04 8.43E+03 7.02E+03 8.05E+03 6.22E+03 5.34E+03 5.88E+03 
alpha-Ketoglutarate 1.90E+04 2.22E+04 2.26E+04 1.97E+04 2.71E+04 8.76E+03 1.51E+04 6.72E+03 7.46E+03 2.08E+04 1.52E+04 1.87E+04 
AMP 3.86E+06 3.01E+06 2.79E+06 2.45E+06 2.66E+06 2.24E+06 1.97E+06 1.81E+06 6.79E+05 4.55E+06 5.52E+06 3.90E+06 
Arginine 4.20E+03 5.16E+03 1.17E+04 8.68E+03 2.19E+04 1.99E+04 1.72E+04 1.62E+04 9.32E+03 5.44E+03 1.39E+04 8.69E+03 
Ascorbate 1.69E+07 2.51E+07 2.62E+07 1.81E+07 2.56E+07 1.32E+07 6.96E+06 2.95E+07 2.61E+06 2.84E+07 3.05E+07 2.88E+07 
Asparagine 1.86E+05 1.56E+05 1.07E+05 8.48E+04 1.38E+05 1.92E+05 2.02E+05 2.08E+05 9.46E+04 1.80E+05 1.37E+05 1.36E+05 
Aspartate 6.69E+06 9.06E+06 9.41E+06 6.81E+06 1.25E+07 1.03E+07 1.06E+07 1.07E+07 5.04E+06 1.02E+07 1.01E+07 8.48E+06 
Atrolactic acid 4.88E+04 5.89E+04 5.17E+04 6.40E+04 5.37E+04 8.08E+04 4.92E+04 1.07E+05 4.21E+04 5.44E+04 8.23E+04 8.02E+04 
cAMP 4.06E+04 3.77E+04 3.59E+04 2.46E+04 2.90E+04 2.56E+04 2.23E+04 2.07E+04 1.28E+04 5.38E+04 6.29E+04 3.35E+04 
CDP-ethanolamine 1.19E+05 1.29E+05 9.61E+04 1.07E+05 1.23E+05 1.63E+05 1.80E+05 1.82E+05 6.36E+04 1.21E+05 1.38E+05 1.25E+05 
Citrate/isocitrate 5.92E+03 5.27E+04 5.36E+04 7.85E+04 6.88E+04 1.36E+04 1.31E+04 2.93E+04 1.14E+04 8.04E+04 7.68E+04 7.07E+04 
Citrulline 7.27E+04 6.56E+04 8.38E+04 8.01E+04 7.52E+04 1.33E+05 1.68E+05 1.24E+05 9.35E+04 6.04E+04 1.00E+05 6.36E+04 
CMP 3.54E+04 3.75E+04 3.62E+04 2.96E+04 3.31E+04 4.39E+04 3.53E+04 5.47E+04 2.15E+04 5.45E+04 5.21E+04 3.68E+04 
Creatine 2.63E+06 3.44E+06 2.92E+06 2.66E+06 3.03E+06 3.06E+06 3.18E+06 4.42E+06 2.96E+06 3.73E+06 3.45E+06 4.24E+06 
Creatinine 2.51E+04 2.57E+04 2.91E+04 2.32E+04 3.19E+04 3.21E+04 3.79E+04 4.40E+04 2.57E+04 3.33E+04 3.87E+04 2.96E+04 
Cystathionine 1.21E+05 1.46E+05 1.30E+05 7.27E+04 1.07E+05 1.87E+05 1.88E+05 2.84E+05 1.28E+05 1.83E+05 2.06E+05 3.11E+05 
Cysteine 2.52E+04 4.61E+04 8.55E+04 4.13E+04 8.65E+04 1.10E+05 3.62E+04 3.01E+05 9.75E+03 2.71E+04 3.94E+04 6.08E+04 
Cystine 3.02E+03 2.53E+03 2.06E+03 7.98E+03 5.54E+04 7.44E+04 6.29E+04 6.21E+04 2.08E+05 5.66E+03 2.85E+03 3.65E+03 
Cytidine 7.43E+04 1.33E+05 8.82E+04 7.25E+04 1.29E+05 7.51E+04 9.57E+04 1.24E+05 7.09E+04 1.15E+05 1.11E+05 1.46E+05 
D-Gluconate 1.12E+05 7.14E+04 7.47E+04 1.28E+05 2.17E+05 2.70E+05 1.95E+05 1.40E+05 1.08E+05 8.37E+04 1.12E+05 1.53E+05 




Table 1.4 Continued 
Sample Name H1 H10 H11 H18 H26 H31 H32 H34 H43 H44 H49 H53 
Diiodothyronine 5.87E+05 6.96E+05 7.23E+05 2.19E+05 5.94E+05 1.04E+06 9.99E+05 1.10E+06 4.61E+05 6.72E+05 7.10E+05 5.60E+05 
Dimethylglycine 1.09E+06 9.78E+05 1.18E+06 8.43E+05 1.27E+06 1.81E+06 2.15E+06 1.81E+06 1.48E+06 1.18E+06 1.23E+06 1.26E+06 
Fumarate 1.75E+05 2.00E+05 1.78E+05 1.98E+05 3.03E+05 6.93E+05 8.73E+05 9.35E+05 1.33E+05 2.84E+05 3.10E+05 2.71E+05 
Glucose 1-phosphate 1.62E+05 1.73E+05 1.78E+05 1.55E+05 2.03E+05 3.93E+05 4.53E+05 4.92E+05 1.75E+05 1.43E+05 2.42E+05 1.62E+05 
Glucose 6-phosphate 2.11E+05 9.35E+04 8.23E+04 7.83E+04 1.14E+05 1.15E+05 9.59E+04 1.53E+05 6.89E+04 1.97E+05 3.12E+05 1.43E+05 
Glutamate 9.90E+07 1.13E+08 9.78E+07 9.41E+07 1.25E+08 9.64E+07 1.06E+08 1.15E+08 2.04E+07 1.10E+08 1.17E+08 1.17E+08 
Glutamine 3.87E+07 3.06E+07 2.98E+07 2.39E+07 3.54E+07 4.17E+07 5.01E+07 5.09E+07 2.65E+07 3.37E+07 3.27E+07 3.46E+07 
Glutathione 1.20E+07 1.64E+07 1.48E+07 1.40E+07 1.65E+07 1.21E+07 8.36E+06 1.45E+07 4.77E+06 1.74E+07 1.74E+07 1.59E+07 
Glutathione disulfide 1.53E+05 1.76E+05 8.41E+04 9.12E+04 1.27E+05 9.90E+05 1.68E+06 6.63E+05 4.69E+05 9.88E+04 1.60E+05 7.25E+04 
Glycerate 9.79E+04 9.55E+04 1.38E+05 2.83E+05 3.88E+05 9.16E+04 7.68E+04 9.70E+04 1.60E+05 9.68E+04 1.08E+06 1.58E+05 
Glycerone phosphate 4.41E+05 2.18E+05 1.98E+05 1.97E+05 2.14E+05 1.08E+05 1.65E+05 1.53E+05 9.56E+04 4.23E+05 5.82E+05 3.85E+05 
GMP 2.45E+05 2.18E+05 1.85E+05 2.40E+05 2.79E+05 4.43E+05 4.23E+05 4.33E+05 1.65E+05 2.44E+05 2.89E+05 2.46E+05 
Guanine 7.67E+03 1.10E+04 6.74E+03 6.55E+03 1.04E+04 1.20E+04 7.15E+03 1.38E+04 4.86E+03 1.22E+04 1.35E+04 1.45E+04 
Guanosine 2.86E+05 2.47E+05 2.30E+05 1.95E+05 4.20E+05 4.82E+05 1.08E+06 1.27E+06 3.29E+05 8.65E+04 1.77E+05 1.32E+05 
Histidine 1.80E+04 1.05E+04 2.04E+04 8.84E+03 2.37E+04 2.67E+04 1.83E+04 3.17E+04 1.13E+04 1.12E+04 2.34E+04 1.76E+04 
Homocysteic acid 2.62E+04 2.39E+04 1.97E+04 1.60E+04 1.93E+04 1.90E+04 7.46E+03 2.20E+04 2.60E+03 2.55E+04 2.43E+04 2.63E+04 
Homoserine 8.89E+05 7.29E+05 8.88E+05 6.19E+05 9.87E+05 1.12E+06 1.44E+06 1.26E+06 8.10E+05 9.63E+05 1.08E+06 1.11E+06 
Homovanillic acid 1.06E+05 8.05E+04 7.94E+04 9.13E+04 9.83E+04 7.23E+04 7.81E+04 9.01E+04 4.11E+04 1.07E+05 9.41E+04 9.73E+04 
Hydroxybenzoate 2.27E+04 1.89E+04 1.84E+04 3.55E+04 2.93E+04 1.82E+04 2.34E+04 2.27E+04 1.55E+04 1.86E+04 2.50E+04 2.23E+04 
Hydroxyisocaproic acid 2.81E+05 2.90E+05 3.89E+05 3.64E+05 4.66E+05 1.73E+05 1.58E+05 1.57E+05 9.75E+04 4.16E+05 1.96E+05 2.87E+05 
Hydroxyphenylpyruvate 3.75E+04 4.88E+04 5.04E+04 4.19E+04 5.14E+04 4.35E+04 4.62E+04 4.57E+04 4.27E+04 4.94E+04 3.78E+04 4.90E+04 
Hypoxanthine 2.81E+05 6.03E+05 4.96E+05 5.00E+05 2.03E+06 1.96E+06 2.18E+06 2.26E+06 9.27E+05 2.31E+05 9.72E+05 5.33E+05 
IMP 1.90E+05 2.99E+05 3.37E+05 3.03E+05 5.79E+05 6.14E+05 4.26E+05 5.67E+05 1.47E+05 1.76E+05 2.01E+05 2.81E+05 
Indole-3-carboxylate 2.59E+03 2.70E+03 2.72E+03 6.25E+03 5.36E+03 3.37E+03 4.54E+03 2.05E+03 2.15E+03 4.36E+03 5.03E+03 2.61E+03 
Inosine 1.76E+06 2.31E+06 1.94E+06 2.13E+06 3.15E+06 5.64E+06 6.36E+06 8.06E+06 4.26E+06 8.81E+05 1.16E+06 1.72E+06 
Lactate 7.10E+07 7.15E+07 6.64E+07 7.03E+07 8.44E+07 6.18E+07 9.12E+07 8.27E+07 1.86E+07 6.22E+07 7.38E+07 6.86E+07 
Leucine/Isoleucine 5.03E+05 5.04E+05 5.74E+05 4.36E+05 7.91E+05 7.09E+05 9.29E+05 6.77E+05 3.86E+05 5.00E+05 8.70E+05 6.39E+05 
Malate 5.95E+05 7.69E+05 6.30E+05 8.95E+05 1.18E+06 3.39E+04 4.10E+04 2.94E+04 2.64E+04 7.28E+05 7.86E+05 5.02E+05 
Malate 3.38E+06 5.22E+06 4.76E+06 4.70E+06 7.25E+06 6.43E+06 7.82E+06 7.52E+06 3.26E+06 5.38E+06 6.24E+06 5.21E+06 
Mandelate 6.53E+05 2.92E+05 3.56E+05 6.69E+05 3.95E+05 2.43E+05 2.74E+05 2.61E+05 2.30E+05 4.00E+05 4.33E+05 6.64E+05 
Methionine 5.01E+05 6.83E+05 6.25E+05 5.52E+05 7.66E+05 5.89E+05 6.51E+05 1.00E+06 4.21E+05 6.73E+05 7.19E+05 6.82E+05 
Methionine sulfoxide 9.99E+04 1.66E+05 1.57E+05 2.24E+05 1.50E+05 6.47E+04 5.19E+04 1.03E+05 1.17E+05 1.46E+05 1.06E+05 1.07E+05 
Methylmalonate 1.44E+07 1.25E+07 1.11E+07 1.06E+07 1.23E+07 3.33E+06 3.47E+06 3.44E+06 2.37E+06 1.77E+07 2.44E+07 1.94E+07 
myo-Inositol 7.23E+05 7.48E+05 7.34E+05 6.75E+05 8.69E+05 1.34E+05 8.74E+05 7.23E+05 4.11E+04 8.66E+05 7.84E+05 7.83E+05 
N-Acetyl-beta-alanine 2.16E+04 2.12E+04 2.63E+04 1.58E+04 3.45E+04 2.23E+04 2.63E+04 3.36E+04 1.22E+04 1.89E+04 4.96E+04 3.50E+04 
N-Acetylglucosamine 2.58E+03 6.07E+03 5.61E+03 2.67E+03 3.57E+03 7.52E+03 2.06E+03 7.73E+03 9.08E+02 5.76E+03 9.64E+03 5.48E+03 
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Table 1.4 Continued 
Sample Name H1 H10 H11 H18 H26 H31 H32 H34 H43 H44 H49 H53 
N-Acetylglucosamine 1/6-
phosphate 6.62E+03 6.79E+03 3.77E+03 5.01E+03 3.93E+03 1.33E+04 1.79E+04 1.71E+04 3.31E+03 5.73E+03 7.57E+03 3.93E+03 
N-Acetylglutamate 3.93E+05 5.60E+05 6.13E+05 4.73E+05 6.47E+05 6.58E+05 7.38E+05 7.65E+05 2.80E+05 5.56E+05 8.53E+05 5.53E+05 
N-Acetylglutamine 3.06E+05 2.83E+05 2.30E+05 3.42E+05 4.07E+05 4.67E+05 5.80E+05 5.89E+05 1.69E+05 3.55E+05 4.98E+05 4.90E+05 
N-Acetylornithine 1.38E+04 8.35E+03 1.42E+04 5.61E+03 1.36E+04 1.21E+04 1.43E+04 1.51E+04 1.06E+04 1.47E+04 1.28E+04 1.45E+04 
N-Carbamoyl-L-aspartate 2.79E+05 3.22E+05 3.96E+05 2.04E+05 3.66E+05 4.08E+05 3.60E+05 4.20E+05 2.72E+05 3.36E+05 3.67E+05 2.91E+05 
NAD+ 1.69E+05 1.60E+05 2.42E+05 1.40E+05 1.35E+05 2.22E+04 8.13E+03 1.04E+04 1.27E+04 2.85E+05 3.31E+05 1.68E+05 
Nicotinate 6.27E+03 7.20E+03 5.46E+03 4.89E+03 1.04E+04 3.74E+03 7.50E+03 5.16E+03 6.97E+03 4.68E+03 1.06E+04 9.70E+03 
Orotate 4.81E+04 7.87E+04 6.76E+04 5.31E+04 1.31E+05 1.11E+05 8.51E+04 1.23E+05 4.33E+04 6.36E+04 7.79E+04 5.47E+04 
Pantothenate 2.34E+06 2.63E+06 2.24E+06 2.29E+06 2.90E+06 2.99E+06 2.90E+06 3.05E+06 2.42E+06 2.37E+06 3.01E+06 2.34E+06 
Phenylalanine 2.15E+05 2.42E+05 2.60E+05 2.24E+05 3.96E+05 5.45E+05 3.26E+05 3.22E+05 4.26E+05 2.21E+05 4.35E+05 2.65E+05 
Phenylpyruvate 2.34E+04 3.74E+04 7.33E+04 5.76E+04 1.00E+02 1.78E+03 2.57E+03 2.75E+03 1.91E+03 5.47E+04 1.53E+04 2.02E+04 
Phosphorylcholine 5.05E+04 8.71E+04 1.11E+05 9.87E+04 1.08E+05 5.66E+04 8.87E+04 6.33E+04 7.63E+04 5.08E+04 6.15E+04 5.23E+04 
Prephenate 1.61E+05 1.20E+05 1.16E+05 1.03E+05 1.31E+05 7.96E+05 8.33E+05 8.66E+05 5.45E+05 1.42E+05 1.32E+05 2.11E+05 
Proline 1.17E+05 1.36E+05 1.36E+05 1.17E+05 1.91E+05 2.05E+05 2.11E+05 2.73E+05 1.26E+05 1.65E+05 1.97E+05 1.97E+05 
Pyroglutamic acid 2.77E+06 2.39E+06 2.67E+06 1.80E+06 5.56E+06 3.33E+06 5.11E+06 4.28E+06 1.05E+06 1.81E+06 4.23E+06 3.39E+06 
Pyruvate 1.47E+06 9.11E+05 8.57E+05 8.66E+05 1.73E+06 2.24E+06 2.13E+06 2.11E+06 7.88E+05 7.94E+05 9.91E+05 1.31E+06 
Ribose phosphate 8.68E+04 1.11E+05 8.94E+04 1.18E+05 1.95E+05 3.38E+05 6.12E+05 6.50E+05 1.57E+05 4.82E+04 6.57E+04 1.07E+05 
S-Adenosyl-L-homocysteine 1.00E+02 4.19E+03 7.18E+03 7.84E+03 6.16E+03 1.01E+04 3.69E+03 8.67E+03 4.13E+03 2.76E+03 1.17E+03 4.12E+03 
Sarcosine 2.10E+06 2.40E+06 2.23E+06 1.90E+06 2.31E+06 2.47E+06 2.50E+06 3.25E+06 2.07E+06 2.70E+06 2.73E+06 3.27E+06 
Sedoheptulose 1/7-phosphate 1.69E+04 1.35E+04 6.80E+03 1.42E+04 1.33E+04 1.99E+03 3.61E+03 7.00E+03 2.67E+03 5.97E+03 1.27E+04 1.44E+04 
Serine 2.72E+06 3.60E+06 3.03E+06 2.38E+06 3.84E+06 3.88E+06 4.04E+06 4.04E+06 2.97E+06 3.36E+06 3.72E+06 4.10E+06 
sn-Glycerol 3-phosphate 1.82E+05 8.94E+04 1.15E+05 1.19E+05 1.12E+05 2.43E+04 2.97E+04 3.02E+04 1.61E+04 2.50E+05 9.75E+05 8.94E+04 
Succinate 1.44E+07 1.25E+07 1.11E+07 1.06E+07 1.23E+07 3.33E+06 3.47E+06 3.44E+06 2.37E+06 1.77E+07 2.44E+07 1.94E+07 
Sulfolactate 2.26E+03 7.23E+03 2.37E+04 4.98E+04 3.30E+04 1.84E+03 2.88E+03 2.81E+03 2.33E+03 2.48E+03 4.76E+03 2.22E+03 
Taurine 2.41E+07 3.16E+07 3.34E+07 2.32E+07 3.16E+07 3.82E+07 3.43E+07 3.77E+07 2.44E+07 2.99E+07 3.40E+07 2.57E+07 
Threonine 8.89E+05 7.29E+05 8.88E+05 6.19E+05 9.87E+05 1.12E+06 1.44E+06 1.26E+06 8.10E+05 9.63E+05 1.08E+06 1.11E+06 
Thymidine 4.53E+03 7.57E+03 1.24E+03 3.39E+03 7.70E+03 3.48E+03 7.04E+03 1.10E+04 1.00E+02 3.15E+03 6.98E+03 4.22E+03 
Trehalose/sucrose 9.91E+04 4.80E+04 6.19E+04 4.02E+04 1.08E+05 5.77E+04 8.48E+04 3.91E+04 6.89E+04 3.02E+04 3.82E+04 6.79E+04 
Tryptophan 2.94E+05 3.73E+05 2.98E+05 3.23E+05 5.15E+05 3.59E+05 3.83E+05 4.43E+05 1.47E+05 3.10E+05 5.64E+05 3.00E+05 
Tyrosine 1.52E+06 1.84E+06 1.55E+06 1.38E+06 2.02E+06 1.76E+06 1.90E+06 1.99E+06 1.28E+06 1.72E+06 2.27E+06 2.00E+06 
UDP-glucose 3.05E+05 3.33E+05 3.12E+05 3.65E+05 4.23E+05 7.69E+05 6.96E+05 1.00E+06 4.79E+05 3.33E+05 3.90E+05 3.74E+05 
UDP-N-acetylglucosamine 2.80E+05 2.71E+05 2.74E+05 3.19E+05 4.09E+05 8.13E+05 8.07E+05 1.00E+06 4.60E+05 3.08E+05 3.80E+05 3.45E+05 
UMP 3.66E+05 4.76E+05 3.86E+05 4.67E+05 5.36E+05 4.13E+05 3.45E+05 4.49E+05 1.49E+05 6.10E+05 6.85E+05 5.13E+05 
Uracil 7.46E+04 2.37E+05 2.35E+05 2.35E+05 4.55E+05 5.22E+05 8.23E+05 7.05E+05 3.51E+05 3.66E+04 4.06E+05 2.07E+05 
Uric acid 1.56E+05 7.75E+04 8.28E+04 5.32E+04 2.51E+05 1.37E+05 9.80E+04 8.66E+04 3.40E+04 3.18E+04 9.07E+04 5.43E+04 
Uridine 3.67E+04 5.52E+04 5.40E+04 4.56E+04 6.26E+04 7.54E+04 6.39E+04 7.63E+04 4.07E+04 6.17E+04 6.43E+04 5.98E+04 
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Table 1.4 Continued 
Sample Name H1 H10 H11 H18 H26 H31 H32 H34 H43 H44 H49 H53 
Uridine 6.41E+05 6.01E+05 5.02E+05 5.80E+05 7.26E+05 1.21E+06 1.10E+06 1.19E+06 4.09E+05 4.32E+05 6.47E+05 5.49E+05 
Valine 6.68E+05 6.58E+05 7.37E+05 5.58E+05 1.10E+06 8.57E+05 8.30E+05 9.35E+05 4.05E+05 8.30E+05 1.06E+06 8.43E+05 
Xanthine 2.25E+03 1.73E+03 3.21E+03 3.61E+03 3.87E+03 7.21E+03 1.47E+03 2.46E+03 2.11E+03 2.29E+03 1.16E+03 6.48E+03 
Xanthine 2.65E+05 4.19E+05 4.06E+05 2.22E+05 1.08E+06 7.13E+05 8.79E+05 1.05E+06 4.61E+05 2.77E+05 8.37E+05 2.05E+05 
Xanthosine 3.40E+03 3.18E+03 2.13E+03 4.12E+03 8.69E+03 9.05E+03 1.45E+04 1.17E+04 1.66E+03 3.29E+03 7.34E+03 2.02E+03 
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Table 1.5 Raw Data of Subordinate Hamsters from BLA 
Sample Name H6 H7 H8 H9 H14 H15 H17 H23 H24 H35 H36 H41 
2-Aminoadipate 6.46E+04 6.86E+04 5.45E+04 3.98E+04 3.62E+04 4.26E+03 5.75E+03 4.81E+04 3.56E+04 6.69E+03 3.81E+04 4.93E+04 
2-Hydroxy-2-
methylsuccinate 1.05E+06 4.90E+05 3.08E+05 2.75E+05 5.88E+05 1.87E+05 3.58E+05 4.46E+05 5.05E+05 1.82E+05 3.77E+05 5.91E+05 
3-Methoxytyramine 1.19E+05 1.03E+05 1.04E+05 1.10E+05 1.40E+05 1.12E+05 1.17E+05 1.31E+05 1.30E+05 1.37E+05 1.26E+05 1.43E+05 
3_4-
Dihydroxyphenylacetate 2.42E+05 5.65E+04 5.45E+04 5.77E+04 1.18E+05 8.05E+04 7.17E+04 4.20E+04 4.75E+04 1.12E+05 6.46E+04 1.14E+05 
4-Aminobutyrate 1.16E+06 1.05E+06 1.12E+06 1.61E+06 1.65E+06 1.72E+06 2.23E+06 1.33E+06 1.40E+06 1.80E+06 5.64E+05 1.75E+06 
5-Hydroxyindoleacetic 
acid 4.28E+04 4.42E+04 5.59E+04 5.32E+04 6.32E+04 4.65E+04 9.08E+04 4.23E+04 3.59E+04 5.02E+04 2.93E+04 7.96E+04 
6-Phospho-D-gluconate 1.25E+05 1.71E+05 1.74E+05 1.30E+05 7.51E+03 5.73E+03 2.67E+03 1.71E+05 8.63E+04 2.93E+03 1.65E+05 2.76E+03 
Acadesine 2.74E+04 2.25E+04 1.11E+04 2.57E+04 1.12E+04 1.69E+04 1.57E+04 1.72E+04 2.30E+04 2.44E+04 1.88E+04 1.09E+04 
Aconitate 1.09E+06 2.78E+04 1.56E+04 9.17E+03 1.69E+03 1.00E+02 1.38E+03 1.38E+04 6.91E+03 1.73E+03 2.08E+04 1.41E+03 
Adenine 1.34E+05 8.50E+04 3.28E+05 9.07E+04 3.54E+05 3.01E+04 4.48E+04 3.17E+05 2.53E+05 5.06E+04 2.85E+05 1.53E+05 
Adenosine 2.87E+05 1.90E+05 5.87E+05 1.87E+05 5.90E+05 4.37E+04 7.09E+04 5.35E+05 4.44E+05 8.74E+04 4.22E+05 2.60E+05 
AICAR 4.53E+04 4.48E+04 5.58E+04 5.89E+04 5.13E+04 5.44E+04 6.94E+04 6.34E+04 6.93E+04 4.13E+04 2.30E+04 6.66E+04 
Alanine 2.89E+06 2.88E+06 2.39E+06 2.85E+06 2.81E+06 2.29E+06 2.49E+06 2.46E+06 2.44E+06 1.93E+06 2.08E+06 2.62E+06 
Allantoin 6.35E+03 3.99E+03 5.25E+03 5.61E+03 5.83E+03 8.07E+03 9.64E+03 5.02E+03 8.78E+03 7.68E+03 5.04E+03 7.09E+03 
alpha-Ketoglutarate 2.33E+04 2.43E+04 1.62E+04 1.62E+04 1.49E+04 9.87E+03 1.27E+04 1.45E+04 1.55E+04 8.43E+03 2.19E+04 1.01E+04 
AMP 3.95E+06 3.27E+06 2.91E+06 3.31E+06 2.11E+06 1.34E+06 3.41E+06 2.54E+06 3.09E+06 1.49E+06 2.17E+06 2.93E+06 
Arginine 7.51E+03 3.46E+03 4.07E+03 1.69E+04 1.51E+04 1.04E+04 3.07E+04 1.25E+04 1.06E+04 1.10E+04 8.78E+03 6.97E+03 
Ascorbate 3.14E+07 2.53E+07 2.69E+07 2.74E+07 2.91E+07 4.61E+06 6.68E+06 3.08E+07 2.63E+07 2.46E+06 1.74E+07 5.72E+06 
Asparagine 1.89E+05 8.95E+04 1.75E+05 2.07E+05 1.73E+05 1.07E+05 2.48E+05 1.46E+05 1.75E+05 1.37E+05 1.09E+05 1.61E+05 
Aspartate 9.97E+06 8.94E+06 1.03E+07 1.07E+07 8.76E+06 5.95E+06 6.86E+06 9.07E+06 8.30E+06 5.88E+06 7.06E+06 8.70E+06 
Atrolactic acid 7.90E+03 3.86E+04 6.66E+04 4.78E+04 8.90E+04 7.89E+04 5.92E+04 4.24E+04 6.89E+04 5.45E+04 3.19E+04 3.53E+04 
cAMP 3.14E+04 2.97E+04 4.07E+04 3.83E+04 2.55E+04 1.15E+04 2.23E+04 1.78E+04 3.08E+04 1.44E+04 3.25E+04 1.77E+04 
CDP-ethanolamine 1.33E+05 1.20E+05 1.71E+05 1.39E+05 1.95E+05 7.22E+04 7.97E+04 1.48E+05 1.43E+05 7.26E+04 1.23E+05 1.56E+05 
Citrate/isocitrate 6.96E+04 3.93E+04 5.09E+04 3.55E+04 5.32E+03 6.26E+03 3.92E+03 6.67E+04 6.06E+04 1.22E+04 8.61E+04 1.04E+04 
Citrulline 9.37E+04 6.86E+04 7.17E+04 8.33E+04 1.16E+05 1.25E+05 1.40E+05 1.03E+05 8.81E+04 1.01E+05 7.68E+04 1.50E+05 
CMP 4.34E+04 4.28E+04 3.90E+04 4.18E+04 5.41E+04 2.50E+04 3.74E+04 3.89E+04 4.20E+04 2.95E+04 3.39E+04 5.02E+04 
Creatine 3.43E+06 3.87E+06 3.03E+06 4.00E+06 3.56E+06 3.00E+06 3.26E+06 3.24E+06 3.14E+06 2.40E+06 2.74E+06 3.18E+06 
Creatinine 3.34E+04 4.25E+04 2.76E+04 3.51E+04 3.80E+04 2.69E+04 3.47E+04 2.51E+04 2.74E+04 2.48E+04 2.45E+04 3.26E+04 
Cystathionine 1.26E+05 1.13E+05 1.39E+05 1.47E+05 2.47E+05 1.68E+05 2.56E+05 1.23E+05 1.75E+05 1.46E+05 7.48E+04 1.69E+05 
Cysteine 8.34E+04 6.04E+04 9.62E+04 8.05E+04 3.26E+05 1.72E+04 2.10E+04 6.36E+04 7.05E+04 1.78E+04 5.39E+04 3.24E+03 
Cystine 3.30E+03 2.94E+03 5.78E+03 5.15E+03 3.84E+03 3.28E+05 5.15E+05 2.53E+03 3.14E+03 1.84E+05 1.46E+04 4.89E+04 
Cytidine 2.94E+05 6.34E+04 1.05E+05 9.31E+04 1.07E+05 1.18E+05 1.34E+05 1.01E+05 1.12E+05 1.51E+05 7.83E+04 1.49E+05 
D-Gluconate 3.97E+05 1.28E+05 7.82E+04 2.58E+05 9.78E+04 2.42E+05 1.48E+05 1.25E+05 8.92E+04 1.40E+05 1.26E+05 1.31E+05 
D-Glyceraldehdye 3-
phosphate 2.84E+05 3.95E+05 2.98E+05 3.24E+05 1.53E+05 2.32E+05 1.41E+05 2.36E+05 3.22E+05 2.64E+05 2.08E+05 4.87E+05 
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Sample Name H6 H7 H8 H9 H14 H15 H17 H23 H24 H35 H36 H41 
Diiodothyronine 6.82E+05 1.92E+05 4.56E+05 5.26E+05 9.25E+05 6.86E+05 1.12E+06 5.53E+05 6.27E+05 6.30E+05 2.11E+05 9.28E+05 
Dimethylglycine 1.16E+06 1.05E+06 1.12E+06 1.61E+06 1.65E+06 1.72E+06 2.23E+06 1.33E+06 1.40E+06 1.80E+06 5.64E+05 1.75E+06 
Fumarate 6.66E+05 3.96E+05 4.16E+05 3.96E+05 6.48E+05 4.57E+05 7.73E+05 3.41E+05 3.34E+05 3.23E+05 1.87E+05 9.25E+05 
Glucose 1-phosphate 1.67E+05 1.76E+05 1.78E+05 1.62E+05 4.32E+05 1.78E+05 2.31E+05 1.85E+05 2.37E+05 2.48E+05 1.59E+05 4.09E+05 
Glucose 6-phosphate 1.17E+05 1.69E+05 8.88E+04 1.38E+05 1.28E+05 9.71E+04 1.34E+05 1.43E+05 1.41E+05 1.00E+05 8.74E+04 1.06E+05 
Glutamate 1.30E+08 1.25E+08 1.14E+08 1.20E+08 1.03E+08 3.08E+07 3.75E+07 1.01E+08 1.03E+08 3.86E+07 9.18E+07 9.68E+07 
Glutamine 3.60E+07 2.17E+07 3.27E+07 3.46E+07 3.18E+07 3.66E+07 5.06E+07 3.32E+07 3.31E+07 2.95E+07 1.83E+07 3.90E+07 
Glutathione 1.78E+07 1.54E+07 1.55E+07 1.62E+07 1.50E+07 5.82E+06 8.34E+06 1.62E+07 1.54E+07 4.62E+06 1.31E+07 5.97E+06 
Glutathione disulfide 6.47E+04 1.42E+05 9.99E+04 9.83E+04 1.47E+05 3.74E+05 3.18E+05 9.99E+04 7.16E+04 6.71E+05 8.82E+04 2.06E+06 
Glycerate 2.62E+06 1.25E+05 9.01E+04 1.09E+05 1.16E+05 1.79E+05 1.30E+05 2.84E+05 2.08E+05 1.39E+05 1.14E+05 7.64E+04 
Glycerone phosphate 2.84E+05 3.95E+05 2.98E+05 3.24E+05 1.53E+05 2.32E+05 1.41E+05 2.36E+05 3.22E+05 2.64E+05 2.08E+05 4.87E+05 
GMP 2.63E+05 2.73E+05 2.22E+05 2.73E+05 4.41E+05 2.22E+05 4.40E+05 1.98E+05 2.62E+05 2.78E+05 1.97E+05 5.28E+05 
Guanine 8.24E+03 8.73E+03 1.37E+04 1.21E+04 1.67E+04 1.27E+04 1.19E+04 7.98E+03 1.56E+04 9.32E+03 6.62E+03 1.52E+04 
Guanosine 2.70E+05 1.96E+05 5.61E+05 2.16E+05 8.91E+05 2.98E+05 2.66E+05 4.08E+05 4.60E+05 2.46E+05 4.28E+05 6.89E+05 
Histidine 8.36E+03 8.18E+03 1.30E+04 4.38E+04 2.06E+04 2.14E+04 3.85E+04 1.74E+04 1.92E+04 2.25E+04 6.00E+03 3.55E+04 
Homocysteic acid 1.97E+04 2.46E+04 2.23E+04 2.42E+04 1.99E+04 1.04E+04 7.02E+03 2.38E+04 2.22E+04 3.07E+03 1.59E+04 8.09E+03 
Homoserine 9.52E+05 7.57E+05 9.34E+05 1.49E+06 6.44E+05 1.03E+06 1.21E+06 1.15E+06 1.01E+06 1.06E+06 8.20E+05 1.01E+06 
Homovanillic acid 8.89E+04 7.51E+04 7.92E+04 9.16E+04 7.02E+04 4.13E+04 2.72E+04 8.65E+04 9.56E+04 5.73E+04 8.04E+04 9.28E+04 
Hydroxybenzoate 5.26E+04 2.09E+04 7.28E+04 2.44E+04 1.84E+04 1.53E+04 1.68E+04 1.38E+04 1.50E+05 1.79E+04 2.63E+04 1.10E+04 
Hydroxyisocaproic acid 2.44E+05 2.56E+05 4.06E+05 3.30E+05 1.66E+05 1.10E+05 1.18E+05 3.68E+05 2.25E+05 9.61E+04 4.99E+05 1.21E+05 
Hydroxyphenylpyruvate 5.06E+04 4.20E+04 4.85E+04 4.58E+04 5.12E+04 3.99E+04 3.61E+04 5.41E+04 4.79E+04 3.11E+04 4.73E+04 4.96E+04 
Hypoxanthine 7.35E+05 5.76E+05 7.19E+05 7.90E+05 2.01E+06 1.68E+06 1.35E+06 8.73E+05 7.92E+05 1.08E+06 5.95E+05 1.80E+06 
IMP 2.93E+05 2.94E+05 2.48E+05 2.96E+05 4.64E+05 2.32E+05 4.07E+05 1.97E+05 2.63E+05 2.56E+05 2.04E+05 3.44E+05 
Indole-3-carboxylate 1.73E+05 2.16E+03 2.50E+03 1.96E+03 1.78E+03 3.27E+03 2.05E+03 2.24E+03 5.14E+03 2.07E+03 2.93E+03 2.21E+03 
Inosine 2.71E+06 2.23E+06 3.10E+06 2.57E+06 5.42E+06 6.22E+06 5.67E+06 2.76E+06 3.21E+06 3.66E+06 2.81E+06 5.12E+06 
Lactate 8.37E+07 7.90E+07 7.40E+07 9.29E+07 7.22E+07 2.05E+07 2.52E+07 7.49E+07 8.48E+07 2.44E+07 7.65E+07 8.28E+07 
Leucine/Isoleucine 5.81E+05 5.29E+05 5.22E+05 1.52E+06 6.04E+05 5.88E+05 5.05E+05 5.99E+05 5.63E+05 4.67E+05 5.38E+05 6.08E+05 
Malate 9.85E+05 1.17E+06 1.04E+06 1.09E+06 3.72E+04 2.70E+04 4.36E+04 1.03E+06 7.87E+05 2.53E+04 7.26E+05 3.38E+04 
Malate 1.06E+07 7.24E+06 6.52E+06 6.08E+06 7.30E+06 4.52E+06 7.07E+06 6.33E+06 6.10E+06 3.35E+06 4.82E+06 7.25E+06 
Mandelate 3.11E+05 7.25E+05 4.36E+05 4.07E+05 3.98E+05 2.48E+05 2.75E+05 3.15E+05 5.71E+05 1.51E+05 5.68E+05 1.49E+05 
Methionine 5.56E+05 6.79E+05 6.54E+05 1.18E+06 9.31E+05 5.89E+05 7.39E+05 6.47E+05 7.31E+05 5.06E+05 4.90E+05 7.17E+05 
Methionine sulfoxide 9.81E+04 2.46E+05 1.64E+05 1.42E+05 8.06E+04 7.24E+04 5.18E+04 1.55E+05 1.27E+05 7.90E+04 2.71E+05 6.28E+04 
Methylmalonate 3.42E+07 2.10E+07 7.26E+06 1.60E+07 2.94E+06 1.06E+06 1.86E+06 1.25E+07 1.30E+07 2.07E+06 6.79E+06 3.13E+06 
myo-Inositol 8.35E+05 7.91E+05 6.92E+05 8.62E+05 5.98E+05 6.29E+04 5.73E+04 9.05E+05 9.74E+05 7.32E+04 7.91E+05 6.89E+05 
N-Acetyl-beta-alanine 3.63E+04 2.19E+04 2.28E+04 4.96E+04 3.20E+04 1.71E+04 1.55E+04 3.26E+04 4.20E+04 1.45E+04 2.14E+04 3.29E+04 
N-Acetylglucosamine 6.48E+03 3.21E+03 3.55E+03 1.85E+04 4.03E+03 2.41E+03 4.95E+03 7.84E+03 7.97E+03 3.26E+03 4.64E+03 2.12E+03 
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Sample Name H6 H7 H8 H9 H14 H15 H17 H23 H24 H35 H36 H41 
N-Acetylglucosamine 
1/6-phosphate 5.09E+03 1.03E+04 6.87E+03 1.11E+04 7.76E+03 7.12E+03 9.26E+03 7.64E+03 8.14E+03 4.95E+03 1.18E+04 1.60E+04 
N-Acetylglutamate 1.05E+06 9.25E+05 7.03E+05 7.72E+05 7.11E+05 3.38E+05 5.46E+05 6.59E+05 6.00E+05 3.64E+05 5.12E+05 7.43E+05 
N-Acetylglutamine 5.01E+05 2.74E+05 3.04E+05 2.97E+05 3.47E+05 2.45E+05 4.18E+05 2.66E+05 3.09E+05 2.14E+05 2.32E+05 4.44E+05 
N-Acetylornithine 7.04E+03 1.02E+04 9.20E+03 1.14E+04 1.23E+04 9.46E+03 1.56E+04 1.09E+04 1.24E+04 6.72E+03 8.41E+03 1.08E+04 
N-Carbamoyl-L-
aspartate 1.33E+05 3.14E+05 3.02E+05 2.87E+05 4.08E+05 2.52E+05 3.91E+05 3.35E+05 3.87E+05 2.26E+05 2.72E+05 3.96E+05 
NAD+ 1.75E+05 1.50E+05 1.08E+05 1.42E+05 1.54E+04 8.76E+03 6.84E+03 1.58E+05 1.72E+05 2.47E+03 1.24E+05 4.06E+03 
Nicotinate 8.20E+03 9.49E+03 5.18E+03 5.76E+03 4.41E+03 5.00E+03 2.65E+03 6.31E+03 6.79E+03 3.91E+03 8.56E+03 9.61E+03 
Orotate 1.29E+05 5.76E+04 5.88E+04 5.85E+04 6.93E+04 4.51E+04 4.10E+04 7.76E+04 7.36E+04 5.17E+04 4.17E+04 6.77E+04 
Pantothenate 2.67E+06 2.87E+06 2.62E+06 2.52E+06 2.83E+06 2.61E+06 2.84E+06 2.68E+06 2.49E+06 2.04E+06 1.94E+06 2.56E+06 
Phenylalanine 2.27E+05 2.24E+05 2.26E+05 8.63E+05 3.51E+05 5.25E+05 4.74E+05 2.52E+05 2.93E+05 4.64E+05 2.41E+05 2.70E+05 
Phenylpyruvate 3.70E+04 5.72E+04 9.68E+04 6.55E+04 3.56E+03 1.00E+02 1.00E+02 2.17E+04 6.02E+03 4.89E+03 5.34E+04 3.64E+03 
Phosphorylcholine 5.01E+04 4.75E+04 5.27E+04 5.21E+04 8.11E+05 4.17E+05 7.75E+04 4.39E+05 1.11E+05 1.07E+05 5.88E+05 1.20E+05 
Prephenate 1.24E+05 1.15E+05 1.29E+05 1.13E+05 7.95E+05 6.51E+05 5.58E+05 1.05E+05 1.65E+05 7.11E+05 1.17E+05 1.03E+06 
Proline 2.10E+05 1.19E+05 1.09E+05 2.63E+05 1.54E+05 1.94E+05 1.99E+05 1.97E+05 2.26E+05 1.67E+05 1.32E+05 1.71E+05 
Pyroglutamic acid 6.32E+06 1.68E+06 1.86E+06 1.35E+07 3.42E+06 1.60E+06 1.06E+06 2.70E+06 3.18E+06 1.73E+06 4.50E+06 3.53E+06 
Pyruvate 1.07E+06 1.69E+06 1.06E+06 2.82E+06 1.30E+06 1.09E+06 9.21E+05 7.74E+05 9.61E+05 1.51E+06 1.14E+06 1.78E+06 
Ribose phosphate 1.23E+05 9.35E+04 1.41E+05 1.10E+05 4.16E+05 2.48E+05 2.33E+05 1.55E+05 1.72E+05 1.91E+05 1.56E+05 5.04E+05 
S-Adenosyl-L-
homocysteine 5.91E+03 4.69E+03 2.21E+03 7.61E+03 5.98E+03 3.66E+03 4.89E+03 6.25E+03 5.51E+03 3.55E+03 1.92E+03 6.56E+03 
Sarcosine 2.89E+06 2.88E+06 2.39E+06 2.85E+06 2.81E+06 2.29E+06 2.49E+06 2.46E+06 2.44E+06 1.93E+06 2.08E+06 2.62E+06 
Sedoheptulose 1/7-
phosphate 2.06E+04 1.81E+04 2.14E+04 2.01E+04 8.81E+03 7.90E+03 1.39E+04 2.43E+04 1.77E+04 2.30E+03 1.15E+04 1.09E+04 
Serine 3.27E+06 2.88E+06 3.41E+06 5.27E+06 3.57E+06 2.92E+06 3.55E+06 2.78E+06 3.09E+06 2.98E+06 3.00E+06 3.49E+06 
sn-Glycerol 3-
phosphate 7.83E+04 5.53E+04 8.58E+04 6.80E+04 2.64E+04 2.14E+04 1.31E+04 1.02E+05 8.81E+04 2.82E+04 7.72E+04 1.74E+04 
Succinate 3.42E+07 2.10E+07 7.26E+06 1.60E+07 2.94E+06 1.06E+06 1.86E+06 1.25E+07 1.30E+07 2.07E+06 6.79E+06 3.13E+06 
Sulfolactate 2.68E+05 2.03E+04 3.32E+04 7.85E+03 2.34E+03 2.44E+03 3.48E+03 1.99E+04 4.70E+03 2.46E+03 2.94E+04 2.39E+03 
Taurine 3.16E+07 2.26E+07 2.39E+07 3.01E+07 3.65E+07 2.50E+07 3.08E+07 2.92E+07 2.82E+07 2.25E+07 2.45E+07 2.85E+07 
Threonine 9.52E+05 7.57E+05 9.34E+05 1.49E+06 6.44E+05 1.03E+06 1.21E+06 1.15E+06 1.01E+06 1.06E+06 8.20E+05 1.01E+06 
Thymidine 1.07E+04 4.01E+03 6.82E+03 7.23E+03 8.41E+03 1.00E+02 1.00E+02 3.68E+03 2.95E+03 1.00E+02 2.55E+03 5.57E+03 
Trehalose/sucrose 3.48E+04 1.11E+05 2.02E+05 1.10E+05 5.05E+04 5.12E+04 3.88E+04 7.68E+04 5.08E+04 7.11E+04 1.06E+05 4.74E+04 
Tryptophan 3.12E+05 3.13E+05 3.63E+05 8.52E+05 3.58E+05 2.43E+05 3.08E+05 2.91E+05 3.39E+05 1.93E+05 2.69E+05 2.91E+05 
Tyrosine 1.70E+06 1.76E+06 1.70E+06 3.44E+06 2.00E+06 1.54E+06 1.65E+06 1.42E+06 1.57E+06 1.08E+06 1.40E+06 1.53E+06 
UDP-glucose 3.91E+05 4.19E+05 3.35E+05 4.13E+05 4.73E+05 2.88E+05 6.94E+05 3.11E+05 3.65E+05 2.11E+05 3.22E+05 4.90E+05 
UDP-N-
acetylglucosamine 3.82E+05 3.62E+05 3.02E+05 3.93E+05 3.89E+05 3.06E+05 6.25E+05 3.20E+05 3.45E+05 2.54E+05 3.07E+05 3.80E+05 
UMP 5.23E+05 4.42E+05 4.07E+05 5.15E+05 3.50E+05 1.80E+05 3.85E+05 4.67E+05 3.99E+05 1.93E+05 4.30E+05 4.92E+05 
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Sample Name H6 H7 H8 H9 H14 H15 H17 H23 H24 H35 H36 H41 
Uracil 2.59E+05 1.38E+05 1.76E+05 1.57E+05 5.94E+05 5.95E+05 5.03E+05 3.88E+05 4.24E+05 5.02E+05 2.57E+05 5.03E+05 
Uric acid 1.02E+05 7.57E+04 7.21E+04 2.57E+05 1.04E+05 1.00E+05 9.48E+04 8.21E+04 8.32E+04 4.94E+04 9.00E+04 6.06E+04 
Uridine 6.38E+04 5.49E+04 5.51E+04 7.10E+04 6.51E+04 4.96E+04 5.57E+04 6.63E+04 6.89E+04 4.55E+04 4.77E+04 6.48E+04 
Valine 9.88E+05 8.26E+05 7.24E+05 1.93E+06 7.36E+05 7.23E+05 7.84E+05 7.83E+05 8.87E+05 5.99E+05 7.67E+05 7.56E+05 
Xanthine 1.49E+03 4.35E+03 2.29E+03 4.09E+03 7.37E+02 1.04E+04 1.12E+04 2.97E+03 3.52E+03 3.52E+03 1.26E+04 9.97E+03 
Xanthine 4.02E+05 3.51E+05 6.90E+05 8.54E+05 8.91E+05 7.12E+05 5.75E+05 6.73E+05 7.43E+05 6.26E+05 3.61E+05 1.19E+06 




Table 1.6 Raw Data of Dominant Hamsters from HPC 
Sample Name H2 H3 H4 H12 H19 H21 H25 H28 H33 H40 
1-Methyladenosine 9.91E+03 6.52E+03 5.54E+03 4.12E+03 3.68E+03 2.06E+03 5.78E+03 2.93E+03 6.05E+03 3.15E+03 
2-Aminoadipate 1.27E+04 1.34E+04 1.54E+04 3.38E+04 4.67E+04 1.65E+04 2.21E+04 4.07E+04 9.84E+03 3.76E+04 
2-Dehydro-D-gluconate 3.79E+03 4.17E+03 3.72E+03 1.17E+04 3.01E+03 3.82E+03 4.83E+03 3.78E+03 3.37E+03 4.85E+03 
2-Hydroxy-2-methylsuccinate 2.10E+05 2.43E+05 2.12E+05 9.52E+05 1.56E+05 1.07E+05 1.75E+05 6.85E+04 1.17E+05 2.25E+05 
3-Methoxytyramine 4.44E+04 5.14E+04 4.68E+04 1.69E+05 5.69E+04 5.73E+04 4.67E+04 4.46E+04 4.74E+04 4.20E+04 
3_4-Dihydroxyphenylacetate 2.37E+04 2.13E+04 2.08E+04 1.02E+05 2.52E+04 3.56E+04 2.63E+04 4.35E+04 3.32E+04 3.71E+04 
4-Aminobutyrate 1.01E+06 1.14E+06 1.09E+06 2.74E+06 5.30E+05 4.45E+05 8.73E+05 4.52E+05 8.10E+05 3.56E+05 
5-Hydroxyindoleacetic acid 5.45E+04 7.39E+04 6.71E+04 3.21E+04 3.03E+04 8.18E+03 1.58E+04 1.05E+04 1.34E+04 9.48E+03 
Acadesine 5.06E+03 5.94E+03 5.94E+03 1.22E+04 8.31E+03 6.36E+03 6.17E+03 7.94E+03 6.93E+03 8.38E+03 
Acetyllysine 3.35E+03 2.56E+03 3.84E+03 6.70E+03 3.17E+03 3.09E+03 4.24E+03 2.99E+03 3.69E+03 3.34E+03 
Adenine 1.76E+04 1.77E+04 1.77E+04 2.94E+04 8.74E+03 5.84E+03 1.27E+04 6.75E+03 1.12E+04 6.02E+03 
Adenosine 3.41E+04 3.33E+04 1.45E+04 7.68E+05 2.98E+04 2.85E+05 6.90E+05 3.29E+05 5.29E+05 9.53E+04 
AICAR 8.61E+03 8.21E+03 1.01E+04 4.41E+04 1.12E+04 9.03E+03 1.06E+04 8.99E+03 6.08E+03 1.30E+04 
Alanine 1.45E+06 1.40E+06 1.20E+06 2.66E+06 1.19E+06 1.12E+06 1.29E+06 1.16E+06 1.23E+06 1.08E+06 
Allantoate 3.06E+03 1.68E+03 3.83E+03 1.11E+04 2.08E+03 6.72E+02 3.22E+03 1.63E+03 2.28E+03 7.37E+02 
alpha-Ketoglutarate 1.80E+03 4.48E+03 2.54E+03 1.45E+04 1.44E+03 2.97E+03 3.17E+03 1.55E+03 1.54E+03 3.30E+03 
AMP 3.35E+04 3.62E+04 1.15E+04 3.44E+06 2.88E+05 7.10E+05 8.03E+05 5.53E+05 6.39E+05 1.18E+06 
Allantoin 2.81E+03 6.22E+03 6.24E+03 1.10E+04 6.29E+03 2.90E+03 3.32E+03 4.05E+03 3.24E+03 8.48E+03 
Arginine 1.70E+04 2.18E+04 1.84E+04 1.13E+04 2.62E+04 1.30E+04 1.83E+04 1.85E+04 1.26E+04 2.13E+04 
Ascorbate 1.11E+07 1.04E+07 1.46E+07 4.85E+07 6.30E+06 7.47E+06 1.54E+07 6.46E+06 1.09E+07 5.20E+06 
Asparagine 4.81E+04 5.58E+04 6.24E+04 1.28E+05 3.91E+04 2.94E+04 5.70E+04 4.44E+04 3.97E+04 3.25E+04 
Aspartate 2.30E+06 2.66E+06 2.53E+06 8.02E+06 2.65E+06 1.18E+06 2.25E+06 1.57E+06 1.75E+06 1.27E+06 
beta-Alanine 1.45E+06 1.40E+06 1.20E+06 2.66E+06 1.19E+06 1.12E+06 1.29E+06 1.16E+06 1.23E+06 1.08E+06 
Betaine 2.56E+05 2.61E+05 2.81E+05 7.73E+05 2.46E+05 1.86E+05 2.54E+05 3.00E+05 1.98E+05 2.33E+05 
CDP-ethanolamine 3.25E+04 2.98E+04 2.47E+04 1.30E+05 3.22E+04 2.66E+04 3.42E+04 2.90E+04 3.42E+04 3.36E+04 
Citrate/isocitrate 3.00E+03 4.75E+03 1.74E+03 7.36E+04 1.05E+04 1.63E+03 1.54E+04 2.44E+03 1.46E+03 3.82E+03 
Citrulline 6.83E+04 7.90E+04 7.05E+04 8.47E+04 4.72E+04 5.04E+04 6.92E+04 6.22E+04 5.67E+04 4.54E+04 
CMP 6.58E+03 7.20E+03 2.93E+03 5.34E+04 1.97E+04 1.68E+04 2.04E+04 1.63E+04 1.41E+04 2.94E+04 
Creatine 1.50E+06 1.50E+06 1.32E+06 3.25E+06 1.37E+06 1.26E+06 1.38E+06 1.26E+06 1.33E+06 1.19E+06 
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Sample Name H2 H3 H4 H12 H19 H21 H25 H28 H33 H40 
Creatinine 1.36E+04 1.14E+04 1.69E+04 3.65E+04 1.39E+04 1.07E+04 1.10E+04 1.01E+04 1.00E+04 1.29E+04 
Cystathionine 1.82E+05 1.75E+05 1.85E+05 3.72E+05 1.96E+05 2.16E+05 2.53E+05 2.38E+05 1.65E+05 2.94E+05 
Cysteine 3.43E+05 3.42E+05 4.74E+05 1.91E+05 5.22E+05 9.10E+04 9.24E+04 1.01E+05 8.83E+04 1.06E+05 
Cystine 1.83E+04 6.26E+04 2.80E+04 3.24E+03 2.83E+04 3.57E+03 2.16E+03 3.32E+03 2.36E+03 4.21E+03 
Cytidine 6.54E+04 6.23E+04 9.61E+04 9.52E+04 3.55E+04 2.11E+04 4.67E+04 2.92E+04 3.75E+04 1.68E+04 
Cytidine 3.30E+04 3.78E+04 3.81E+04 7.58E+04 4.85E+04 4.12E+04 3.56E+04 4.28E+04 2.96E+04 6.52E+04 
D-Gluconate 5.16E+04 6.29E+04 5.81E+04 1.09E+05 4.27E+04 3.04E+04 4.76E+04 4.20E+04 3.69E+04 4.32E+04 
D-Glucosamine 1-phosphate 7.72E+03 5.52E+03 6.52E+03 8.82E+02 4.77E+02 1.82E+02 2.56E+02 2.85E+02 2.06E+02 1.75E+02 
D-Glyceraldehdye 3-phosphate 5.45E+05 5.49E+05 4.36E+05 8.39E+05 3.56E+05 1.53E+05 3.94E+05 1.79E+05 2.79E+05 3.01E+05 
Diiodothyronine 1.73E+04 1.79E+04 1.27E+04 6.09E+04 2.30E+04 1.68E+04 1.57E+04 7.52E+03 1.03E+04 2.09E+04 
Dimethylglycine 9.85E+04 1.07E+05 9.33E+04 3.69E+05 7.78E+04 7.22E+04 1.02E+05 6.87E+04 9.19E+04 7.01E+04 
Dimethylglycine 1.01E+06 1.14E+06 1.09E+06 2.74E+06 5.30E+05 4.45E+05 8.73E+05 4.52E+05 8.10E+05 3.56E+05 
Fumarate 1.37E+05 1.59E+05 1.65E+05 4.09E+05 4.43E+04 7.19E+04 1.69E+05 3.97E+04 9.54E+04 7.02E+04 
Glucosamine 1.00E+02 3.86E+03 4.28E+02 1.00E+02 1.00E+02 4.08E+02 1.00E+02 1.42E+04 2.74E+02 4.16E+02 
Glucose 1-phosphate 1.62E+05 1.74E+05 1.92E+05 4.56E+05 1.03E+05 8.30E+04 2.58E+05 9.85E+04 2.25E+05 9.33E+04 
Glucose 6-phosphate 8.84E+05 3.79E+05 8.04E+05 1.61E+05 1.02E+05 3.44E+04 1.39E+05 1.12E+05 8.71E+04 8.92E+04 
Glutamate 3.17E+07 3.14E+07 3.18E+07 1.04E+08 2.54E+07 2.26E+07 3.43E+07 2.32E+07 2.82E+07 2.38E+07 
Glutamine 1.42E+07 1.37E+07 1.49E+07 3.09E+07 1.22E+07 9.81E+06 1.40E+07 1.09E+07 1.28E+07 1.11E+07 
Glutathione 5.74E+06 5.98E+06 5.63E+06 1.88E+07 4.32E+06 5.21E+06 9.15E+06 5.68E+06 6.96E+06 6.62E+06 
Glutathione disulfide 8.46E+04 1.05E+05 6.43E+04 9.93E+04 2.62E+04 1.28E+04 3.58E+04 1.86E+04 2.09E+04 2.78E+04 
GMP 4.48E+03 6.72E+03 6.66E+02 2.99E+05 3.14E+04 5.23E+04 7.53E+04 5.70E+04 6.96E+04 7.51E+04 
Guanine 6.57E+03 5.07E+03 6.24E+03 7.08E+03 5.40E+03 2.12E+03 1.50E+03 2.33E+03 4.69E+03 3.12E+03 
Guanosine 1.05E+06 1.04E+06 1.10E+06 5.19E+05 4.96E+05 1.37E+05 3.19E+05 2.18E+05 2.49E+05 1.10E+05 
Histidine 2.61E+04 2.12E+04 3.02E+04 3.66E+04 1.92E+04 1.47E+04 1.84E+04 2.35E+04 1.53E+04 1.78E+04 
Homocysteic acid 1.45E+04 8.34E+03 1.33E+04 2.75E+04 1.37E+04 8.69E+03 1.03E+04 1.24E+04 9.68E+03 7.77E+03 
Homoserine 3.15E+05 3.59E+05 3.74E+05 6.41E+05 3.97E+05 3.02E+05 3.70E+05 4.12E+05 2.52E+05 3.65E+05 
Hydroxyphenylacetate 1.56E+05 1.88E+05 1.49E+05 2.49E+05 7.73E+04 9.30E+04 5.38E+04 3.34E+05 1.34E+05 8.12E+04 
Hypoxanthine 8.87E+05 8.69E+05 9.16E+05 6.59E+05 9.62E+05 1.32E+05 2.60E+05 2.89E+05 1.58E+05 2.76E+05 
Hypoxanthine 4.50E+03 6.64E+03 3.12E+03 5.35E+03 2.29E+03 3.67E+02 2.03E+03 1.82E+03 1.69E+03 2.22E+03 
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Sample Name H2 H3 H4 H12 H19 H21 H25 H28 H33 H40 
IMP 2.21E+04 1.81E+04 1.87E+04 2.64E+05 3.41E+04 5.54E+04 9.76E+04 5.82E+04 1.08E+05 3.72E+04 
Inosine 5.34E+06 5.13E+06 5.35E+06 3.24E+06 3.59E+06 8.63E+05 1.87E+06 1.69E+06 1.47E+06 1.40E+06 
Lactate 3.57E+07 4.40E+07 4.61E+07 9.17E+07 4.26E+07 3.47E+07 4.14E+07 4.15E+07 3.61E+07 4.42E+07 
Leucine/Isoleucine 1.70E+05 2.17E+05 2.54E+05 3.71E+05 1.85E+05 8.52E+04 1.31E+05 1.50E+05 7.81E+04 1.30E+05 
Lysine 7.98E+03 7.99E+03 7.17E+03 5.89E+03 9.04E+03 7.81E+03 8.51E+03 6.45E+03 4.28E+03 6.98E+03 
Malate 3.63E+06 4.59E+06 4.36E+06 1.04E+07 1.68E+06 1.52E+06 2.84E+06 1.27E+06 1.84E+06 2.02E+06 
Mandelate 6.42E+04 5.50E+04 5.13E+04 1.67E+05 9.25E+04 7.39E+04 1.02E+05 6.53E+04 7.65E+04 9.03E+04 
Methionine 3.69E+05 3.36E+05 4.09E+05 8.30E+05 3.61E+05 1.68E+05 2.64E+05 2.42E+05 2.64E+05 2.20E+05 
Methionine sulfoxide 2.59E+04 3.53E+04 3.06E+04 3.92E+04 3.26E+04 3.23E+04 3.43E+04 2.56E+04 2.93E+04 2.91E+04 
Methylmalonate 5.03E+05 6.34E+05 3.88E+05 5.63E+06 5.39E+05 1.52E+06 1.88E+06 1.41E+06 1.17E+06 2.10E+06 
myo-Inositol 2.89E+05 3.30E+05 3.51E+05 6.69E+05 3.24E+05 3.54E+05 3.39E+05 3.93E+05 3.31E+05 3.52E+05 
N-Acetyl-beta-alanine 1.41E+04 1.42E+04 1.92E+04 3.12E+04 2.02E+04 9.01E+03 1.12E+04 1.05E+04 9.77E+03 1.41E+04 
N-Acetylglutamate 3.63E+05 3.46E+05 3.30E+05 1.07E+06 2.04E+05 2.34E+05 3.60E+05 1.49E+05 2.47E+05 1.89E+05 
N-Acetylglutamine 2.98E+05 2.73E+05 3.46E+05 4.11E+05 4.01E+05 1.75E+05 2.49E+05 1.84E+05 2.23E+05 4.25E+05 
N-Acetylornithine 5.09E+03 4.90E+03 4.63E+03 1.52E+04 3.97E+03 3.96E+03 6.02E+03 3.29E+03 5.69E+03 4.44E+03 
N-Acetyltaurine 1.23E+05 1.01E+05 8.26E+04 1.46E+05 4.59E+04 6.55E+04 1.24E+05 6.32E+04 7.98E+04 5.01E+04 
N-Acetyltaurine 3.15E+03 3.12E+03 3.91E+03 2.46E+03 1.17E+04 2.47E+03 2.16E+03 4.58E+03 1.47E+03 2.87E+03 
N-Carbamoyl-L-aspartate 5.09E+04 1.00E+05 1.01E+05 3.58E+05 8.49E+04 7.47E+04 1.00E+05 6.50E+04 8.67E+04 6.92E+04 
NAD+ 7.16E+02 1.57E+03 6.07E+02 4.69E+04 2.72E+03 9.22E+03 3.65E+03 3.25E+03 2.93E+03 7.88E+03 
Orotate 1.45E+04 1.68E+04 1.22E+04 3.69E+04 1.03E+04 7.44E+03 1.42E+04 8.21E+03 1.26E+04 8.36E+03 
Pantothenate 4.63E+05 4.80E+05 4.55E+05 1.59E+06 6.92E+05 3.83E+05 5.08E+05 4.50E+05 3.91E+05 6.46E+05 
Phenylalanine 1.67E+05 1.68E+05 1.91E+05 2.26E+05 2.30E+05 1.05E+05 1.12E+05 1.79E+05 1.16E+05 1.70E+05 
Phenyllactic acid 9.86E+04 1.14E+05 1.05E+05 2.61E+05 7.34E+04 7.68E+04 5.67E+04 2.01E+05 8.55E+04 7.42E+04 
Proline 9.99E+04 9.59E+04 8.50E+04 1.85E+05 7.05E+04 4.21E+04 7.96E+04 9.72E+04 6.45E+04 7.31E+04 
Pyroglutamic acid 2.41E+06 2.39E+06 3.64E+06 2.92E+06 2.31E+06 1.18E+06 7.54E+05 1.83E+06 9.69E+05 1.39E+06 
Pyruvate 4.55E+05 4.85E+05 6.53E+05 1.02E+06 3.04E+05 4.25E+05 3.19E+05 5.54E+05 3.42E+05 6.27E+05 




Table 1.6 Continued 
Sample Name H2 H3 H4 H12 H19 H21 H25 H28 H33 H40 
Sedoheptulose 1/7-phosphate 8.05E+04 5.86E+04 1.07E+05 2.03E+04 3.34E+04 3.65E+03 1.20E+04 9.69E+03 1.08E+04 5.80E+03 
Serine 1.06E+06 1.10E+06 1.22E+06 2.30E+06 1.05E+06 9.04E+05 1.14E+06 1.21E+06 9.11E+05 1.12E+06 
sn-Glycerol 3-phosphate 2.27E+04 2.43E+04 1.19E+04 6.57E+04 2.36E+04 5.81E+04 2.30E+04 2.07E+04 1.99E+04 3.30E+04 
Succinate 5.03E+05 6.34E+05 3.88E+05 5.63E+06 5.39E+05 1.52E+06 1.88E+06 1.41E+06 1.17E+06 2.10E+06 
Taurine 1.29E+07 1.17E+07 1.15E+07 3.93E+07 9.15E+06 8.71E+06 1.24E+07 9.90E+06 1.07E+07 1.06E+07 
Thymidine 7.69E+03 5.80E+03 7.67E+03 4.78E+03 5.32E+03 2.23E+03 5.58E+03 3.73E+03 6.16E+03 3.60E+03 
Thymine 5.91E+03 5.98E+03 5.32E+03 3.99E+03 5.81E+03 2.50E+03 6.14E+03 4.43E+03 2.67E+03 4.07E+03 
Trehalose/sucrose 3.99E+04 4.52E+04 4.82E+04 3.24E+04 3.39E+04 5.79E+04 2.39E+04 1.55E+05 7.08E+04 6.95E+04 
Tryptophan 2.29E+05 2.05E+05 2.09E+05 3.63E+05 2.09E+05 1.44E+05 1.96E+05 1.86E+05 1.88E+05 1.74E+05 
Tyrosine 6.21E+05 5.92E+05 6.28E+05 1.46E+06 5.72E+05 4.96E+05 5.82E+05 5.87E+05 6.39E+05 5.51E+05 
UDP-glucose 3.92E+04 6.06E+04 7.39E+04 4.23E+05 1.02E+05 1.02E+05 1.39E+05 1.31E+05 1.07E+05 1.20E+05 
UDP-N-acetylglucosamine 7.74E+04 8.34E+04 9.07E+04 3.84E+05 7.89E+04 8.17E+04 1.44E+05 1.13E+05 1.15E+05 9.79E+04 
UMP 8.12E+03 8.30E+03 2.61E+03 5.53E+05 4.89E+04 1.12E+05 1.33E+05 9.03E+04 9.24E+04 1.77E+05 
Uracil 4.02E+05 4.09E+05 4.42E+05 4.70E+05 2.86E+05 4.18E+04 1.75E+05 9.26E+04 1.25E+05 6.94E+04 
Uric acid 3.73E+04 4.24E+04 3.77E+04 1.18E+05 5.85E+04 3.73E+04 3.18E+04 5.36E+04 3.67E+04 7.97E+04 
Uridine 2.88E+04 2.59E+04 2.71E+04 7.66E+04 1.73E+04 1.39E+04 2.46E+04 1.63E+04 2.27E+04 1.56E+04 
Xanthine 6.69E+05 6.36E+05 6.62E+05 6.57E+05 5.41E+05 9.27E+04 2.39E+05 2.40E+05 1.66E+05 2.15E+05 




Table 1.7 Raw Data of Handled Control Hamsters from HPC  
Sample Name H1 H10 H18 H26 H19 H32 H34 H43 H44 H49 H52 H53 
1-Methyladenosine 4.89E+03 5.04E+03 6.05E+03 4.96E+03 6.29E+03 4.28E+03 4.88E+03 6.28E+03 9.10E+03 1.11E+04 9.67E+03 7.23E+03 
2-Aminoadipate 2.97E+04 2.64E+04 8.87E+03 1.26E+04 1.14E+04 8.96E+03 1.40E+04 1.20E+04 1.07E+04 1.10E+04 1.33E+04 1.45E+04 
2-Dehydro-D-gluconate 1.35E+03 9.26E+03 4.12E+03 4.27E+03 5.05E+03 5.75E+03 4.85E+03 5.41E+03 6.09E+03 4.32E+03 4.10E+03 3.89E+03 
2-Hydroxy-2-methylsuccinate 5.49E+04 4.56E+05 1.63E+05 1.06E+05 9.35E+04 1.61E+05 1.37E+05 1.73E+05 2.09E+05 1.88E+05 1.64E+05 1.23E+05 
3-Methoxytyramine 4.76E+04 1.33E+05 4.44E+04 4.73E+04 5.35E+04 5.04E+04 5.67E+04 4.16E+04 5.30E+04 1.73E+05 5.54E+04 3.65E+04 
3_4-Dihydroxyphenylacetate 2.07E+04 1.25E+05 3.04E+04 2.73E+04 2.14E+04 3.64E+04 3.23E+04 2.47E+04 2.09E+04 2.92E+04 2.21E+04 2.05E+04 
4-Aminobutyrate 4.83E+05 2.30E+06 7.61E+05 8.07E+05 1.01E+06 8.61E+05 1.01E+06 1.20E+06 1.08E+06 1.06E+06 7.56E+05 8.27E+05 
5-Hydroxyindoleacetic acid 4.04E+04 1.73E+04 7.31E+03 1.12E+04 5.16E+04 1.24E+04 3.54E+04 6.66E+04 4.89E+04 6.37E+04 2.89E+04 4.89E+04 
Acadesine 7.60E+03 9.00E+03 4.30E+03 5.82E+03 5.65E+03 6.01E+03 5.93E+03 5.87E+03 7.18E+03 7.53E+03 7.12E+03 5.75E+03 
Acetyllysine 2.89E+03 7.57E+03 2.88E+03 3.20E+03 3.58E+03 4.01E+03 2.72E+03 2.40E+03 1.27E+03 2.62E+03 1.73E+03 2.19E+03 
Adenine 6.16E+03 3.18E+04 8.44E+03 1.20E+04 1.54E+04 1.44E+04 1.29E+04 1.80E+04 1.54E+04 1.77E+04 1.74E+04 1.25E+04 
Adenosine 1.51E+04 7.16E+05 4.78E+05 5.54E+05 7.60E+04 4.67E+05 5.28E+04 6.95E+04 2.16E+04 3.87E+04 4.08E+04 4.54E+04 
AICAR 1.22E+04 4.01E+04 1.07E+04 1.15E+04 1.18E+04 8.83E+03 8.92E+03 1.21E+04 7.26E+03 1.18E+04 8.58E+03 8.51E+03 
Alanine 9.87E+05 2.62E+06 1.11E+06 1.41E+06 1.32E+06 1.39E+06 1.29E+06 1.38E+06 1.16E+06 1.25E+06 1.32E+06 1.31E+06 
Allantoate 3.60E+02 5.51E+03 2.36E+03 2.84E+03 5.61E+03 4.17E+03 3.96E+03 4.68E+03 3.59E+02 1.38E+03 1.00E+02 1.88E+03 
alpha-Ketoglutarate 1.16E+03 9.32E+03 3.13E+03 2.94E+03 3.27E+03 4.13E+03 2.73E+03 1.81E+03 2.62E+03 1.63E+03 2.32E+03 1.16E+03 
AMP 5.81E+05 3.19E+06 8.33E+05 9.90E+05 3.91E+04 9.01E+05 3.16E+04 2.20E+04 1.64E+04 1.28E+04 2.01E+04 4.15E+04 
Allantoin 4.16E+03 1.26E+04 2.39E+03 4.11E+03 3.91E+03 3.26E+03 3.67E+03 4.66E+03 1.18E+04 2.43E+03 3.92E+03 4.66E+03 
Arginine 2.44E+04 1.94E+04 1.30E+04 1.63E+04 2.69E+04 1.57E+04 2.12E+04 2.19E+04 1.60E+04 2.35E+04 1.75E+04 1.80E+04 
Ascorbate 3.98E+06 2.96E+07 1.32E+07 1.53E+07 1.45E+07 1.59E+07 1.27E+07 1.55E+07 3.65E+06 5.24E+06 1.06E+03 7.44E+06 
Asparagine 3.98E+04 1.08E+05 3.93E+04 5.17E+04 6.01E+04 5.02E+04 5.79E+04 5.66E+04 5.88E+04 5.60E+04 4.58E+04 4.70E+04 
Aspartate 2.55E+06 7.68E+06 1.82E+06 2.29E+06 2.57E+06 2.26E+06 2.62E+06 3.15E+06 2.67E+06 2.62E+06 2.36E+06 2.28E+06 
beta-Alanine 9.87E+05 2.62E+06 1.11E+06 1.41E+06 1.32E+06 1.39E+06 1.29E+06 1.38E+06 1.16E+06 1.25E+06 1.32E+06 1.31E+06 
Betaine 2.05E+05 7.15E+05 1.66E+05 2.20E+05 2.75E+05 2.47E+05 2.60E+05 2.88E+05 2.52E+05 2.76E+05 2.40E+05 2.37E+05 
CDP-ethanolamine 2.72E+04 1.33E+05 3.08E+04 3.11E+04 3.54E+04 4.12E+04 3.20E+04 4.23E+04 2.72E+04 2.56E+04 2.48E+04 2.44E+04 
Citrate/isocitrate 2.71E+03 2.59E+03 2.69E+03 2.73E+03 3.43E+03 3.35E+03 5.74E+04 4.50E+03 1.59E+04 5.05E+03 3.51E+03 2.40E+03 
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Table 1.7 Continued 
Sample Name H1 H10 H18 H26 H19 H32 H34 H43 H44 H49 H52 H53 
Citrulline 3.86E+04 8.31E+04 5.85E+04 8.60E+04 9.17E+04 5.94E+04 8.19E+04 6.61E+04 6.46E+04 5.33E+04 6.14E+04 4.61E+04 
CMP 1.64E+04 3.94E+04 1.45E+04 2.10E+04 1.07E+04 1.62E+04 8.87E+03 7.04E+03 5.43E+03 3.42E+03 3.45E+03 7.09E+03 
Creatine 1.09E+06 3.05E+06 1.25E+06 1.52E+06 1.37E+06 1.47E+06 1.40E+06 1.52E+06 1.28E+06 1.44E+06 1.38E+06 1.42E+06 
Creatinine 9.96E+03 2.96E+04 9.85E+03 1.24E+04 1.44E+04 1.54E+04 1.35E+04 1.26E+04 1.49E+04 1.48E+04 1.72E+04 1.18E+04 
Cystathionine 1.06E+05 4.21E+05 1.64E+05 2.50E+05 2.37E+05 2.64E+05 2.12E+05 1.91E+05 1.24E+05 1.82E+05 1.11E+05 1.64E+05 
Cysteine 3.51E+05 1.90E+05 1.01E+05 1.18E+05 4.47E+05 1.10E+05 4.31E+05 5.38E+05 6.19E+04 1.20E+05 1.56E+04 4.15E+05 
Cystine 2.40E+04 5.92E+03 2.31E+03 3.72E+03 1.63E+04 8.29E+03 2.54E+04 2.41E+04 1.34E+05 1.67E+05 1.05E+05 2.00E+04 
Cytidine 2.31E+04 1.10E+05 3.49E+04 4.28E+04 7.39E+04 5.12E+04 5.85E+04 8.87E+04 8.23E+04 7.73E+04 3.83E+04 4.90E+04 
Cytidine 6.25E+04 8.11E+04 3.62E+04 3.49E+04 2.97E+04 3.85E+04 3.13E+04 2.90E+04 3.97E+04 3.42E+04 2.89E+04 3.25E+04 
D-Gluconate 3.60E+04 1.16E+05 3.00E+04 3.72E+04 8.16E+04 5.99E+04 5.10E+04 5.56E+04 7.77E+04 5.44E+04 6.21E+04 4.23E+04 
D-Glucosamine 1-phosphate 1.00E+02 5.00E+02 2.30E+02 1.78E+02 5.10E+03 4.14E+02 6.31E+03 6.79E+03 5.98E+03 6.55E+03 5.38E+03 3.85E+03 
D-Glyceraldehdye 3-
phosphate 
1.75E+05 7.99E+05 2.12E+05 3.72E+05 4.81E+05 3.32E+05 4.98E+05 5.71E+05 4.52E+05 4.49E+05 4.02E+05 3.45E+05 
Diiodothyronine 1.92E+04 4.55E+04 1.58E+04 1.55E+04 1.36E+04 1.78E+04 1.49E+04 1.29E+04 1.46E+04 1.65E+04 9.96E+03 1.28E+04 
Dimethylglycine 5.09E+04 3.25E+05 8.55E+04 1.06E+05 1.06E+05 1.10E+05 9.06E+04 1.16E+05 9.02E+04 1.14E+05 9.86E+04 8.00E+04 
Dimethylglycine 4.83E+05 2.30E+06 7.61E+05 8.07E+05 1.01E+06 8.61E+05 1.01E+06 1.20E+06 1.08E+06 1.06E+06 7.56E+05 8.27E+05 
Fumarate 3.34E+04 2.75E+05 1.37E+05 1.11E+05 1.07E+05 1.88E+05 1.15E+05 1.11E+05 1.32E+05 1.25E+05 8.92E+04 1.02E+05 
Glucosamine 5.74E+02 1.00E+02 3.31E+03 4.09E+02 1.00E+02 1.37E+03 4.12E+02 5.91E+02 1.00E+02 2.48E+03 3.60E+02 4.99E+02 
Glucose 1-phosphate 4.74E+04 3.22E+05 1.97E+05 1.51E+05 1.34E+05 2.58E+05 1.43E+05 2.52E+05 1.96E+05 2.22E+05 1.04E+05 1.25E+05 
Glucose 6-phosphate 6.50E+04 1.87E+05 5.22E+04 1.04E+05 6.52E+05 8.02E+04 7.49E+05 7.79E+05 6.51E+05 8.02E+05 5.61E+05 3.29E+05 
Glutamate 2.30E+07 9.87E+07 2.79E+07 3.10E+07 3.10E+07 3.61E+07 3.09E+07 3.38E+07 2.91E+07 3.13E+07 2.96E+07 2.93E+07 
Glutamine 1.26E+07 2.63E+07 1.37E+07 1.33E+07 1.43E+07 1.42E+07 1.42E+07 1.36E+07 1.23E+07 1.24E+07 1.19E+07 1.29E+07 
Glutathione 3.61E+06 1.56E+07 7.14E+06 8.02E+06 6.48E+06 9.71E+06 5.64E+06 6.95E+06 2.92E+06 4.16E+06 2.91E+06 4.92E+06 
Glutathione disulfide 2.49E+04 7.16E+04 1.55E+04 2.25E+04 5.45E+04 6.72E+04 6.26E+04 1.04E+05 3.72E+05 2.86E+05 1.70E+05 4.08E+04 
GMP 4.43E+04 2.86E+05 6.97E+04 7.56E+04 7.05E+03 8.36E+04 9.19E+03 2.04E+03 1.61E+03 8.00E+02 5.46E+03 1.27E+04 




Table 1.7 Continued 
Sample Name H1 H10 H18 H26 H19 H32 H34 H43 H44 H49 H52 H53 
Guanosine 2.06E+05 5.23E+05 1.78E+05 2.45E+05 1.09E+06 3.05E+05 1.04E+06 1.24E+06 9.79E+05 1.01E+06 8.72E+05 8.77E+05 
Histidine 2.09E+04 3.42E+04 1.69E+04 1.67E+04 1.82E+04 1.67E+04 2.54E+04 2.75E+04 1.84E+04 2.43E+04 1.94E+04 2.21E+04 
Homocysteic acid 6.90E+03 1.31E+04 1.27E+04 1.18E+04 1.51E+04 1.26E+04 1.15E+04 1.28E+04 9.76E+03 1.10E+04 4.68E+02 1.21E+04 
Homoserine 3.19E+05 6.96E+05 2.33E+05 3.65E+05 3.98E+05 3.60E+05 3.71E+05 3.01E+05 3.42E+05 3.17E+05 2.87E+05 3.04E+05 
Hydroxyphenylacetate 7.08E+04 1.79E+05 1.75E+05 1.13E+05 1.02E+05 4.70E+04 1.32E+05 3.02E+05 2.30E+05 3.51E+05 1.16E+05 1.66E+05 
Hypoxanthine 7.40E+05 7.26E+05 1.41E+05 2.21E+05 8.67E+05 2.54E+05 7.02E+05 9.41E+05 8.30E+05 9.26E+05 7.99E+05 7.39E+05 
Hypoxanthine 2.77E+03 2.07E+03 1.22E+03 1.92E+03 3.52E+03 4.88E+03 4.04E+03 3.28E+03 1.18E+04 1.25E+04 1.42E+04 8.93E+03 
IMP 5.67E+04 2.28E+05 1.17E+05 1.19E+05 1.56E+04 1.12E+05 1.56E+04 1.74E+04 1.70E+04 1.68E+04 1.68E+04 2.10E+04 
Inosine 2.29E+06 3.41E+06 1.02E+06 1.44E+06 5.50E+06 1.98E+06 5.12E+06 5.53E+06 4.94E+06 5.18E+06 4.78E+06 4.48E+06 
Lactate 3.78E+07 8.85E+07 3.61E+07 4.35E+07 4.53E+07 4.41E+07 3.87E+07 4.45E+07 4.01E+07 3.98E+07 3.83E+07 3.78E+07 
Leucine/Isoleucine 1.66E+05 4.55E+05 8.26E+04 1.03E+05 2.41E+05 1.89E+05 1.62E+05 2.02E+05 2.26E+05 2.50E+05 2.04E+05 1.72E+05 
Lysine 1.02E+04 7.72E+03 4.36E+03 5.81E+03 8.64E+03 6.35E+03 7.18E+03 1.05E+04 7.72E+03 6.93E+03 6.30E+03 7.97E+03 
Malate 1.09E+06 7.12E+06 2.41E+06 2.22E+06 3.17E+06 3.73E+06 2.80E+06 3.65E+06 3.86E+06 3.75E+06 2.39E+06 2.22E+06 
Mandelate 6.10E+04 1.87E+05 5.35E+04 9.38E+04 8.83E+04 7.10E+04 8.24E+04 1.13E+05 7.16E+04 6.43E+04 7.20E+04 5.87E+04 
Methionine 2.95E+05 7.33E+05 2.33E+05 2.55E+05 3.50E+05 2.70E+05 3.38E+05 4.47E+05 3.59E+05 4.08E+05 3.25E+05 3.34E+05 
Methionine sulfoxide 1.88E+04 6.89E+04 2.32E+04 2.78E+04 2.73E+04 2.38E+04 3.29E+04 3.09E+04 4.51E+04 2.38E+04 3.03E+04 2.54E+04 
Methylmalonate 6.13E+05 4.93E+06 2.08E+06 1.55E+06 4.57E+05 2.34E+06 7.24E+05 5.94E+05 4.71E+05 7.03E+05 3.73E+05 4.06E+05 
myo-Inositol 3.14E+05 1.14E+06 3.08E+05 3.64E+05 3.44E+05 3.67E+05 3.47E+05 3.79E+05 3.26E+05 3.40E+05 3.25E+05 2.95E+05 
N-Acetyl-beta-alanine 1.40E+04 2.87E+04 1.30E+04 1.07E+04 2.18E+04 1.63E+04 1.45E+04 2.39E+04 1.98E+04 2.27E+04 1.88E+04 1.44E+04 
N-Acetylglutamate 1.56E+05 5.95E+05 2.64E+05 3.82E+05 4.68E+05 3.98E+05 3.97E+05 3.67E+05 2.57E+05 2.51E+05 3.60E+05 3.12E+05 
N-Acetylglutamine 2.80E+05 3.78E+05 2.46E+05 2.94E+05 4.23E+05 4.32E+05 3.71E+05 4.07E+05 2.89E+05 2.47E+05 3.20E+05 3.20E+05 
N-Acetylornithine 3.35E+03 1.22E+04 3.73E+03 8.23E+03 4.81E+03 5.67E+03 6.77E+03 7.80E+03 4.57E+03 4.38E+03 6.32E+03 4.45E+03 
N-Acetyltaurine 2.91E+04 1.05E+05 8.89E+04 1.56E+05 1.59E+05 1.64E+05 8.32E+04 1.22E+05 7.81E+04 8.69E+04 7.09E+04 7.61E+04 
N-Acetyltaurine 2.65E+03 2.39E+03 9.53E+02 7.92E+02 4.86E+03 1.48E+03 1.14E+04 5.05E+03 1.98E+04 9.98E+03 7.36E+03 3.00E+04 




Table 1.7 Continued 
Sample Name H1 H10 H18 H26 H19 H32 H34 H43 H44 H49 H52 H53 
NAD+ 3.67E+03 2.02E+04 1.42E+04 3.94E+03 1.52E+03 9.39E+03 9.94E+02 1.53E+03 6.90E+02 1.00E+02 6.66E+02 1.13E+03 
Orotate 9.40E+03 2.44E+04 1.55E+04 1.54E+04 1.64E+04 1.85E+04 1.49E+04 2.22E+04 5.51E+04 2.39E+04 1.38E+04 1.25E+04 
Pantothenate 6.66E+05 1.45E+06 4.50E+05 4.97E+05 5.48E+05 5.41E+05 4.74E+05 5.69E+05 4.72E+05 4.84E+05 4.84E+05 4.83E+05 
Phenylalanine 1.90E+05 1.75E+05 8.83E+04 9.85E+04 1.73E+05 9.84E+04 1.82E+05 2.11E+05 1.88E+05 2.08E+05 1.75E+05 1.67E+05 
Phenyllactic acid 6.65E+04 2.02E+05 1.04E+05 7.15E+04 7.70E+04 6.55E+04 7.77E+04 1.52E+05 1.30E+05 6.02E+05 9.16E+04 1.03E+05 
Proline 5.46E+04 1.57E+05 5.49E+04 7.17E+04 8.86E+04 7.24E+04 8.26E+04 1.04E+05 9.66E+04 1.02E+05 1.02E+05 8.79E+04 
Pyroglutamic acid 1.48E+06 2.48E+06 7.56E+05 6.43E+05 2.91E+06 8.87E+05 2.94E+06 3.89E+06 3.04E+06 3.34E+06 2.62E+06 2.20E+06 
Pyruvate 2.70E+05 9.48E+05 4.63E+05 3.18E+05 4.40E+05 4.34E+05 4.16E+05 4.80E+05 4.74E+05 4.48E+05 4.98E+05 3.97E+05 
Ribose phosphate 1.96E+05 3.01E+05 1.15E+05 1.57E+05 4.54E+05 1.73E+05 4.83E+05 4.73E+05 4.09E+05 4.49E+05 3.99E+05 3.13E+05 
Ribose phosphate 1.21E+05 1.57E+05 6.47E+04 7.62E+04 4.58E+05 1.11E+05 4.44E+05 4.97E+05 4.08E+05 4.27E+05 3.94E+05 2.91E+05 
Ribose phosphate 3.33E+05 3.24E+05 1.39E+05 1.37E+05 2.42E+05 2.10E+05 2.67E+05 2.21E+05 2.27E+05 2.58E+05 2.85E+05 2.10E+05 
Ribose phosphate 3.33E+05 3.24E+05 1.39E+05 1.57E+05 4.58E+05 2.10E+05 4.83E+05 4.97E+05 4.08E+05 4.27E+05 3.94E+05 3.13E+05 
Sedoheptulose 1/7-phosphate 2.07E+04 2.83E+04 6.21E+03 8.34E+03 6.92E+04 8.91E+03 8.26E+04 1.12E+05 6.48E+04 9.10E+04 8.41E+04 5.65E+04 
Serine 1.01E+06 2.24E+06 8.54E+05 1.16E+06 1.33E+06 1.08E+06 1.32E+06 1.38E+06 1.29E+06 1.19E+06 1.05E+06 9.74E+05 
sn-Glycerol 3-phosphate 2.88E+04 7.32E+04 2.68E+04 1.85E+04 1.67E+04 3.50E+04 1.26E+04 1.98E+04 1.01E+04 1.32E+04 1.32E+04 1.27E+04 
Succinate 6.13E+05 4.93E+06 2.08E+06 1.55E+06 4.57E+05 2.34E+06 7.24E+05 5.94E+05 4.71E+05 7.03E+05 3.73E+05 4.06E+05 
Taurine 7.94E+06 3.32E+07 1.03E+07 1.26E+07 1.29E+07 1.27E+07 1.20E+07 1.28E+07 1.13E+07 1.26E+07 1.08E+07 9.79E+06 
Thymidine 1.71E+03 7.90E+03 3.25E+03 3.75E+03 7.79E+03 5.15E+03 6.18E+03 6.28E+03 5.75E+03 8.16E+03 7.16E+03 4.60E+03 
Thymine 4.17E+03 4.08E+03 2.57E+03 4.06E+03 4.71E+03 2.81E+03 6.04E+03 5.34E+03 7.34E+03 4.15E+03 3.88E+03 4.05E+03 
Trehalose/sucrose 7.42E+05 8.95E+04 1.63E+04 1.46E+04 4.17E+05 7.44E+04 4.03E+04 1.02E+05 6.21E+04 6.33E+04 2.88E+04 2.93E+04 
Tryptophan 1.72E+05 3.31E+05 1.59E+05 2.01E+05 1.99E+05 2.29E+05 2.64E+05 2.72E+05 1.86E+05 2.33E+05 1.91E+05 1.89E+05 
Tyrosine 4.76E+05 1.57E+06 5.42E+05 5.88E+05 5.74E+05 6.29E+05 6.41E+05 8.30E+05 5.62E+05 6.97E+05 5.86E+05 5.62E+05 
UDP-glucose 5.81E+04 2.87E+05 1.20E+05 9.80E+04 5.27E+04 1.03E+05 7.94E+04 7.33E+04 7.40E+04 8.03E+04 5.12E+04 8.06E+04 
UDP-N-acetylglucosamine 4.07E+04 3.26E+05 1.11E+05 1.05E+05 8.55E+04 1.46E+05 1.00E+05 9.20E+04 8.21E+04 1.02E+05 5.68E+04 7.94E+04 




Table 1.7 Continued 
Sample Name H1 H10 H18 H26 H19 H32 H34 H43 H44 H49 H52 H53 
Uracil 2.41E+05 4.33E+05 9.68E+04 1.54E+05 3.04E+05 1.90E+05 4.17E+05 4.80E+05 3.46E+05 4.54E+05 3.44E+05 3.37E+05 
Uric acid 2.06E+04 5.97E+04 1.53E+04 2.55E+04 2.62E+04 2.28E+04 1.36E+04 3.51E+04 2.89E+04 4.13E+04 1.79E+04 2.28E+04 
Uridine 1.29E+04 7.34E+04 1.99E+04 2.56E+04 2.69E+04 2.72E+04 2.49E+04 3.16E+04 3.12E+04 2.79E+04 2.12E+04 2.09E+04 
Xanthine 3.69E+05 5.08E+05 1.22E+05 1.30E+05 5.08E+05 2.27E+05 4.24E+05 6.18E+05 5.38E+05 6.28E+05 5.81E+05 4.84E+05 
Xanthosine 7.98E+03 2.02E+03 6.39E+02 3.67E+03 7.31E+03 2.71E+03 8.22E+03 7.76E+03 7.56E+03 1.05E+04 9.86E+03 8.13E+03 
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Table 1.8 Raw Data of Subordinate Hamsters from HPC  
Sample Name H6 H8 H9 H14 H15 H17 H23 H24 H36 H41 
1-Methyladenosine 5.92E+03 6.67E+03 3.61E+03 3.03E+03 2.86E+03 1.59E+03 4.68E+03 5.40E+03 3.82E+03 3.14E+03 
2-Aminoadipate 1.51E+04 1.25E+04 2.44E+04 4.02E+04 2.05E+04 7.03E+03 1.28E+04 1.39E+04 1.29E+04 2.93E+04 
2-Dehydro-D-gluconate 4.78E+03 2.97E+03 3.26E+03 9.61E+03 3.14E+03 3.54E+02 3.99E+03 4.27E+03 3.31E+03 2.76E+03 
2-Hydroxy-2-methylsuccinate 2.52E+05 1.79E+05 1.16E+05 1.17E+05 1.92E+05 2.85E+04 2.61E+05 1.79E+05 1.46E+05 1.21E+05 
3-Methoxytyramine 4.52E+04 4.79E+04 4.82E+04 4.13E+04 4.15E+04 4.38E+04 4.20E+04 4.71E+04 4.64E+04 4.98E+04 
3_4-Dihydroxyphenylacetate 2.49E+04 2.22E+04 1.86E+04 3.30E+04 2.76E+04 2.44E+04 3.00E+04 3.02E+04 3.46E+04 2.28E+04 
4-Aminobutyrate 1.33E+06 7.87E+05 4.77E+05 1.46E+06 3.81E+05 1.73E+05 7.99E+05 8.01E+05 8.06E+05 4.86E+05 
5-Hydroxyindoleacetic acid 8.84E+04 5.86E+04 3.94E+04 8.33E+03 1.16E+04 2.25E+03 1.29E+04 1.57E+04 1.24E+04 2.62E+04 
Acadesine 5.17E+03 5.95E+03 9.13E+03 1.18E+04 6.05E+03 9.14E+03 5.73E+03 7.43E+03 6.99E+03 8.28E+03 
Acetyllysine 3.46E+03 2.75E+03 1.76E+03 7.10E+03 1.97E+03 1.00E+03 3.92E+03 4.74E+03 2.02E+03 2.42E+03 
Adenine 2.16E+04 2.30E+04 8.92E+03 3.18E+04 8.12E+03 3.57E+03 8.22E+03 8.34E+03 8.31E+03 5.45E+03 
Adenosine 9.51E+04 8.07E+04 2.94E+04 4.80E+05 8.23E+04 7.76E+04 4.98E+05 5.36E+05 4.93E+05 2.93E+04 
AICAR 1.10E+04 7.04E+03 1.30E+04 5.65E+04 1.07E+04 3.22E+03 7.57E+03 1.01E+04 1.17E+04 1.19E+04 
Alanine 1.48E+06 1.28E+06 1.25E+06 2.83E+06 1.22E+06 5.83E+05 1.28E+06 1.32E+06 1.21E+06 1.21E+06 
Allantoate 3.04E+03 3.42E+02 4.04E+02 4.50E+03 9.19E+02 4.44E+02 5.13E+03 1.55E+03 2.68E+03 1.10E+03 
alpha-Ketoglutarate 3.15E+03 4.36E+03 1.82E+03 2.96E+03 6.35E+03 1.80E+03 3.47E+03 3.65E+03 3.24E+03 1.16E+03 
AMP 2.27E+04 1.87E+04 2.84E+05 9.05E+05 1.16E+06 4.28E+05 9.46E+05 8.57E+05 7.12E+05 3.94E+05 
Allantoin 3.69E+03 2.44E+03 1.64E+03 7.83E+03 2.92E+03 1.68E+03 3.06E+03 3.80E+03 3.31E+03 5.09E+03 
Arginine 2.24E+04 2.29E+04 2.31E+04 1.34E+04 1.41E+04 6.15E+03 1.54E+04 1.79E+04 1.36E+04 2.66E+04 
Ascorbate 1.47E+07 2.38E+06 3.94E+06 2.79E+07 5.27E+06 1.38E+06 1.32E+07 1.32E+07 1.29E+07 5.69E+06 
Asparagine 7.79E+04 5.06E+04 4.81E+04 1.28E+05 3.55E+04 1.38E+04 4.48E+04 5.84E+04 3.98E+04 4.41E+04 
Aspartate 3.09E+06 2.93E+06 2.55E+06 6.08E+06 1.61E+06 4.93E+05 1.96E+06 1.94E+06 2.00E+06 1.82E+06 
beta-Alanine 1.48E+06 1.28E+06 1.25E+06 2.83E+06 1.22E+06 5.83E+05 1.28E+06 1.32E+06 1.21E+06 1.21E+06 
Betaine 3.27E+05 2.76E+05 2.61E+05 6.01E+05 1.99E+05 5.98E+04 2.46E+05 2.30E+05 2.30E+05 2.35E+05 
CDP-ethanolamine 3.09E+04 3.31E+04 3.08E+04 1.10E+05 3.17E+04 1.28E+04 3.33E+04 3.18E+04 2.99E+04 3.19E+04 
Citrate/isocitrate 3.42E+03 3.42E+03 4.49E+03 1.82E+03 2.03E+03 1.96E+03 2.31E+03 2.64E+03 3.81E+03 4.75E+03 
Citrulline 6.10E+04 5.99E+04 4.67E+04 5.41E+04 4.83E+04 1.84E+04 7.75E+04 6.33E+04 6.13E+04 4.33E+04 
CMP 4.44E+03 1.30E+03 1.92E+04 5.12E+04 1.78E+04 9.24E+03 1.80E+04 2.04E+04 1.48E+04 2.22E+04 
Creatine 1.62E+06 1.41E+06 1.41E+06 3.80E+06 1.29E+06 6.34E+05 1.41E+06 1.51E+06 1.33E+06 1.34E+06 
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Table 1.8 Continued 
Sample Name H6 H8 H9 H14 H15 H17 H23 H24 H36 H41 
Creatinine 1.55E+04 1.30E+04 1.27E+04 2.72E+04 8.16E+03 4.96E+03 1.44E+04 1.12E+04 1.16E+04 1.09E+04 
Cystathionine 1.72E+05 1.06E+05 1.19E+05 4.76E+05 1.56E+05 7.66E+04 1.82E+05 2.34E+05 2.14E+05 1.88E+05 
Cysteine 5.46E+05 3.65E+05 5.52E+05 2.01E+05 1.18E+05 1.12E+04 7.12E+04 9.20E+04 9.17E+04 3.09E+05 
Cystine 2.62E+04 5.74E+04 3.80E+04 9.62E+03 3.49E+03 1.02E+04 2.19E+03 1.97E+03 3.57E+03 1.32E+04 
Cytidine 8.30E+04 4.23E+04 3.24E+04 7.48E+04 2.14E+04 8.34E+03 4.10E+04 3.26E+04 3.44E+04 2.06E+04 
Cytidine 3.58E+04 2.94E+04 4.62E+04 7.69E+04 5.98E+04 4.29E+04 3.71E+04 3.81E+04 2.93E+04 6.51E+04 
D-Gluconate 6.02E+04 6.20E+04 4.74E+04 9.98E+04 4.11E+04 1.23E+04 4.69E+04 4.41E+04 4.97E+04 3.16E+04 
D-Glucosamine 1-phosphate 6.67E+03 5.62E+03 5.42E+02 1.00E+02 1.00E+02 1.00E+02 2.38E+02 3.91E+02 2.01E+02 1.82E+03 
D-Glyceraldehdye 3-phosphate 4.96E+05 5.16E+05 2.02E+05 3.41E+05 4.64E+04 3.03E+04 3.03E+05 2.48E+05 3.30E+05 4.13E+05 
Diiodothyronine 1.35E+04 1.14E+04 1.82E+04 6.79E+04 1.63E+04 1.35E+04 1.80E+04 9.87E+03 2.03E+04 1.72E+04 
Dimethylglycine 1.21E+05 9.50E+04 9.17E+04 2.68E+05 7.40E+04 3.37E+04 1.03E+05 1.01E+05 1.01E+05 7.11E+04 
Dimethylglycine 1.33E+06 7.87E+05 4.77E+05 1.46E+06 3.81E+05 1.73E+05 7.99E+05 8.01E+05 8.06E+05 4.86E+05 
Fumarate 1.84E+05 1.23E+05 3.61E+04 5.45E+04 8.61E+04 1.45E+04 1.41E+05 1.58E+05 1.12E+05 4.83E+04 
Glucosamine 1.00E+02 5.64E+02 3.86E+02 2.02E+03 1.00E+02 3.33E+02 1.00E+02 5.27E+02 1.00E+02 2.22E+02 
Glucose 1-phosphate 1.88E+05 1.10E+05 7.11E+04 2.03E+05 9.39E+04 2.86E+04 1.75E+05 1.55E+05 1.87E+05 8.83E+04 
Glucose 6-phosphate 6.00E+05 6.00E+05 9.71E+04 1.30E+05 2.98E+04 1.13E+04 8.23E+04 1.07E+05 5.96E+04 2.91E+05 
Glutamate 3.35E+07 3.02E+07 2.53E+07 8.48E+07 2.36E+07 1.22E+07 3.25E+07 3.10E+07 2.93E+07 2.24E+07 
Glutamine 1.44E+07 1.29E+07 1.11E+07 2.04E+07 1.18E+07 5.70E+06 1.36E+07 1.32E+07 1.21E+07 1.09E+07 
Glutathione 6.97E+06 4.54E+06 3.33E+06 1.32E+07 5.58E+06 9.77E+05 7.38E+06 7.77E+06 7.25E+06 4.90E+06 
Glutathione disulfide 9.44E+04 7.90E+04 2.60E+04 1.15E+04 1.64E+04 6.23E+04 3.01E+04 2.07E+04 2.76E+04 2.89E+04 
GMP 2.99E+03 1.95E+03 3.48E+04 5.62E+04 7.44E+04 2.76E+04 7.91E+04 6.65E+04 6.23E+04 4.58E+04 
Guanine 6.03E+03 5.52E+03 6.60E+03 8.98E+03 3.12E+03 2.91E+02 1.05E+03 3.03E+03 2.88E+03 4.09E+03 
Guanosine 1.23E+06 1.03E+06 4.37E+05 3.12E+05 1.00E+05 3.48E+04 2.20E+05 2.17E+05 2.24E+05 3.42E+05 
Histidine 1.93E+04 2.34E+04 1.90E+04 2.18E+04 1.73E+04 6.89E+03 1.63E+04 2.08E+04 1.52E+04 1.69E+04 
Homocysteic acid 1.05E+04 5.76E+03 1.05E+04 3.48E+04 1.15E+04 3.21E+03 1.06E+04 9.35E+03 1.29E+04 1.03E+04 
Homoserine 3.89E+05 3.57E+05 3.75E+05 7.12E+05 2.82E+05 2.02E+05 3.04E+05 3.75E+05 2.94E+05 3.94E+05 
Hydroxyphenylacetate 1.35E+05 1.37E+05 2.65E+05 1.41E+05 1.24E+05 5.46E+04 5.12E+04 2.14E+05 1.83E+05 9.61E+04 




Table 1.8 Continued 
Sample Name H6 H8 H9 H14 H15 H17 H23 H24 H36 H41 
IMP 1.84E+04 1.82E+04 4.20E+04 5.15E+04 6.37E+04 1.87E+04 8.24E+04 6.31E+04 5.91E+04 2.55E+04 
Inosine 5.65E+06 5.22E+06 3.58E+06 2.57E+06 1.01E+06 4.28E+05 1.29E+06 1.42E+06 1.57E+06 3.04E+06 
Lactate 4.47E+07 3.52E+07 3.86E+07 9.07E+07 3.34E+07 2.19E+07 3.93E+07 4.70E+07 4.04E+07 3.72E+07 
Leucine/Isoleucine 2.43E+05 2.23E+05 2.45E+05 4.22E+05 9.11E+04 2.36E+04 1.10E+05 1.12E+05 1.02E+05 1.45E+05 
Lysine 8.72E+03 7.00E+03 9.27E+03 3.94E+03 5.69E+03 1.89E+03 5.96E+03 7.32E+03 5.63E+03 5.88E+03 
Malate 5.08E+06 2.84E+06 1.21E+06 1.14E+06 1.61E+06 3.22E+05 2.94E+06 2.88E+06 2.13E+06 1.76E+06 
Mandelate 5.35E+04 7.31E+04 4.84E+04 6.66E+04 6.39E+04 7.27E+04 8.72E+04 1.18E+05 9.87E+04 8.54E+04 
Methionine 4.00E+05 3.60E+05 3.58E+05 6.94E+05 1.98E+05 5.63E+04 2.18E+05 2.37E+05 1.93E+05 2.90E+05 
Methionine sulfoxide 2.33E+04 3.34E+04 4.01E+04 7.46E+04 2.20E+04 2.18E+04 1.88E+04 2.51E+04 2.97E+04 3.34E+04 
Methylmalonate 6.35E+05 5.89E+05 4.15E+05 1.55E+06 1.80E+06 7.57E+05 1.86E+06 2.28E+06 1.41E+06 4.22E+05 
myo-Inositol 3.54E+05 2.87E+05 3.24E+05 6.65E+05 2.64E+05 2.10E+05 3.33E+05 3.97E+05 3.42E+05 2.80E+05 
N-Acetyl-beta-alanine 1.58E+04 1.80E+04 2.12E+04 3.07E+04 8.26E+03 6.47E+03 1.26E+04 1.12E+04 1.28E+04 1.59E+04 
N-Acetylglutamate 4.54E+05 3.60E+05 2.22E+05 2.09E+05 2.22E+05 5.82E+04 3.55E+05 3.32E+05 3.16E+05 1.60E+05 
N-Acetylglutamine 3.19E+05 2.85E+05 3.14E+05 4.98E+05 2.36E+05 5.57E+04 2.11E+05 2.12E+05 2.16E+05 3.07E+05 
N-Acetylornithine 4.24E+03 5.36E+03 4.72E+03 7.14E+03 3.37E+03 1.30E+03 3.70E+03 6.60E+03 6.19E+03 3.53E+03 
N-Acetyltaurine 1.11E+05 7.76E+04 3.29E+04 1.42E+05 5.01E+04 1.78E+04 1.46E+05 1.20E+05 8.29E+04 4.09E+04 
N-Acetyltaurine 2.09E+03 4.40E+03 2.94E+03 1.24E+03 2.04E+03 1.56E+03 7.72E+02 2.03E+03 3.25E+03 5.63E+03 
N-Carbamoyl-L-aspartate 6.94E+04 9.50E+04 7.85E+04 9.44E+04 8.51E+04 5.14E+04 8.42E+04 8.16E+04 9.58E+04 7.66E+04 
NAD+ 1.15E+03 2.97E+03 2.95E+03 2.60E+04 1.84E+04 7.16E+03 6.32E+03 5.11E+03 6.07E+03 1.54E+03 
Orotate 2.51E+04 1.09E+04 9.06E+03 2.67E+04 1.02E+04 3.35E+03 1.13E+04 1.46E+04 1.20E+04 1.02E+04 
Pantothenate 5.77E+05 3.38E+05 6.21E+05 4.05E+05 4.51E+05 2.52E+05 6.46E+05 5.85E+05 4.07E+05 4.76E+05 
Phenylalanine 1.90E+05 1.80E+05 2.47E+05 2.19E+05 1.09E+05 4.10E+04 9.11E+04 1.19E+05 8.71E+04 1.96E+05 
Phenyllactic acid 1.10E+05 9.18E+04 1.42E+05 9.57E+04 7.77E+04 5.31E+04 5.38E+04 1.44E+05 9.34E+04 7.60E+04 
Proline 1.15E+05 7.94E+04 6.17E+04 9.61E+04 4.37E+04 1.98E+04 8.84E+04 8.28E+04 7.33E+04 6.65E+04 
Pyroglutamic acid 3.24E+06 2.90E+06 2.93E+06 2.88E+06 8.29E+05 6.17E+05 9.51E+05 1.18E+06 9.61E+05 1.59E+06 
Pyruvate 5.80E+05 5.53E+05 4.12E+05 9.03E+05 3.44E+05 2.72E+05 3.81E+05 4.30E+05 4.25E+05 2.78E+05 
Ribose phosphate 4.05E+05 4.05E+05 1.88E+05 2.20E+05 7.49E+04 2.81E+04 1.32E+05 1.15E+05 1.24E+05 2.68E+05 




Table 1.8 Continued 
Sample Name H6 H8 H9 H14 H15 H17 H23 H24 H36 H41 
Serine 1.42E+06 1.19E+06 1.16E+06 2.92E+06 8.39E+05 5.19E+05 1.11E+06 1.07E+06 9.01E+05 1.11E+06 
sn-Glycerol 3-phosphate 1.82E+04 1.85E+04 3.35E+04 7.14E+04 3.73E+04 4.52E+04 3.44E+04 1.93E+04 2.09E+04 1.74E+04 
Succinate 6.35E+05 5.89E+05 4.15E+05 1.55E+06 1.80E+06 7.57E+05 1.86E+06 2.28E+06 1.41E+06 4.22E+05 
Taurine 1.26E+07 1.25E+07 8.96E+06 3.36E+07 7.94E+06 4.41E+06 1.18E+07 1.02E+07 1.20E+07 9.77E+06 
Thymidine 7.78E+03 9.78E+03 5.45E+03 1.06E+04 2.72E+03 5.85E+02 4.38E+03 4.76E+03 5.01E+03 2.40E+03 
Thymine 5.30E+03 4.05E+03 4.26E+03 5.45E+03 2.25E+03 9.30E+02 3.01E+03 3.73E+03 3.23E+03 4.50E+03 
Trehalose/sucrose 2.87E+04 4.15E+04 8.57E+04 6.53E+04 2.77E+04 2.99E+04 5.91E+04 3.37E+04 3.07E+04 3.07E+04 
Tryptophan 2.14E+05 2.11E+05 1.99E+05 3.41E+05 1.76E+05 4.51E+04 1.69E+05 1.92E+05 1.57E+05 1.48E+05 
Tyrosine 6.72E+05 6.10E+05 5.68E+05 1.72E+06 5.69E+05 1.89E+05 5.43E+05 6.10E+05 4.99E+05 4.86E+05 
UDP-glucose 7.44E+04 2.84E+04 5.84E+04 7.73E+04 8.40E+04 4.56E+04 1.01E+05 9.77E+04 9.92E+04 1.08E+05 
UDP-N-acetylglucosamine 9.87E+04 5.18E+04 4.56E+04 6.79E+04 7.97E+04 3.19E+04 1.04E+05 9.25E+04 9.97E+04 8.00E+04 
UMP 5.78E+03 2.38E+03 5.79E+04 1.42E+05 1.33E+05 4.81E+04 1.29E+05 1.28E+05 1.08E+05 7.55E+04 
Uracil 4.60E+05 3.27E+05 2.09E+05 3.17E+05 4.04E+04 2.02E+04 1.21E+05 1.21E+05 1.34E+05 1.93E+05 
Uric acid 2.62E+04 1.81E+04 1.09E+05 1.28E+05 3.73E+04 8.66E+03 2.28E+04 2.95E+04 3.79E+04 4.12E+04 
Uridine 3.07E+04 2.59E+04 1.51E+04 4.37E+04 1.68E+04 4.03E+03 2.28E+04 2.09E+04 2.05E+04 1.49E+04 
Xanthine 6.85E+05 7.59E+05 4.84E+05 3.05E+05 1.14E+05 3.39E+04 2.17E+05 2.00E+05 1.68E+05 3.74E+05 




Table 1.9 Raw Data of Dominant Hamsters from NAc  
Sample Name H2 H5 H12 H19 H25 H28 H33 H38 H45 H47 
2-Hydroxy-2-methylsuccinate 5.68E+05 1.54E+05 5.48E+05 5.55E+05 4.08E+05 5.20E+05 6.13E+05 5.19E+05 3.04E+05 4.90E+05 
3-Phosphoglycerate 9.59E+04 2.82E+04 1.00E+02 4.82E+03 1.00E+02 4.37E+03 1.00E+02 2.11E+05 6.28E+04 1.05E+05 
3_4-Dihydroxyphenylacetate 5.28E+03 1.27E+04 2.42E+04 2.76E+04 2.81E+04 1.76E+04 2.44E+04 1.80E+04 2.92E+04 6.42E+03 
4-Aminobutyrate 1.01E+06 1.76E+06 5.85E+05 8.49E+05 9.67E+05 6.60E+05 1.17E+06 6.99E+05 1.08E+06 6.42E+05 
5-Hydroxyindoleacetic acid 3.60E+04 4.17E+04 8.14E+04 5.64E+04 5.03E+04 2.57E+04 5.70E+04 5.01E+04 7.19E+04 4.42E+04 
Aconitate 1.21E+05 9.93E+04 9.26E+04 1.37E+05 9.99E+04 1.35E+05 9.51E+04 2.07E+05 1.04E+05 1.45E+05 
Alanine 1.91E+06 1.42E+06 1.45E+06 1.41E+06 1.73E+06 1.55E+06 2.02E+06 1.89E+06 1.51E+06 1.53E+06 
alpha-Ketoglutarate 9.24E+04 3.46E+04 2.89E+04 1.15E+05 5.45E+04 8.54E+04 6.02E+04 6.13E+04 4.18E+04 7.54E+04 
AMP 6.14E+04 1.89E+04 3.79E+05 9.11E+04 2.67E+05 5.48E+04 6.79E+04 5.20E+04 4.79E+04 5.56E+04 
Arginine 1.97E+04 1.72E+04 1.23E+04 7.83E+03 1.45E+04 1.22E+04 2.15E+04 2.34E+04 2.07E+04 2.89E+04 
Ascorbate 1.00E+02 1.00E+02 1.32E+06 2.39E+04 1.00E+02 1.00E+02 7.31E+04 4.29E+05 4.21E+04 3.41E+04 
Asparagine 6.45E+04 2.95E+04 5.25E+04 5.33E+04 5.94E+04 6.25E+04 6.47E+04 5.08E+04 6.49E+04 6.72E+04 
Aspartate 8.03E+06 4.33E+06 5.76E+06 5.59E+06 6.11E+06 5.40E+06 6.88E+06 7.40E+06 7.29E+04 6.84E+06 
CDP-ethanolamine 2.39E+04 5.98E+03 2.63E+04 2.25E+04 1.69E+04 7.35E+03 1.48E+04 2.98E+04 1.36E+03 1.91E+04 
Citrate/isocitrate 4.95E+06 3.04E+06 2.71E+06 4.30E+06 2.64E+06 4.66E+06 4.24E+06 1.22E+07 2.94E+06 8.30E+06 
Citrulline 1.88E+04 4.49E+03 1.17E+04 7.81E+03 5.49E+03 2.17E+04 1.17E+04 1.60E+04 9.52E+03 1.96E+04 
Creatine 1.80E+06 1.29E+06 9.39E+05 9.24E+05 1.55E+06 1.29E+06 1.80E+06 1.55E+06 1.05E+06 1.31E+06 
Creatinine 1.21E+05 4.52E+04 3.17E+04 4.20E+04 4.66E+04 4.77E+04 6.56E+04 8.76E+04 6.44E+04 1.12E+05 
Cysteine 2.42E+03 1.68E+03 4.53E+02 7.99E+02 2.78E+03 1.00E+02 3.40E+03 1.23E+05 2.04E+03 1.13E+05 
Cystine 1.41E+05 1.57E+05 9.32E+04 7.39E+04 5.38E+04 5.52E+04 9.93E+04 8.44E+04 1.11E+05 3.87E+04 
Cytidine 4.04E+04 1.81E+04 1.81E+04 2.13E+04 1.84E+04 2.67E+04 2.56E+04 2.72E+04 5.16E+04 1.47E+04 
Cytidine 2.26E+04 4.52E+04 1.01E+04 8.90E+03 2.42E+04 3.66E+04 4.13E+04 1.71E+04 1.30E+04 1.68E+04 
D-Glyceraldehdye 3-phosphate 3.06E+05 4.33E+04 8.78E+04 4.24E+04 7.15E+04 9.34E+04 4.16E+04 3.01E+05 1.63E+05 2.74E+05 
Dopamine 4.51E+04 1.74E+04 5.42E+04 4.17E+04 6.39E+04 3.71E+04 1.00E+05 1.41E+04 2.79E+04 4.95E+04 
Fructose 1_6-bisphosphate 5.85E+04 6.30E+03 3.29E+03 1.00E+02 1.00E+02 1.00E+02 5.18E+03 1.73E+05 1.24E+05 1.31E+05 
Fumarate 4.82E+06 8.44E+05 2.79E+06 2.19E+06 2.45E+06 3.42E+06 2.69E+06 4.21E+06 2.23E+06 4.27E+06 
Glutamate 1.98E+07 6.96E+06 1.53E+07 1.55E+07 1.47E+07 1.52E+07 1.77E+07 1.65E+07 9.21E+06 1.55E+07 
Glutamine 1.01E+07 5.78E+06 8.06E+06 7.55E+06 7.45E+06 7.77E+06 8.11E+06 8.20E+06 8.60E+06 7.94E+06 
Glutathione 1.00E+02 3.81E+03 2.46E+05 2.63E+05 2.90E+05 1.00E+02 4.65E+05 3.28E+05 2.43E+05 4.38E+05 
Glutathione disulfide 9.94E+04 4.92E+03 1.35E+05 6.91E+04 1.10E+05 3.02E+05 9.54E+04 1.06E+05 8.99E+04 2.10E+05 
Glycine 3.90E+05 4.34E+05 7.56E+04 1.21E+05 2.60E+05 4.23E+05 2.79E+05 2.69E+05 3.09E+05 1.98E+05 
Guanosine 4.51E+05 3.16E+05 2.96E+05 2.98E+05 2.74E+05 3.87E+05 3.65E+05 3.94E+05 2.37E+05 3.64E+05 
Histidine 7.23E+04 3.89E+04 5.85E+04 4.24E+04 4.79E+04 4.94E+04 9.29E+04 7.30E+04 4.43E+04 8.24E+04 
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Table 1.9 Continued 
Sample Name H2 H5 H12 H19 H25 H28 H33 H38 H45 H47 
Homoserine 8.17E+05 4.33E+05 6.34E+05 4.99E+05 7.30E+05 6.97E+05 8.46E+05 6.23E+05 5.62E+05 7.31E+05 
Homovanillic acid 1.22E+05 5.14E+04 9.89E+04 1.40E+05 9.59E+04 9.01E+04 1.42E+05 1.38E+05 7.29E+04 1.39E+05 
Hydroxybenzoate 1.50E+06 5.57E+05 3.76E+06 3.09E+06 3.02E+06 4.43E+06 4.26E+06 9.37E+05 1.80E+06 1.77E+06 
Hypoxanthine 2.85E+06 1.38E+06 1.06E+06 9.18E+05 1.07E+06 1.32E+06 1.41E+06 2.44E+06 2.62E+06 2.10E+06 
IMP 1.68E+04 7.72E+03 8.79E+04 2.81E+04 7.89E+04 5.76E+03 2.18E+04 7.11E+03 6.12E+03 5.40E+03 
Inosine 2.82E+06 1.50E+06 2.17E+06 2.19E+06 2.20E+06 2.42E+06 2.84E+06 2.39E+06 1.13E+06 2.61E+06 
Lactate 7.55E+07 4.78E+07 6.74E+07 6.05E+07 6.73E+07 6.96E+07 6.46E+07 7.60E+07 2.23E+07 7.19E+07 
Leucine/Isoleucine 1.89E+05 7.16E+04 8.95E+04 4.43E+04 7.46E+04 8.71E+04 1.14E+05 1.09E+05 1.37E+05 1.04E+05 
Malate 5.46E+07 1.69E+07 3.28E+07 2.91E+07 3.25E+07 3.98E+07 3.44E+07 4.81E+07 2.48E+07 4.77E+07 
Methionine 6.93E+04 3.14E+04 3.75E+04 2.94E+04 3.36E+04 4.38E+04 4.73E+04 6.32E+04 5.32E+04 4.56E+04 
Methylmalonate 2.46E+06 1.13E+06 2.33E+06 3.18E+06 2.75E+06 3.68E+06 3.17E+06 2.88E+06 1.92E+05 1.91E+06 
myo-Inositol 4.22E+05 2.15E+05 3.16E+05 3.06E+05 3.52E+05 3.94E+05 3.27E+05 4.21E+05 4.84E+04 2.93E+05 
N-Acetyl-beta-alanine 1.04E+06 5.72E+05 6.83E+05 8.38E+05 7.71E+05 6.89E+05 8.23E+05 8.52E+05 5.45E+05 9.82E+05 
N-Acetylglutamate 8.01E+05 3.27E+05 7.24E+05 6.36E+05 5.69E+05 4.30E+05 6.00E+05 6.68E+05 3.41E+05 5.73E+05 
N-Carbamoyl-L-aspartate 1.74E+05 4.24E+05 4.12E+05 5.80E+05 5.55E+05 2.94E+05 3.93E+05 3.68E+05 3.72E+05 6.07E+05 
Pantothenate 7.61E+05 5.82E+05 1.79E+06 8.94E+05 9.32E+05 4.85E+05 9.87E+05 6.91E+05 9.62E+05 7.83E+05 
Phenylalanine 8.80E+04 4.99E+04 5.51E+04 4.91E+04 5.37E+04 5.86E+04 9.73E+04 7.94E+04 3.95E+04 9.75E+04 
Phosphoenolpyruvate 1.13E+05 3.60E+04 1.00E+02 9.05E+03 1.00E+02 6.03E+03 1.00E+02 1.27E+05 5.85E+04 6.39E+04 
Proline 1.15E+05 6.60E+04 6.86E+04 5.86E+04 6.81E+04 8.38E+04 9.06E+04 8.57E+04 8.10E+04 8.73E+04 
Pyroglutamic acid 2.61E+06 1.43E+06 1.00E+06 7.03E+05 6.31E+05 1.75E+06 1.29E+06 2.44E+06 1.62E+06 1.28E+06 
Serine 1.10E+06 5.71E+05 9.86E+05 1.00E+06 1.01E+06 1.14E+06 1.09E+06 8.38E+05 8.92E+05 1.01E+06 
Succinate 2.46E+06 1.13E+06 2.33E+06 3.18E+06 2.75E+06 3.68E+06 3.17E+06 2.88E+06 1.92E+05 1.91E+06 
Sulfolactate 1.15E+04 1.71E+04 1.21E+05 1.72E+05 1.14E+05 1.40E+05 7.36E+04 8.75E+04 1.06E+05 1.10E+05 
Sulfolactate 4.38E+04 1.06E+04 4.33E+04 7.59E+04 3.14E+04 4.77E+04 3.62E+04 1.57E+04 2.85E+04 1.99E+04 
Taurine 1.54E+07 5.52E+06 1.28E+07 9.92E+06 1.01E+07 1.27E+07 1.13E+07 1.31E+07 9.20E+06 1.18E+07 
Trehalose/sucrose 2.58E+04 3.52E+04 2.45E+04 3.31E+04 3.72E+04 3.56E+04 4.49E+04 1.34E+04 4.53E+04 2.29E+04 
Tyrosine 8.81E+04 5.78E+04 6.44E+04 5.25E+04 8.08E+04 6.77E+04 9.92E+04 9.62E+04 1.05E+05 9.71E+04 
UDP-glucose 1.02E+05 5.30E+04 3.55E+05 1.33E+05 1.52E+05 8.49E+04 1.23E+05 1.17E+05 1.31E+05 1.14E+05 
UDP-N-acetylglucosamine 8.61E+04 2.55E+04 2.19E+05 1.04E+05 8.46E+04 7.24E+04 8.69E+04 7.90E+04 6.77E+04 7.03E+04 
UMP 5.77E+03 6.65E+03 1.25E+05 1.87E+04 8.51E+04 5.27E+03 8.72E+03 4.14E+03 5.66E+03 1.00E+02 
Uracil 1.46E+06 5.53E+05 5.50E+05 5.40E+05 5.93E+05 7.57E+05 7.82E+05 1.44E+06 8.38E+05 9.47E+05 
Uric acid 2.64E+04 7.70E+03 3.33E+04 4.57E+04 2.35E+04 4.50E+04 5.42E+04 4.19E+04 1.67E+04 9.76E+04 
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Table 1.9 Continued 
Sample Name H2 H5 H12 H19 H25 H28 H33 H38 H45 H47 
Uridine 2.07E+05 9.29E+04 1.52E+05 1.60E+05 1.55E+05 1.70E+05 2.07E+05 1.62E+05 1.47E+05 1.80E+05 
Valine 1.72E+05 7.10E+04 1.81E+05 1.29E+05 1.60E+05 2.08E+05 1.59E+05 1.31E+05 1.20E+05 1.37E+05 




Table 1.10 Raw Data of Handled Control Hamsters from NAc  
Sample Name H1 H18 H26 H31 H32 H34 H43 H44 H49 H52 H53 
2-Hydroxy-2-methylsuccinate 3.99E+05 3.92E+05 7.28E+05 4.79E+05 2.31E+05 5.15E+05 2.94E+05 3.84E+05 4.14E+05 4.74E+05 2.67E+05 
3-Phosphoglycerate 1.14E+05 3.73E+03 3.38E+03 1.00E+02 1.00E+02 4.38E+03 2.72E+05 6.09E+04 3.41E+05 9.09E+05 1.01E+05 
3_4-Dihydroxyphenylacetate 1.97E+04 4.02E+04 1.49E+04 1.19E+04 1.30E+04 5.57E+03 1.44E+04 3.82E+03 1.47E+04 7.11E+03 6.78E+03 
4-Aminobutyrate 7.86E+05 7.55E+05 5.16E+05 5.18E+05 1.33E+06 6.61E+05 1.93E+06 7.17E+05 1.08E+06 8.50E+05 1.37E+06 
5-Hydroxyindoleacetic acid 3.18E+04 7.09E+04 3.07E+04 3.26E+04 3.11E+04 5.82E+04 8.02E+04 3.06E+04 3.45E+04 1.37E+04 4.28E+04 
Aconitate 1.01E+05 1.23E+05 1.38E+05 9.16E+04 1.08E+05 1.08E+05 1.74E+05 9.41E+04 1.29E+05 1.48E+05 8.64E+04 
Alanine 1.70E+06 1.36E+06 1.72E+06 1.53E+06 1.74E+06 1.93E+06 1.65E+06 1.36E+06 1.40E+06 1.47E+06 1.24E+06 
alpha-Ketoglutarate 4.34E+04 4.90E+04 5.09E+04 2.66E+04 5.02E+04 5.24E+04 5.78E+04 4.03E+04 6.07E+04 6.33E+04 3.00E+04 
AMP 1.14E+05 9.49E+04 1.19E+05 1.53E+05 1.85E+05 1.34E+05 4.55E+04 2.37E+04 3.69E+04 4.40E+04 5.16E+04 
Arginine 1.86E+04 1.01E+04 2.00E+04 1.84E+04 1.72E+04 2.65E+04 1.51E+04 2.46E+04 2.14E+04 2.20E+04 8.05E+03 
Ascorbate 3.87E+05 1.63E+06 5.97E+04 1.20E+06 8.82E+05 3.22E+06 5.64E+04 3.37E+04 2.30E+03 2.71E+03 2.51E+04 
Asparagine 5.53E+04 4.66E+04 5.06E+04 4.13E+04 4.60E+04 5.01E+04 3.24E+04 2.88E+04 3.55E+04 3.75E+04 2.37E+04 
Aspartate 5.76E+06 4.25E+06 6.80E+06 4.22E+06 4.52E+06 5.42E+06 7.39E+06 6.90E+04 5.52E+06 5.37E+06 8.92E+04 
CDP-ethanolamine 2.77E+04 1.98E+04 1.36E+04 1.58E+04 4.24E+03 2.40E+04 1.99E+04 9.92E+02 1.06E+04 1.67E+04 1.00E+02 
Citrate/isocitrate 2.23E+06 5.00E+06 3.26E+06 2.39E+06 2.68E+06 4.96E+06 1.18E+07 1.64E+06 8.25E+06 1.29E+07 2.00E+06 
Citrulline 1.01E+04 4.05E+03 2.02E+04 2.33E+04 2.06E+04 1.03E+04 9.99E+03 1.12E+04 6.73E+03 3.71E+03 3.18E+03 
Creatine 1.30E+06 8.94E+05 1.49E+06 1.42E+06 1.34E+06 1.70E+06 1.43E+06 8.88E+05 1.03E+06 1.08E+06 6.82E+05 
Creatinine 1.01E+05 4.15E+04 6.15E+04 4.08E+04 4.01E+04 7.44E+04 1.04E+05 3.74E+04 8.28E+04 1.30E+05 3.55E+04 
Cysteine 9.50E+03 9.66E+02 1.57E+03 2.97E+03 1.20E+03 6.21E+03 1.42E+04 3.46E+03 5.12E+04 2.36E+03 7.53E+02 
Cystine 1.09E+05 8.79E+04 7.03E+04 7.69E+04 9.77E+04 1.12E+05 1.31E+05 9.13E+04 7.17E+04 1.05E+05 8.51E+04 
Cytidine 2.90E+04 2.40E+04 2.90E+04 2.22E+04 1.71E+04 3.12E+04 2.92E+04 3.64E+04 3.21E+04 1.90E+04 3.79E+04 
Cytidine 4.35E+04 3.63E+03 1.38E+04 3.46E+04 2.27E+04 6.21E+04 1.86E+04 8.83E+03 5.04E+03 2.06E+04 4.06E+03 
D-Glyceraldehdye 3-phosphate 3.61E+05 3.66E+04 1.48E+05 1.27E+05 1.33E+05 8.14E+04 1.36E+05 1.56E+05 3.41E+05 3.30E+05 7.76E+04 
Dopamine 8.61E+04 7.22E+04 4.46E+04 8.56E+04 4.41E+04 8.32E+04 1.59E+04 6.15E+03 2.22E+04 2.19E+04 4.60E+03 
Fructose 1_6-bisphosphate 1.17E+05 1.00E+02 1.36E+04 6.54E+03 1.00E+02 1.52E+04 2.12E+04 1.26E+05 2.17E+05 2.49E+05 9.50E+04 
Fumarate 3.87E+06 1.99E+06 2.59E+06 1.94E+06 2.11E+06 2.82E+06 1.59E+06 1.55E+06 3.21E+06 2.99E+06 1.04E+06 
Glutamate 1.74E+07 1.42E+07 1.95E+07 1.55E+07 1.51E+07 1.92E+07 1.31E+07 1.17E+07 1.30E+07 1.45E+07 5.55E+06 
Glutamine 9.90E+06 8.51E+06 7.95E+06 8.90E+06 9.60E+06 9.63E+06 6.81E+06 6.06E+06 5.66E+06 5.89E+06 3.48E+06 
Glutathione 2.53E+05 3.56E+05 1.54E+05 4.97E+05 4.22E+05 6.30E+05 3.36E+04 1.75E+05 1.54E+05 2.97E+04 3.66E+04 
Glutathione disulfide 1.16E+05 2.39E+04 1.23E+05 6.94E+04 4.75E+04 5.88E+04 9.44E+04 3.60E+04 1.19E+05 1.48E+05 1.83E+04 
Glycine 4.01E+05 7.76E+04 1.13E+05 9.13E+04 3.79E+05 3.38E+05 3.09E+05 9.35E+04 3.40E+05 3.86E+05 1.19E+05 
Guanosine 3.17E+05 3.41E+05 4.14E+05 3.24E+05 2.81E+05 4.31E+05 2.77E+05 2.30E+05 2.95E+05 3.19E+05 1.63E+05 
Histidine 1.06E+05 5.92E+04 5.84E+04 5.35E+04 4.42E+04 6.48E+04 8.90E+04 2.30E+04 4.99E+04 6.65E+04 2.06E+04 
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Table 1.10 Continued 
Sample Name H1 H18 H26 H31 H32 H34 H43 H44 H49 H52 H53 
Homoserine 6.23E+05 5.80E+05 6.55E+05 7.91E+05 5.85E+05 6.96E+05 4.80E+05 3.59E+05 4.76E+05 5.83E+05 2.23E+05 
Homovanillic acid 5.23E+04 1.04E+05 9.84E+04 7.27E+04 6.64E+04 1.16E+05 9.25E+04 8.64E+04 1.13E+05 1.20E+05 5.82E+04 
Hydroxybenzoate 1.29E+06 1.86E+06 2.53E+06 3.09E+06 1.86E+06 2.03E+06 6.87E+05 5.74E+05 4.63E+05 1.41E+06 5.76E+05 
Hypoxanthine 2.55E+06 9.43E+05 1.19E+06 9.60E+05 9.59E+05 1.39E+06 2.65E+06 2.50E+06 2.57E+06 2.56E+06 2.17E+06 
IMP 2.02E+04 2.55E+04 1.92E+04 5.92E+04 3.98E+04 5.71E+04 4.99E+03 6.49E+03 1.09E+04 5.55E+03 6.15E+03 
Inosine 2.24E+06 2.37E+06 2.81E+06 2.49E+06 2.61E+06 2.88E+06 2.29E+06 9.59E+05 1.82E+06 1.92E+06 8.35E+05 
Lactate 7.03E+07 5.77E+07 6.16E+07 6.76E+07 6.81E+07 6.90E+07 5.60E+07 1.83E+07 5.60E+07 6.01E+07 1.52E+07 
Leucine/Isoleucine 1.38E+05 7.44E+04 7.60E+04 8.75E+04 8.50E+04 1.04E+05 1.00E+05 1.23E+05 1.09E+05 1.23E+05 1.19E+05 
Malate 4.68E+07 2.33E+07 3.21E+07 2.69E+07 2.78E+07 3.65E+07 2.36E+07 2.02E+07 3.61E+07 3.53E+07 1.41E+07 
Methionine 7.04E+04 3.35E+04 3.98E+04 3.46E+04 3.44E+04 4.54E+04 6.42E+04 4.70E+04 5.68E+04 5.28E+04 4.11E+04 
Methylmalonate 2.47E+06 1.73E+06 2.34E+06 2.25E+06 2.35E+06 2.65E+06 1.58E+06 1.64E+05 1.45E+06 1.93E+06 1.98E+05 
myo-Inositol 3.35E+05 2.49E+05 2.68E+05 3.63E+05 3.38E+05 3.60E+05 2.68E+05 2.77E+04 2.85E+05 2.44E+05 2.05E+04 
N-Acetyl-beta-alanine 8.08E+05 9.83E+05 8.69E+05 8.83E+05 7.31E+05 8.40E+05 7.59E+05 5.78E+05 6.05E+05 7.73E+05 4.93E+05 
N-Acetylglutamate 3.99E+05 6.01E+05 5.33E+05 4.69E+05 4.62E+05 5.52E+05 6.00E+05 2.84E+05 4.73E+05 6.02E+05 2.09E+05 
N-Carbamoyl-L-aspartate 4.58E+05 4.10E+05 5.34E+05 3.40E+05 5.42E+05 2.03E+05 4.88E+05 4.85E+05 3.41E+05 5.06E+05 4.51E+05 
Pantothenate 7.25E+05 9.75E+05 5.66E+05 6.66E+05 6.95E+05 7.92E+05 1.04E+06 5.74E+05 7.08E+05 7.23E+05 9.92E+05 
Phenylalanine 1.03E+05 6.77E+04 6.41E+04 5.46E+04 7.05E+04 6.48E+04 7.38E+04 3.48E+04 6.86E+04 6.90E+04 2.56E+04 
Phosphoenolpyruvate 9.70E+04 5.72E+03 1.00E+02 3.67E+03 1.00E+02 6.25E+03 1.94E+05 8.22E+04 1.42E+05 3.00E+05 7.23E+04 
Proline 1.07E+05 4.48E+04 8.94E+04 8.62E+04 8.18E+04 1.31E+05 6.54E+04 6.93E+04 7.25E+04 1.05E+05 5.22E+04 
Pyroglutamic acid 1.85E+06 8.39E+05 8.58E+05 8.56E+05 6.82E+05 8.44E+05 2.75E+06 1.52E+06 1.53E+06 3.22E+06 1.29E+06 
Serine 1.10E+06 6.74E+05 1.06E+06 8.19E+05 8.75E+05 9.81E+05 7.38E+05 5.21E+05 7.52E+05 7.54E+05 2.92E+05 
Succinate 2.47E+06 1.73E+06 2.34E+06 2.25E+06 2.35E+06 2.65E+06 1.58E+06 1.64E+05 1.45E+06 1.93E+06 1.98E+05 
Sulfolactate 1.82E+04 1.67E+05 9.15E+04 1.99E+05 8.96E+04 1.14E+05 1.16E+05 1.84E+04 1.39E+04 2.59E+04 1.57E+04 
Sulfolactate 5.40E+04 2.68E+04 4.71E+04 2.93E+04 2.28E+04 7.90E+03 2.93E+04 1.86E+04 2.97E+04 2.86E+04 3.62E+04 
Taurine 1.30E+07 8.82E+06 1.46E+07 1.19E+07 1.14E+07 1.40E+07 9.64E+06 9.13E+06 1.01E+07 9.43E+06 4.82E+06 
Trehalose/sucrose 2.19E+05 2.53E+04 2.97E+04 4.25E+04 4.53E+04 1.40E+04 8.98E+03 8.64E+03 4.55E+03 1.38E+04 1.30E+04 
Tyrosine 9.70E+04 6.24E+04 6.74E+04 6.04E+04 5.65E+04 9.13E+04 1.12E+05 6.03E+04 6.64E+04 8.55E+04 6.05E+04 
UDP-glucose 2.15E+05 1.48E+05 1.19E+05 1.46E+05 8.71E+04 1.26E+05 1.07E+05 1.20E+05 1.44E+05 7.28E+04 7.06E+04 
UDP-N-acetylglucosamine 9.94E+04 9.43E+04 9.17E+04 1.14E+05 8.39E+04 8.23E+04 6.72E+04 7.85E+04 7.81E+04 4.58E+04 3.80E+04 
UMP 1.65E+04 2.28E+04 2.07E+04 4.31E+04 4.69E+04 2.63E+04 1.00E+02 1.00E+02 1.00E+02 1.00E+02 1.00E+02 




Table 1.11 Raw Data of Subordinate Hamsters from NAc 
Sample Name H6 H7 H8 H9 H14 H15 H17 H23 H24 H35 H36 H41 
2-Hydroxy-2-
methylsuccinate 3.49E+05 2.10E+05 1.88E+05 5.16E+05 1.81E+05 1.67E+05 4.98E+05 6.02E+05 5.30E+05 3.43E+05 5.10E+05 2.42E+05 
3-Phosphoglycerate 5.38E+04 8.13E+04 1.17E+05 1.23E+05 1.00E+02 1.00E+02 2.55E+03 1.00E+02 1.00E+02 4.87E+03 4.84E+03 4.82E+04 
3_4-
Dihydroxyphenylaceta
te 1.12E+04 4.79E+03 4.07E+03 5.47E+03 8.07E+03 1.02E+04 2.25E+04 3.58E+04 7.96E+03 1.10E+04 1.77E+04 5.21E+03 
4-Aminobutyrate 8.34E+05 1.05E+06 1.97E+06 7.40E+05 8.56E+05 2.92E+05 3.45E+05 8.80E+05 6.64E+05 1.60E+06 1.42E+06 5.78E+05 
5-Hydroxyindoleacetic 
acid 5.70E+04 6.21E+04 1.17E+04 3.18E+04 3.48E+04 1.44E+04 3.44E+04 3.76E+04 1.51E+04 2.59E+04 4.09E+04 1.38E+04 
Aconitate 1.68E+05 1.42E+05 1.35E+05 1.44E+05 2.32E+04 2.32E+04 9.32E+04 1.44E+05 9.13E+04 7.51E+04 6.73E+04 1.14E+05 
Alanine 1.95E+06 1.50E+06 1.49E+06 1.53E+06 1.19E+06 5.71E+05 1.29E+06 1.63E+06 1.29E+06 1.46E+06 1.76E+06 1.39E+06 
alpha-Ketoglutarate 5.69E+04 4.50E+04 3.88E+04 6.08E+04 1.86E+04 1.80E+04 3.85E+04 4.88E+04 4.84E+04 4.26E+04 2.34E+04 3.02E+04 
AMP 3.45E+04 3.71E+04 1.95E+04 6.83E+04 1.55E+05 8.32E+04 4.45E+04 1.46E+05 1.46E+05 4.69E+04 1.47E+05 3.03E+04 
Arginine 3.57E+04 1.46E+04 1.98E+04 2.34E+04 9.11E+03 2.53E+03 1.41E+04 1.86E+04 1.55E+04 2.50E+04 2.30E+04 1.29E+04 
Ascorbate 2.33E+04 3.97E+04 1.00E+02 1.00E+02 6.71E+04 1.00E+02 7.85E+05 3.75E+05 2.79E+04 1.00E+02 1.63E+06 1.95E+04 
Asparagine 4.71E+04 5.50E+04 3.90E+04 5.09E+04 3.55E+04 2.62E+04 6.27E+04 6.99E+04 4.19E+04 4.40E+04 4.37E+04 2.95E+04 
Aspartate 8.30E+04 9.81E+04 6.05E+04 7.12E+06 3.76E+06 1.52E+06 4.36E+06 5.62E+06 3.78E+06 5.35E+06 5.98E+06 4.45E+04 
CDP-ethanolamine 5.12E+02 5.28E+03 4.70E+02 1.82E+04 1.04E+04 2.92E+03 3.45E+04 2.65E+04 9.36E+03 1.26E+04 2.44E+04 7.53E+02 
Citrate/isocitrate 2.55E+06 3.87E+06 2.35E+06 7.18E+06 8.34E+05 3.33E+05 4.71E+06 3.37E+06 1.76E+06 1.91E+06 4.02E+06 2.06E+06 
Citrulline 1.69E+04 1.07E+04 4.68E+03 1.49E+04 8.65E+03 1.61E+03 1.51E+04 2.71E+04 2.02E+04 1.06E+04 8.16E+03 8.44E+03 
Creatine 1.57E+06 1.17E+06 1.27E+06 1.32E+06 9.89E+05 3.92E+05 1.03E+06 1.50E+06 9.90E+05 1.34E+06 1.68E+06 9.98E+05 
Creatinine 5.22E+04 3.94E+04 3.47E+04 6.79E+04 2.20E+04 1.13E+04 4.64E+04 4.81E+04 2.18E+04 4.37E+04 5.50E+04 3.14E+04 
Cysteine 2.70E+03 8.59E+02 1.87E+03 1.48E+04 1.60E+03 1.00E+02 1.81E+03 1.50E+03 1.53E+03 1.28E+03 1.02E+04 1.30E+03 
Cystine 1.59E+05 1.09E+05 1.42E+05 2.27E+05 7.13E+04 2.58E+04 9.67E+04 9.20E+04 4.69E+04 6.74E+04 9.57E+04 9.30E+04 
Cytidine 2.98E+04 2.36E+04 2.53E+04 3.08E+04 1.67E+04 5.64E+03 2.39E+04 1.64E+04 1.31E+04 2.04E+04 1.55E+04 2.07E+04 
Cytidine 2.05E+04 1.55E+04 4.05E+04 3.98E+04 1.49E+04 1.18E+04 2.56E+04 2.32E+04 3.99E+03 3.91E+04 3.03E+04 1.23E+04 
D-Glyceraldehdye 3-
phosphate 7.64E+04 6.08E+04 1.04E+05 2.89E+05 2.89E+04 7.61E+03 4.56E+04 1.11E+05 8.13E+04 3.42E+04 6.29E+04 1.06E+05 
Dopamine 1.82E+04 3.97E+04 6.44E+03 2.38E+04 3.41E+04 2.12E+04 5.71E+04 9.71E+04 2.23E+04 3.61E+04 3.92E+04 1.14E+04 
Fructose 1_6-
bisphosphate 1.26E+04 7.91E+03 2.47E+04 5.18E+04 3.97E+03 1.00E+02 4.31E+03 1.31E+04 4.71E+03 8.16E+03 6.79E+03 2.67E+04 
Fumarate 6.54E+05 6.74E+05 5.27E+05 3.48E+06 1.85E+06 4.24E+05 2.26E+06 2.89E+06 1.57E+06 9.98E+05 2.29E+06 1.21E+06 
Glutamate 1.43E+07 7.00E+06 7.04E+06 1.99E+07 9.62E+06 5.05E+06 1.49E+07 1.55E+07 1.21E+07 1.15E+07 1.43E+07 1.07E+07 
Glutamine 1.03E+07 7.38E+06 6.11E+06 7.41E+06 6.21E+06 3.72E+06 8.61E+06 1.09E+07 6.09E+06 7.18E+06 7.59E+06 4.98E+06 
Glutathione 9.63E+04 7.38E+03 7.09E+04 3.14E+04 1.04E+05 1.04E+04 2.63E+05 3.79E+05 1.80E+05 1.76E+05 4.59E+05 2.24E+05 
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Table 1.11 Continued 
Sample Name H6 H7 H8 H9 H14 H15 H17 H23 H24 H35 H36 H41 
Glutathione disulfide 4.60E+04 2.27E+04 2.80E+04 5.98E+04 5.84E+04 2.67E+04 1.12E+05 6.97E+04 3.17E+04 4.95E+04 7.38E+04 9.68E+04 
Glycine 2.89E+05 3.47E+05 1.19E+05 3.21E+05 1.42E+05 4.74E+04 8.32E+04 2.16E+05 1.61E+05 3.88E+05 2.76E+05 5.22E+04 
Guanosine 2.59E+05 2.24E+05 1.71E+05 3.54E+05 2.13E+05 9.53E+04 3.89E+05 2.92E+05 1.64E+05 2.84E+05 2.75E+05 2.11E+05 
Histidine 8.59E+04 5.40E+04 5.27E+04 9.29E+04 3.74E+04 2.32E+04 6.10E+04 9.02E+04 3.55E+04 4.87E+04 4.34E+04 2.89E+04 
Homoserine 7.69E+05 5.99E+05 5.16E+05 6.43E+05 3.87E+05 2.87E+05 6.28E+05 6.24E+05 4.36E+05 6.09E+05 5.40E+05 3.90E+05 
Homovanillic acid 1.35E+05 9.95E+04 4.27E+04 7.68E+04 5.37E+04 2.36E+04 1.09E+05 1.04E+05 3.68E+04 8.42E+04 9.93E+04 8.50E+04 
Hydroxybenzoate 7.62E+05 6.85E+05 7.84E+05 1.03E+06 1.58E+06 2.53E+06 3.52E+06 2.37E+06 3.73E+06 1.21E+06 2.59E+06 9.06E+05 
Hypoxanthine 3.14E+06 2.27E+06 2.20E+06 2.09E+06 4.93E+05 2.90E+05 9.64E+05 1.05E+06 5.00E+05 9.42E+05 9.39E+05 2.49E+06 
IMP 6.39E+03 9.99E+03 1.08E+04 9.41E+03 3.60E+04 2.54E+04 1.21E+04 3.79E+04 4.44E+04 2.16E+04 5.17E+04 5.96E+03 
Inosine 1.12E+06 1.80E+06 7.28E+05 2.09E+06 1.58E+06 1.23E+06 2.47E+06 2.17E+06 1.70E+06 2.28E+06 2.29E+06 9.23E+05 
Lactate 2.78E+07 2.44E+07 1.93E+07 6.52E+07 5.18E+07 3.91E+07 7.72E+07 6.40E+07 6.07E+07 4.97E+07 6.41E+07 2.17E+07 
Leucine/Isoleucine 1.63E+05 9.75E+04 7.46E+04 1.21E+05 4.67E+04 3.16E+04 5.74E+04 9.17E+04 4.87E+04 4.48E+04 1.05E+05 1.18E+05 
Malate 1.37E+07 1.38E+07 1.18E+07 3.83E+07 2.22E+07 7.73E+06 2.66E+07 3.29E+07 2.22E+07 1.80E+07 3.13E+07 1.98E+07 
Methionine 1.19E+05 3.32E+04 4.38E+04 4.13E+04 3.06E+04 1.58E+04 3.42E+04 3.23E+04 2.08E+04 3.12E+04 4.65E+04 4.09E+04 
Methylmalonate 1.39E+05 1.95E+05 1.92E+05 2.12E+06 1.23E+06 1.12E+06 1.60E+06 2.30E+06 2.01E+06 1.79E+06 2.10E+06 2.08E+05 
myo-Inositol 7.32E+04 3.97E+04 3.76E+04 3.26E+05 1.99E+05 1.67E+05 3.84E+05 4.02E+05 2.95E+05 2.69E+05 3.07E+05 4.48E+04 
N-Acetyl-beta-alanine 8.67E+05 5.53E+05 4.67E+05 8.41E+05 6.07E+05 3.45E+05 5.57E+05 8.67E+05 5.84E+05 6.98E+05 7.75E+05 6.81E+05 
N-Acetylglutamate 3.41E+05 3.13E+05 2.27E+05 5.25E+05 2.69E+05 1.64E+05 5.42E+05 5.97E+05 3.02E+05 3.48E+05 4.44E+05 2.44E+05 
N-Carbamoyl-L-
aspartate 4.77E+05 2.52E+05 3.74E+05 3.52E+05 2.21E+05 1.48E+05 3.51E+05 2.35E+05 4.83E+05 2.96E+05 2.20E+05 5.70E+05 
Pantothenate 8.05E+05 5.34E+05 6.42E+05 5.60E+05 1.06E+06 3.24E+05 8.45E+05 8.70E+05 3.88E+05 4.55E+05 8.83E+05 4.91E+05 
Phenylalanine 4.97E+04 5.82E+04 2.51E+04 7.02E+04 4.10E+04 3.25E+04 5.39E+04 5.32E+04 5.59E+04 7.87E+04 6.08E+04 4.04E+04 
Phosphoenolpyruvate 1.68E+05 1.15E+05 1.99E+05 8.84E+04 1.00E+02 1.00E+02 9.28E+03 4.44E+03 1.00E+02 4.32E+03 5.43E+03 6.12E+04 
Proline 1.09E+05 7.33E+04 6.08E+04 6.93E+04 4.29E+04 5.59E+04 5.38E+04 8.57E+04 5.58E+04 6.07E+04 6.92E+04 8.42E+04 
Pyroglutamic acid 2.69E+06 2.00E+06 1.59E+06 3.38E+06 6.01E+05 3.97E+05 1.15E+06 6.52E+05 6.24E+05 7.32E+05 1.03E+06 9.93E+05 
Serine 9.02E+05 7.68E+05 6.94E+05 1.13E+06 8.44E+05 4.45E+05 1.12E+06 9.36E+05 7.32E+05 8.56E+05 9.48E+05 3.57E+05 
Succinate 1.39E+05 1.95E+05 1.92E+05 2.12E+06 1.23E+06 1.12E+06 1.60E+06 2.30E+06 2.01E+06 1.79E+06 2.10E+06 2.08E+05 
Sulfolactate 1.33E+04 1.85E+04 7.88E+03 2.75E+04 1.27E+05 1.24E+05 9.66E+04 1.29E+05 1.87E+05 2.04E+05 1.47E+05 9.37E+04 
Sulfolactate 3.59E+04 1.64E+04 3.07E+04 1.73E+04 2.22E+04 2.10E+04 1.81E+04 2.90E+04 2.32E+04 2.73E+04 2.07E+04 1.93E+04 
Taurine 1.39E+07 8.62E+06 8.07E+06 1.30E+07 7.39E+06 5.34E+06 9.70E+06 1.04E+07 9.11E+06 9.65E+06 1.06E+07 9.20E+06 
Trehalose/sucrose 5.14E+04 1.73E+04 2.15E+04 4.78E+04 2.96E+04 3.55E+04 3.09E+04 1.71E+04 1.28E+05 1.79E+04 3.97E+04 1.69E+04 
Tyrosine 1.05E+05 5.98E+04 6.17E+04 8.46E+04 5.87E+04 3.80E+04 6.94E+04 5.05E+04 3.65E+04 6.81E+04 6.74E+04 5.88E+04 
UDP-glucose 1.24E+05 7.68E+04 6.69E+04 9.99E+04 1.86E+05 1.27E+05 2.54E+05 1.72E+05 5.75E+04 6.87E+04 1.29E+05 8.67E+04 
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Table 1.11 Continued 
Sample Name H6 H7 H8 H9 H14 H15 H17 H23 H24 H35 H36 H41 
UDP-N-
acetylglucosamine 5.76E+04 4.46E+04 2.03E+04 5.20E+04 1.36E+05 8.20E+04 1.97E+05 1.11E+05 4.47E+04 4.79E+04 5.38E+04 6.03E+04 
UMP 1.00E+02 1.00E+02 4.76E+03 4.98E+03 4.00E+04 1.96E+04 4.87E+03 4.34E+04 2.88E+04 6.24E+03 3.37E+04 1.00E+02 
Uracil 1.21E+06 8.85E+05 7.47E+05 1.06E+06 2.62E+05 1.67E+05 6.38E+05 5.99E+05 3.94E+05 4.92E+05 5.37E+05 8.75E+05 
Uric acid 1.63E+04 1.59E+04 1.78E+04 1.03E+04 6.67E+03 1.01E+04 2.37E+04 2.02E+04 3.55E+04 1.91E+04 3.57E+04 1.50E+04 
Uridine 2.39E+05 8.81E+04 1.80E+05 1.17E+05 1.11E+05 6.64E+04 1.71E+05 1.63E+05 1.09E+05 1.18E+05 1.50E+05 1.57E+05 
Valine 2.49E+05 1.10E+05 6.98E+04 1.22E+05 9.27E+04 5.09E+04 1.44E+05 1.54E+05 1.04E+05 7.79E+04 1.41E+05 8.73E+04 




Table 1.12 Raw Data of Dominant Hamsters from vmPFC  
Sample Name H2 H4 H5 H19 H21 H25 H33 H38 H47 
2-Hydroxy-2-methylsuccinate 4.18E+05 3.85E+05 4.92E+05 2.07E+05 1.41E+06 2.17E+05 7.77E+05 7.10E+05 1.95E+05 
3_4-Dihydroxyphenylacetate 6.97E+03 3.87E+03 3.22E+03 5.06E+03 7.11E+03 8.61E+03 3.61E+03 5.36E+04 4.86E+04 
4-Aminobutyrate 2.82E+05 6.26E+05 2.55E+05 2.56E+05 1.82E+05 9.78E+04 9.47E+04 1.52E+05 2.33E+05 
5-Hydroxyindoleacetic acid 3.02E+04 5.26E+04 2.23E+04 1.01E+04 7.51E+03 6.63E+03 2.68E+03 1.06E+04 1.23E+04 
Aconitate 3.78E+04 5.76E+04 7.01E+04 2.93E+04 8.18E+04 2.52E+04 1.87E+04 2.91E+04 1.82E+04 
Alanine 1.26E+06 1.51E+06 1.37E+06 6.74E+05 1.31E+06 6.84E+05 1.06E+06 1.27E+06 1.06E+06 
alpha-Ketoglutarate 2.35E+04 1.81E+04 2.48E+04 1.86E+04 5.22E+04 1.23E+04 2.37E+04 3.21E+04 1.08E+04 
AMP 2.89E+05 6.13E+04 1.47E+05 7.85E+05 2.88E+06 1.06E+06 1.16E+06 1.95E+06 3.66E+05 
Ascorbate 8.65E+04 2.66E+05 1.00E+06 5.18E+04 1.00E+02 1.74E+04 3.07E+05 8.26E+05 6.87E+04 
Asparagine 5.23E+04 6.37E+04 7.13E+04 2.14E+04 4.55E+04 1.96E+04 3.19E+04 4.89E+04 4.90E+04 
Aspartate 4.48E+06 5.52E+06 5.21E+06 1.35E+06 4.45E+06 2.26E+06 2.40E+06 4.57E+06 2.85E+06 
Citrate/isocitrate 4.24E+05 7.51E+05 1.09E+06 1.48E+05 8.47E+05 7.78E+04 1.90E+05 3.94E+05 9.85E+04 
Citrulline 2.57E+04 7.54E+03 3.07E+04 5.99E+03 2.45E+04 1.04E+04 1.17E+04 3.47E+04 1.43E+04 
Creatine 1.05E+06 1.33E+06 8.45E+05 3.72E+05 9.27E+05 4.59E+05 6.76E+05 1.02E+06 6.59E+05 
Creatinine 3.13E+04 3.37E+04 5.49E+04 7.87E+03 1.68E+04 8.36E+03 1.40E+04 2.62E+04 3.29E+04 
Cysteine 1.85E+03 1.57E+05 8.89E+04 1.98E+04 1.00E+02 2.09E+03 3.40E+04 3.25E+04 6.37E+03 
Cystine 8.58E+04 1.82E+05 9.57E+04 1.22E+04 1.91E+04 6.56E+03 1.52E+04 1.03E+04 1.21E+04 
Cytidine 3.44E+03 5.15E+03 7.01E+03 1.48E+04 1.49E+04 1.31E+04 1.59E+04 4.74E+03 2.71E+04 
Cytidine 2.02E+04 2.03E+04 1.58E+04 1.57E+03 1.92E+04 3.11E+03 1.25E+04 1.71E+04 1.00E+04 
dGMP 2.89E+05 6.13E+04 1.47E+05 7.85E+05 2.88E+06 1.06E+06 1.16E+06 1.95E+06 3.66E+05 
Fumarate 2.63E+06 2.98E+06 2.65E+06 3.58E+05 2.06E+06 5.57E+05 1.35E+06 2.89E+06 1.67E+06 
Glucose 1-phosphate 2.50E+04 1.22E+04 8.22E+03 1.00E+02 5.88E+03 1.00E+02 5.77E+03 8.37E+03 2.18E+04 
Glutamate 1.52E+07 1.40E+07 1.46E+07 9.42E+06 1.64E+07 7.56E+06 1.14E+07 1.66E+07 1.15E+07 
Glutamine 9.18E+06 1.00E+07 7.42E+06 3.54E+06 6.76E+06 3.49E+06 5.04E+06 7.81E+06 5.05E+06 
Glutathione 1.14E+05 1.68E+05 2.08E+05 2.65E+05 1.00E+02 2.14E+05 4.37E+05 7.61E+05 2.54E+05 
Glutathione disulfide 1.52E+05 2.13E+04 3.27E+04 2.89E+04 5.98E+05 1.29E+04 1.51E+04 6.32E+04 5.16E+04 
Glycerone phosphate 8.24E+04 1.43E+05 8.36E+04 1.25E+04 6.23E+03 1.36E+04 6.32E+03 2.98E+04 2.05E+04 
Glycine 1.27E+05 1.71E+05 1.16E+05 8.89E+04 1.78E+05 1.05E+05 9.67E+04 8.20E+04 1.80E+05 
GMP 5.44E+04 1.73E+04 3.49E+04 4.41E+04 1.08E+05 2.61E+04 4.89E+04 1.02E+05 5.97E+04 
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Table 1.12 Continued 
Sample Name H2 H4 H5 H19 H21 H25 H33 H38 H47 
Guanosine 1.83E+05 2.73E+05 2.31E+05 3.17E+04 5.76E+04 1.52E+04 4.57E+04 5.38E+04 5.75E+04 
Histidine 3.70E+04 5.09E+04 6.60E+04 2.67E+04 5.08E+04 9.74E+03 2.40E+04 5.63E+04 3.56E+04 
Homoserine 5.82E+05 6.97E+05 5.57E+05 2.51E+05 4.57E+05 2.71E+05 3.20E+05 4.72E+05 4.02E+05 
Hypoxanthine 8.47E+05 1.80E+06 1.13E+06 1.84E+05 2.39E+05 8.55E+04 1.50E+05 2.42E+05 2.68E+05 
IMP 4.80E+04 1.83E+04 4.74E+04 7.66E+04 2.18E+05 4.94E+04 9.19E+04 1.94E+05 6.48E+04 
Inosine 1.72E+06 2.07E+06 1.50E+06 6.77E+05 8.06E+05 5.45E+05 7.49E+05 8.82E+05 9.05E+05 
Lactate 5.44E+07 6.01E+07 5.65E+07 3.62E+07 5.66E+07 3.36E+07 4.12E+07 5.73E+07 5.15E+07 
Leucine/Isoleucine 8.03E+04 9.54E+04 9.09E+04 2.64E+04 5.82E+04 3.19E+04 4.53E+04 3.97E+04 4.91E+04 
Malate 2.87E+07 3.46E+07 3.01E+07 7.74E+06 2.41E+07 9.08E+06 1.54E+07 3.21E+07 1.94E+07 
Methionine 4.86E+04 3.71E+04 4.34E+04 2.58E+04 4.54E+04 1.21E+04 1.34E+04 2.38E+04 2.27E+04 
Methylmalonate 8.62E+05 5.96E+05 6.83E+05 8.00E+05 1.18E+06 6.31E+05 6.61E+05 1.58E+06 9.13E+05 
myo-Inositol 2.46E+05 2.40E+05 1.99E+05 1.27E+05 2.82E+05 1.02E+05 1.25E+05 2.91E+05 2.08E+05 
N-Acetylglutamate 4.90E+05 6.03E+05 4.46E+05 1.71E+05 4.96E+05 1.27E+05 2.25E+05 5.65E+05 2.31E+05 
N-Carbamoyl-L-aspartate 2.68E+05 3.38E+05 2.19E+05 1.55E+05 4.58E+05 6.37E+04 2.68E+05 3.79E+05 2.07E+05 
N-Carbamoyl-L-aspartate 5.47E+03 8.24E+04 6.31E+03 6.26E+03 6.02E+03 8.22E+03 6.93E+03 1.38E+05 2.14E+04 
Pantothenate 5.96E+05 1.65E+06 5.87E+05 7.01E+05 3.95E+05 3.48E+05 2.98E+05 4.54E+05 2.83E+05 
Phenylalanine 6.34E+04 7.00E+04 5.89E+04 1.33E+04 3.96E+04 3.97E+04 4.85E+04 5.61E+04 4.41E+04 
Proline 5.85E+04 5.13E+04 7.18E+04 3.71E+04 6.99E+04 2.93E+04 2.95E+04 5.68E+04 4.61E+04 
Pyroglutamic acid 5.70E+05 1.53E+06 9.63E+05 2.88E+05 2.86E+05 2.27E+05 2.89E+05 2.43E+05 3.41E+05 
Ribose phosphate 1.98E+05 2.80E+05 3.61E+05 3.01E+05 1.97E+05 7.78E+04 1.48E+05 1.09E+05 8.25E+04 
Serine 1.17E+06 1.19E+06 1.39E+06 6.70E+05 1.19E+06 7.81E+05 9.42E+05 1.26E+06 1.02E+06 
Succinate 8.62E+05 5.96E+05 6.83E+05 8.00E+05 1.18E+06 6.31E+05 6.61E+05 1.58E+06 9.13E+05 
Sulfolactate 1.61E+04 1.95E+04 2.25E+04 9.88E+04 5.10E+04 1.07E+05 8.47E+04 1.17E+05 1.15E+05 
Taurine 1.15E+07 8.75E+06 1.08E+07 4.62E+06 1.09E+07 5.30E+06 7.93E+06 1.20E+07 7.73E+06 
Trehalose/sucrose 3.69E+04 1.49E+05 2.60E+05 3.16E+04 4.48E+04 2.94E+04 3.02E+04 2.54E+04 8.68E+04 
Tyrosine 8.07E+04 6.11E+04 8.73E+04 3.47E+04 5.68E+04 2.37E+04 5.05E+04 4.70E+04 5.95E+04 
UDP-glucose 1.73E+05 3.56E+05 3.75E+05 1.84E+05 1.77E+05 1.17E+05 1.55E+05 2.04E+05 1.51E+05 
UDP-N-acetylglucosamine 1.47E+05 2.54E+05 2.51E+05 1.08E+05 1.86E+05 8.85E+04 1.26E+05 1.89E+05 1.37E+05 
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Table 1.12 Continued 
Sample Name H2 H4 H5 H19 H21 H25 H33 H38 H47 
UMP 1.22E+05 2.24E+04 1.03E+05 1.03E+05 2.12E+05 9.21E+04 1.19E+05 1.94E+05 1.37E+05 
Uracil 3.55E+05 7.34E+05 5.81E+05 1.29E+05 2.88E+05 5.38E+04 8.07E+04 3.02E+05 1.90E+05 
Uridine 8.86E+04 1.08E+05 1.21E+05 3.50E+04 7.27E+04 1.39E+04 5.38E+04 5.99E+04 3.45E+04 
Valine 1.44E+05 1.41E+05 1.98E+05 5.64E+04 1.38E+05 5.55E+04 7.67E+04 1.07E+05 8.98E+04 




Table 1.13 Raw Data of Handled Control Hamsters from vmPFC  
Sample Name H1 H10 H18 H26 H31 H32 H34 H43 H44 H52 H53 
2-Hydroxy-2-methylsuccinate 2.72E+05 4.02E+05 1.58E+05 3.28E+05 2.77E+05 4.06E+05 2.21E+05 2.87E+05 1.58E+05 2.81E+05 2.72E+05 
3_4-Dihydroxyphenylacetate 1.24E+04 7.91E+03 1.12E+04 3.78E+03 5.48E+03 3.27E+03 4.17E+03 7.99E+03 6.72E+03 2.15E+04 7.97E+03 
4-Aminobutyrate 3.14E+05 1.58E+05 9.44E+04 1.08E+05 1.96E+05 1.88E+05 5.87E+04 1.08E+05 1.80E+05 1.64E+05 3.51E+05 
5-Hydroxyindoleacetic acid 1.33E+04 1.05E+04 7.68E+03 2.29E+03 1.04E+04 1.81E+04 2.59E+03 6.48E+03 8.11E+03 3.63E+03 3.19E+04 
Aconitate 5.69E+04 8.15E+04 1.32E+04 1.98E+04 2.15E+04 4.85E+04 8.28E+03 1.70E+04 2.56E+04 5.96E+04 3.19E+04 
Alanine 1.17E+06 9.40E+05 4.86E+05 9.17E+05 1.21E+06 1.39E+06 7.68E+05 1.05E+06 9.30E+05 1.13E+06 1.09E+06 
alpha-Ketoglutarate 3.57E+04 2.91E+04 1.18E+04 2.15E+04 1.77E+04 1.81E+04 1.22E+04 1.79E+04 1.38E+04 3.29E+04 2.70E+04 
AMP 9.28E+04 3.11E+06 8.85E+05 1.46E+06 2.54E+06 2.99E+06 6.29E+05 2.06E+05 3.33E+05 1.61E+05 1.93E+04 
Ascorbate 1.00E+02 1.77E+06 2.25E+05 4.94E+04 2.58E+06 2.94E+06 1.00E+02 6.48E+03 1.22E+05 1.00E+02 1.00E+02 
Asparagine 5.62E+04 3.96E+04 1.71E+04 3.53E+04 4.58E+04 7.60E+04 1.95E+04 2.42E+04 4.00E+04 3.52E+04 3.72E+04 
Aspartate 4.32E+06 1.57E+06 6.35E+05 2.84E+06 3.45E+06 3.78E+06 1.16E+06 2.68E+06 2.88E+06 3.17E+06 3.48E+06 
Citrate/isocitrate 1.27E+05 1.61E+06 1.19E+05 1.50E+05 2.52E+05 4.59E+05 5.40E+04 1.33E+05 2.06E+05 5.23E+05 4.28E+05 
Citrulline 6.46E+03 2.18E+04 1.34E+04 1.41E+04 3.01E+04 2.03E+04 1.03E+04 8.56E+03 1.93E+04 2.02E+04 4.70E+03 
Creatine 6.50E+05 4.76E+05 2.93E+05 6.16E+05 1.02E+06 1.16E+06 5.27E+05 8.73E+05 7.13E+05 9.30E+05 9.55E+05 
Creatinine 2.54E+04 1.23E+04 4.94E+03 1.03E+04 1.91E+04 2.48E+04 6.16E+03 1.79E+04 1.74E+04 2.38E+04 3.44E+04 
Cysteine 4.86E+04 5.28E+04 2.39E+04 1.52E+04 4.73E+04 6.58E+04 1.00E+02 1.13E+04 2.19E+04 4.39E+03 4.89E+03 
Cystine 8.93E+04 1.51E+04 7.16E+03 1.43E+04 1.48E+04 2.06E+04 1.64E+04 8.39E+04 2.70E+04 9.18E+04 1.44E+05 
Cytidine 1.24E+04 1.63E+04 9.69E+03 3.14E+04 1.57E+04 9.09E+03 1.09E+04 3.60E+04 1.04E+04 2.47E+04 6.69E+03 
Cytidine 1.88E+04 7.37E+03 1.11E+03 4.53E+03 1.75E+04 2.38E+04 7.37E+03 7.25E+03 9.39E+03 1.24E+04 2.50E+04 
dGMP 9.28E+04 3.11E+06 8.85E+05 1.46E+06 2.54E+06 2.99E+06 6.29E+05 2.06E+05 3.33E+05 1.61E+05 1.93E+04 
Fumarate 2.44E+06 5.60E+05 1.33E+05 6.91E+05 1.45E+06 2.13E+06 6.81E+05 9.80E+05 1.14E+06 9.46E+05 2.44E+06 
Glucose 1-phosphate 1.78E+05 1.00E+02 1.00E+02 4.45E+03 8.00E+03 5.52E+03 1.00E+02 5.63E+03 9.56E+03 5.26E+03 1.35E+05 
Glutamate 1.47E+07 8.85E+06 5.80E+06 1.10E+07 1.44E+07 1.49E+07 8.12E+06 9.97E+06 1.18E+07 1.06E+07 1.06E+07 
Glutamine 6.69E+06 6.29E+06 3.66E+06 6.34E+06 5.95E+06 8.82E+06 3.45E+06 3.73E+06 4.76E+06 5.03E+06 5.73E+06 
Glutathione 3.67E+05 6.49E+05 1.97E+05 3.57E+05 8.43E+05 1.02E+06 5.29E+04 4.81E+04 2.32E+05 3.18E+04 1.00E+02 
Glutathione disulfide 4.25E+04 1.07E+05 1.16E+04 3.35E+04 2.81E+04 2.98E+04 5.78E+04 9.45E+03 2.41E+04 1.47E+04 1.62E+04 
Glycerone phosphate 2.11E+05 5.34E+04 5.95E+03 1.74E+04 7.47E+04 4.29E+04 5.13E+03 3.96E+04 5.83E+04 3.75E+04 2.16E+05 




Table 1.13 Continued 
Sample Name H1 H10 H18 H26 H31 H32 H34 H43 H44 H52 H53 
GMP 1.57E+04 1.83E+05 4.61E+04 6.34E+04 9.45E+04 1.31E+05 2.51E+04 2.40E+04 5.52E+04 3.41E+04 3.00E+03 
Guanosine 2.76E+05 4.72E+04 2.32E+04 4.99E+04 5.56E+04 7.41E+04 2.87E+04 9.95E+04 5.24E+04 1.15E+05 2.09E+05 
Histidine 5.58E+04 1.32E+04 8.18E+03 2.85E+04 2.40E+04 2.87E+04 1.70E+04 2.62E+04 2.13E+04 3.42E+04 3.32E+04 
Homoserine 4.82E+05 2.82E+05 2.40E+05 3.63E+05 4.57E+05 4.73E+05 2.92E+05 3.11E+05 3.30E+05 4.02E+05 4.40E+05 
Hypoxanthine 1.56E+06 1.84E+05 9.17E+04 1.80E+05 2.49E+05 3.13E+05 9.48E+04 4.86E+05 3.95E+05 5.05E+05 4.39E+05 
IMP 2.49E+04 4.38E+05 8.43E+04 8.93E+04 1.41E+05 1.65E+05 9.34E+04 9.17E+04 4.59E+04 5.67E+04 5.71E+03 
Inosine 2.31E+06 3.64E+05 3.63E+05 6.80E+05 8.60E+05 9.40E+05 4.83E+05 1.35E+06 9.36E+05 1.19E+06 1.78E+06 
Lactate 4.98E+07 4.06E+07 3.49E+07 4.56E+07 5.10E+07 5.87E+07 3.71E+07 4.55E+07 3.55E+07 4.31E+07 5.22E+07 
Leucine/Isoleucine 8.16E+04 3.15E+04 1.46E+04 3.92E+04 5.67E+04 5.68E+04 3.10E+04 4.44E+04 4.03E+04 4.85E+04 5.00E+04 
Malate 2.75E+07 9.13E+06 3.99E+06 1.01E+07 1.68E+07 2.31E+07 9.73E+06 1.27E+07 1.40E+07 1.29E+07 2.83E+07 
Methionine 3.79E+04 3.67E+04 9.24E+03 1.82E+04 2.08E+04 2.12E+04 8.36E+03 2.72E+04 1.95E+04 2.45E+04 2.36E+04 
Methylmalonate 6.34E+05 6.83E+05 1.17E+06 8.23E+05 6.30E+05 8.54E+05 7.65E+05 6.19E+05 3.82E+05 8.77E+05 5.90E+05 
myo-Inositol 2.20E+05 1.80E+05 1.16E+05 1.93E+05 1.70E+05 2.75E+05 1.41E+05 1.69E+05 1.03E+05 1.86E+05 2.18E+05 
N-Acetylglutamate 3.79E+05 4.32E+05 1.19E+05 2.09E+05 3.41E+05 4.04E+05 1.06E+05 1.61E+05 2.21E+05 2.54E+05 3.71E+05 
N-Carbamoyl-L-aspartate 3.80E+05 4.63E+05 1.28E+05 2.76E+05 2.83E+05 3.85E+05 1.15E+05 1.43E+05 2.34E+05 2.33E+05 2.62E+05 
N-Carbamoyl-L-aspartate 2.86E+04 3.41E+03 6.00E+03 4.49E+03 5.70E+03 4.70E+03 1.06E+04 6.38E+04 3.05E+04 1.45E+05 2.57E+04 
Pantothenate 7.85E+05 4.26E+05 2.51E+05 4.02E+05 5.77E+05 7.10E+05 3.06E+05 4.67E+05 3.12E+05 3.88E+05 8.53E+05 
Phenylalanine 7.27E+04 2.37E+04 2.50E+04 3.17E+04 2.53E+04 4.05E+04 3.10E+04 4.62E+04 3.50E+04 4.05E+04 4.15E+04 
Proline 6.43E+04 4.05E+04 1.12E+04 4.42E+04 4.67E+04 5.50E+04 3.45E+04 5.21E+04 4.76E+04 5.19E+04 4.72E+04 
Pyroglutamic acid 5.11E+05 2.36E+05 2.09E+05 2.49E+05 2.23E+05 3.05E+05 2.31E+05 4.83E+05 2.48E+05 5.47E+05 6.45E+05 
Ribose phosphate 7.41E+05 2.93E+05 6.18E+04 1.38E+05 1.22E+05 2.34E+05 3.67E+04 8.85E+04 9.90E+04 9.04E+04 3.27E+05 
Serine 1.21E+06 7.97E+05 6.20E+05 9.67E+05 1.01E+06 1.26E+06 8.23E+05 1.02E+06 9.02E+05 1.27E+06 9.53E+05 
Succinate 6.34E+05 6.83E+05 1.17E+06 8.23E+05 6.30E+05 8.54E+05 7.65E+05 6.19E+05 3.82E+05 8.77E+05 5.90E+05 
Sulfolactate 1.21E+04 7.08E+04 1.54E+05 7.91E+04 6.62E+04 7.87E+04 1.03E+05 9.35E+04 1.58E+04 2.06E+04 9.04E+03 
Taurine 1.22E+07 1.01E+07 4.17E+06 7.75E+06 1.03E+07 1.02E+07 5.95E+06 8.77E+06 7.81E+06 8.06E+06 7.77E+06 
Trehalose/sucrose 5.24E+05 1.81E+04 3.17E+04 2.92E+04 1.89E+04 2.91E+04 5.21E+04 3.84E+04 5.21E+04 6.61E+04 4.40E+04 
Tyrosine 5.51E+04 5.11E+04 2.40E+04 3.02E+04 5.54E+04 5.70E+04 1.92E+04 2.67E+04 3.87E+04 3.94E+04 4.23E+04 
UDP-glucose 4.67E+05 2.98E+05 1.27E+05 1.73E+05 1.97E+05 3.68E+05 1.09E+05 1.61E+05 1.62E+05 1.79E+05 2.84E+05 
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Table 1.13 Continued 
Sample Name H1 H10 H18 H26 H31 H32 H34 H43 H44 H52 H53 
UDP-N-acetylglucosamine 2.74E+05 2.88E+05 7.48E+04 1.29E+05 2.06E+05 3.12E+05 8.18E+04 1.07E+05 1.12E+05 1.10E+05 1.33E+05 
UMP 4.92E+04 2.44E+05 9.38E+04 1.33E+05 2.01E+05 2.25E+05 6.72E+04 7.63E+04 1.36E+05 7.74E+04 3.34E+03 
Uracil 6.11E+05 2.30E+05 5.27E+04 1.23E+05 1.46E+05 2.81E+05 6.35E+04 3.10E+05 2.23E+05 3.60E+05 5.96E+05 
Uridine 1.29E+05 4.15E+04 1.82E+04 3.94E+04 8.18E+04 6.57E+04 2.04E+04 4.77E+04 2.23E+04 4.77E+04 8.31E+04 
Valine 1.36E+05 8.54E+04 3.65E+04 9.48E+04 1.21E+05 1.39E+05 5.98E+04 7.57E+04 8.92E+04 1.04E+05 1.05E+05 




Table 1.14 Raw Data of Subordinate Hamsters from vmPFC  
Sample Name H6 H7 H8 H9 H15 H17 H23 H24 H35 H36 H41 
2-Hydroxy-2-methylsuccinate 3.31E+05 3.76E+05 1.33E+05 3.97E+05 4.85E+05 4.97E+05 7.26E+05 1.52E+06 5.92E+05 2.79E+05 5.36E+05 
3_4-Dihydroxyphenylacetate 3.38E+03 3.07E+03 1.04E+04 5.39E+03 5.55E+03 5.72E+03 7.34E+03 6.79E+03 3.35E+04 4.64E+03 2.12E+04 
4-Aminobutyrate 2.59E+05 3.08E+05 5.47E+05 3.12E+05 1.57E+05 1.11E+05 1.63E+05 1.50E+05 7.26E+04 1.03E+05 1.67E+05 
5-Hydroxyindoleacetic acid 3.41E+04 1.02E+04 2.30E+04 1.44E+04 1.16E+04 1.33E+04 5.55E+03 1.65E+04 9.57E+03 6.80E+03 1.89E+04 
Aconitate 5.88E+04 7.30E+04 3.95E+04 5.16E+04 6.99E+04 3.97E+04 3.92E+04 4.53E+04 1.94E+04 2.27E+04 3.95E+04 
Alanine 1.55E+06 1.53E+06 1.03E+06 1.26E+06 1.02E+06 1.10E+06 1.12E+06 1.09E+06 9.73E+05 7.73E+05 1.37E+06 
alpha-Ketoglutarate 2.14E+04 3.96E+04 1.52E+04 1.73E+04 2.30E+04 2.17E+04 2.03E+04 3.08E+04 1.68E+04 9.88E+03 2.90E+04 
AMP 3.96E+05 1.07E+05 3.67E+04 2.26E+05 2.80E+06 2.95E+06 2.33E+06 2.83E+06 9.25E+05 1.07E+06 7.12E+05 
Ascorbate 5.59E+05 4.51E+03 2.19E+03 2.32E+05 4.97E+05 1.00E+02 1.00E+02 3.85E+05 1.00E+02 2.24E+05 8.90E+05 
Asparagine 7.14E+04 6.39E+04 4.09E+04 7.29E+04 3.14E+04 5.93E+04 3.50E+04 5.65E+04 3.14E+04 2.54E+04 7.03E+04 
Aspartate 5.48E+06 5.16E+06 2.72E+06 4.90E+06 3.21E+06 3.03E+06 2.41E+05 4.74E+06 2.73E+06 9.91E+05 4.68E+06 
Citrate/isocitrate 1.48E+06 1.94E+06 3.69E+05 8.65E+05 8.55E+05 4.18E+05 2.24E+05 5.77E+05 9.25E+04 1.84E+05 8.56E+05 
Citrulline 2.81E+04 2.27E+04 1.13E+04 1.95E+04 1.50E+04 1.26E+04 2.34E+04 2.01E+04 1.33E+04 1.08E+04 3.56E+04 
Creatine 1.15E+06 1.06E+06 6.38E+05 1.10E+06 5.84E+05 7.23E+05 1.12E+06 1.01E+06 6.14E+05 4.74E+05 1.18E+06 
Creatinine 3.49E+04 2.40E+04 1.68E+04 3.20E+04 1.20E+04 8.72E+03 1.26E+04 2.25E+04 1.43E+04 7.15E+03 2.49E+04 
Cysteine 7.88E+04 2.33E+03 2.08E+04 9.21E+04 5.43E+04 2.78E+04 1.00E+02 1.50E+04 1.00E+02 1.24E+04 5.59E+04 
Cystine 6.89E+04 1.52E+05 8.13E+04 7.99E+04 3.55E+03 3.47E+03 2.10E+04 2.34E+04 4.27E+04 8.16E+03 4.07E+04 
Cytidine 2.00E+04 1.72E+04 1.91E+04 1.69E+04 2.63E+04 3.67E+04 2.19E+04 4.16E+04 1.62E+04 9.19E+03 2.76E+04 
Cytidine 1.58E+04 1.88E+04 9.13E+03 2.44E+04 8.59E+03 1.22E+04 1.41E+04 1.94E+04 1.23E+04 4.61E+03 1.51E+04 
dGMP 3.96E+05 1.07E+05 3.67E+04 2.26E+05 2.80E+06 2.95E+06 2.33E+06 2.83E+06 9.25E+05 1.07E+06 7.12E+05 
Fumarate 2.35E+06 2.07E+06 1.15E+06 2.40E+06 5.72E+05 6.79E+05 1.19E+06 2.40E+06 9.02E+05 7.47E+05 2.87E+06 
Glucose 1-phosphate 6.08E+03 1.02E+04 5.14E+03 6.40E+03 1.00E+02 1.00E+02 4.85E+03 5.59E+03 1.00E+02 1.00E+02 8.89E+04 
Glutamate 1.53E+07 1.67E+07 8.70E+06 2.07E+07 1.21E+07 1.32E+07 3.22E+06 1.55E+07 1.08E+07 6.77E+06 1.70E+07 
Glutamine 6.96E+06 6.59E+06 4.34E+06 5.89E+06 4.98E+06 6.41E+06 6.27E+06 7.15E+06 4.12E+06 3.34E+06 8.80E+06 
Glutathione 3.55E+05 4.36E+03 3.67E+04 4.51E+05 5.77E+05 5.88E+05 2.44E+05 6.28E+05 3.20E+04 2.58E+05 6.17E+05 
Glutathione disulfide 6.29E+04 7.88E+04 4.88E+03 7.08E+04 7.99E+04 1.05E+05 4.55E+04 1.26E+05 7.41E+04 1.47E+04 7.10E+04 
Glycerone phosphate 5.94E+04 9.91E+04 8.27E+04 8.63E+04 1.14E+04 1.58E+04 3.40E+04 1.47E+04 9.11E+03 1.60E+04 1.09E+05 




Table 1.14 Continued 
Sample Name H6 H7 H8 H9 H15 H17 H23 H24 H35 H36 H41 
GMP 9.15E+04 2.17E+04 6.51E+03 4.43E+04 1.29E+05 1.21E+05 9.83E+04 1.19E+05 2.94E+04 7.23E+04 1.07E+05 
Guanosine 1.21E+05 2.53E+05 1.09E+05 1.79E+05 4.95E+04 4.83E+04 3.76E+04 4.37E+04 6.02E+04 3.08E+04 9.88E+04 
Histidine 4.19E+04 3.85E+04 3.27E+04 4.38E+04 3.06E+04 2.63E+04 5.05E+04 4.23E+04 2.69E+04 1.42E+04 4.57E+04 
Homoserine 5.71E+05 6.82E+05 3.77E+05 5.69E+05 3.33E+05 3.88E+05 3.52E+05 4.87E+05 2.71E+05 2.35E+05 6.33E+05 
Hypoxanthine 9.55E+05 1.34E+06 7.75E+05 9.11E+05 1.68E+05 2.33E+05 2.62E+05 2.87E+05 1.58E+05 9.77E+04 6.82E+05 
IMP 1.60E+05 3.62E+04 1.21E+04 1.23E+05 2.34E+05 1.39E+05 1.80E+05 2.04E+05 6.06E+04 6.36E+04 9.34E+04 
Inosine 1.56E+06 1.88E+06 1.18E+06 1.66E+06 5.58E+05 6.65E+05 5.20E+05 8.94E+05 8.20E+05 4.47E+05 1.42E+06 
Lactate 6.46E+07 5.08E+07 4.11E+07 5.97E+07 4.87E+07 5.38E+07 4.40E+07 6.31E+07 4.08E+07 3.60E+07 5.33E+07 
Leucine/Isoleucine 1.05E+05 8.10E+04 4.47E+04 8.38E+04 4.44E+04 3.78E+04 5.56E+04 1.05E+05 3.64E+04 2.95E+04 9.57E+04 
Malate 2.68E+07 2.37E+07 1.41E+07 2.63E+07 9.67E+06 1.09E+07 1.50E+07 2.72E+07 1.26E+07 1.04E+07 3.24E+07 
Methionine 3.11E+04 2.65E+04 1.21E+04 2.57E+04 2.58E+04 2.67E+04 2.94E+04 2.82E+04 1.30E+04 9.72E+03 4.02E+04 
Methylmalonate 7.73E+05 9.02E+05 4.57E+05 6.50E+05 7.03E+05 6.75E+05 7.37E+05 1.67E+06 9.79E+05 5.26E+05 1.12E+06 
myo-Inositol 3.34E+05 2.18E+05 1.48E+05 3.11E+05 1.94E+05 2.02E+05 1.10E+05 2.78E+05 2.76E+05 1.15E+05 2.59E+05 
N-Acetylglutamate 5.27E+05 5.90E+05 2.07E+05 5.12E+05 3.94E+05 3.90E+05 2.90E+05 4.65E+05 2.36E+05 1.87E+05 5.20E+05 
N-Carbamoyl-L-aspartate 3.33E+05 3.16E+05 1.99E+05 3.31E+05 3.57E+05 2.11E+05 2.35E+05 4.68E+05 1.55E+05 1.79E+05 2.93E+05 
N-Carbamoyl-L-aspartate 1.63E+04 5.00E+04 5.03E+03 3.54E+04 6.60E+03 3.95E+03 2.37E+03 2.56E+03 6.58E+03 3.04E+03 1.59E+05 
Pantothenate 7.30E+05 5.06E+05 6.41E+05 4.55E+05 5.03E+05 4.18E+05 6.01E+05 7.70E+05 3.24E+05 2.95E+05 5.24E+05 
Phenylalanine 8.36E+04 5.05E+04 3.44E+04 6.57E+04 3.60E+04 2.99E+04 2.71E+04 5.64E+04 3.61E+04 3.07E+04 4.99E+04 
Proline 7.45E+04 6.05E+04 3.50E+04 6.53E+04 4.72E+04 5.10E+04 6.79E+04 5.42E+04 4.74E+04 3.79E+04 6.98E+04 
Pyroglutamic acid 8.25E+05 8.20E+05 5.55E+05 7.34E+05 2.59E+05 1.94E+05 2.29E+05 3.47E+05 2.17E+05 2.07E+05 3.57E+05 
Ribose phosphate 1.21E+05 2.10E+05 2.77E+05 1.03E+05 2.22E+05 1.67E+05 9.96E+04 1.24E+05 1.10E+05 1.20E+05 3.09E+05 
Serine 1.39E+06 1.29E+06 7.82E+05 1.41E+06 9.85E+05 1.11E+06 1.02E+06 1.35E+06 8.02E+05 6.98E+05 1.24E+06 
Succinate 7.73E+05 9.02E+05 4.57E+05 6.50E+05 7.03E+05 6.75E+05 7.37E+05 1.67E+06 9.79E+05 5.26E+05 1.12E+06 
Sulfolactate 1.14E+04 6.97E+03 2.29E+04 7.65E+03 1.06E+05 5.07E+04 1.31E+05 1.25E+05 7.87E+04 1.26E+05 1.04E+05 
Taurine 1.08E+07 1.21E+07 5.28E+06 1.32E+07 7.59E+06 7.89E+06 8.76E+06 1.07E+07 7.82E+06 5.26E+06 1.19E+07 
Trehalose/sucrose 6.24E+04 2.13E+05 4.07E+05 7.12E+04 2.08E+04 2.15E+04 3.36E+04 3.90E+04 2.80E+04 3.66E+04 2.94E+04 
Tyrosine 6.44E+04 5.86E+04 2.63E+04 5.29E+04 3.72E+04 3.12E+04 4.74E+04 4.79E+04 3.86E+04 2.55E+04 6.86E+04 
UDP-glucose 3.25E+05 3.26E+05 1.35E+05 2.26E+05 2.70E+05 2.12E+05 1.76E+05 2.52E+05 1.45E+05 2.72E+05 2.53E+05 
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Table 1.14 Continued 
Sample Name H6 H7 H8 H9 H15 H17 H23 H24 H35 H36 H41 
UDP-N-acetylglucosamine 2.12E+05 2.57E+05 1.01E+05 1.73E+05 1.55E+05 1.54E+05 1.42E+05 2.35E+05 1.00E+05 2.00E+05 2.20E+05 
UMP 1.82E+05 5.88E+04 1.89E+04 1.19E+05 2.31E+05 2.25E+05 1.99E+05 2.31E+05 1.07E+05 1.16E+05 2.44E+05 
Uracil 5.59E+05 7.32E+05 2.79E+05 6.26E+05 1.39E+05 2.17E+05 1.36E+05 1.82E+05 9.29E+04 5.83E+04 4.58E+05 
Uridine 6.47E+04 8.30E+04 6.22E+04 6.16E+04 4.05E+04 4.93E+04 7.57E+04 5.25E+04 4.27E+04 1.77E+04 4.77E+04 
Valine 1.55E+05 1.50E+05 7.90E+04 1.72E+05 9.68E+04 9.98E+04 1.37E+05 1.62E+05 6.24E+04 6.40E+04 1.73E+05 




Table 1.15 Raw Data of Resilient Mice from BLA/CeA  
Sample Name M2 M13 M16 M18 M44 M45 M46 M64 M69 M70 
2-Aminoadipate 3.16E+04 3.20E+04 3.12E+04 5.76E+04 3.02E+04 7.18E+04 5.92E+04 7.84E+04 5.30E+04 7.59E+04 
2-Hydroxy-2-methylsuccinate 1.98E+06 2.53E+06 2.11E+06 3.47E+06 2.86E+06 4.34E+06 4.04E+06 4.92E+06 2.28E+06 5.28E+06 
2-Isopropylmalate 7.59E+04 7.00E+04 7.41E+04 6.96E+04 6.98E+04 8.68E+04 9.69E+04 7.81E+04 6.29E+04 6.35E+04 
3_4-Dihydroxyphenylacetate 1.98E+05 1.60E+04 3.11E+04 1.83E+04 4.14E+04 2.37E+04 3.99E+04 1.81E+04 4.86E+03 9.24E+03 
4-Aminobutyrate 1.52E+06 1.70E+06 1.30E+06 1.79E+06 1.53E+06 1.96E+06 2.04E+06 1.96E+06 1.60E+06 1.78E+06 
5-Hydroxyindoleacetic acid 2.18E+04 2.99E+04 3.76E+04 3.82E+04 4.48E+04 4.45E+04 4.25E+04 7.76E+04 5.63E+04 5.02E+04 
Aconitate 2.19E+06 3.15E+06 4.09E+06 6.27E+06 7.10E+06 6.15E+06 8.49E+06 6.29E+06 4.18E+06 5.45E+06 
Adenine 3.50E+04 2.29E+04 2.33E+04 3.20E+04 2.21E+04 4.74E+04 3.78E+04 3.39E+04 2.89E+04 2.10E+04 
Adenosine 1.11E+05 6.32E+04 3.00E+04 3.29E+04 2.56E+04 1.12E+05 7.28E+04 1.82E+05 5.48E+04 2.12E+03 
Alanine/Sarcosine 1.36E+06 1.76E+06 1.46E+06 2.08E+06 2.05E+06 2.21E+06 2.16E+06 2.03E+06 1.95E+06 2.27E+06 
alpha-Ketoglutarate 5.28E+04 2.57E+04 2.19E+04 3.82E+04 4.05E+04 4.11E+04 5.58E+04 4.10E+04 9.29E+03 1.85E+04 
AMP/dGMP 1.33E+06 2.03E+06 1.88E+06 2.85E+06 3.89E+06 3.92E+06 3.78E+06 3.73E+06 2.77E+06 3.52E+06 
Ascorbate 2.66E+06 7.40E+06 8.91E+06 1.36E+07 1.33E+07 1.81E+07 2.20E+07 1.91E+07 1.20E+07 1.54E+07 
Asparagine 8.14E+04 4.49E+04 5.04E+04 4.80E+04 5.01E+04 7.95E+04 9.48E+04 9.70E+04 6.84E+04 6.49E+04 
Aspartate 5.08E+06 6.42E+06 4.46E+06 8.06E+06 6.10E+06 9.32E+06 8.59E+06 7.46E+06 5.90E+06 7.72E+06 
cAMP 1.40E+04 1.29E+04 1.24E+04 8.75E+03 2.36E+04 1.74E+04 2.50E+04 2.76E+04 1.70E+04 9.74E+03 
CDP-ethanolamine 2.87E+04 2.97E+04 2.36E+04 3.39E+04 3.46E+04 3.86E+04 5.22E+04 3.69E+04 3.42E+04 3.46E+04 
Citraconate 1.44E+05 1.76E+05 1.96E+05 2.76E+05 2.79E+05 3.01E+05 3.33E+05 2.32E+05 2.08E+05 2.69E+05 
Citrate/isocitrate 1.37E+06 1.75E+06 2.61E+06 3.73E+06 4.10E+06 3.43E+06 6.24E+06 4.08E+06 2.29E+06 4.13E+06 
Citrulline 9.29E+03 1.42E+04 1.34E+04 1.86E+04 4.14E+04 2.49E+04 2.79E+04 1.74E+04 1.48E+04 9.64E+03 
Creatine 1.70E+06 2.12E+06 1.64E+06 2.40E+06 2.61E+06 2.70E+06 2.57E+06 2.60E+06 2.24E+06 2.83E+06 
Cysteine 1.21E+04 6.91E+04 5.39E+04 7.79E+04 4.95E+04 1.38E+05 1.25E+05 1.16E+05 1.01E+05 1.25E+05 
Cytidine 3.19E+03 7.75E+03 7.59E+03 1.06E+04 2.09E+04 1.30E+04 2.03E+04 1.11E+04 1.41E+04 1.50E+04 
D-Glyceraldehdye 3-phosphate 1.96E+03 2.47E+03 1.00E+02 5.62E+03 4.30E+03 2.75E+03 4.36E+03 2.15E+03 3.19E+03 4.98E+04 
Fumarate 3.16E+05 3.00E+05 1.96E+05 1.36E+06 5.22E+05 1.51E+06 9.51E+05 1.42E+06 6.84E+05 1.33E+06 
Glucose 1-phosphate 5.99E+03 2.42E+04 1.27E+04 2.12E+04 3.81E+04 1.57E+04 1.54E+04 1.66E+04 2.75E+04 2.10E+04 
Glucose 6-phosphate 1.33E+04 1.21E+04 1.27E+04 2.89E+04 2.13E+04 2.52E+04 2.09E+04 2.04E+04 2.27E+04 4.00E+04 
Glutamate 1.39E+07 1.23E+07 1.13E+07 2.06E+07 1.63E+07 2.51E+07 2.08E+07 1.96E+07 1.69E+07 1.86E+07 
Glutamine 3.04E+06 4.36E+06 3.21E+06 4.59E+06 4.47E+06 4.91E+06 5.79E+06 5.09E+06 3.39E+06 5.03E+06 
Glutathione 5.56E+05 1.61E+06 8.96E+05 1.15E+06 1.39E+06 2.32E+06 2.26E+06 2.26E+06 1.38E+06 1.67E+06 
Glutathione disulfide 2.44E+05 2.22E+05 2.62E+05 3.75E+05 3.41E+05 1.63E+05 3.18E+05 2.41E+05 2.10E+05 4.28E+05 
Glycerate 1.88E+05 4.48E+04 3.74E+04 7.56E+04 4.25E+04 5.29E+04 1.73E+05 2.95E+04 4.23E+04 3.61E+04 
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Table 1.15 Continued 
Sample Name M2 M13 M16 M18 M44 M45 M46 M64 M69 M70 
Glycine 6.41E+04 1.12E+05 9.76E+04 2.92E+04 5.43E+04 1.90E+05 1.32E+05 5.39E+04 5.60E+04 1.06E+05 
GMP 1.78E+05 2.06E+05 2.45E+05 3.05E+05 3.43E+05 4.27E+05 4.37E+05 4.70E+05 2.99E+05 3.57E+05 
Guanosine 2.59E+04 2.65E+04 1.51E+04 4.32E+04 1.82E+04 4.79E+04 3.09E+04 2.70E+04 2.49E+04 2.32E+04 
Histidine 4.71E+03 9.25E+03 6.17E+03 1.19E+04 8.46E+03 1.14E+04 9.19E+03 2.85E+03 1.13E+04 6.57E+03 
Homoserine/Threonine 1.71E+05 1.36E+05 1.06E+05 1.83E+05 2.21E+05 1.53E+05 2.54E+05 1.62E+05 1.17E+05 1.78E+05 
Homovanillic acid 7.49E+04 1.14E+05 7.49E+04 9.00E+04 1.63E+05 1.35E+05 1.40E+05 1.39E+05 1.07E+05 1.60E+05 
Hydroxyisocaproic acid 3.10E+05 6.58E+05 4.10E+05 2.14E+05 1.30E+05 1.61E+05 2.03E+05 1.43E+05 1.56E+05 1.71E+05 
Hypoxanthine 1.11E+06 1.27E+06 1.16E+06 2.29E+06 1.54E+06 2.13E+06 2.57E+06 1.92E+06 1.52E+06 1.69E+06 
IMP 2.36E+05 4.76E+05 6.22E+05 5.24E+05 6.00E+05 8.08E+05 9.33E+05 7.45E+05 6.87E+05 1.14E+06 
Inosine 7.97E+05 1.10E+06 7.39E+05 1.59E+06 1.01E+06 1.33E+06 1.39E+06 1.24E+06 1.14E+06 1.12E+06 
Lactate 6.72E+07 6.12E+07 5.45E+07 7.02E+07 7.16E+07 7.27E+07 7.87E+07 7.36E+07 7.99E+07 6.77E+07 
Leucine/Isoleucine 3.43E+05 3.06E+05 1.16E+05 5.64E+05 3.51E+05 5.24E+05 4.45E+05 3.97E+05 3.25E+05 4.62E+05 
Lysine 2.20E+03 5.31E+03 3.20E+03 3.51E+03 3.06E+03 2.99E+03 2.55E+03 4.53E+03 5.85E+03 5.85E+03 
Malate 1.62E+05 1.48E+05 1.10E+05 2.14E+05 1.36E+05 2.15E+05 1.75E+05 2.10E+05 1.83E+05 2.11E+05 
Malate 5.93E+06 5.47E+06 3.45E+06 9.89E+06 6.09E+06 1.07E+07 7.99E+06 1.05E+07 5.79E+06 1.04E+07 
Methionine 1.06E+05 1.41E+05 8.31E+04 2.40E+05 1.62E+05 2.88E+05 2.45E+05 3.03E+05 1.55E+05 1.69E+05 
myo-Inositol 3.60E+05 3.77E+05 4.29E+05 4.49E+05 4.65E+05 5.38E+05 5.15E+05 4.67E+05 6.03E+05 4.96E+05 
N-Acetylglutamate 8.15E+05 9.39E+05 8.91E+05 1.89E+06 1.43E+06 2.52E+06 2.03E+06 2.87E+06 1.19E+06 1.90E+06 
N-Acetylglutamine 1.37E+04 1.73E+04 4.26E+03 2.74E+04 1.69E+04 4.24E+04 2.22E+04 3.40E+04 3.25E+04 1.95E+04 
N-Carbamoyl-L-aspartate 5.48E+05 5.87E+05 3.65E+05 5.30E+05 7.87E+05 7.88E+05 7.13E+05 5.60E+05 4.28E+05 7.00E+05 
Orotate 5.63E+03 2.34E+03 3.24E+03 4.47E+03 9.87E+03 3.84E+04 1.58E+04 1.62E+04 5.34E+03 6.50E+03 
Pantothenate 2.35E+06 2.27E+06 2.19E+06 3.71E+06 2.96E+06 4.29E+06 4.23E+06 4.71E+06 3.00E+06 3.00E+06 
Phenylalanine 9.05E+04 1.20E+05 7.13E+04 2.02E+05 8.06E+04 1.82E+05 1.65E+05 1.41E+05 1.57E+05 1.12E+05 
Phosphoenolpyruvate 5.77E+04 3.56E+04 5.41E+04 5.95E+04 2.88E+04 5.38E+04 4.42E+04 5.94E+04 6.05E+04 7.45E+04 
Proline 5.69E+04 4.56E+04 3.68E+04 6.90E+04 7.36E+04 7.74E+04 6.28E+04 4.92E+04 5.34E+04 5.62E+04 
Pyroglutamic acid 3.94E+06 1.25E+06 1.07E+06 2.53E+06 3.14E+06 2.21E+06 3.34E+06 1.87E+06 1.93E+06 2.01E+06 
Pyruvate 7.81E+05 7.41E+04 9.12E+04 7.67E+04 3.66E+05 1.14E+05 1.73E+05 1.25E+05 1.20E+05 8.17E+04 
Ribose phosphate 2.45E+04 4.37E+04 3.60E+04 5.45E+04 7.46E+04 5.93E+04 5.58E+04 6.06E+04 5.52E+04 7.84E+04 
Serine 8.43E+05 6.88E+05 6.03E+05 1.07E+06 1.11E+06 1.11E+06 1.12E+06 8.60E+05 8.43E+05 9.08E+05 
Shikimate 5.71E+04 2.18E+04 3.37E+04 3.20E+04 2.66E+04 4.09E+04 4.32E+04 4.94E+04 4.21E+04 2.65E+04 
Succinate 4.98E+06 3.63E+06 2.00E+06 3.80E+06 2.64E+06 3.81E+06 3.92E+06 3.08E+06 1.86E+06 1.66E+06 
Sulfolactate 8.90E+04 6.70E+04 4.81E+04 3.88E+04 6.82E+04 9.01E+04 5.19E+04 5.19E+04 5.65E+04 7.37E+04 
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Table 1.15 Continued 
Sample Name M2 M13 M16 M18 M44 M45 M46 M64 M69 M70 
Taurine 1.71E+07 2.06E+07 1.87E+07 2.40E+07 2.08E+07 2.65E+07 2.68E+07 2.78E+07 2.01E+07 2.43E+07 
Trehalose/sucrose 1.16E+05 1.65E+04 1.57E+04 6.96E+03 5.28E+04 1.20E+04 2.23E+04 3.39E+04 3.00E+04 1.14E+04 
Tryptophan 2.62E+04 2.48E+04 1.17E+04 5.03E+04 3.41E+04 2.69E+04 8.02E+04 3.50E+04 3.51E+04 3.59E+04 
Tyrosine 1.25E+05 1.32E+05 1.18E+05 2.21E+05 2.02E+05 1.87E+05 2.60E+05 2.29E+05 1.64E+05 1.41E+05 
UDP-glucose 5.84E+04 8.08E+04 1.44E+05 1.81E+05 1.85E+05 2.46E+05 1.76E+05 1.90E+05 1.97E+05 1.28E+05 
UDP-N-acetylglucosamine 6.71E+04 8.24E+04 8.70E+04 1.22E+05 1.60E+05 1.94E+05 1.37E+05 1.96E+05 1.57E+05 1.10E+05 
UMP 8.59E+04 1.60E+05 1.78E+05 1.84E+05 2.58E+05 2.54E+05 2.51E+05 2.32E+05 1.58E+05 2.16E+05 
Uracil 1.17E+05 1.47E+05 1.46E+05 2.93E+05 3.43E+05 3.90E+05 4.12E+05 3.25E+05 1.76E+05 3.12E+05 
Uric acid 7.44E+04 3.05E+04 2.14E+04 2.35E+04 5.26E+04 3.57E+04 3.37E+04 2.11E+04 2.85E+04 3.26E+04 
Uridine 2.23E+05 3.82E+05 2.39E+05 4.93E+05 3.33E+05 6.10E+05 5.73E+05 4.75E+05 4.61E+05 4.38E+05 
Valine 2.80E+05 2.27E+05 1.83E+05 4.28E+05 3.45E+05 3.41E+05 3.96E+05 3.43E+05 2.97E+05 3.44E+05 




Table 1.16 Raw Data of Control Mice from BLA/CeA  
Sample Name M3 M5 M10 M12 M14 M26 M30 M32 M38 
2-Aminoadipate 3.51E+04 6.24E+04 4.89E+04 6.51E+04 2.92E+04 8.09E+04 3.89E+04 7.26E+04 1.42E+05 
2-Hydroxy-2-methylsuccinate 2.45E+06 4.54E+06 3.83E+06 3.64E+06 2.43E+06 3.73E+06 4.07E+06 4.12E+06 7.22E+06 
2-Isopropylmalate 5.20E+04 4.51E+04 4.69E+04 3.88E+04 5.55E+04 6.73E+04 5.05E+04 4.98E+04 3.40E+04 
3_4-Dihydroxyphenylacetate 1.79E+04 2.27E+04 6.35E+04 1.24E+04 2.32E+04 9.38E+03 1.72E+04 2.26E+04 6.97E+04 
4-Aminobutyrate 1.34E+06 1.82E+06 1.61E+06 2.10E+06 1.33E+06 1.95E+06 1.71E+06 1.88E+06 2.34E+06 
5-Hydroxyindoleacetic acid 1.73E+04 6.58E+04 5.54E+04 6.10E+04 2.89E+04 5.41E+04 6.44E+04 6.72E+04 7.29E+04 
Aconitate 4.66E+06 7.50E+06 5.99E+06 6.69E+06 4.96E+06 7.74E+06 7.27E+06 6.19E+06 9.21E+06 
Adenine 2.14E+04 3.12E+04 3.33E+04 3.41E+04 2.63E+04 3.01E+04 2.40E+04 2.00E+04 5.54E+04 
Adenosine 4.34E+04 6.56E+04 7.34E+04 5.97E+04 4.55E+04 4.35E+03 2.23E+04 2.11E+03 1.62E+05 
Alanine/Sarcosine 1.51E+06 1.84E+06 1.90E+06 2.09E+06 1.77E+06 2.19E+06 1.89E+06 2.36E+06 2.75E+06 
alpha-Ketoglutarate 2.05E+04 5.24E+04 4.17E+04 4.09E+04 2.30E+04 4.19E+04 2.29E+04 3.11E+04 4.62E+04 
AMP/dGMP 2.34E+06 3.58E+06 3.47E+06 4.09E+06 2.86E+06 3.85E+06 3.71E+06 3.29E+06 6.60E+06 
Ascorbate 6.71E+06 1.51E+07 8.17E+06 1.98E+07 6.85E+06 1.86E+07 1.62E+07 2.26E+07 2.88E+07 
Asparagine 6.02E+04 8.30E+04 8.30E+04 7.76E+04 6.06E+04 7.14E+04 5.13E+04 8.67E+04 9.86E+04 
Aspartate 5.76E+06 9.02E+06 7.71E+06 8.73E+06 7.12E+06 9.39E+06 7.34E+06 8.46E+06 1.23E+07 
cAMP 1.29E+04 2.98E+04 2.36E+04 3.74E+04 2.11E+04 4.05E+04 2.12E+04 1.98E+04 4.31E+04 
CDP-ethanolamine 3.22E+04 3.92E+04 4.35E+04 4.15E+04 4.27E+04 3.81E+04 4.45E+04 3.79E+04 7.32E+04 
Citraconate 2.02E+05 3.24E+05 2.51E+05 2.81E+05 2.03E+05 3.32E+05 2.83E+05 2.60E+05 4.19E+05 
Citrate/isocitrate 2.10E+06 6.24E+06 3.81E+06 4.94E+06 2.46E+06 4.68E+06 6.02E+06 4.89E+06 5.89E+06 
Citrulline 1.67E+04 1.73E+04 1.51E+04 2.72E+04 1.37E+04 3.25E+04 2.89E+04 1.34E+04 3.58E+04 
Creatine 1.88E+06 2.16E+06 2.18E+06 2.51E+06 2.07E+06 2.85E+06 2.15E+06 2.63E+06 3.07E+06 
Cysteine 6.22E+04 8.36E+04 7.50E+04 1.10E+05 5.14E+04 1.56E+05 1.04E+05 1.04E+05 2.24E+05 
Cytidine 9.88E+03 1.35E+04 9.02E+03 1.54E+04 1.03E+04 2.31E+04 1.23E+04 8.55E+03 1.67E+04 
D-Glyceraldehdye 3-phosphate 4.31E+03 2.14E+03 3.08E+03 3.26E+03 4.62E+03 1.59E+04 3.84E+03 1.50E+04 1.80E+04 
Fumarate 4.68E+05 6.06E+05 6.25E+05 1.10E+06 3.38E+05 1.02E+06 7.86E+05 1.69E+06 2.60E+06 
Glucose 1-phosphate 1.43E+04 2.13E+04 1.78E+04 1.27E+04 2.49E+04 3.64E+04 3.37E+04 3.71E+04 3.02E+04 
Glucose 6-phosphate 1.32E+04 2.79E+04 2.46E+04 1.96E+04 2.00E+04 2.59E+04 2.20E+04 2.07E+04 4.38E+04 
Glutamate 1.68E+07 1.99E+07 1.90E+07 2.35E+07 1.99E+07 2.18E+07 1.75E+07 1.91E+07 2.63E+07 
Glutamine 3.39E+06 4.10E+06 3.63E+06 4.99E+06 4.57E+06 5.55E+06 4.77E+06 5.09E+06 5.54E+06 
Glutathione 1.10E+06 1.33E+06 1.30E+06 2.18E+06 9.76E+05 2.04E+06 1.68E+06 1.96E+06 3.21E+06 
Glutathione disulfide 2.22E+05 4.58E+05 4.49E+05 3.45E+05 3.94E+05 2.83E+05 3.96E+05 3.62E+05 2.57E+05 
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Table 1.16 Continued 
Sample Name M3 M5 M10 M12 M14 M26 M30 M32 M38 
Glycerate 4.55E+04 5.38E+04 8.72E+05 3.71E+04 5.62E+04 3.77E+04 3.94E+04 7.38E+04 4.96E+04 
Glycine 3.16E+05 7.40E+04 3.26E+05 8.43E+04 1.91E+05 6.06E+04 2.44E+05 2.19E+05 7.02E+04 
GMP 2.39E+05 3.72E+05 3.97E+05 3.72E+05 2.86E+05 4.09E+05 4.07E+05 3.85E+05 5.95E+05 
Guanosine 1.89E+04 2.46E+04 2.99E+04 2.49E+04 1.65E+04 2.69E+04 2.06E+04 2.83E+04 3.53E+04 
Histidine 9.37E+03 4.42E+03 3.11E+03 7.62E+03 8.09E+03 1.14E+04 1.12E+04 1.07E+04 1.66E+04 
Homoserine/Threonine 1.70E+05 2.07E+05 1.95E+05 1.54E+05 1.46E+05 1.83E+05 2.00E+05 1.92E+05 2.52E+05 
Homovanillic acid 6.73E+04 7.54E+04 8.08E+04 1.12E+05 8.31E+04 1.50E+05 1.40E+05 8.89E+04 2.17E+05 
Hydroxyisocaproic acid 2.33E+05 1.86E+05 3.70E+05 2.72E+05 2.55E+05 1.98E+05 2.25E+05 1.50E+05 1.63E+05 
Hypoxanthine 1.44E+06 2.12E+06 1.88E+06 1.98E+06 1.53E+06 2.45E+06 2.11E+06 2.04E+06 2.48E+06 
IMP 4.64E+05 9.71E+05 8.00E+05 8.74E+05 6.87E+05 1.12E+06 9.29E+05 1.34E+06 6.86E+05 
Inosine 9.05E+05 1.18E+06 1.11E+06 1.24E+06 1.02E+06 1.38E+06 1.20E+06 1.30E+06 1.43E+06 
Lactate 5.78E+07 6.50E+07 7.69E+07 7.07E+07 5.64E+07 7.21E+07 7.03E+07 7.86E+07 1.03E+08 
Leucine/Isoleucine 2.72E+05 4.27E+05 5.24E+05 4.41E+05 2.68E+05 6.48E+05 4.02E+05 6.56E+05 7.80E+05 
Lysine 4.75E+03 3.62E+03 3.37E+03 2.79E+03 3.38E+03 6.46E+03 4.98E+03 7.25E+03 1.20E+04 
Malate 1.59E+05 1.67E+05 1.66E+05 1.80E+05 1.78E+05 1.79E+05 1.76E+05 2.34E+05 2.12E+05 
Malate 4.12E+06 7.30E+06 7.16E+06 6.30E+06 4.68E+06 7.31E+06 6.85E+06 1.30E+07 1.78E+07 
Methionine 1.12E+05 1.64E+05 2.04E+05 2.41E+05 2.11E+05 3.41E+05 2.20E+05 3.50E+05 3.86E+05 
myo-Inositol 4.32E+05 4.11E+05 5.22E+05 6.26E+05 4.21E+05 4.86E+05 4.42E+05 4.73E+05 7.14E+05 
N-Acetylglutamate 1.53E+06 2.04E+06 2.09E+06 2.04E+06 1.19E+06 2.09E+06 1.88E+06 2.33E+06 3.55E+06 
N-Acetylglutamine 1.97E+04 2.32E+04 2.76E+04 2.15E+04 2.27E+04 3.83E+04 3.47E+04 2.66E+04 4.07E+04 
N-Carbamoyl-L-aspartate 3.45E+05 8.11E+05 2.68E+05 5.22E+05 4.64E+05 5.10E+05 3.75E+05 9.28E+05 3.71E+05 
Orotate 4.01E+03 9.78E+03 2.32E+04 1.25E+04 2.75E+03 1.03E+04 8.73E+03 5.57E+03 1.56E+04 
Pantothenate 2.65E+06 3.80E+06 3.24E+06 4.13E+06 2.92E+06 4.71E+06 4.12E+06 4.07E+06 7.00E+06 
Phenylalanine 8.95E+04 1.52E+05 1.01E+05 1.68E+05 1.33E+05 2.32E+05 1.36E+05 1.90E+05 2.32E+05 
Phosphoenolpyruvate 3.95E+04 3.36E+04 6.19E+04 3.45E+04 2.41E+04 4.89E+04 6.96E+04 3.61E+04 4.91E+04 
Proline 5.72E+04 6.07E+04 7.22E+04 5.40E+04 5.57E+04 6.03E+04 6.41E+04 7.63E+04 1.02E+05 
Pyroglutamic acid 2.57E+06 3.76E+06 1.32E+07 1.69E+06 2.58E+06 3.64E+06 2.99E+06 3.16E+06 4.30E+06 
Pyruvate 1.54E+05 2.56E+05 4.60E+05 6.66E+04 1.75E+05 2.54E+05 1.74E+05 2.11E+05 5.78E+05 
Ribose phosphate 4.39E+04 4.93E+04 6.91E+04 6.43E+04 5.10E+04 1.38E+05 6.45E+04 6.94E+04 8.25E+04 
Serine 1.15E+06 1.03E+06 1.37E+06 9.09E+05 8.16E+05 1.49E+06 1.08E+06 1.22E+06 1.75E+06 
Shikimate 2.40E+04 2.98E+04 7.64E+04 1.58E+04 2.26E+04 2.52E+04 1.99E+04 1.74E+04 1.71E+05 
Succinate 2.20E+06 4.36E+06 7.78E+06 3.23E+06 3.68E+06 2.57E+06 2.25E+06 2.46E+06 6.10E+06 
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Table 1.16 Continued 
Sample Name M3 M5 M10 M12 M14 M26 M30 M32 M38 
Sulfolactate 5.64E+04 7.06E+04 2.62E+05 5.29E+04 7.22E+04 5.58E+04 5.32E+04 6.70E+04 7.92E+04 
Taurine 1.97E+07 2.40E+07 2.23E+07 2.47E+07 2.12E+07 2.59E+07 2.32E+07 2.41E+07 3.20E+07 
Trehalose/sucrose 4.00E+04 5.11E+04 1.42E+05 2.37E+04 3.48E+04 3.88E+04 2.56E+04 5.57E+04 4.44E+04 
Tryptophan 2.50E+04 3.94E+04 3.27E+04 3.46E+04 2.17E+04 5.45E+04 3.69E+04 5.00E+04 7.72E+04 
Tyrosine 1.37E+05 1.46E+05 1.49E+05 1.65E+05 1.77E+05 2.09E+05 3.34E+05 1.60E+05 3.27E+05 
UDP-glucose 9.87E+04 1.39E+05 1.50E+05 1.51E+05 1.38E+05 2.39E+05 1.56E+05 1.70E+05 3.63E+05 
UDP-N-acetylglucosamine 7.74E+04 1.14E+05 1.32E+05 1.41E+05 9.45E+04 1.83E+05 1.11E+05 1.76E+05 3.28E+05 
UMP 1.99E+05 1.89E+05 2.08E+05 2.57E+05 1.85E+05 3.13E+05 2.42E+05 2.74E+05 3.15E+05 
Uracil 1.83E+05 3.07E+05 3.27E+05 3.36E+05 2.94E+05 5.14E+05 3.28E+05 3.62E+05 4.64E+05 
Uric acid 2.66E+04 3.60E+04 8.61E+04 1.90E+04 2.94E+04 3.67E+04 3.89E+04 4.79E+04 9.56E+04 
Uridine 3.38E+05 5.09E+05 5.91E+05 4.97E+05 2.58E+05 4.79E+05 3.60E+05 3.76E+05 7.38E+05 
Valine 2.97E+05 3.90E+05 3.84E+05 3.82E+05 2.85E+05 4.29E+05 3.59E+05 4.53E+05 5.84E+05 





Table 1.17 Raw Data of Susceptible Mice from BLA/CeA  
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 
2-Aminoadipate 3.81E+04 8.97E+04 2.01E+04 3.90E+04 7.79E+04 1.49E+05 8.38E+04 1.31E+04 7.67E+04 4.16E+04 
2-Hydroxy-2-methylsuccinate 2.29E+06 4.19E+06 2.38E+06 2.37E+06 3.85E+06 5.70E+06 4.37E+06 1.04E+06 4.80E+06 3.06E+06 
2-Isopropylmalate 5.96E+04 7.65E+04 1.01E+05 5.10E+04 6.80E+04 6.20E+04 5.45E+04 4.77E+04 5.25E+04 7.02E+04 
3_4-Dihydroxyphenylacetate 1.73E+04 2.79E+04 1.24E+04 2.05E+04 1.51E+04 2.20E+04 1.28E+04 1.90E+04 2.30E+04 3.72E+04 
4-Aminobutyrate 1.51E+06 2.13E+06 1.28E+06 1.37E+06 1.98E+06 2.27E+06 2.19E+06 5.77E+05 1.80E+06 1.48E+06 
5-Hydroxyindoleacetic acid 3.75E+04 5.22E+04 2.55E+04 1.79E+04 6.31E+04 7.64E+04 6.31E+04 2.23E+04 3.34E+04 1.28E+04 
Aconitate 3.71E+06 6.41E+06 3.94E+06 3.10E+06 5.76E+06 8.76E+06 5.67E+06 3.12E+06 6.05E+06 7.00E+06 
Adenine 1.65E+04 3.56E+04 2.44E+04 2.50E+04 4.40E+04 3.71E+04 2.41E+04 1.14E+04 1.70E+04 1.30E+04 
Adenosine 3.56E+04 7.74E+03 4.64E+04 5.03E+04 6.16E+04 7.49E+04 4.94E+03 1.00E+02 6.31E+03 1.81E+04 
Alanine/Sarcosine 1.68E+06 2.36E+06 1.58E+06 1.68E+06 2.56E+06 2.33E+06 2.34E+06 5.81E+05 2.28E+06 1.87E+06 
alpha-Ketoglutarate 2.19E+04 3.41E+04 2.73E+04 4.02E+04 2.88E+04 1.92E+04 2.94E+04 3.58E+04 4.76E+04 3.19E+04 
AMP/dGMP 2.20E+06 3.28E+06 2.23E+06 2.13E+06 3.69E+06 4.97E+06 3.96E+06 1.05E+06 4.60E+06 2.79E+06 
Ascorbate 1.02E+07 1.95E+07 5.49E+06 1.09E+07 2.07E+07 2.43E+07 1.58E+07 4.23E+06 1.63E+07 6.33E+06 
Asparagine 5.13E+04 7.48E+04 6.16E+04 4.69E+04 7.54E+04 5.72E+04 9.76E+04 2.94E+04 9.19E+04 8.43E+04 
Aspartate 6.33E+06 9.52E+06 6.25E+06 6.06E+06 8.43E+06 9.60E+06 9.12E+06 3.30E+06 9.32E+06 7.52E+06 
cAMP 1.46E+04 2.66E+04 1.45E+04 2.00E+04 3.41E+04 4.06E+04 2.14E+04 2.77E+03 2.75E+04 2.49E+04 
CDP-ethanolamine 3.10E+04 5.44E+04 3.23E+04 2.90E+04 3.77E+04 5.00E+04 4.71E+04 1.39E+04 5.83E+04 3.61E+04 
Citraconate 2.21E+05 2.88E+05 2.13E+05 1.52E+05 2.68E+05 3.14E+05 2.55E+05 1.35E+05 2.66E+05 3.27E+05 
Citrate/isocitrate 2.62E+06 4.67E+06 2.12E+06 1.73E+06 3.68E+06 6.41E+06 2.92E+06 1.96E+06 4.56E+06 3.66E+06 
Citrulline 1.53E+04 1.78E+04 8.71E+03 2.10E+04 2.65E+04 3.27E+04 2.01E+04 1.45E+04 2.56E+04 2.88E+04 
Creatine 2.00E+06 2.88E+06 1.88E+06 2.00E+06 3.11E+06 2.75E+06 2.71E+06 6.06E+05 3.05E+06 2.17E+06 
Cysteine 6.50E+04 1.62E+05 3.80E+04 4.82E+04 1.28E+05 2.18E+05 1.28E+05 1.99E+03 6.99E+04 9.62E+04 
Cytidine 1.18E+04 1.02E+04 1.08E+04 9.67E+03 2.02E+04 1.76E+04 2.82E+04 9.25E+03 9.04E+03 1.07E+04 
D-Glyceraldehdye 3-phosphate 2.34E+03 3.46E+03 1.06E+04 2.73E+03 3.37E+03 8.20E+03 2.04E+04 1.00E+02 2.68E+04 2.93E+03 
Fumarate 3.81E+05 1.30E+06 3.23E+05 7.91E+05 1.35E+06 1.46E+06 1.70E+06 1.53E+05 9.68E+05 5.50E+05 
Glucose 1-phosphate 3.20E+04 1.54E+04 1.89E+04 2.54E+04 1.28E+04 3.15E+04 3.75E+04 3.48E+03 4.70E+04 3.03E+04 
Glucose 6-phosphate 1.69E+04 2.94E+04 8.90E+03 1.10E+04 3.50E+04 2.36E+04 2.69E+04 4.73E+03 4.86E+04 2.63E+04 
Glutamate 1.71E+07 2.15E+07 1.54E+07 1.60E+07 2.14E+07 2.22E+07 2.44E+07 8.10E+06 2.10E+07 1.76E+07 
Glutamine 3.81E+06 4.98E+06 3.55E+06 3.67E+06 5.75E+06 4.60E+06 5.09E+06 2.13E+06 5.18E+06 4.88E+06 
Glutathione 1.11E+06 1.65E+06 6.58E+05 1.44E+06 2.69E+06 2.86E+06 2.17E+06 3.36E+05 1.61E+06 1.54E+06 
Glutathione disulfide 2.41E+05 3.92E+05 3.83E+05 1.65E+05 2.55E+05 3.11E+05 2.44E+05 2.24E+05 7.07E+05 2.50E+05 
Glycerate 5.45E+04 4.75E+04 4.78E+04 2.99E+04 3.96E+04 4.06E+04 4.23E+04 5.64E+04 5.16E+04 5.80E+04 
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Table 1.17 Continued 
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 
Glycine 1.15E+05 1.82E+05 8.50E+04 1.36E+05 9.56E+04 2.67E+05 5.79E+05 2.18E+05 2.99E+05 2.92E+05 
GMP 2.61E+05 3.54E+05 2.82E+05 2.23E+05 3.98E+05 4.81E+05 4.04E+05 1.37E+05 4.87E+05 3.01E+05 
Guanosine 1.47E+04 3.38E+04 2.01E+04 2.40E+04 2.16E+04 2.42E+04 3.11E+04 6.04E+03 2.53E+04 3.82E+04 
Histidine 6.44E+03 1.09E+04 8.35E+03 4.18E+03 1.09E+04 1.16E+04 8.56E+03 5.11E+03 1.54E+04 1.79E+04 
Homoserine/Threonine 1.49E+05 2.34E+05 1.53E+05 1.11E+05 1.99E+05 1.66E+05 2.14E+05 1.31E+05 2.57E+05 2.67E+05 
Homovanillic acid 5.85E+04 1.36E+05 8.12E+04 8.08E+04 1.52E+05 1.76E+05 1.22E+05 6.17E+04 1.47E+05 1.01E+05 
Hydroxyisocaproic acid 1.90E+05 1.63E+05 3.38E+05 5.53E+05 1.92E+05 1.95E+05 1.34E+05 1.71E+05 1.54E+05 2.54E+05 
Hypoxanthine 1.30E+06 2.45E+06 1.41E+06 1.52E+06 2.22E+06 2.25E+06 2.67E+06 5.29E+05 1.89E+06 1.87E+06 
IMP 7.24E+05 1.06E+06 4.88E+05 4.78E+05 1.05E+06 1.53E+06 1.33E+06 4.06E+05 2.28E+06 8.93E+05 
Inosine 8.69E+05 1.56E+06 9.46E+05 9.04E+05 1.78E+06 1.55E+06 1.25E+06 4.55E+05 1.17E+06 1.19E+06 
Lactate 5.94E+07 7.15E+07 5.88E+07 6.32E+07 8.36E+07 8.41E+07 8.34E+07 5.08E+07 9.13E+07 8.31E+07 
Leucine/Isoleucine 2.03E+05 4.77E+05 2.87E+05 1.86E+05 3.65E+05 4.72E+05 5.02E+05 1.69E+05 6.39E+05 6.04E+05 
Lysine 3.37E+03 6.84E+03 4.70E+03 1.58E+03 1.07E+04 9.20E+03 6.81E+03 1.61E+03 7.71E+03 2.76E+03 
Malate 1.34E+05 1.85E+05 1.74E+05 1.64E+05 2.37E+05 2.09E+05 2.65E+05 1.03E+05 2.10E+05 1.63E+05 
Malate 4.28E+06 8.73E+06 5.20E+06 6.90E+06 1.02E+07 8.98E+06 7.97E+06 1.62E+06 1.45E+07 5.64E+06 
Methionine 1.33E+05 2.95E+05 1.62E+05 1.36E+05 3.32E+05 2.96E+05 2.74E+05 5.71E+04 3.05E+05 2.69E+05 
myo-Inositol 4.36E+05 4.55E+05 4.13E+05 4.58E+05 5.65E+05 6.24E+05 5.45E+05 3.09E+05 6.21E+05 5.57E+05 
N-Acetylglutamate 1.09E+06 2.02E+06 8.21E+05 1.36E+06 2.43E+06 2.85E+06 2.11E+06 5.19E+05 2.11E+06 1.16E+06 
N-Acetylglutamine 1.30E+04 3.66E+04 1.25E+04 1.47E+04 3.39E+04 3.21E+04 2.81E+04 1.91E+03 2.37E+04 1.20E+04 
N-Carbamoyl-L-aspartate 6.39E+05 2.65E+05 3.59E+05 6.71E+05 5.42E+05 8.71E+05 5.16E+05 2.59E+05 5.02E+05 6.74E+05 
Orotate 4.35E+03 8.39E+03 2.46E+03 7.70E+03 1.69E+04 1.41E+04 1.73E+04 2.54E+03 1.09E+04 5.99E+03 
Pantothenate 2.26E+06 4.02E+06 2.38E+06 2.76E+06 5.01E+06 4.62E+06 4.18E+06 1.75E+06 4.15E+06 3.57E+06 
Phenylalanine 8.35E+04 1.61E+05 1.02E+05 1.37E+05 2.06E+05 1.67E+05 1.77E+05 9.28E+04 2.18E+05 2.07E+05 
Phosphoenolpyruvate 4.46E+04 4.62E+04 4.61E+04 3.45E+04 6.21E+04 2.46E+04 2.81E+04 6.85E+04 4.38E+04 3.46E+04 
Proline 4.74E+04 6.94E+04 4.10E+04 4.19E+04 5.44E+04 6.95E+04 6.89E+04 3.66E+04 1.05E+05 8.31E+04 
Pyroglutamic acid 1.71E+06 2.76E+06 2.57E+06 1.47E+06 1.75E+06 3.14E+06 3.39E+06 3.31E+06 6.34E+06 6.44E+06 
Pyruvate 1.63E+05 1.02E+05 1.44E+05 1.03E+05 1.02E+05 1.83E+05 3.20E+05 3.31E+05 1.10E+06 8.41E+05 
Ribose phosphate 4.77E+04 6.08E+04 5.20E+04 4.08E+04 7.21E+04 9.25E+04 8.07E+04 1.24E+04 8.73E+04 5.88E+04 
Serine 6.35E+05 1.11E+06 7.31E+05 6.44E+05 1.39E+06 1.10E+06 1.43E+06 1.06E+06 1.71E+06 1.71E+06 
Shikimate 2.59E+04 1.70E+04 2.63E+04 2.51E+04 5.32E+04 2.03E+04 3.72E+04 1.93E+04 2.21E+04 3.00E+04 
Succinate 3.06E+06 2.79E+06 2.44E+06 4.59E+06 2.91E+06 2.21E+06 3.26E+06 2.08E+06 3.22E+06 2.87E+06 
Sulfolactate 5.38E+04 5.00E+04 6.11E+04 5.70E+04 6.54E+04 4.73E+04 7.75E+04 5.72E+04 6.05E+04 8.96E+04 
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Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 
Taurine 1.93E+07 2.61E+07 1.84E+07 1.96E+07 2.84E+07 2.77E+07 2.76E+07 1.25E+07 2.56E+07 2.18E+07 
Trehalose/sucrose 1.96E+04 1.44E+04 4.51E+04 3.25E+04 1.01E+04 2.21E+04 4.42E+04 1.52E+06 6.72E+04 8.36E+04 
Tryptophan 1.48E+04 4.49E+04 2.08E+04 5.61E+04 4.72E+04 3.98E+04 5.32E+04 1.74E+04 4.37E+04 6.70E+04 
Tyrosine 9.01E+04 1.63E+05 9.67E+04 1.83E+05 3.22E+05 2.31E+05 1.99E+05 8.53E+04 3.84E+05 2.46E+05 
UDP-glucose 1.10E+05 1.19E+05 1.22E+05 1.22E+05 2.14E+05 2.63E+05 2.23E+05 5.29E+04 3.90E+05 1.24E+05 
UDP-N-acetylglucosamine 7.45E+04 1.19E+05 8.53E+04 9.84E+04 2.10E+05 2.16E+05 1.80E+05 3.42E+04 2.57E+05 1.25E+05 
UMP 1.21E+05 2.24E+05 1.55E+05 1.25E+05 2.43E+05 2.97E+05 2.90E+05 7.18E+04 4.01E+05 2.38E+05 
Uracil 1.47E+05 3.39E+05 2.17E+05 1.81E+05 3.59E+05 3.94E+05 3.55E+05 5.20E+04 3.23E+05 3.75E+05 
Uric acid 3.49E+04 3.37E+04 1.59E+04 3.25E+04 2.48E+04 3.64E+04 3.04E+04 6.51E+04 8.73E+04 6.09E+04 
Uridine 2.86E+05 4.59E+05 3.16E+05 3.57E+05 6.30E+05 7.70E+05 4.31E+05 1.46E+05 3.60E+05 3.01E+05 
Valine 2.41E+05 4.11E+05 1.97E+05 2.06E+05 3.74E+05 4.25E+05 4.60E+05 1.23E+05 5.25E+05 4.29E+05 




Table 1.18 Raw Data of Resilient Mice from HPC  
Sample Name M2 M13 M16 M44 M46 M69 M70 
2-Hydroxy-2-methylsuccinate 1.02E+05 1.11E+05 1.43E+05 2.10E+05 1.78E+05 2.26E+05 2.32E+05 
4-Aminobutyrate 7.28E+04 1.92E+05 1.08E+06 5.56E+05 1.52E+06 1.45E+06 1.38E+06 
5-Hydroxyindoleacetic acid 1.00E+02 3.74E+03 8.84E+03 1.08E+04 1.52E+04 1.59E+04 1.11E+04 
Acadesine 8.06E+03 1.26E+04 1.29E+04 1.24E+04 1.75E+04 1.37E+04 1.38E+04 
Aconitate 2.97E+04 2.33E+04 5.48E+04 1.09E+05 7.70E+04 5.19E+04 7.28E+04 
Adenosine 1.00E+02 1.00E+02 8.68E+04 1.00E+02 1.34E+05 1.54E+05 5.75E+04 
Alanine 5.30E+05 6.96E+05 1.20E+06 1.06E+06 1.51E+06 1.57E+06 1.45E+06 
AMP 2.69E+06 3.38E+06 5.06E+06 5.71E+06 5.42E+06 6.97E+06 6.06E+06 
Arginine 1.84E+04 2.27E+04 1.84E+04 4.37E+04 1.65E+04 1.39E+04 2.88E+04 
Ascorbate 2.10E+06 4.55E+05 6.40E+06 3.45E+06 7.54E+06 5.97E+06 8.99E+06 
Asparagine 1.17E+04 1.37E+04 2.92E+04 2.16E+04 2.95E+04 2.28E+04 3.30E+04 
Aspartate 2.31E+06 1.98E+06 4.40E+06 5.30E+06 6.05E+06 4.57E+06 5.53E+06 
CDP-ethanolamine 5.70E+04 4.60E+04 6.85E+04 5.89E+04 4.70E+04 6.44E+04 5.17E+04 
Citrate/isocitrate 7.51E+05 3.73E+05 1.72E+07 2.39E+06 3.96E+06 1.65E+06 2.07E+06 
Citrulline 8.60E+03 6.23E+03 7.34E+03 7.91E+03 7.90E+03 4.85E+03 7.66E+03 
CMP 3.79E+04 5.09E+04 6.24E+04 9.37E+04 5.57E+04 8.25E+04 6.23E+04 
Creatine 6.55E+05 7.86E+05 1.40E+06 1.50E+06 1.91E+06 2.12E+06 1.99E+06 
Creatinine 4.23E+04 2.03E+04 4.04E+04 3.91E+04 4.99E+04 4.20E+04 6.69E+04 
Cysteine 1.00E+02 1.00E+02 5.16E+03 3.17E+04 2.58E+04 1.45E+04 2.38E+04 
Cytidine 8.45E+03 1.47E+04 1.30E+04 1.66E+04 1.45E+04 1.16E+04 2.17E+04 
Cytidine 8.57E+04 1.23E+05 1.43E+05 1.42E+05 1.73E+05 1.86E+05 1.90E+05 
Diiodothyronine 3.86E+03 6.74E+03 4.54E+04 3.25E+04 4.66E+04 6.87E+04 5.54E+04 
Glutamate 1.38E+07 1.46E+07 2.61E+07 2.53E+07 3.27E+07 3.85E+07 3.98E+07 
Glutamine 3.02E+06 3.48E+06 6.57E+06 6.46E+06 7.83E+06 8.30E+06 9.22E+06 
Glutathione 4.28E+05 2.68E+05 1.28E+06 1.43E+06 1.41E+06 1.88E+06 1.91E+06 
Glutathione disulfide 1.00E+02 5.09E+03 8.59E+04 2.50E+04 9.12E+04 1.16E+05 8.18E+04 
Glycerone phosphate 6.04E+03 4.08E+04 9.09E+04 7.61E+04 1.06E+05 1.25E+05 1.21E+05 
GMP 1.47E+05 1.32E+05 1.76E+05 2.86E+05 2.20E+05 2.77E+05 3.54E+05 
Guanosine 4.00E+04 1.93E+04 2.99E+04 7.36E+04 5.74E+04 6.50E+04 7.47E+04 
Histidine 2.51E+04 3.23E+04 5.17E+04 4.07E+04 3.66E+04 4.96E+04 3.40E+04 
Homoserine 1.70E+05 2.17E+05 3.01E+05 2.84E+05 3.75E+05 3.68E+05 3.57E+05 
Homovanillic acid 2.43E+04 1.50E+04 3.39E+04 3.29E+04 4.48E+04 4.57E+04 5.49E+04 
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Table 1.18 Continued 
Sample Name M2 M13 M16 M44 M46 M69 M70 
Hydroxyphenylpyruvate 2.14E+06 2.07E+06 2.25E+06 2.22E+06 2.08E+06 2.21E+06 2.26E+06 
Hypoxanthine 3.18E+05 3.51E+05 6.91E+05 8.04E+05 7.02E+05 4.89E+05 6.97E+05 
IMP 1.81E+05 3.06E+05 3.08E+05 4.21E+05 4.08E+05 5.03E+05 5.05E+05 
Inosine 1.43E+06 1.51E+06 2.45E+06 2.63E+06 2.53E+06 2.27E+06 2.83E+06 
Lactate 3.12E+07 3.29E+07 3.96E+07 4.65E+07 4.88E+07 6.62E+07 5.01E+07 
Leucine/Isoleucine 4.42E+04 4.19E+04 6.80E+04 4.31E+04 4.67E+04 5.77E+04 6.21E+04 
Malate 7.14E+06 9.78E+06 1.74E+07 1.61E+07 2.06E+07 3.31E+07 2.76E+07 
Methionine 2.42E+04 2.71E+04 6.22E+04 3.70E+04 5.16E+04 5.52E+04 5.49E+04 
Methionine sulfoxide 3.82E+04 1.88E+04 2.60E+04 2.97E+04 5.25E+04 4.05E+04 6.11E+04 
Methylmalonate 9.32E+05 1.05E+06 8.69E+05 8.01E+05 9.04E+05 8.11E+05 6.26E+05 
myo-Inositol 3.72E+04 4.72E+04 7.60E+04 8.58E+04 9.09E+04 1.77E+05 1.13E+05 
N-Acetylglutamate 3.47E+04 5.33E+04 1.15E+05 9.66E+04 1.26E+05 1.80E+05 1.82E+05 
N-Carbamoyl-L-aspartate 3.11E+04 3.97E+04 9.63E+04 8.31E+04 1.80E+05 1.47E+05 1.18E+05 
Normetanephrine 2.06E+05 1.99E+05 1.78E+05 2.05E+05 1.94E+05 2.38E+05 2.00E+05 
Pantothenate 1.44E+05 1.32E+05 3.56E+05 2.74E+05 3.33E+05 3.41E+05 2.86E+05 
Phenylalanine 7.86E+04 7.50E+04 9.55E+04 1.04E+05 1.19E+05 1.29E+05 1.27E+05 
Proline 2.54E+04 2.91E+04 4.46E+04 4.22E+04 4.16E+04 3.93E+04 4.68E+04 
Pyroglutamic acid 2.89E+05 2.68E+05 1.93E+05 3.23E+05 4.10E+05 2.30E+05 2.44E+05 
S-Methyl-5--thioadenosine 2.91E+05 3.10E+05 3.53E+05 4.13E+05 3.68E+05 4.15E+05 4.16E+05 
Serine 6.20E+05 6.57E+05 6.75E+05 8.85E+05 8.85E+05 9.71E+05 8.73E+05 
Taurine 9.43E+06 1.13E+07 1.88E+07 1.89E+07 2.54E+07 3.07E+07 2.84E+07 
Trehalose/sucrose 6.37E+04 5.39E+04 3.66E+04 1.07E+05 2.16E+04 3.16E+04 2.29E+04 
Tyrosine 5.79E+04 5.46E+04 9.01E+04 6.50E+04 6.27E+04 7.21E+04 7.28E+04 
UMP 2.35E+05 2.34E+05 2.38E+05 3.38E+05 2.43E+05 2.64E+05 3.17E+05 
Uracil 9.02E+04 5.18E+04 2.12E+05 7.41E+04 1.97E+05 2.55E+05 2.29E+05 
Uridine 1.18E+05 1.13E+05 3.27E+05 2.15E+05 2.69E+05 3.60E+05 3.17E+05 
Valine 1.39E+05 1.15E+05 1.89E+05 1.32E+05 1.92E+05 2.18E+05 2.64E+05 




Table 1.19 Raw Data of Control Mice from HPC  
Sample Name M3 M5 M10 M12 M14 M26 M30 M32 M38 M40 
2-Hydroxy-2-methylsuccinate 2.63E+04 1.72E+05 1.97E+05 1.18E+05 1.49E+05 2.67E+05 1.58E+05 1.72E+05 2.56E+05 1.90E+05 
4-Aminobutyrate 1.73E+05 1.22E+06 1.69E+06 9.91E+05 4.92E+05 1.55E+06 1.05E+06 1.44E+06 1.72E+06 1.31E+06 
5-Hydroxyindoleacetic acid 2.81E+03 1.25E+04 1.72E+04 1.18E+04 1.20E+04 1.20E+04 1.29E+04 1.32E+04 1.57E+04 9.19E+03 
Acadesine 9.22E+02 1.28E+04 1.96E+04 1.50E+04 7.29E+03 1.94E+04 1.42E+04 1.56E+04 2.20E+04 2.06E+04 
Aconitate 7.63E+03 9.72E+04 6.83E+04 5.58E+04 3.78E+04 7.87E+04 3.64E+04 6.83E+04 8.05E+04 6.03E+04 
Adenosine 1.53E+04 2.37E+04 1.18E+05 3.17E+04 1.00E+02 1.50E+05 5.07E+04 1.42E+04 6.82E+04 2.36E+04 
Alanine 2.38E+05 9.94E+05 1.45E+06 1.17E+06 7.56E+05 1.56E+06 1.15E+06 1.12E+06 1.69E+06 1.44E+06 
AMP 8.88E+05 5.45E+06 7.00E+06 5.11E+06 3.11E+06 8.44E+06 4.67E+06 5.64E+06 7.28E+06 7.70E+06 
Arginine 1.43E+03 2.58E+04 2.87E+04 2.57E+04 1.30E+04 8.80E+03 2.76E+04 1.42E+04 2.18E+04 1.17E+04 
Ascorbate 8.25E+05 5.46E+06 1.16E+07 5.58E+06 7.60E+05 1.22E+07 3.38E+06 5.93E+06 2.59E+06 8.02E+06 
Asparagine 2.65E+03 1.92E+04 3.73E+04 2.61E+04 2.06E+04 3.01E+04 2.71E+04 2.47E+04 4.09E+04 3.27E+04 
Aspartate 3.81E+05 5.27E+06 7.53E+06 3.91E+06 2.17E+06 6.79E+06 4.98E+06 4.95E+06 7.83E+06 4.99E+06 
CDP-ethanolamine 4.65E+03 5.92E+04 6.98E+04 5.92E+04 3.43E+04 6.11E+04 4.98E+04 6.15E+04 6.44E+04 9.23E+04 
Citrate/isocitrate 2.89E+04 5.63E+06 5.19E+06 1.98E+06 9.60E+05 4.22E+06 1.64E+06 1.35E+06 2.01E+06 2.74E+06 
Citrulline 4.37E+03 6.38E+03 1.42E+04 3.74E+03 3.25E+03 7.17E+03 9.68E+03 4.89E+03 1.14E+04 4.80E+03 
CMP 1.32E+04 4.97E+04 7.63E+04 3.79E+04 2.52E+04 7.54E+04 2.61E+04 5.85E+04 6.08E+04 6.75E+04 
Creatine 1.89E+05 1.23E+06 1.82E+06 1.49E+06 8.94E+05 1.97E+06 1.44E+06 1.53E+06 2.25E+06 1.88E+06 
Creatinine 2.00E+04 1.03E+05 4.97E+04 3.11E+04 3.57E+04 4.98E+04 3.63E+04 3.25E+04 4.93E+04 4.76E+04 
Cysteine 1.00E+02 1.00E+02 1.40E+03 9.41E+02 5.20E+02 1.07E+04 9.35E+03 6.20E+03 2.94E+04 1.13E+04 
Cytidine 2.44E+03 1.14E+04 1.83E+04 1.16E+04 6.98E+03 8.80E+03 1.48E+04 1.49E+04 2.12E+04 1.16E+04 
Cytidine 2.40E+03 1.04E+05 1.44E+05 1.09E+05 5.76E+04 2.05E+05 7.95E+04 1.21E+05 1.88E+05 1.75E+05 
Diiodothyronine 1.00E+02 2.17E+04 8.05E+04 2.92E+04 1.27E+04 6.85E+04 3.43E+04 2.92E+04 6.95E+04 5.89E+04 
Glutamate 6.64E+06 2.67E+07 3.98E+07 2.58E+07 1.85E+07 3.71E+07 3.03E+07 3.03E+07 4.06E+07 3.65E+07 
Glutamine 1.15E+06 6.20E+06 7.95E+06 6.33E+06 4.21E+06 6.94E+06 5.94E+06 6.77E+06 8.98E+06 6.74E+06 
Glutathione 1.52E+05 6.72E+05 1.44E+06 1.07E+06 5.00E+05 1.62E+06 1.25E+06 1.47E+06 2.22E+06 1.46E+06 
Glutathione disulfide 3.79E+03 1.11E+05 1.37E+05 7.91E+04 3.13E+04 1.91E+05 5.21E+04 5.74E+04 6.09E+04 1.36E+05 
Glycerone phosphate 5.59E+03 6.36E+04 1.03E+05 7.29E+04 1.19E+04 1.22E+05 9.66E+04 1.03E+05 1.73E+05 1.54E+05 
GMP 1.69E+04 2.52E+05 2.25E+05 1.76E+05 1.05E+05 2.93E+05 1.54E+05 2.34E+05 3.38E+05 3.05E+05 
Guanosine 4.74E+03 5.90E+04 6.83E+04 6.19E+04 4.36E+04 5.43E+04 4.07E+04 3.98E+04 7.59E+04 4.54E+04 
Histidine 4.60E+03 3.39E+04 5.49E+04 3.19E+04 2.85E+04 4.65E+04 4.64E+04 4.31E+04 6.45E+04 4.17E+04 
Homoserine 4.46E+04 2.88E+05 3.44E+05 2.68E+05 1.84E+05 3.34E+05 2.79E+05 3.47E+05 5.80E+05 3.66E+05 




Table 1.19 Continued 
Sample Name M3 M5 M10 M12 M14 M26 M30 M32 M38 M40 
Hydroxyphenylpyruvate 2.00E+06 1.92E+06 1.96E+06 2.02E+06 2.11E+06 2.01E+06 2.11E+06 2.25E+06 2.09E+06 2.25E+06 
Hypoxanthine 6.49E+04 5.74E+05 5.86E+05 4.19E+05 3.07E+05 5.50E+05 5.61E+05 5.56E+05 1.08E+06 5.29E+05 
IMP 5.86E+04 5.83E+05 5.15E+05 3.40E+05 3.51E+05 7.22E+05 3.59E+05 3.68E+05 3.87E+05 1.14E+06 
Inosine 4.08E+05 2.31E+06 2.39E+06 2.31E+06 1.53E+06 2.35E+06 2.26E+06 2.47E+06 3.09E+06 2.09E+06 
Lactate 1.77E+07 3.49E+07 5.04E+07 3.30E+07 2.80E+07 4.91E+07 4.43E+07 4.81E+07 7.73E+07 4.70E+07 
Leucine/Isoleucine 1.23E+04 5.43E+04 4.99E+04 4.29E+04 3.17E+04 5.31E+04 5.11E+04 7.01E+04 8.51E+04 3.59E+04 
Malate 1.76E+06 1.08E+07 1.92E+07 1.52E+07 8.08E+06 2.51E+07 1.69E+07 1.77E+07 3.13E+07 1.89E+07 
Methionine 2.90E+03 3.74E+04 3.82E+04 2.92E+04 2.33E+04 3.30E+04 3.99E+04 3.61E+04 4.74E+04 3.50E+04 
Methionine sulfoxide 4.06E+04 1.12E+04 2.68E+04 1.82E+04 2.93E+04 3.74E+04 4.37E+04 4.39E+04 3.89E+04 3.39E+04 
Methylmalonate 6.80E+05 8.20E+05 1.28E+06 7.50E+05 6.66E+05 9.74E+05 6.74E+05 6.93E+05 1.82E+06 7.75E+05 
myo-Inositol 4.78E+03 5.01E+04 7.50E+04 4.34E+04 2.80E+04 1.25E+05 7.39E+04 1.22E+05 2.01E+05 9.51E+04 
N-Acetylglutamate 1.37E+04 1.52E+05 2.00E+05 1.10E+05 7.80E+04 2.19E+05 1.18E+05 1.04E+05 1.71E+05 1.26E+05 
N-Carbamoyl-L-aspartate 1.18E+04 1.09E+05 1.71E+05 9.67E+04 4.65E+04 1.64E+05 1.11E+05 1.37E+05 1.76E+05 1.44E+05 
Normetanephrine 1.86E+05 2.32E+05 2.27E+05 2.24E+05 2.07E+05 2.28E+05 2.66E+05 2.31E+05 2.00E+05 2.66E+05 
Pantothenate 6.12E+04 2.29E+05 2.64E+05 1.98E+05 1.62E+05 4.06E+05 2.44E+05 2.72E+05 3.61E+05 3.52E+05 
Phenylalanine 2.05E+04 1.09E+05 1.28E+05 8.42E+04 9.75E+04 1.51E+05 1.10E+05 1.21E+05 1.76E+05 1.13E+05 
Proline 1.57E+04 3.52E+04 5.24E+04 3.05E+04 2.16E+04 4.29E+04 4.71E+04 3.49E+04 5.83E+04 5.37E+04 
Pyroglutamic acid 1.27E+05 2.29E+05 3.33E+05 2.32E+05 2.23E+05 1.84E+05 2.24E+05 2.05E+05 2.62E+05 3.18E+05 
S-Methyl-5--thioadenosine 2.98E+05 2.81E+05 3.28E+05 2.92E+05 3.29E+05 4.12E+05 3.25E+05 3.83E+05 4.21E+05 3.92E+05 
Serine 1.65E+05 6.24E+05 1.18E+06 8.31E+05 4.72E+05 8.93E+05 7.90E+05 7.89E+05 1.36E+06 9.83E+05 
Taurine 5.81E+06 1.70E+07 2.35E+07 1.63E+07 1.06E+07 2.71E+07 1.63E+07 2.21E+07 2.59E+07 2.63E+07 
Trehalose/sucrose 5.47E+04 4.74E+04 4.06E+04 4.87E+04 5.19E+04 2.51E+04 3.07E+04 3.73E+04 7.83E+04 4.73E+04 
Tyrosine 1.25E+04 5.65E+04 6.45E+04 6.31E+04 5.94E+04 9.40E+04 6.83E+04 6.15E+04 1.23E+05 5.81E+04 
UMP 4.23E+04 2.00E+05 2.65E+05 2.54E+05 1.35E+05 2.67E+05 1.66E+05 2.00E+05 2.81E+05 2.98E+05 
Uracil 2.23E+04 1.11E+05 1.66E+05 8.27E+04 5.42E+04 2.24E+05 1.30E+05 1.82E+05 2.03E+05 3.10E+05 
Uridine 7.68E+04 2.42E+05 3.32E+05 2.30E+05 1.80E+05 3.07E+05 2.43E+05 2.55E+05 3.62E+05 1.96E+05 
Valine 5.55E+04 1.81E+05 2.19E+05 1.16E+05 1.17E+05 2.65E+05 1.53E+05 1.87E+05 3.31E+05 2.33E+05 




Table 1.20 Raw Data of Susceptible Mice from HPC  
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 M28 
2-Hydroxy-2-methylsuccinate 2.55E+05 1.47E+05 4.84E+05 1.83E+05 3.06E+05 2.62E+05 1.25E+05 1.86E+05 1.13E+05 1.44E+05 1.83E+05 
4-Aminobutyrate 1.52E+06 1.13E+06 1.32E+06 1.70E+06 1.69E+06 1.34E+06 1.03E+06 1.68E+06 9.70E+05 1.18E+06 1.61E+06 
5-Hydroxyindoleacetic acid 2.70E+04 7.85E+03 1.84E+04 2.82E+04 1.91E+04 1.60E+04 4.96E+03 2.72E+04 4.59E+03 6.74E+03 1.57E+04 
Acadesine 1.22E+04 1.69E+04 7.51E+03 2.26E+04 2.15E+04 1.98E+04 1.04E+04 2.19E+04 1.72E+04 1.47E+04 1.31E+04 
Aconitate 8.11E+04 3.61E+04 5.00E+04 8.72E+04 1.09E+05 6.89E+04 4.26E+04 7.25E+04 4.01E+04 6.91E+04 9.10E+04 
Adenosine 2.19E+04 6.08E+04 7.35E+03 1.15E+05 9.50E+04 5.99E+04 6.69E+04 3.90E+04 1.86E+04 1.74E+04 6.44E+03 
Alanine 1.18E+06 9.28E+05 1.07E+06 1.59E+06 1.55E+06 1.48E+06 9.75E+05 1.16E+06 1.00E+06 1.11E+06 1.29E+06 
AMP 7.62E+06 5.78E+06 2.85E+06 7.82E+06 7.98E+06 7.86E+06 4.19E+06 6.27E+06 5.30E+06 5.78E+06 6.36E+06 
Arginine 2.74E+04 7.40E+03 8.95E+03 3.58E+04 1.53E+04 1.88E+04 7.26E+03 1.85E+04 6.18E+03 7.73E+03 2.61E+04 
Ascorbate 1.08E+07 7.60E+06 1.35E+03 1.06E+07 1.07E+07 7.87E+06 4.61E+06 5.94E+06 1.56E+06 4.86E+06 6.23E+06 
Asparagine 2.04E+04 2.37E+04 1.18E+04 3.36E+04 2.96E+04 3.39E+04 1.68E+04 3.17E+04 1.89E+04 1.50E+04 2.90E+04 
Aspartate 6.56E+06 4.06E+06 6.78E+05 6.97E+06 7.25E+06 6.90E+06 3.22E+06 5.64E+06 2.35E+06 3.63E+06 5.75E+06 
CDP-ethanolamine 6.34E+04 4.60E+04 4.82E+02 8.31E+04 5.34E+04 9.05E+04 5.18E+04 5.12E+04 3.62E+04 3.88E+04 4.50E+04 
Citrate/isocitrate 7.58E+06 1.98E+06 9.57E+04 4.46E+06 3.84E+06 3.22E+06 9.97E+05 4.58E+06 6.36E+05 1.49E+06 3.23E+06 
Citrulline 9.84E+03 1.54E+04 7.01E+03 8.62E+03 1.95E+03 1.03E+04 5.48E+03 1.58E+04 8.21E+03 7.10E+03 6.86E+03 
CMP 7.60E+04 3.39E+04 1.00E+02 5.89E+04 5.97E+04 9.00E+04 3.75E+04 5.18E+04 4.43E+04 6.94E+04 4.75E+04 
Creatine 1.49E+06 1.16E+06 1.29E+06 1.99E+06 1.97E+06 1.90E+06 1.23E+06 1.63E+06 1.23E+06 1.44E+06 1.68E+06 
Creatinine 3.50E+04 5.43E+04 3.63E+04 4.68E+04 3.19E+04 3.38E+04 2.90E+04 4.43E+04 2.21E+04 3.03E+04 4.09E+04 
Cysteine 1.00E+02 1.00E+02 1.00E+02 1.19E+04 8.89E+03 1.52E+04 6.83E+02 9.04E+03 6.83E+02 3.20E+03 1.21E+04 
Cytidine 1.24E+04 9.68E+03 8.30E+03 2.15E+04 1.17E+04 1.60E+04 7.22E+03 2.98E+04 7.08E+03 1.14E+04 2.14E+04 
Cytidine 1.16E+05 8.85E+04 5.57E+04 1.44E+05 1.67E+05 1.50E+05 9.43E+04 1.53E+05 7.75E+04 7.98E+04 1.19E+05 
Diiodothyronine 4.15E+04 1.77E+04 1.92E+04 6.63E+04 8.32E+04 6.17E+04 2.31E+04 5.27E+04 2.83E+04 2.77E+04 5.04E+04 
Glutamate 2.97E+07 2.69E+07 9.59E+06 3.83E+07 3.85E+07 3.83E+07 2.29E+07 3.09E+07 2.57E+07 2.71E+07 3.25E+07 
Glutamine 7.47E+06 5.27E+06 5.34E+06 9.83E+06 9.46E+06 8.90E+06 5.12E+06 7.68E+06 4.46E+06 6.03E+06 9.42E+06 
Glutathione 9.30E+05 1.05E+06 4.89E+05 1.77E+06 1.88E+06 1.85E+06 9.95E+05 1.22E+06 7.08E+05 1.19E+06 1.56E+06 
Glutathione disulfide 8.70E+04 9.03E+04 5.65E+04 1.05E+05 9.55E+04 7.80E+04 8.58E+04 1.33E+05 1.01E+05 1.00E+05 8.46E+04 
Glycerone phosphate 9.61E+04 8.17E+04 2.83E+03 8.69E+04 1.03E+05 1.03E+05 7.94E+04 1.41E+05 9.36E+04 1.25E+05 1.06E+05 
GMP 2.65E+05 1.67E+05 7.79E+04 2.88E+05 2.96E+05 2.59E+05 1.14E+05 2.01E+05 1.73E+05 2.26E+05 2.40E+05 
Guanosine 5.25E+04 3.91E+04 1.91E+04 5.37E+04 5.10E+04 5.76E+04 2.28E+04 5.36E+04 2.00E+04 3.69E+04 4.70E+04 
Histidine 3.00E+04 3.43E+04 6.92E+03 5.82E+04 4.33E+04 4.68E+04 3.41E+04 5.46E+04 3.25E+04 2.38E+04 5.34E+04 
Homoserine 2.79E+05 2.87E+05 1.63E+05 3.90E+05 3.81E+05 3.98E+05 2.02E+05 3.99E+05 1.76E+05 2.38E+05 3.29E+05 
Homovanillic acid 4.49E+04 3.66E+04 3.66E+04 6.20E+04 6.42E+04 3.54E+04 2.41E+04 5.65E+04 3.12E+04 3.33E+04 4.88E+04 
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Table 1.20 Continued 
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 M28 
Hydroxyphenylpyruvate 2.04E+06 2.19E+06 1.97E+06 2.17E+06 1.94E+06 2.15E+06 2.07E+06 2.22E+06 2.16E+06 2.00E+06 1.95E+06 
Hypoxanthine 6.49E+05 3.87E+05 3.30E+05 7.47E+05 6.52E+05 7.04E+05 2.90E+05 7.06E+05 2.50E+05 4.20E+05 6.42E+05 
IMP 8.02E+05 3.59E+05 1.48E+05 6.04E+05 6.64E+05 6.24E+05 2.94E+05 4.24E+05 5.94E+05 4.88E+05 4.47E+05 
Inosine 2.42E+06 1.57E+06 1.06E+06 2.53E+06 2.45E+06 2.85E+06 1.72E+06 3.00E+06 1.40E+06 1.79E+06 2.75E+06 
Lactate 4.12E+07 4.22E+07 5.51E+06 5.94E+07 5.65E+07 5.36E+07 3.91E+07 7.03E+07 4.20E+07 4.51E+07 5.17E+07 
Leucine/Isoleucine 5.02E+04 3.68E+04 5.89E+04 5.15E+04 5.24E+04 6.40E+04 3.99E+04 8.18E+04 4.25E+04 4.06E+04 6.86E+04 
Malate 1.90E+07 1.53E+07 1.35E+07 2.84E+07 2.36E+07 2.44E+07 1.46E+07 2.09E+07 1.32E+07 1.61E+07 2.26E+07 
Methionine 3.79E+04 3.25E+04 4.03E+04 7.09E+04 4.58E+04 5.01E+04 2.25E+04 3.98E+04 3.14E+04 2.71E+04 5.23E+04 
Methionine sulfoxide 3.69E+04 1.56E+04 3.96E+04 4.05E+04 3.82E+04 2.91E+04 3.40E+04 4.07E+04 2.17E+04 4.87E+04 2.51E+04 
Methylmalonate 7.38E+05 7.97E+05 7.12E+05 8.61E+05 1.12E+06 9.74E+05 8.87E+05 7.88E+05 8.54E+05 1.07E+06 7.73E+05 
myo-Inositol 4.92E+04 9.00E+04 1.13E+03 1.31E+05 1.47E+05 9.70E+04 6.55E+04 1.74E+05 5.94E+04 7.29E+04 1.15E+05 
N-Acetylglutamate 1.84E+05 1.08E+05 3.37E+04 1.92E+05 1.84E+05 1.52E+05 1.04E+05 1.46E+05 1.07E+05 1.05E+05 1.48E+05 
N-Carbamoyl-L-aspartate 1.01E+05 6.91E+04 4.13E+04 1.48E+05 1.70E+05 1.21E+05 1.00E+05 1.49E+05 9.49E+04 1.02E+05 1.13E+05 
Normetanephrine 2.18E+05 2.20E+05 2.14E+05 2.58E+05 1.97E+05 2.12E+05 2.29E+05 2.43E+05 2.15E+05 2.20E+05 2.53E+05 
Pantothenate 2.78E+05 2.15E+05 1.89E+05 4.01E+05 4.37E+05 2.42E+05 2.24E+05 3.60E+05 2.10E+05 2.31E+05 3.65E+05 
Phenylalanine 9.89E+04 1.08E+05 4.65E+04 1.62E+05 1.47E+05 1.22E+05 8.10E+04 1.52E+05 7.87E+04 1.10E+05 1.26E+05 
Proline 3.42E+04 3.74E+04 2.80E+04 4.52E+04 4.77E+04 3.89E+04 3.38E+04 5.68E+04 3.34E+04 3.59E+04 3.86E+04 
Pyroglutamic acid 2.34E+05 2.70E+05 1.59E+05 2.97E+05 2.83E+05 2.62E+05 2.41E+05 4.89E+05 2.71E+05 2.21E+05 2.88E+05 
S-Methyl-5--thioadenosine 2.68E+05 2.86E+05 2.63E+05 3.36E+05 3.43E+05 3.81E+05 3.24E+05 3.66E+05 3.52E+05 3.88E+05 3.31E+05 
Serine 6.69E+05 9.94E+05 5.03E+05 1.07E+06 1.10E+06 1.12E+06 6.34E+05 1.41E+06 7.52E+05 7.01E+05 8.87E+05 
Taurine 2.07E+07 1.50E+07 1.89E+07 2.41E+07 2.82E+07 2.37E+07 1.81E+07 2.23E+07 1.71E+07 1.64E+07 1.89E+07 
Trehalose/sucrose 3.07E+04 5.91E+04 2.52E+04 5.06E+04 4.99E+04 4.51E+04 6.73E+04 1.10E+05 1.27E+05 4.83E+04 4.08E+04 
Tyrosine 5.69E+04 7.90E+04 4.94E+04 9.44E+04 7.51E+04 1.01E+05 4.67E+04 1.09E+05 4.47E+04 6.44E+04 9.15E+04 
UMP 2.73E+05 1.73E+05 8.64E+04 2.94E+05 2.43E+05 3.43E+05 1.47E+05 1.66E+05 1.94E+05 2.78E+05 2.41E+05 
Uracil 1.71E+05 9.04E+04 1.07E+05 1.82E+05 2.85E+05 1.38E+05 1.37E+05 2.29E+05 1.03E+05 1.68E+05 1.51E+05 
Uridine 2.71E+05 2.16E+05 1.88E+05 3.84E+05 3.50E+05 2.96E+05 2.00E+05 3.06E+05 1.71E+05 1.51E+05 2.71E+05 
Valine 1.85E+05 1.95E+05 1.28E+05 2.28E+05 2.51E+05 2.10E+05 1.32E+05 3.49E+05 1.31E+05 1.65E+05 2.06E+05 




Table 1.21 Raw Data of Resilient Mice from NAc 
Sample Name M2 M8 M13 M16 M18 M44 M45 M46 M64 M69 M70 
2-Aminoadipate 3.51E+04 2.16E+04 2.77E+04 3.18E+04 5.82E+04 1.09E+04 8.31E+04 1.68E+05 5.51E+04 1.02E+05 3.00E+04 
2-Hydroxy-2-methylsuccinate 5.00E+06 2.62E+06 5.04E+06 4.78E+06 2.80E+06 3.72E+06 3.77E+06 5.97E+06 3.18E+06 1.84E+06 3.53E+06 
2-Isopropylmalate 7.47E+04 5.32E+04 5.32E+04 5.93E+04 5.61E+04 5.42E+04 6.07E+04 5.98E+04 5.79E+04 5.45E+04 5.92E+04 
3-Phosphoglycerate 3.77E+04 1.21E+04 2.47E+04 5.80E+03 1.21E+04 1.78E+04 2.10E+04 1.99E+04 1.75E+04 2.63E+04 3.42E+04 
3_4-Dihydroxyphenylacetate 4.14E+04 2.33E+04 7.10E+04 2.31E+04 4.62E+04 7.16E+04 5.51E+04 4.67E+06 3.46E+04 2.01E+04 3.20E+04 
4-Aminobutyrate 2.07E+06 2.81E+06 1.39E+06 1.55E+06 2.51E+06 3.07E+06 2.23E+06 2.32E+06 1.74E+06 2.79E+06 3.65E+06 
5-Hydroxyindoleacetic acid 1.88E+04 2.83E+04 1.57E+04 2.09E+04 3.43E+04 3.00E+04 2.01E+04 2.92E+04 1.45E+04 1.55E+04 3.18E+04 
Aconitate 5.13E+06 3.71E+06 8.16E+06 5.79E+06 7.30E+06 8.38E+06 7.08E+06 8.50E+06 5.85E+06 4.45E+06 5.09E+06 
Adenine 3.14E+04 2.32E+04 3.45E+04 2.77E+04 4.38E+04 3.75E+04 3.63E+04 3.54E+04 3.45E+04 4.83E+04 3.53E+04 
Adenosine 2.25E+05 5.50E+04 2.79E+05 1.89E+05 5.35E+04 1.11E+05 8.11E+04 5.98E+04 5.60E+04 4.63E+04 8.21E+04 
Alanine/Sarcosine 1.32E+06 1.09E+06 1.14E+06 9.88E+05 1.29E+06 1.38E+06 1.28E+06 1.20E+06 1.26E+06 1.13E+06 1.33E+06 
alpha-Ketoglutarate 3.07E+04 2.91E+04 1.67E+04 3.18E+04 3.88E+04 3.83E+04 2.98E+04 6.05E+04 1.94E+04 1.62E+04 2.56E+04 
AMP/dGMP 3.22E+05 4.90E+05 3.32E+05 4.97E+05 2.04E+05 1.63E+05 2.07E+05 2.19E+05 1.88E+05 1.14E+05 9.87E+04 
Arginine 4.76E+03 3.03E+04 5.52E+03 4.91E+03 3.66E+03 8.55E+03 6.63E+03 2.13E+03 6.53E+03 3.77E+03 7.83E+03 
Ascorbate 4.89E+06 2.46E+06 7.26E+06 3.31E+06 4.41E+06 4.60E+06 4.23E+06 1.98E+06 1.23E+06 1.60E+06 4.24E+06 
Asparagine 2.86E+04 2.33E+04 3.73E+04 2.88E+04 4.02E+04 4.34E+04 3.28E+04 2.94E+04 4.70E+04 5.35E+04 3.02E+04 
Aspartate 6.04E+06 6.24E+06 6.12E+06 6.71E+06 2.37E+06 6.10E+06 4.05E+06 4.07E+06 4.83E+06 2.67E+06 7.02E+06 
cAMP 1.49E+04 2.97E+04 4.13E+04 1.39E+04 3.69E+04 3.53E+04 3.25E+04 1.95E+04 3.71E+04 1.26E+04 1.25E+04 
CDP-ethanolamine 2.60E+04 2.14E+04 2.47E+04 1.54E+04 1.34E+04 2.73E+04 1.48E+04 1.38E+04 1.67E+04 8.77E+03 2.19E+04 
Citraconate 1.30E+05 1.22E+05 2.33E+05 1.97E+05 2.21E+05 1.98E+05 2.66E+05 2.84E+05 1.78E+05 1.58E+05 1.97E+05 
Citrate/isocitrate 3.01E+06 1.79E+06 5.46E+06 3.01E+06 5.70E+06 5.84E+06 4.64E+06 5.29E+06 3.72E+06 2.54E+06 2.88E+06 
Creatine 1.45E+06 1.40E+06 1.64E+06 1.32E+06 1.65E+06 1.60E+06 1.52E+06 1.23E+06 1.68E+06 1.62E+06 1.61E+06 
Cysteine 7.47E+04 7.38E+04 1.07E+05 7.58E+04 2.65E+04 4.12E+04 2.86E+04 2.44E+04 3.81E+04 3.62E+04 1.28E+05 
Cystine 4.34E+03 1.00E+02 1.00E+02 8.45E+03 6.83E+04 7.56E+04 6.13E+04 4.51E+04 5.54E+04 5.04E+04 1.85E+04 
D-Gluconate 1.07E+04 8.82E+03 1.10E+04 4.97E+03 1.41E+04 2.38E+04 2.67E+04 2.56E+04 1.27E+04 1.55E+04 1.12E+04 
D-Glyceraldehdye 3-phosphate 1.39E+04 3.72E+04 2.70E+03 1.88E+03 3.24E+03 3.32E+03 1.72E+04 1.63E+03 1.50E+04 1.74E+04 3.17E+04 
Dopamine 1.25E+04 4.17E+03 2.00E+04 2.06E+03 2.19E+04 1.51E+04 1.53E+04 2.55E+03 6.87E+03 5.35E+03 8.68E+03 




Table 1.21 Continued 
 
Sample Name M2 M8 M13 M16 M18 M44 M45 M46 M64 M69 M70 
Fumarate 1.71E+06 1.19E+06 1.24E+06 1.17E+06 7.44E+05 1.31E+06 1.82E+06 1.48E+06 1.09E+06 1.00E+06 1.47E+06 
Glucose 1-phosphate 4.88E+03 1.76E+04 8.33E+03 3.52E+03 2.01E+03 4.06E+03 1.45E+03 1.41E+03 2.69E+03 4.94E+03 1.05E+04 
Glutamate 9.62E+06 7.52E+06 8.97E+06 8.91E+06 9.43E+06 3.70E+06 6.48E+06 6.11E+06 4.54E+06 4.38E+06 5.92E+06 
Glutamate 5.66E+04 1.04E+05 5.02E+04 5.29E+04 2.03E+04 3.28E+04 2.68E+04 2.02E+04 1.33E+04 1.67E+04 1.78E+04 
Glutamine 4.24E+06 2.35E+06 2.17E+06 2.67E+06 3.15E+06 4.16E+06 2.83E+06 1.48E+06 2.88E+06 2.91E+06 2.67E+06 
Glutathione 8.75E+05 5.51E+05 1.17E+06 6.33E+05 7.32E+05 9.85E+05 6.26E+05 5.07E+05 6.55E+05 5.11E+05 6.56E+05 
Glutathione disulfide 3.94E+05 3.22E+05 2.86E+05 2.53E+05 3.41E+05 3.97E+05 3.15E+05 2.42E+05 2.51E+05 2.45E+05 2.23E+05 
Glycerate 9.44E+04 2.11E+04 3.40E+04 4.26E+04 1.41E+05 1.45E+05 1.54E+05 1.21E+05 1.43E+05 1.44E+05 7.42E+04 
Glycine 5.77E+04 6.97E+04 1.11E+05 4.45E+04 6.00E+04 5.36E+04 1.35E+05 1.20E+05 3.60E+04 9.46E+04 1.01E+05 
GMP 9.27E+04 1.23E+05 1.10E+05 1.04E+05 6.92E+04 8.44E+04 9.77E+04 6.07E+04 5.63E+04 4.34E+04 2.42E+04 
Guanosine 1.07E+05 7.40E+04 9.82E+04 5.77E+04 9.06E+04 8.67E+04 8.51E+04 8.25E+04 9.13E+04 9.69E+04 9.29E+04 
Histidine 3.60E+03 1.07E+04 6.30E+03 1.72E+03 6.60E+03 4.69E+03 6.31E+03 3.89E+03 3.91E+03 2.38E+03 4.08E+03 
Homoserine/Threonine 1.50E+05 1.72E+05 1.00E+05 1.15E+05 1.38E+05 1.49E+05 1.15E+05 1.33E+05 9.52E+04 1.29E+05 1.43E+05 
Homovanillic acid 1.56E+05 6.87E+04 2.55E+05 1.21E+05 2.17E+05 3.43E+05 2.66E+05 6.48E+05 1.83E+05 1.15E+05 1.51E+05 
Hydroxyisocaproic acid 1.24E+05 1.01E+05 1.87E+05 1.02E+05 2.97E+05 1.70E+05 1.98E+05 2.41E+05 1.62E+05 1.03E+05 2.01E+05 
Hypoxanthine 1.33E+06 1.46E+06 1.31E+06 1.01E+06 1.49E+06 1.48E+06 6.15E+05 6.24E+05 1.61E+06 1.05E+06 1.85E+06 
IMP 9.75E+04 1.33E+05 1.78E+05 1.76E+05 1.27E+05 1.40E+05 1.41E+05 9.92E+04 1.07E+05 7.47E+04 5.55E+04 
Inosine 1.07E+06 1.06E+06 1.06E+06 1.16E+06 1.07E+06 1.28E+06 9.84E+05 8.51E+05 1.29E+06 1.28E+06 1.34E+06 
Lactate 4.85E+07 4.71E+07 4.43E+07 3.76E+07 6.18E+06 9.70E+06 7.32E+06 6.42E+06 7.38E+06 5.66E+06 2.08E+07 
Leucine/Isoleucine 2.25E+05 1.97E+05 1.37E+05 1.34E+05 6.44E+04 1.98E+05 1.69E+05 1.49E+05 1.75E+05 1.35E+05 2.85E+05 
Malate 1.77E+05 1.55E+05 1.27E+05 1.37E+05 8.93E+04 1.35E+05 1.97E+05 1.83E+05 1.45E+05 1.31E+05 1.60E+05 
Malate 1.05E+07 5.98E+06 5.71E+06 6.24E+06 2.42E+06 4.61E+06 5.45E+06 5.94E+06 5.70E+06 4.04E+06 7.82E+06 
Methionine 1.05E+05 8.90E+04 1.74E+05 8.38E+04 1.55E+05 1.37E+05 1.31E+05 1.29E+05 1.50E+05 1.05E+05 1.34E+05 
myo-Inositol 4.67E+05 6.58E+05 3.90E+05 3.53E+05 2.35E+04 2.85E+04 2.99E+04 2.89E+04 2.96E+04 2.87E+04 1.05E+05 
N-Acetyl-beta-alanine 1.11E+04 9.54E+03 8.29E+03 2.69E+03 4.15E+03 6.17E+03 6.88E+03 9.03E+03 4.16E+03 9.51E+03 1.90E+04 
N-Acetylglutamate 7.77E+05 7.70E+05 9.93E+05 1.20E+06 6.21E+05 8.30E+05 7.88E+05 1.05E+06 6.62E+05 5.13E+05 9.25E+05 
N-Acetylglutamine 1.12E+04 5.18E+03 9.02E+03 4.48E+03 3.37E+03 6.45E+03 4.93E+03 6.64E+03 5.36E+03 2.05E+03 1.13E+04 




Table 1.21 Continued 
 
Sample Name M2 M8 M13 M16 M18 M44 M45 M46 M64 M69 M70 
O-Acetyl-L-serine 9.62E+06 7.52E+06 8.97E+06 8.91E+06 9.43E+06 3.70E+06 6.48E+06 6.11E+06 4.54E+06 4.38E+06 5.92E+06 
Pantothenate 3.51E+06 3.74E+06 4.14E+06 2.71E+06 4.02E+06 5.08E+06 3.74E+06 4.41E+06 3.72E+06 3.95E+06 4.41E+06 
Phenylalanine 1.60E+05 7.35E+04 6.40E+04 4.26E+04 1.66E+05 5.80E+04 8.80E+04 7.06E+04 6.57E+04 8.06E+04 5.79E+04 
Proline 3.36E+04 2.83E+04 3.63E+04 3.68E+04 2.95E+04 3.50E+04 2.49E+04 3.36E+04 2.70E+04 2.52E+04 2.63E+04 
Pyroglutamic acid 2.39E+06 3.11E+06 1.77E+06 2.09E+06 1.18E+06 1.65E+06 1.21E+06 1.15E+06 1.43E+06 8.44E+05 2.68E+06 
Pyruvate 2.10E+05 2.25E+05 7.67E+04 1.25E+05 1.01E+05 1.22E+05 1.51E+05 1.34E+05 9.50E+04 6.13E+04 1.17E+05 
Ribose phosphate 2.03E+04 3.43E+04 3.28E+04 1.36E+04 1.44E+04 1.97E+04 1.77E+04 1.20E+04 2.67E+04 2.02E+04 1.78E+04 
Serine 3.56E+05 5.30E+05 3.84E+05 4.05E+05 4.78E+05 4.84E+05 5.36E+05 4.24E+05 3.53E+05 3.84E+05 3.20E+05 
Succinate/Methylmalonate 1.77E+06 1.37E+06 1.70E+06 1.82E+06 4.09E+05 7.62E+05 1.25E+06 2.92E+06 6.42E+05 2.81E+05 1.22E+06 
Sulfolactate 6.55E+04 4.90E+04 2.80E+04 4.76E+04 2.97E+04 3.00E+04 3.90E+04 1.00E+05 3.26E+04 3.57E+04 2.48E+04 
Taurine 1.84E+07 1.17E+07 1.52E+07 1.42E+07 1.77E+07 1.79E+07 1.74E+07 1.61E+07 1.75E+07 1.52E+07 1.38E+07 
Trehalose/sucrose 9.41E+03 3.61E+04 4.51E+03 1.19E+04 2.99E+03 4.26E+03 1.10E+04 5.69E+03 7.98E+03 2.19E+03 4.65E+03 
Tryptophan 3.39E+04 1.81E+04 1.09E+04 7.77E+03 2.70E+04 3.29E+04 2.43E+04 1.71E+04 2.53E+04 1.61E+04 3.18E+04 
Tyrosine 1.09E+05 6.09E+04 8.98E+04 7.38E+04 1.04E+05 8.72E+04 4.46E+04 4.20E+04 1.06E+05 8.22E+04 6.93E+04 
UDP-glucose 9.66E+04 6.43E+04 1.62E+05 9.03E+04 1.13E+05 1.65E+05 1.56E+05 1.23E+05 1.14E+05 9.98E+04 1.20E+05 
UDP-N-acetylglucosamine 8.65E+04 5.89E+04 9.89E+04 8.33E+04 8.93E+04 1.12E+05 1.32E+05 1.07E+05 8.71E+04 8.54E+04 8.38E+04 
UMP 2.51E+04 2.07E+04 1.96E+04 3.88E+04 1.54E+04 1.44E+04 2.49E+04 1.84E+04 3.09E+04 6.01E+03 5.68E+03 
Uracil 3.62E+05 2.78E+05 3.98E+05 4.36E+05 4.96E+05 6.42E+05 6.08E+05 5.95E+05 4.72E+05 4.15E+05 4.52E+05 
Uric acid 1.35E+04 1.69E+04 2.44E+04 1.37E+04 1.90E+04 8.87E+03 1.73E+04 1.15E+04 7.55E+03 7.92E+03 6.24E+03 
Uridine 1.06E+04 7.71E+03 1.70E+04 6.10E+03 1.23E+04 1.12E+04 1.32E+04 1.30E+04 1.27E+04 8.85E+03 9.64E+03 
Valine 2.18E+05 2.24E+05 1.95E+05 1.69E+05 1.86E+05 2.34E+05 1.87E+05 1.39E+05 1.62E+05 1.53E+05 1.92E+05 
Xanthine 4.21E+05 3.29E+05 5.54E+05 3.92E+05 4.22E+05 4.95E+05 5.61E+05 4.61E+05 3.82E+05 2.34E+05 4.57E+05 




Table 1.22 Raw Data of Control Mice from NAc  
Sample Name M3 M5 M10 M12 M14 M19 M26 M31 M32 M38 M40 
2-Aminoadipate 2.43E+04 2.16E+04 1.09E+04 2.33E+04 3.44E+04 3.10E+04 1.65E+04 2.73E+04 2.12E+04 3.72E+04 3.80E+04 
2-Hydroxy-2-methylsuccinate 3.20E+06 4.13E+06 1.43E+06 3.16E+06 1.26E+06 2.55E+06 1.57E+06 4.53E+06 4.25E+06 4.18E+06 4.89E+06 
2-Isopropylmalate 4.02E+04 5.59E+04 4.74E+04 2.95E+04 5.29E+04 3.77E+04 3.11E+04 5.79E+04 2.58E+04 2.65E+04 3.74E+04 
3-Phosphoglycerate 1.42E+04 1.09E+04 8.35E+03 2.37E+04 1.33E+04 3.77E+03 6.30E+03 2.51E+04 3.49E+04 2.12E+04 1.98E+04 
3_4-Dihydroxyphenylacetate 2.29E+04 5.53E+04 2.44E+04 3.20E+04 2.03E+04 2.85E+04 2.92E+04 3.22E+05 3.48E+04 3.99E+04 1.76E+04 
4-Aminobutyrate 3.45E+06 2.32E+06 1.08E+06 2.14E+06 1.52E+06 2.57E+06 1.52E+06 3.55E+06 3.66E+06 3.40E+06 4.81E+06 
5-Hydroxyindoleacetic acid 2.19E+04 2.78E+04 9.33E+03 1.23E+04 8.98E+03 1.97E+04 6.49E+03 3.60E+04 2.63E+04 3.81E+04 3.40E+04 
Aconitate 3.80E+06 7.04E+06 2.95E+06 7.11E+06 4.16E+06 5.08E+06 4.44E+06 6.16E+06 7.24E+06 5.88E+06 7.88E+06 
Adenine 2.08E+04 2.35E+04 1.66E+04 3.41E+04 2.48E+04 3.21E+04 2.23E+04 3.06E+04 4.92E+04 2.75E+04 3.99E+04 
Adenosine 1.03E+05 1.85E+05 1.71E+05 2.31E+05 2.89E+04 6.10E+04 1.60E+05 1.77E+05 2.47E+05 2.34E+05 1.87E+05 
Alanine/Sarcosine 1.10E+06 1.20E+06 7.81E+05 1.02E+06 1.16E+06 1.00E+06 9.76E+05 1.40E+06 1.31E+06 1.26E+06 1.47E+06 
alpha-Ketoglutarate 1.31E+04 1.63E+04 2.94E+04 3.40E+04 2.00E+04 2.67E+04 1.95E+04 1.83E+04 3.95E+04 2.97E+04 2.74E+04 
AMP/dGMP 2.57E+05 1.93E+05 6.01E+04 9.03E+04 9.34E+04 6.54E+04 5.27E+04 7.20E+04 9.96E+04 1.11E+05 1.72E+05 
Arginine 4.91E+03 3.32E+03 2.79E+03 8.76E+02 2.15E+03 2.93E+03 4.55E+03 7.88E+03 7.55E+03 8.21E+03 7.51E+03 
Ascorbate 1.84E+06 4.50E+06 1.15E+06 3.53E+04 1.60E+06 2.13E+06 1.30E+06 6.03E+06 5.75E+06 5.29E+06 3.33E+06 
Asparagine 2.07E+04 2.52E+04 1.35E+04 3.74E+04 2.30E+04 5.35E+04 2.10E+04 3.64E+04 4.33E+04 5.34E+04 3.57E+04 
Aspartate 6.53E+06 6.42E+06 3.03E+06 4.30E+06 1.13E+06 4.29E+06 4.98E+06 8.20E+06 7.44E+06 7.21E+06 9.47E+06 
cAMP 1.04E+04 2.93E+04 2.02E+04 2.97E+04 4.17E+03 2.35E+04 2.33E+04 3.05E+04 3.61E+04 2.70E+04 2.10E+04 
CDP-ethanolamine 2.06E+04 2.48E+04 1.29E+04 2.11E+04 4.02E+03 2.63E+04 1.44E+04 2.94E+04 3.19E+04 2.48E+04 2.29E+04 
Citraconate 1.53E+05 2.22E+05 1.05E+05 2.62E+05 1.21E+05 1.76E+05 1.58E+05 2.00E+05 2.45E+05 2.22E+05 2.60E+05 
Citrate/isocitrate 1.57E+06 4.33E+06 1.58E+06 5.01E+06 2.20E+06 3.68E+06 2.04E+06 3.17E+06 5.19E+06 2.55E+06 4.60E+06 
Creatine 1.49E+06 1.53E+06 9.77E+05 1.19E+06 1.54E+06 1.37E+06 1.28E+06 1.67E+06 1.77E+06 1.58E+06 1.85E+06 
Cysteine 8.11E+04 9.82E+04 3.54E+04 3.72E+04 1.95E+04 3.67E+04 4.70E+04 1.58E+05 1.47E+05 1.47E+05 1.58E+05 
Cystine 4.70E+03 1.00E+02 2.46E+03 3.76E+03 3.08E+04 7.94E+04 6.26E+03 1.00E+02 1.00E+02 2.22E+03 1.05E+04 
D-Gluconate 3.87E+03 8.62E+03 6.67E+03 5.02E+03 7.61E+03 1.41E+04 1.03E+04 1.17E+04 1.03E+04 6.82E+03 1.35E+04 
D-Glyceraldehdye 3-phosphate 3.77E+04 1.46E+04 2.12E+03 4.45E+03 1.00E+02 5.95E+03 1.91E+03 2.06E+04 1.12E+04 4.18E+04 3.62E+04 
Dopamine 2.54E+03 9.30E+03 3.20E+03 1.24E+04 7.82E+03 1.14E+04 6.93E+03 7.19E+03 1.84E+04 1.08E+04 1.45E+03 




Table 1.22 Continued 
Sample Name M3 M5 M10 M12 M14 M19 M26 M31 M32 M38 M40 
Fumarate 9.62E+05 1.25E+06 3.24E+05 6.63E+05 4.06E+05 1.04E+06 2.91E+05 1.57E+06 1.34E+06 1.88E+06 1.59E+06 
Glucose 1-phosphate 9.64E+03 1.16E+04 9.74E+02 1.87E+03 1.10E+03 8.70E+02 1.82E+03 9.88E+03 1.33E+04 7.15E+03 7.50E+03 
Glutamate 5.31E+06 8.71E+06 5.32E+06 7.19E+06 1.32E+07 3.34E+06 4.84E+06 8.07E+06 8.94E+06 8.72E+06 7.60E+06 
Glutamate 5.02E+04 8.23E+04 7.27E+04 4.51E+04 3.24E+04 2.22E+04 3.01E+04 1.33E+05 1.25E+05 1.06E+05 8.19E+04 
Glutamine 2.46E+06 2.52E+06 2.36E+06 2.19E+06 3.71E+06 2.57E+06 2.05E+06 2.93E+06 2.80E+06 2.61E+06 3.15E+06 
Glutathione 5.47E+05 9.38E+05 3.60E+05 4.84E+05 2.09E+05 4.66E+05 2.97E+05 1.13E+06 1.09E+06 8.95E+05 6.75E+05 
Glutathione disulfide 2.25E+05 3.30E+05 2.06E+05 3.59E+05 1.86E+05 3.21E+05 2.44E+05 3.12E+05 2.92E+05 2.81E+05 3.61E+05 
Glycerate 3.33E+04 3.11E+04 3.62E+04 3.91E+04 1.78E+05 1.44E+05 3.48E+04 4.57E+04 4.39E+04 2.47E+04 4.86E+04 
Glycine 1.34E+05 7.04E+04 7.06E+04 1.14E+05 2.78E+04 1.22E+04 1.96E+04 1.34E+05 8.74E+04 1.38E+05 2.05E+05 
GMP 8.54E+04 1.06E+05 1.63E+04 3.71E+04 1.87E+04 5.56E+04 2.05E+04 4.63E+04 2.80E+04 7.38E+04 6.44E+04 
Guanosine 8.13E+04 1.00E+05 4.83E+04 9.86E+04 5.72E+04 6.51E+04 7.73E+04 1.39E+05 1.42E+05 1.08E+05 1.31E+05 
Histidine 2.74E+03 2.19E+03 2.72E+03 1.02E+04 8.88E+02 4.23E+03 2.79E+03 8.91E+03 9.40E+03 2.67E+03 3.73E+03 
Homoserine/Threonine 1.31E+05 1.51E+05 1.07E+05 1.07E+05 1.53E+05 1.58E+05 9.88E+04 1.39E+05 1.52E+05 1.64E+05 1.85E+05 
Homovanillic acid 8.24E+04 1.75E+05 9.16E+04 1.33E+05 7.63E+04 1.88E+05 1.17E+05 1.81E+05 1.73E+05 1.60E+05 1.80E+05 
Hydroxyisocaproic acid 4.89E+05 2.59E+05 2.54E+05 1.62E+05 1.40E+05 1.60E+05 1.48E+05 1.26E+05 1.48E+05 1.72E+05 2.38E+05 
Hypoxanthine 1.40E+06 1.43E+06 8.31E+05 1.12E+06 6.62E+05 1.49E+06 8.68E+05 1.88E+06 1.71E+06 2.26E+06 2.37E+06 
IMP 8.46E+04 1.39E+05 3.13E+04 6.54E+04 4.18E+04 8.06E+04 4.25E+04 8.37E+04 4.36E+04 5.92E+04 1.35E+05 
Inosine 9.70E+05 1.05E+06 6.05E+05 7.07E+05 5.27E+05 1.18E+06 7.88E+05 1.64E+06 1.29E+06 1.00E+06 1.54E+06 
Lactate 3.83E+07 3.45E+07 3.57E+07 3.69E+07 3.66E+06 6.33E+06 3.69E+07 5.23E+07 5.25E+07 4.55E+07 4.71E+07 
Leucine/Isoleucine 1.46E+05 1.75E+05 1.04E+05 1.73E+05 5.46E+04 1.03E+05 1.06E+05 2.64E+05 3.22E+05 2.40E+05 2.55E+05 
Malate 2.00E+05 1.35E+05 8.56E+04 1.26E+05 8.10E+04 1.20E+05 9.63E+04 1.98E+05 1.73E+05 1.81E+05 1.45E+05 
Malate 5.10E+06 4.27E+06 9.36E+05 2.48E+06 8.47E+05 3.34E+06 9.23E+05 9.07E+06 6.81E+06 6.96E+06 8.02E+06 
Methionine 9.00E+04 2.17E+05 9.61E+04 1.25E+05 6.06E+04 1.37E+05 6.90E+04 2.26E+05 1.57E+05 1.33E+05 1.36E+05 
myo-Inositol 3.34E+05 3.15E+05 3.44E+05 3.34E+05 1.51E+04 1.64E+04 3.32E+05 5.13E+05 4.69E+05 4.73E+05 3.96E+05 
N-Acetyl-beta-alanine 1.20E+04 8.92E+03 4.18E+03 4.35E+03 1.58E+03 6.55E+03 2.16E+03 1.71E+04 1.28E+04 1.02E+04 2.27E+04 
N-Acetylglutamate 7.91E+05 8.88E+05 2.81E+05 4.44E+05 2.95E+05 4.95E+05 2.94E+05 9.17E+05 8.50E+05 8.59E+05 1.36E+06 
N-Acetylglutamine 7.22E+03 1.38E+04 1.61E+03 7.47E+03 4.81E+03 2.23E+03 3.51E+03 1.70E+04 1.20E+04 1.15E+04 1.61E+04 
N-Carbamoyl-L-aspartate 5.14E+05 3.72E+05 3.03E+05 5.57E+05 1.24E+05 5.11E+05 2.80E+05 5.82E+05 6.44E+05 5.87E+05 5.43E+05 
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Table 1.22 Continued 
Sample Name M3 M5 M10 M12 M14 M19 M26 M31 M32 M38 M40 
O-Acetyl-L-serine 5.31E+06 8.71E+06 5.32E+06 7.19E+06 1.32E+07 3.34E+06 4.84E+06 8.07E+06 8.94E+06 8.72E+06 7.60E+06 
Pantothenate 2.92E+06 4.72E+06 2.36E+06 3.70E+06 2.75E+06 3.52E+06 2.11E+06 4.96E+06 5.15E+06 4.74E+06 5.85E+06 
Phenylalanine 9.86E+04 8.27E+04 4.33E+04 7.50E+04 6.34E+04 8.87E+04 5.66E+04 1.07E+05 9.24E+04 9.25E+04 8.21E+04 
Proline 3.21E+04 3.17E+04 2.01E+04 3.13E+04 3.06E+04 2.62E+04 2.18E+04 4.30E+04 4.38E+04 3.73E+04 3.93E+04 
Pyroglutamic acid 1.56E+06 2.34E+06 1.69E+06 2.47E+06 6.29E+05 1.44E+06 1.93E+06 3.23E+06 2.87E+06 3.60E+06 4.33E+06 
Pyruvate 7.58E+04 1.32E+05 1.99E+05 9.60E+04 9.74E+04 9.20E+04 8.55E+04 2.95E+05 1.77E+05 1.57E+05 1.07E+05 
Ribose phosphate 4.52E+04 3.42E+04 1.62E+04 2.80E+04 7.64E+03 8.42E+03 1.11E+04 3.44E+04 4.82E+04 2.78E+04 3.49E+04 
Serine 3.82E+05 4.53E+05 3.65E+05 3.49E+05 3.54E+05 3.74E+05 3.47E+05 5.53E+05 4.75E+05 4.52E+05 4.29E+05 
Succinate/Methylmalonate 7.10E+05 1.45E+06 8.92E+05 1.12E+06 4.07E+05 5.22E+05 1.01E+06 2.06E+06 1.17E+06 1.81E+06 1.37E+06 
Sulfolactate 5.05E+04 4.42E+04 4.65E+04 4.99E+04 3.64E+04 2.66E+04 2.66E+04 2.47E+04 4.51E+04 3.78E+04 3.63E+04 
Taurine 1.31E+07 1.44E+07 1.08E+07 1.30E+07 1.62E+07 1.50E+07 1.23E+07 1.70E+07 1.65E+07 1.44E+07 1.81E+07 
Trehalose/sucrose 2.02E+04 1.51E+04 4.78E+04 1.69E+04 4.44E+03 4.32E+03 1.52E+04 1.36E+04 1.31E+04 6.07E+03 1.11E+04 
Tryptophan 1.54E+04 2.64E+04 6.84E+03 1.04E+04 1.09E+04 2.42E+04 1.09E+04 2.83E+04 2.07E+04 1.75E+04 2.37E+04 
Tyrosine 9.11E+04 9.47E+04 4.86E+04 7.13E+04 4.39E+04 1.02E+05 5.18E+04 1.28E+05 7.46E+04 9.79E+04 8.49E+04 
UDP-glucose 1.05E+05 1.55E+05 5.90E+04 1.10E+05 5.92E+04 9.34E+04 6.37E+04 1.68E+05 1.42E+05 1.52E+05 1.43E+05 
UDP-N-acetylglucosamine 5.38E+04 1.01E+05 4.62E+04 6.80E+04 4.32E+04 8.25E+04 4.34E+04 1.27E+05 1.07E+05 9.75E+04 1.15E+05 
UMP 1.27E+04 1.40E+04 4.27E+03 3.99E+03 4.94E+03 5.09E+03 3.96E+03 1.00E+02 4.22E+03 7.09E+03 6.31E+03 
Uracil 3.05E+05 3.59E+05 2.16E+05 3.97E+05 4.18E+05 4.70E+05 2.69E+05 4.75E+05 5.59E+05 5.35E+05 7.07E+05 
Uric acid 1.89E+04 1.96E+04 1.43E+04 1.45E+04 1.48E+04 1.18E+04 1.46E+04 3.70E+04 1.60E+04 2.61E+04 1.72E+04 
Uridine 8.38E+03 7.48E+03 4.52E+03 6.41E+03 5.38E+03 7.58E+03 6.00E+03 1.30E+04 8.84E+03 7.53E+03 8.57E+03 
Valine 1.65E+05 1.90E+05 1.23E+05 1.29E+05 1.06E+05 1.52E+05 1.36E+05 2.81E+05 2.48E+05 2.63E+05 2.34E+05 
Xanthine 4.65E+05 4.88E+05 3.33E+05 5.85E+05 3.11E+05 4.30E+05 3.81E+05 8.47E+05 5.56E+05 5.74E+05 7.00E+05 




Table 1.23 Raw Data of Susceptible Mice from NAc  
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 M28 
2-Aminoadipate 3.18E+04 2.26E+04 2.89E+04 2.29E+04 1.87E+04 2.40E+04 3.00E+04 2.25E+04 2.30E+04 2.79E+04 2.58E+04 
2-Hydroxy-2-methylsuccinate 5.47E+06 3.51E+06 3.64E+06 2.43E+06 2.97E+06 3.53E+06 3.69E+06 3.74E+06 3.75E+06 4.57E+06 3.27E+06 
2-Isopropylmalate 3.02E+04 4.45E+04 6.37E+04 7.37E+04 5.09E+04 5.24E+04 6.63E+04 3.96E+04 6.06E+04 5.02E+04 5.11E+04 
3-Phosphoglycerate 1.04E+04 2.58E+04 7.23E+03 4.55E+04 7.45E+03 6.13E+03 1.48E+04 1.56E+04 2.76E+03 1.36E+04 2.63E+03 
3_4-Dihydroxyphenylacetate 1.99E+04 2.86E+04 3.57E+04 2.93E+04 1.58E+05 2.59E+04 2.89E+04 5.42E+04 3.72E+04 5.02E+04 7.70E+04 
4-Aminobutyrate 1.51E+06 2.39E+06 1.55E+06 2.90E+06 1.61E+06 2.03E+06 2.13E+06 1.68E+06 2.64E+06 2.02E+06 1.93E+06 
5-Hydroxyindoleacetic acid 2.02E+04 1.51E+04 1.76E+04 2.35E+04 3.12E+04 4.23E+04 3.52E+04 1.74E+04 2.25E+04 9.55E+03 3.13E+04 
Aconitate 9.25E+06 6.53E+06 6.39E+06 3.92E+06 5.17E+06 6.50E+06 6.43E+06 6.64E+06 6.35E+06 6.99E+06 7.05E+06 
Adenine 2.43E+04 3.70E+04 3.01E+04 2.15E+04 2.01E+04 2.29E+04 2.77E+04 3.00E+04 3.72E+04 4.56E+04 3.58E+04 
Adenosine 1.32E+05 4.66E+05 1.94E+05 9.63E+04 1.04E+05 8.88E+04 1.92E+05 1.59E+05 1.37E+05 3.45E+05 1.93E+05 
Alanine/Sarcosine 1.08E+06 1.14E+06 1.12E+06 8.58E+05 9.79E+05 1.15E+06 1.00E+06 1.18E+06 1.32E+06 1.34E+06 1.19E+06 
alpha-Ketoglutarate 4.32E+04 2.71E+04 4.13E+04 1.51E+04 3.36E+04 3.02E+04 4.78E+04 3.47E+04 2.35E+04 3.11E+04 2.27E+04 
AMP/dGMP 8.09E+05 3.30E+05 5.27E+05 2.67E+05 5.94E+05 1.25E+06 1.49E+05 1.46E+05 2.85E+05 1.35E+05 1.35E+05 
Arginine 5.45E+03 3.78E+03 3.71E+03 2.91E+03 4.95E+03 3.74E+03 4.63E+03 5.63E+03 3.27E+03 4.93E+03 1.06E+04 
Ascorbate 4.83E+06 1.81E+05 1.43E+06 2.20E+06 3.61E+06 2.43E+06 4.78E+06 1.55E+06 4.85E+06 1.49E+06 3.61E+06 
Asparagine 1.42E+04 3.19E+04 2.95E+04 4.41E+04 2.20E+04 2.75E+04 6.96E+04 4.06E+04 4.53E+04 3.08E+04 3.78E+04 
Aspartate 6.65E+06 6.03E+06 5.78E+06 4.71E+06 4.72E+06 6.22E+06 5.66E+06 6.04E+06 6.18E+06 6.60E+06 6.29E+06 
cAMP 2.37E+04 3.85E+04 2.02E+04 2.18E+04 3.16E+04 2.80E+04 3.66E+04 2.67E+04 2.57E+04 2.48E+04 3.21E+04 
CDP-ethanolamine 2.43E+04 2.77E+04 2.52E+04 2.03E+04 1.66E+04 2.59E+04 2.65E+04 2.38E+04 2.45E+04 2.53E+04 2.64E+04 
Citraconate 2.59E+05 2.26E+05 2.34E+05 1.25E+05 1.79E+05 2.12E+05 1.93E+05 1.88E+05 2.22E+05 2.01E+05 2.24E+05 
Citrate/isocitrate 5.16E+06 3.04E+06 3.65E+06 1.77E+06 2.51E+06 2.82E+06 3.54E+06 2.53E+06 3.03E+06 3.62E+06 3.29E+06 
Creatine 1.37E+06 1.56E+06 1.33E+06 1.03E+06 1.11E+06 1.67E+06 1.25E+06 1.58E+06 1.64E+06 1.85E+06 1.44E+06 
Cysteine 1.21E+05 3.97E+04 7.07E+04 4.93E+04 7.11E+04 1.14E+05 7.78E+04 4.48E+04 1.11E+05 1.26E+05 1.11E+05 
Cystine 1.00E+02 1.52E+03 1.00E+02 1.00E+02 2.47E+03 3.79E+03 1.00E+02 2.19E+04 1.00E+02 5.20E+03 3.71E+03 
D-Gluconate 4.76E+03 8.94E+03 7.23E+03 7.30E+03 8.82E+03 7.64E+03 1.04E+04 9.78E+03 8.25E+03 8.76E+03 1.07E+04 
D-Glyceraldehdye 3-phosphate 4.66E+03 5.46E+03 2.27E+03 2.88E+04 9.93E+03 2.58E+04 9.81E+03 2.43E+03 1.12E+04 2.52E+03 2.09E+03 
Dopamine 2.01E+03 2.42E+04 5.54E+03 3.78E+03 1.64E+04 2.39E+03 1.21E+04 1.02E+04 8.76E+03 1.21E+04 1.48E+04 




Table 1.23 Continued 
 
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 M28 
Fumarate 7.71E+05 6.69E+05 7.95E+05 7.30E+05 9.17E+05 9.52E+05 1.32E+06 1.20E+06 1.55E+06 1.56E+06 7.15E+05 
Glucose 1-phosphate 7.03E+03 1.11E+04 3.58E+03 2.24E+04 1.75E+03 1.96E+04 9.44E+03 5.20E+03 8.92E+03 8.28E+03 2.00E+03 
Glutamate 1.19E+07 8.07E+06 8.81E+06 4.21E+06 6.15E+06 7.51E+06 7.67E+06 8.69E+06 6.71E+06 8.59E+06 9.22E+06 
Glutamate 6.01E+04 6.57E+04 5.96E+04 4.93E+04 2.42E+05 4.58E+04 7.03E+04 8.45E+04 5.02E+04 3.15E+04 5.95E+04 
Glutamine 1.84E+06 2.71E+06 4.00E+06 1.89E+06 2.08E+06 2.27E+06 3.17E+06 2.64E+06 3.37E+06 3.40E+06 2.91E+06 
Glutathione 7.50E+05 6.90E+05 7.32E+05 3.92E+05 5.69E+05 5.53E+05 9.18E+05 4.81E+05 1.13E+06 1.07E+06 1.08E+06 
Glutathione disulfide 1.63E+05 4.89E+05 3.85E+05 2.98E+05 1.80E+05 3.22E+05 4.61E+05 3.83E+05 3.35E+05 2.99E+05 2.07E+05 
Glycerate 3.55E+04 4.74E+04 4.27E+04 4.92E+04 4.54E+04 3.93E+04 4.92E+04 4.68E+04 3.69E+04 6.03E+04 3.35E+04 
Glycine 1.33E+05 7.58E+04 4.36E+04 1.10E+05 1.41E+05 1.35E+05 1.32E+05 1.11E+05 6.68E+04 7.12E+04 6.63E+04 
GMP 1.44E+05 9.07E+04 1.05E+05 7.67E+04 1.03E+05 1.70E+05 4.97E+04 4.46E+04 1.46E+05 4.37E+04 9.55E+04 
Guanosine 5.11E+04 9.02E+04 6.05E+04 7.23E+04 3.68E+04 5.52E+04 9.65E+04 9.81E+04 8.07E+04 1.14E+05 1.08E+05 
Histidine 3.45E+03 4.36E+03 5.01E+03 4.67E+03 2.70E+03 2.41E+03 2.88E+03 5.57E+03 7.65E+03 4.71E+03 7.00E+03 
Homoserine/Threonine 1.13E+05 1.77E+05 1.26E+05 1.23E+05 1.23E+05 1.07E+05 1.49E+05 1.30E+05 1.60E+05 1.19E+05 1.34E+05 
Homovanillic acid 1.04E+05 1.68E+05 1.66E+05 7.67E+04 1.85E+05 1.21E+05 2.29E+05 1.59E+05 1.69E+05 2.09E+05 2.02E+05 
Hydroxyisocaproic acid 1.94E+05 1.11E+05 1.87E+05 1.88E+05 1.88E+05 2.65E+05 3.43E+05 1.17E+05 1.99E+05 2.98E+05 1.79E+05 
Hypoxanthine 1.31E+06 1.41E+06 9.76E+05 1.18E+06 1.08E+06 1.31E+06 1.43E+06 1.46E+06 1.82E+06 1.49E+06 1.52E+06 
IMP 1.68E+05 1.19E+05 1.65E+05 7.42E+04 2.17E+05 4.50E+05 8.42E+04 1.01E+05 2.87E+05 8.06E+04 1.99E+05 
Inosine 7.36E+05 7.70E+05 6.50E+05 6.84E+05 7.46E+05 9.31E+05 1.18E+06 1.26E+06 1.24E+06 1.02E+06 1.18E+06 
Lactate 4.34E+07 4.33E+07 4.80E+07 3.58E+07 3.71E+07 3.51E+07 4.43E+07 4.85E+07 4.63E+07 4.56E+07 4.59E+07 
Leucine/Isoleucine 2.02E+05 1.51E+05 1.15E+05 1.08E+05 1.60E+05 1.13E+05 1.79E+05 2.26E+05 1.81E+05 2.37E+05 1.62E+05 
Malate 1.34E+05 1.19E+05 1.46E+05 1.22E+05 1.42E+05 1.24E+05 1.76E+05 1.39E+05 1.52E+05 1.70E+05 1.10E+05 
Malate 3.83E+06 4.34E+06 5.54E+06 4.69E+06 3.87E+06 5.27E+06 6.08E+06 4.69E+06 7.02E+06 8.10E+06 3.34E+06 
Methionine 6.05E+04 1.11E+05 1.92E+05 1.17E+05 7.56E+04 1.48E+05 1.24E+05 1.30E+05 1.57E+05 1.67E+05 1.59E+05 
myo-Inositol 4.10E+05 4.41E+05 4.33E+05 3.11E+05 3.26E+05 2.84E+05 3.80E+05 3.56E+05 3.96E+05 3.91E+05 3.53E+05 
N-Acetyl-beta-alanine 7.91E+03 5.06E+03 1.00E+04 7.93E+03 9.32E+03 5.55E+03 1.01E+04 7.10E+03 5.68E+03 6.85E+03 9.28E+03 
N-Acetylglutamate 1.55E+06 7.19E+05 6.17E+05 5.80E+05 6.43E+05 7.53E+05 6.14E+05 6.82E+05 7.09E+05 5.07E+05 5.56E+05 
N-Acetylglutamine 1.00E+04 1.12E+04 5.88E+03 8.37E+03 8.37E+03 1.04E+04 8.03E+03 1.36E+04 1.92E+04 1.03E+04 9.39E+03 




Table 1.23 Continued 
 
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 M28 
O-Acetyl-L-serine 1.19E+07 8.07E+06 8.81E+06 4.21E+06 6.15E+06 7.51E+06 7.67E+06 8.69E+06 6.71E+06 8.59E+06 9.22E+06 
Pantothenate 3.52E+06 3.89E+06 3.04E+06 3.34E+06 3.50E+06 3.54E+06 4.70E+06 3.99E+06 4.40E+06 3.96E+06 3.22E+06 
Phenylalanine 7.21E+04 8.29E+04 6.47E+04 5.96E+04 8.53E+04 6.16E+04 5.92E+04 6.24E+04 9.92E+04 9.40E+04 1.00E+05 
Proline 3.42E+04 3.87E+04 2.87E+04 1.95E+04 3.23E+04 3.11E+04 3.48E+04 2.93E+04 2.71E+04 3.65E+04 2.61E+04 
Pyroglutamic acid 2.27E+06 2.14E+06 2.10E+06 2.22E+06 3.88E+06 2.27E+06 2.57E+06 2.44E+06 2.57E+06 2.06E+06 2.30E+06 
Pyruvate 2.95E+05 9.40E+04 1.17E+05 1.17E+05 2.81E+05 3.65E+04 1.60E+05 3.37E+05 8.81E+04 1.23E+05 6.24E+04 
Ribose phosphate 3.84E+04 3.29E+04 1.87E+04 2.66E+04 2.14E+04 5.24E+04 1.60E+04 2.21E+04 2.88E+04 1.31E+04 1.79E+04 
Serine 3.71E+05 4.77E+05 3.02E+05 3.29E+05 5.77E+05 3.11E+05 4.78E+05 4.73E+05 3.61E+05 4.30E+05 4.22E+05 
Succinate/Methylmalonate 1.56E+06 1.61E+06 1.84E+06 1.06E+06 3.55E+06 1.47E+06 1.93E+06 1.55E+06 1.41E+06 1.84E+06 9.45E+05 
Sulfolactate 4.18E+04 4.28E+04 3.59E+04 3.66E+04 1.57E+05 2.52E+04 5.45E+04 3.41E+04 5.58E+04 2.95E+04 1.85E+04 
Taurine 1.39E+07 1.62E+07 1.72E+07 1.04E+07 1.16E+07 1.27E+07 1.53E+07 1.55E+07 1.59E+07 1.85E+07 1.51E+07 
Trehalose/sucrose 9.32E+04 1.97E+04 5.02E+03 7.00E+03 1.01E+04 3.25E+04 9.52E+03 2.98E+04 6.42E+03 1.97E+04 9.48E+02 
Tryptophan 9.30E+03 2.44E+04 1.64E+04 1.00E+04 2.69E+04 1.98E+04 2.57E+04 1.11E+04 2.11E+04 2.73E+04 2.48E+04 
Tyrosine 5.45E+04 1.57E+05 6.22E+04 7.73E+04 8.90E+04 6.38E+04 7.22E+04 9.07E+04 9.41E+04 1.41E+05 1.56E+05 
UDP-glucose 1.03E+05 9.80E+04 8.40E+04 7.10E+04 1.05E+05 1.31E+05 1.59E+05 1.04E+05 1.58E+05 1.32E+05 1.40E+05 
UDP-N-acetylglucosamine 1.02E+05 6.45E+04 6.72E+04 7.02E+04 6.61E+04 7.57E+04 1.17E+05 9.25E+04 9.16E+04 1.21E+05 8.32E+04 
UMP 8.13E+04 2.28E+04 4.06E+04 6.89E+03 3.76E+04 5.35E+04 4.69E+03 6.23E+03 2.89E+04 1.34E+04 1.22E+04 
Uracil 3.89E+05 3.33E+05 3.83E+05 3.07E+05 2.92E+05 3.95E+05 3.97E+05 4.01E+05 4.31E+05 5.18E+05 3.69E+05 
Uric acid 3.43E+04 1.72E+04 1.21E+04 1.09E+04 1.79E+04 1.28E+04 1.30E+04 2.00E+04 1.19E+04 1.73E+04 2.05E+04 
Uridine 8.64E+03 9.91E+03 5.80E+03 4.73E+03 4.16E+03 8.17E+03 1.06E+04 7.41E+03 6.58E+03 8.30E+03 8.60E+03 
Valine 1.90E+05 2.23E+05 1.59E+05 1.40E+05 2.12E+05 1.42E+05 2.09E+05 2.06E+05 2.10E+05 2.13E+05 1.71E+05 
Xanthine 2.14E+05 5.25E+05 5.06E+05 3.64E+05 1.95E+05 2.89E+05 5.25E+05 5.31E+05 3.75E+05 5.50E+05 6.47E+05 




Table 1.24 Raw Data of Resilient Mice from vmPFC 
Sample Name M2 M8 M13 M16 M18 M44 M45 M46 M64 M70 
2-Aminoadipate 5.54E+03 1.19E+05 2.06E+04 7.58E+03 4.11E+04 1.41E+04 2.33E+04 6.41E+04 8.33E+04 1.89E+04 
2-Hydroxy-2-methylsuccinate 4.79E+06 1.37E+06 3.05E+06 3.55E+06 2.31E+06 4.42E+06 5.63E+06 2.10E+06 1.59E+06 2.86E+06 
2-Isopropylmalate 7.47E+04 5.88E+04 5.91E+04 8.57E+04 8.59E+04 6.34E+04 8.49E+04 8.94E+04 8.66E+04 7.42E+04 
3_4-Dihydroxyphenylacetate 1.31E+04 1.49E+04 3.90E+03 7.91E+03 2.27E+04 5.96E+03 1.15E+04   8.11E+03 
3-Phosphoglycerate 5.37E+04 8.39E+04 1.74E+04 2.86E+04 2.09E+05 3.81E+04 4.38E+04 7.20E+03 4.47E+03 1.31E+05 
4-Aminobutyrate 1.88E+06 2.86E+06 1.41E+06 2.29E+06 3.13E+06 1.64E+06 1.37E+06 1.55E+06 2.04E+06 1.54E+06 
5-Hydroxyindoleacetic acid 3.59E+04 7.40E+03 1.43E+04 2.50E+04 1.57E+04 1.35E+04 2.24E+04 1.66E+04 2.22E+04 1.07E+04 
Aconitate 6.10E+06 4.12E+06 5.21E+06 6.74E+06 7.27E+06 8.06E+06 8.70E+06 6.66E+06 4.85E+06 5.11E+06 
Alanine/Sarcosine 1.88E+06 1.31E+06 1.60E+06 1.87E+06 2.05E+06 1.77E+06 1.67E+06 1.58E+06 1.97E+06 1.51E+06 
alpha-Ketoglutarate 3.36E+04 7.88E+03 2.40E+04 2.03E+04 3.42E+04 3.91E+04 8.00E+04 2.84E+04 6.12E+03 2.14E+04 
AMP/dGMP 8.44E+05 9.08E+04 9.21E+05 6.80E+05 1.23E+05 1.63E+06 1.02E+06 8.72E+05 7.88E+05 5.31E+05 
Arginine 1.47E+04 4.72E+03 8.67E+03 1.99E+04 1.36E+04 7.89E+03 1.77E+04 6.51E+03 1.15E+04 1.65E+04 
Ascorbate 2.03E+06  1.36E+04 1.26E+06 9.64E+04 2.48E+05 5.89E+03 8.46E+05 6.29E+05 7.42E+05 
Asparagine 4.62E+04 5.51E+04 6.25E+04 5.55E+04 8.99E+04 6.12E+04 6.47E+04 4.64E+04 6.17E+04 4.86E+04 
Aspartate 9.19E+06 3.68E+06 6.20E+06 7.26E+06 1.99E+06 6.66E+06 1.11E+07 3.42E+06 2.33E+06 6.15E+06 
cAMP 1.60E+04 1.60E+04 1.23E+04 3.06E+04 1.57E+04 1.48E+04 2.59E+04 1.17E+04 1.17E+04 1.43E+04 
CDP-ethanolamine 2.95E+04 1.05E+04 3.20E+04 2.92E+04 9.45E+03 3.69E+04 4.34E+04 1.56E+04 1.23E+04 2.95E+04 
Citraconate 2.28E+05 2.08E+05 2.19E+05 2.51E+05 2.28E+05 2.98E+05 3.48E+05 2.73E+05 2.20E+05 2.33E+05 
Citrate/isocitrate 3.75E+06 2.61E+06 2.46E+06 4.87E+06 6.62E+06 6.26E+06 6.84E+06 6.24E+06 2.41E+06 2.68E+06 
Creatine 2.18E+06 1.67E+06 1.85E+06 2.08E+06 2.25E+06 2.01E+06 1.80E+06 1.82E+06 2.29E+06 1.81E+06 
Cysteine 4.10E+04 3.06E+04 3.50E+03 2.92E+04 2.82E+04 2.72E+04 4.04E+04 2.28E+04 4.16E+04 8.04E+04 
Cystine 6.19E+04 5.86E+04 3.24E+04 6.36E+04 1.38E+05 1.70E+04 5.93E+04 8.25E+04 7.77E+04 1.17E+04 
D-Gluconate 2.27E+04 2.01E+04 1.87E+04 2.41E+04 2.14E+04 1.24E+04 7.15E+04 1.22E+04 2.18E+04 1.47E+04 
Fumarate 1.76E+06 6.00E+05 7.03E+05 9.82E+05 8.45E+05 9.19E+05 1.36E+06 3.70E+05 9.10E+05 6.54E+05 
Glucose 6-phosphate 7.24E+03 1.46E+03 1.25E+04 6.14E+03 3.99E+03 2.30E+04 2.64E+04 3.55E+03 8.87E+03 5.51E+04 
Glutamate 8.05E+06 2.99E+06 1.10E+07 4.82E+06 2.54E+07 9.41E+06 1.36E+07 5.95E+06 2.31E+07 1.17E+07 
Glutamine 2.99E+06 3.62E+06 2.09E+06 3.37E+06 5.52E+06 2.76E+06 2.97E+06 2.86E+06 3.70E+06 3.11E+06 




Table 1.24 Continued 
 
Sample Name M2 M8 M13 M16 M18 M44 M45 M46 M64 M70 
Glutathione disulfide 4.29E+05 2.71E+05 3.65E+05 5.64E+05 3.75E+05 4.17E+05 4.71E+05 2.24E+05 2.21E+05 2.48E+05 
Glycerone phosphate 3.10E+03 1.68E+04 1.72E+04 1.00E+04 3.16E+03 2.40E+04 1.61E+04 2.86E+03 2.51E+04 4.76E+04 
Glycine 2.64E+05 9.24E+04 2.82E+05 2.44E+05 1.12E+05 1.10E+05 2.38E+05 2.05E+05 2.85E+05 2.51E+05 
GMP 2.20E+05 2.14E+04 2.41E+05 2.20E+05 4.31E+04 2.78E+05 3.13E+05 1.83E+05 2.03E+05 1.51E+05 
Guanosine 7.12E+04 8.66E+04 3.72E+04 7.05E+04 7.04E+04 5.14E+04 8.47E+04 2.38E+04 3.51E+04 6.71E+04 
Histidine 9.69E+03 1.51E+03 1.06E+04 1.42E+04 7.29E+03 8.49E+03 1.59E+04 4.64E+03 1.15E+04 6.48E+03 
Homoserine/Threonine 1.93E+05 2.23E+05 1.28E+05 1.69E+05 1.67E+05 1.20E+05 2.94E+05 1.34E+05 1.43E+05 2.08E+05 
Homovanillic acid 2.04E+05 7.13E+04 1.16E+05 1.29E+05 1.30E+05 1.74E+05 2.23E+05 9.75E+04 1.51E+05 1.03E+05 
Hypoxanthine 3.45E+06 1.75E+06 2.48E+06 3.17E+06 2.96E+06 2.60E+06 3.27E+06 1.98E+06 2.67E+06 2.72E+06 
IMP 2.53E+05 4.71E+04 5.39E+05 4.43E+05 4.68E+04 7.08E+05 7.28E+05 5.46E+05 5.78E+05 2.82E+05 
Inosine 2.08E+06 1.54E+06 1.20E+06 1.77E+06 1.88E+06 1.24E+06 1.79E+06 9.37E+05 1.14E+06 1.21E+06 
Lactate 1.70E+07 7.10E+06 6.16E+07 1.46E+07 6.10E+06 5.62E+07 1.08E+08 6.99E+06 6.94E+06 5.11E+07 
Leucine/Isoleucine 8.02E+05 2.04E+05 5.49E+05 6.45E+05 2.33E+05 3.85E+05 7.86E+05 1.66E+05 2.92E+05 6.03E+05 
Malate 9.35E+06 3.06E+06 5.97E+06 5.61E+06 2.54E+06 7.09E+06 1.38E+07 1.38E+06 3.22E+06 4.59E+06 
Malate 1.66E+05 1.24E+05 1.46E+05 1.41E+05 9.73E+04 1.48E+05 1.94E+05 8.33E+04 1.36E+05 1.34E+05 
Methionine 2.61E+05 2.06E+05 1.69E+05 1.92E+05 3.30E+05 1.72E+05 3.01E+05 1.07E+05 3.31E+05 3.18E+05 
myo-Inositol 3.67E+04 1.94E+04 3.81E+05 3.45E+04 1.72E+04 2.84E+05 5.34E+05 1.82E+04 2.67E+04 3.24E+05 
N-Acetyl-beta-alanine 5.24E+04 7.58E+03 2.35E+04 1.65E+04 1.58E+04 2.52E+04 3.98E+04 1.17E+04 1.87E+04 4.77E+04 
N-Acetylglutamate 1.94E+06 3.99E+05 1.18E+06 1.57E+06 8.02E+05 1.53E+06 1.78E+06 9.32E+05 1.10E+06 9.67E+05 
N-Carbamoyl-L-aspartate 5.68E+05 4.87E+05 5.41E+05 4.03E+05 2.77E+05 3.75E+05 3.84E+05 2.93E+05 4.64E+05 2.81E+05 
O-Acetyl-L-serine 6.23E+02 2.99E+06 5.92E+02 6.04E+02 2.54E+07 6.02E+02 9.65E+02 5.95E+06 2.31E+07 4.58E+02 
Pantothenate 2.73E+06 3.54E+06 2.03E+06 2.66E+06 3.37E+06 2.37E+06 2.94E+06 2.15E+06 2.37E+06 2.21E+06 
Phenylalanine 7.99E+04 7.84E+04 1.39E+05 8.09E+04 1.34E+05 1.33E+05 1.67E+05 8.59E+04 1.16E+05 1.15E+05 
Phosphoenolpyruvate 4.22E+04 3.04E+04 2.42E+04 2.85E+04 5.29E+04 6.31E+04 5.44E+04 3.94E+04 3.64E+04 9.07E+04 
Proline 7.64E+04 4.22E+04 5.97E+04 8.41E+04 5.86E+04 6.52E+04 9.67E+04 4.82E+04 9.10E+04 6.20E+04 
Pyroglutamic acid 2.97E+06 2.32E+06 3.76E+06 3.23E+06 2.14E+06 4.14E+06 1.22E+07 1.66E+06 1.71E+06 3.95E+06 
Pyruvate 1.40E+05 1.48E+05 1.66E+05 1.69E+05 1.94E+05 1.17E+05 2.44E+06 5.55E+04 1.51E+05 8.97E+04 




Table 1.24 Continued 
 
Sample Name M2 M8 M13 M16 M18 M44 M45 M46 M64 M70 
Serine 9.34E+05 7.55E+05 9.67E+05 9.96E+05 1.11E+06 7.60E+05 2.14E+06 9.64E+05 9.57E+05 7.63E+05 
Succinate 1.33E+06 2.59E+05 1.44E+06 8.07E+05 2.46E+05 1.53E+06 3.74E+06 2.96E+05 3.51E+05 7.69E+05 
Taurine 2.31E+07 1.95E+07 1.89E+07 2.29E+07 2.15E+07 2.03E+07 2.07E+07 1.73E+07 2.10E+07 2.02E+07 
Trehalose/sucrose 5.76E+03 6.79E+03 1.16E+04 1.58E+04 4.70E+03 1.36E+04 1.06E+05 1.06E+04 1.06E+04 6.67E+03 
Tryptophan 4.03E+04 2.00E+04 2.97E+04 3.28E+04 2.95E+04 3.17E+04 4.79E+04 2.73E+04 3.41E+04 2.79E+04 
Tyrosine 1.49E+05 6.69E+04 1.27E+05 1.16E+05 1.11E+05 1.02E+05 2.49E+05 6.05E+04 1.29E+05 1.74E+05 
UDP-glucose 1.13E+05 6.49E+04 1.13E+05 1.38E+05 1.33E+05 1.34E+05 1.37E+05 7.71E+04 9.84E+04 1.08E+05 
UDP-N-acetylglucosamine 8.02E+04 3.77E+04 6.23E+04 7.85E+04 7.04E+04 9.46E+04 6.73E+04 5.48E+04 6.64E+04 4.17E+04 
UMP 9.61E+04 7.89E+03 1.08E+05 9.78E+04 4.99E+03 1.62E+05 1.40E+05 9.02E+04 9.50E+04 7.79E+04 
Uracil 8.05E+05 6.83E+05 5.16E+05 6.77E+05 8.85E+05 7.64E+05 8.33E+05 8.02E+05 7.93E+05 5.40E+05 
Uric acid 1.63E+04 1.44E+04 4.45E+04 1.54E+04 2.82E+04 2.14E+04 8.95E+04 1.13E+04 3.86E+04 1.96E+04 
Uridine 4.14E+05 2.91E+05 2.79E+05 3.71E+05 3.49E+05 1.78E+05 4.34E+05 2.58E+05 2.07E+05 2.05E+05 
Valine 3.46E+05 2.32E+05 3.06E+05 3.01E+05 3.25E+05 2.85E+05 5.21E+05 2.51E+05 3.43E+05 2.86E+05 




Table 1.25 Raw Data of Control Mice from vmPFC 
Sample Name M3 M5 M10 M12 M14 M19 M26 M30 M32 M40 
2-Aminoadipate 1.50E+05 7.66E+04 2.83E+04 1.95E+04 5.57E+04 1.54E+04 1.35E+04 1.82E+04 3.20E+04 9.04E+03 
2-Hydroxy-2-methylsuccinate 2.12E+06 8.79E+05 3.72E+06 2.06E+06 1.60E+06 2.89E+06 1.35E+06 2.92E+06 2.27E+06 3.80E+06 
2-Isopropylmalate 5.00E+04 5.21E+04 3.93E+04 5.30E+04 6.79E+04 4.56E+04 6.10E+04 5.67E+04 2.74E+04 6.69E+04 
3_4-Dihydroxyphenylacetate 2.12E+04 9.44E+03 5.05E+03 8.55E+03 1.51E+04 4.30E+04  1.86E+04  9.96E+04 
3-Phosphoglycerate 4.36E+04 5.59E+04 4.41E+04 5.73E+04 7.45E+04 1.30E+05 1.39E+04 1.67E+05 1.68E+04 2.88E+05 
4-Aminobutyrate 2.61E+06 1.71E+06 3.53E+06 1.52E+06 2.13E+06 2.15E+06 1.45E+06 3.30E+06 2.59E+06 1.77E+06 
5-Hydroxyindoleacetic acid 1.44E+04 9.87E+03 5.73E+04 8.51E+03 1.18E+04 3.02E+04 1.13E+04 1.09E+04 3.23E+04 9.83E+03 
Aconitate 7.61E+06 4.83E+06 6.73E+06 7.02E+06 6.01E+06 8.58E+06 4.85E+06 8.28E+06 5.80E+06 1.09E+07 
Alanine/Sarcosine 1.79E+06 1.34E+06 1.91E+06 1.36E+06 1.57E+06 1.64E+06 1.26E+06 1.70E+06 1.35E+06 1.55E+06 
alpha-Ketoglutarate 2.02E+04 1.35E+04 2.59E+04 3.30E+04 9.58E+03 1.73E+04 2.10E+04 1.69E+04 1.50E+04 1.82E+04 
AMP/dGMP 1.80E+05 1.34E+05 7.54E+05 1.68E+05 1.91E+05 1.01E+05 7.81E+05 1.00E+05 3.41E+05 5.51E+04 
Arginine 1.23E+04 3.33E+03 1.47E+04 9.45E+03 9.19E+03 2.05E+04 6.29E+03 7.08E+03 1.24E+04 1.32E+04 
Ascorbate 1.17E+06 5.33E+04  6.08E+04 1.35E+05 2.70E+05 2.80E+05 4.36E+03 4.26E+04 1.02E+05 
Asparagine 6.38E+04 4.07E+04 7.57E+04 1.16E+05 4.77E+04 6.29E+04 3.62E+04 6.32E+04 5.32E+04 5.76E+04 
Aspartate 3.53E+06 2.00E+06 9.92E+06 6.08E+06 1.33E+06 6.74E+06 4.83E+06 6.22E+06 5.62E+06 7.81E+06 
cAMP 1.67E+04 6.64E+03 1.15E+04 5.25E+03 1.23E+04 2.13E+04 1.39E+04 2.50E+04 1.33E+04 1.35E+04 
CDP-ethanolamine 1.80E+04 1.33E+04 3.64E+04 2.72E+04 1.01E+04 2.25E+04 1.99E+04 2.77E+04 2.18E+04 3.48E+04 
Citraconate 3.09E+05 1.82E+05 2.56E+05 3.00E+05 2.23E+05 3.16E+05 2.00E+05 3.04E+05 2.39E+05 4.24E+05 
Citrate/isocitrate 4.63E+06 2.66E+06 2.72E+06 3.60E+06 3.23E+06 7.54E+06 2.60E+06 6.28E+06 3.35E+06 9.35E+06 
Creatine 2.08E+06 1.59E+06 2.15E+06 1.59E+06 1.85E+06 2.11E+06 1.49E+06 1.86E+06 1.58E+06 2.00E+06 
Cysteine 2.10E+04 2.52E+04 1.85E+04 1.32E+03 3.39E+04 3.62E+04 2.70E+04 4.54E+04 3.16E+04 5.41E+04 
Cystine 8.45E+04 4.78E+04 1.40E+05 7.96E+04 5.77E+04 8.76E+04 2.92E+04 9.49E+04 5.35E+04 9.33E+04 
D-Gluconate 2.74E+04 1.53E+04 1.91E+04 2.17E+04 2.14E+04 3.73E+04 1.20E+04 2.28E+04 8.71E+03 1.05E+04 
Fumarate 4.56E+05 1.84E+05 9.40E+05 3.55E+05 3.70E+05 2.38E+05 2.64E+05 9.05E+05 6.78E+05 1.95E+05 
Glucose 6-phosphate 1.89E+03 2.21E+03 2.93E+04 5.32E+03 4.56E+03 2.30E+03 5.17E+03 2.87E+03 1.10E+04 4.88E+03 
Glutamate 7.26E+06 3.92E+06 7.26E+06 9.10E+06 1.44E+07 4.13E+06 4.30E+06 3.22E+06 5.29E+06 1.03E+07 
Glutamine 3.88E+06 3.01E+06 4.39E+06 4.56E+06 3.08E+06 2.93E+06 2.11E+06 3.20E+06 3.28E+06 5.14E+06 




Table 1.25 Continued 
 
Sample Name M3 M5 M10 M12 M14 M19 M26 M30 M32 M40 
Glutathione disulfide 3.68E+05 2.83E+05 2.85E+05 2.87E+05 2.90E+05 2.76E+05 3.34E+05 3.73E+05 2.37E+05 2.69E+05 
Glycerone phosphate 4.94E+03 3.28E+03 6.02E+04 4.45E+03 4.63E+03 1.63E+03 7.23E+03 1.11E+04 3.56E+04 2.87E+03 
Glycine 4.01E+05 1.37E+05 1.48E+05 9.68E+04 1.76E+05 2.59E+05 2.29E+05 4.92E+04 1.14E+05 8.40E+04 
GMP 4.11E+04 5.21E+04 2.16E+05 6.60E+04 6.15E+04 3.70E+04 1.96E+05 2.42E+04 1.27E+05 1.03E+04 
Guanosine 1.74E+05 5.58E+04 9.81E+04 1.57E+05 9.05E+04 1.49E+05 4.15E+04 1.22E+05 6.43E+04 2.13E+05 
Histidine 9.79E+03 6.98E+03 8.32E+03 7.70E+03 7.44E+03 4.83E+03 3.74E+03 2.31E+03 1.20E+04 1.07E+04 
Homoserine/Threonine 2.18E+05 1.87E+05 2.24E+05 1.39E+05 1.60E+05 2.07E+05 1.51E+05 2.18E+05 1.69E+05 1.56E+05 
Homovanillic acid 8.07E+04 5.93E+04 1.07E+05 1.00E+05 5.43E+04 1.11E+05 7.28E+04 9.70E+04 6.29E+04 1.14E+05 
Hypoxanthine 2.97E+06 1.86E+06 3.69E+06 2.28E+06 2.61E+06 2.82E+06 1.92E+06 3.04E+06 2.41E+06 3.46E+06 
IMP 1.12E+05 8.94E+04 4.89E+05 1.01E+05 8.75E+04 3.96E+04 3.34E+05 3.61E+04 3.43E+05 1.21E+04 
Inosine 2.14E+06 1.18E+06 1.50E+06 1.33E+06 1.55E+06 1.72E+06 1.03E+06 2.10E+06 1.13E+06 2.25E+06 
Lactate 7.77E+06 6.05E+06 5.80E+07 5.08E+07 5.73E+06 9.15E+06 7.07E+06 1.13E+07 5.51E+07 5.14E+07 
Leucine/Isoleucine 1.61E+05 1.23E+05 6.43E+05 3.91E+05 1.57E+05 2.66E+05 1.50E+05 5.24E+05 3.59E+05 3.30E+05 
Malate 2.31E+06 6.26E+05 7.48E+06 1.81E+06 1.82E+06 8.28E+05 1.30E+06 4.37E+06 3.91E+06 8.26E+05 
Malate 1.19E+05 1.18E+05 1.67E+05 1.23E+05 1.33E+05 9.55E+04 1.07E+05 1.51E+05 1.64E+05 8.04E+04 
Methionine 1.77E+05 1.06E+05 2.58E+05 1.71E+05 2.13E+05 1.31E+05 1.76E+05 2.58E+05 1.60E+05 2.25E+05 
myo-Inositol 2.63E+04 1.51E+04 3.78E+05 3.41E+05 1.23E+04 1.94E+04 1.69E+04 2.64E+04 3.29E+05 3.55E+05 
N-Acetyl-beta-alanine 1.40E+04 8.08E+03 4.65E+04 3.03E+04 1.05E+04 1.58E+04 1.10E+04 2.33E+04 2.60E+04 3.85E+04 
N-Acetylglutamate 4.82E+05 3.49E+05 1.07E+06 6.09E+05 5.35E+05 8.12E+05 8.38E+05 6.91E+05 6.58E+05 5.01E+05 
N-Carbamoyl-L-aspartate 4.67E+05 3.55E+05 2.02E+05 3.68E+05 2.77E+05 2.67E+05 4.60E+05 6.68E+05 4.76E+05 4.95E+05 
O-Acetyl-L-serine 7.26E+06 3.92E+06 4.95E+02 4.68E+02 1.44E+07 6.29E+02 5.97E+02 5.97E+02 4.50E+02 5.13E+02 
Pantothenate 2.95E+06 2.50E+06 3.92E+06 2.06E+06 3.12E+06 2.65E+06 2.05E+06 3.99E+06 3.26E+06 2.88E+06 
Phenylalanine 1.05E+05 6.81E+04 1.34E+05 1.16E+05 9.98E+04 7.97E+04 6.02E+04 6.82E+04 7.72E+04 1.37E+05 
Phosphoenolpyruvate 3.83E+04 3.83E+04 4.35E+04 3.76E+04 2.72E+04 4.41E+04 3.01E+04 5.99E+04 3.59E+04 1.17E+05 
Proline 4.81E+04 4.70E+04 4.46E+04 6.63E+04 5.43E+04 6.89E+04 4.50E+04 4.77E+04 4.26E+04 5.36E+04 
Pyroglutamic acid 2.29E+06 1.77E+06 9.37E+06 5.68E+06 1.74E+06 3.20E+06 1.72E+06 3.89E+06 4.08E+06 5.84E+06 
Pyruvate 1.80E+05 1.64E+05 1.93E+05 4.97E+05 1.15E+05 1.64E+05 6.38E+04 2.09E+05 6.89E+04 8.94E+04 




Table 1.25 Continued 
 
Sample Name M3 M5 M10 M12 M14 M19 M26 M30 M32 M40 
Serine 9.59E+05 6.53E+05 5.32E+05 1.29E+06 8.24E+05 7.56E+05 6.99E+05 8.82E+05 6.44E+05 7.29E+05 
Succinate 3.59E+05 2.02E+05 1.07E+06 1.21E+06 1.83E+05 3.50E+05 4.15E+05 3.42E+05 5.01E+05 7.66E+05 
Taurine 2.22E+07 1.69E+07 1.80E+07 1.56E+07 1.92E+07 1.88E+07 1.64E+07 1.97E+07 1.46E+07 1.82E+07 
Trehalose/sucrose 1.14E+06 7.79E+03 2.65E+04 2.28E+04 6.83E+03 5.11E+03 6.78E+03 5.55E+03 4.24E+03 3.33E+03 
Tryptophan 2.93E+04 1.75E+04 3.29E+04 1.72E+04 2.20E+04 3.77E+04 1.38E+04 3.74E+04 2.81E+04 3.92E+04 
Tyrosine 7.59E+04 6.12E+04 1.64E+05 1.15E+05 8.97E+04 7.63E+04 9.09E+04 1.20E+05 1.05E+05 9.63E+04 
UDP-glucose 9.10E+04 7.66E+04 9.76E+04 6.49E+04 9.29E+04 7.08E+04 6.79E+04 1.25E+05 8.20E+04 9.61E+04 
UDP-N-acetylglucosamine 5.12E+04 2.94E+04 5.46E+04 5.44E+04 4.64E+04 4.19E+04 4.40E+04 6.51E+04 3.27E+04 4.26E+04 
UMP 2.55E+04 6.48E+03 8.60E+04 1.33E+04 1.58E+04 6.24E+03 7.92E+04 1.23E+04 3.97E+04 4.97E+03 
Uracil 8.86E+05 4.97E+05 8.94E+05 4.25E+05 6.25E+05 7.37E+05 4.26E+05 9.17E+05 6.14E+05 9.35E+05 
Uric acid 2.49E+04 1.76E+04 3.08E+04 4.04E+04 1.78E+04 1.44E+04 1.25E+04 9.35E+03 1.20E+04 2.27E+04 
Uridine 2.47E+05 1.62E+05 1.28E+05 2.30E+05 2.75E+05 3.89E+05 1.51E+05 2.53E+05 8.54E+04 2.81E+05 
Valine 2.09E+05 1.89E+05 3.11E+05 2.89E+05 2.63E+05 2.42E+05 1.80E+05 2.55E+05 2.30E+05 2.71E+05 




Table 1.26 Raw Data of Susceptible Mice from vmPFC 
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 M28 
2-Aminoadipate 1.54E+04 2.14E+04 4.35E+04 1.58E+04 2.59E+04 4.57E+04 4.65E+04 2.82E+04 4.82E+04 1.59E+05 9.01E+03 
2-Hydroxy-2-methylsuccinate 3.81E+06 3.92E+06 1.10E+06 7.28E+05 3.37E+06 4.13E+06 4.86E+06 3.37E+06 1.00E+06 2.50E+06 3.40E+06 
2-Isopropylmalate 7.25E+04 7.25E+04 7.45E+04 4.87E+04 8.60E+04 6.65E+04 1.00E+05 1.03E+05 5.40E+04 4.88E+04 7.51E+04 
3_4-Dihydroxyphenylacetate 3.35E+04 1.69E+04 1.48E+04 1.57E+04 7.49E+03 1.56E+04 1.43E+04 3.53E+04 1.85E+04 6.10E+03 4.90E+03 
3-Phosphoglycerate 1.58E+05 7.47E+05 3.89E+04 8.96E+04 1.75E+04 2.44E+05 3.22E+04 1.42E+05 1.38E+05 4.24E+05 2.17E+04 
4-Aminobutyrate 3.30E+06 2.86E+06 2.11E+06 1.16E+06 1.71E+06 3.12E+06 2.36E+06 1.85E+06 1.86E+06 3.44E+06 1.67E+06 
5-Hydroxyindoleacetic acid 3.15E+04 1.26E+04 1.34E+04 2.97E+03 2.66E+04 3.46E+04 3.00E+04 3.05E+04 1.39E+04 4.79E+04 1.92E+04 
Aconitate 1.04E+07 9.23E+06 3.85E+06 3.78E+06 7.45E+06 7.89E+06 9.07E+06 9.69E+06 5.84E+06 7.82E+06 7.02E+06 
Alanine/Sarcosine 2.16E+06 1.72E+06 1.39E+06 1.20E+06 1.82E+06 1.91E+06 1.91E+06 1.51E+06 1.40E+06 1.68E+06 1.48E+06 
alpha-Ketoglutarate 3.16E+04 4.05E+04 1.18E+04 1.79E+04 1.94E+04 1.98E+04 2.87E+04 1.58E+04 9.89E+03 3.44E+04 2.40E+04 
AMP/dGMP 2.05E+05 1.48E+05 1.95E+05 9.02E+04 9.59E+05 6.73E+04 2.79E+05 3.04E+05 8.26E+04 1.22E+05 8.56E+05 
Arginine 1.25E+04 1.35E+04 3.65E+03 6.33E+03 1.20E+04 9.90E+03 7.86E+03 1.78E+04 6.78E+03 1.20E+04 3.52E+03 
Ascorbate 2.33E+06 7.09E+05 1.89E+04  1.94E+05 6.77E+04 3.12E+05 2.38E+05 2.42E+05 2.02E+05 1.59E+06 
Asparagine 1.05E+05 5.02E+04 4.91E+04 3.57E+04 5.30E+04 6.04E+04 7.60E+04 2.39E+04 5.91E+04 7.27E+04 4.16E+04 
Aspartate 1.09E+07 8.55E+06 2.77E+06 1.09E+06 7.16E+06 7.53E+06 8.26E+06 6.87E+06 1.59E+06 3.05E+06 6.00E+06 
cAMP 1.94E+04 2.08E+04 2.90E+03 3.05E+03 2.35E+04 2.45E+04 1.76E+04 1.45E+04 6.99E+03 1.60E+04 5.18E+03 
CDP-ethanolamine 3.90E+04 3.04E+04 9.44E+03 4.23E+03 3.39E+04 3.48E+04 3.06E+04 2.72E+04 1.03E+04 1.24E+04 2.77E+04 
Citraconate 4.34E+05 3.92E+05 1.68E+05 1.72E+05 2.79E+05 3.71E+05 3.63E+05 4.01E+05 2.52E+05 3.06E+05 2.73E+05 
Citrate/isocitrate 7.22E+06 8.22E+06 1.91E+06 2.08E+06 4.40E+06 6.48E+06 7.64E+06 6.51E+06 3.64E+06 6.82E+06 5.28E+06 
Creatine 2.72E+06 1.84E+06 1.68E+06 1.53E+06 2.14E+06 2.18E+06 2.24E+06 1.77E+06 1.63E+06 1.96E+06 1.45E+06 
Cysteine 3.99E+04 3.87E+04 2.13E+04 1.57E+04 9.40E+03 3.44E+04 4.82E+04 4.45E+04 2.25E+04 3.21E+04 5.14E+04 
Cystine 1.28E+05 8.81E+04 5.59E+04 3.99E+04 5.18E+04 5.99E+04 3.34E+04 2.64E+04 6.83E+04 9.60E+04 5.07E+04 
D-Gluconate 2.95E+04 4.21E+04 1.50E+04 1.12E+04 1.47E+04 1.69E+04 1.52E+04 5.48E+03 2.08E+04 3.11E+04 1.03E+04 
Fumarate 7.10E+05 6.77E+05 2.69E+05 1.56E+05 8.62E+05 1.47E+06 1.25E+06 2.82E+05 3.57E+05 1.17E+06 6.47E+05 
Glucose 6-phosphate 6.67E+03 6.31E+03 2.21E+03 1.87E+03 1.96E+04 7.75E+03 7.06E+03 4.74E+03 3.50E+03 5.77E+03 4.41E+03 
Glutamate 5.41E+06 3.68E+06 3.09E+06 2.30E+07 1.13E+07 8.52E+06 1.32E+07 1.18E+07 8.69E+06 8.40E+06 9.08E+06 
Glutamine 4.08E+06 3.15E+06 3.37E+06 2.62E+06 2.95E+06 3.36E+06 3.66E+06 3.73E+06 3.42E+06 3.93E+06 2.85E+06 




Table 1.26 Continued 
 
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 M28 
Glutathione disulfide 5.46E+05 6.47E+05 1.93E+05 2.06E+05 2.72E+05 4.21E+05 4.62E+05 3.25E+05 3.39E+05 3.75E+05 3.58E+05 
Glycerone phosphate 6.06E+03 9.83E+03 5.86E+03 2.12E+03 1.85E+04 2.22E+04 2.78E+03 2.18E+04 2.19E+04 3.50E+04 1.19E+04 
Glycine 3.50E+05 1.13E+05 2.15E+05 1.29E+05 1.48E+05 1.62E+05 3.08E+05 7.02E+04 3.84E+05 8.47E+04 6.63E+04 
GMP 7.31E+04 3.33E+04 7.44E+04 2.36E+04 2.30E+05 1.59E+04 1.24E+05 7.99E+04 2.79E+04 2.91E+04 2.34E+05 
Guanosine 1.66E+05 1.16E+05 6.22E+04 5.63E+04 4.94E+04 1.47E+05 1.97E+05 1.31E+05 5.73E+04 9.73E+04 2.42E+04 
Histidine 3.39E+03 8.38E+03 7.87E+03 4.56E+03 5.28E+03 9.78E+03 9.52E+03 9.79E+03 3.65E+03 8.76E+03 9.57E+03 
Homoserine/Threonine 2.97E+05 2.27E+05 1.54E+05 1.32E+05 1.56E+05 1.41E+05 2.10E+05 1.45E+05 1.63E+05 1.64E+05 1.73E+05 
Homovanillic acid 9.08E+04 1.75E+05 7.72E+04 6.88E+04 1.47E+05 1.78E+05 1.47E+05 1.09E+05 7.84E+04 1.26E+05 1.40E+05 
Hypoxanthine 4.26E+06 3.26E+06 1.48E+06 1.41E+06 3.18E+06 5.00E+06 3.69E+06 3.16E+06 2.12E+06 3.65E+06 2.59E+06 
IMP 9.98E+04 3.64E+04 1.35E+05 7.84E+04 3.91E+05 2.76E+04 1.73E+05 1.47E+05 2.65E+04 2.83E+04 5.71E+05 
Inosine 2.81E+06 2.61E+06 1.20E+06 1.02E+06 1.51E+06 2.36E+06 2.96E+06 1.57E+06 1.44E+06 1.90E+06 1.28E+06 
Lactate 1.36E+07 1.34E+07 6.96E+06 4.21E+06 5.85E+07 5.23E+07 5.84E+07 4.90E+07 5.13E+06 7.61E+06 2.25E+07 
Leucine/Isoleucine 5.68E+05 5.69E+05 1.42E+05 1.05E+05 3.80E+05 4.02E+05 5.13E+05 3.19E+05 1.41E+05 2.01E+05 4.20E+05 
Malate 4.34E+06 5.50E+06 1.21E+06 4.52E+05 5.96E+06 8.38E+06 7.04E+06 2.46E+06 9.99E+05 6.82E+06 4.57E+06 
Malate 1.79E+05 1.52E+05 9.56E+04 8.53E+04 1.42E+05 2.01E+05 1.53E+05 1.06E+05 1.13E+05 1.68E+05 1.60E+05 
Methionine 3.30E+05 2.61E+05 1.73E+05 2.26E+05 1.86E+05 2.81E+05 2.54E+05 1.71E+05 1.40E+05 3.43E+05 2.47E+05 
myo-Inositol 2.27E+04 3.07E+04 1.76E+04 7.80E+03 3.81E+05 2.92E+05 3.79E+05 2.85E+05 1.29E+04 2.33E+04 3.17E+04 
N-Acetyl-beta-alanine 3.93E+04 3.93E+04 9.28E+03 8.61E+03 2.07E+04 1.93E+04 2.41E+04 1.25E+04 1.43E+04 2.29E+04 1.70E+04 
N-Acetylglutamate 1.50E+06 7.98E+05 2.91E+05 1.83E+05 1.40E+06 9.80E+05 2.01E+06 7.69E+05 3.20E+05 6.62E+05 1.60E+06 
N-Carbamoyl-L-aspartate 3.60E+05 3.92E+05 2.53E+05 1.66E+05 4.47E+05 4.52E+05 4.32E+05 2.88E+05 2.09E+05 6.22E+05 3.85E+05 
O-Acetyl-L-serine 6.34E+02  3.09E+06 2.30E+07 5.57E+02 4.33E+02 4.10E+02 3.73E+02 8.69E+06 8.40E+06 4.72E+02 
Pantothenate 3.45E+06 3.44E+06 2.38E+06 2.34E+06 3.01E+06 3.78E+06 3.30E+06 2.87E+06 2.60E+06 3.82E+06 2.42E+06 
Phenylalanine 1.28E+05 1.98E+05 9.37E+04 6.31E+04 9.53E+04 1.46E+05 1.43E+05 1.14E+05 8.73E+04 1.47E+05 6.37E+04 
Phosphoenolpyruvate 6.49E+04 2.75E+05 4.24E+04 3.28E+04 3.07E+04 7.40E+04 6.18E+04 6.15E+04 7.51E+04 1.93E+05 2.56E+04 
Proline 6.79E+04 5.51E+04 4.15E+04 3.17E+04 6.54E+04 6.25E+04 6.12E+04 4.63E+04 3.70E+04 6.35E+04 5.29E+04 
Pyroglutamic acid 4.04E+06 5.02E+06 1.87E+06 1.03E+06 4.12E+06 6.53E+06 4.39E+06 3.63E+06 1.65E+06 3.05E+06 3.12E+06 
Pyruvate 2.37E+05 1.41E+06 8.54E+04 6.25E+04 1.21E+05 2.34E+05 1.43E+05 5.86E+04 1.57E+05 5.77E+05 1.10E+05 




Table 1.26 Continued 
 
Sample Name M1 M4 M15 M17 M20 M22 M23 M24 M25 M27 M28 
Ribose phosphate 3.58E+05 3.25E+05 9.98E+04 8.13E+04 1.19E+05 2.55E+05 1.85E+05 2.62E+05 2.48E+05 1.40E+05 8.95E+04 
Serine 1.24E+06 1.17E+06 7.00E+05 6.67E+05 9.28E+05 6.33E+05 9.52E+05 5.29E+05 8.90E+05 1.00E+06 6.59E+05 
Succinate 3.86E+05 8.15E+05 3.61E+05 1.79E+05 1.09E+06 1.22E+06 1.60E+06 8.53E+05 2.38E+05 3.63E+05 1.68E+06 
Taurine 2.74E+07 2.24E+07 1.66E+07 1.69E+07 2.01E+07 2.11E+07 2.31E+07 1.75E+07 1.70E+07 1.94E+07 1.86E+07 
Trehalose/sucrose 1.23E+04 4.12E+04 1.21E+04 8.68E+03 6.61E+03 6.73E+03 4.53E+03 4.13E+03 1.91E+04 5.37E+04 5.18E+03 
Tryptophan 3.15E+04 3.51E+04 1.31E+04 1.46E+04 2.25E+04 4.58E+04 2.91E+04 2.61E+04 1.68E+04 3.20E+04 4.30E+04 
Tyrosine 1.37E+05 1.32E+05 7.82E+04 7.44E+04 1.12E+05 2.82E+05 8.92E+04 9.59E+04 6.12E+04 1.37E+05 1.02E+05 
UDP-glucose 1.52E+05 1.55E+05 6.19E+04 6.93E+04 1.40E+05 9.15E+04 1.70E+05 9.92E+04 8.44E+04 1.40E+05 1.03E+05 
UDP-N-acetylglucosamine 7.73E+04 9.48E+04 3.71E+04 4.40E+04 6.36E+04 5.47E+04 8.13E+04 4.44E+04 4.02E+04 8.21E+04 7.32E+04 
UMP 2.69E+04 1.54E+04 1.65E+04 8.43E+03 1.12E+05 7.33E+03 6.04E+04 5.78E+04 1.13E+04 2.16E+04 1.19E+05 
Uracil 9.50E+05 9.02E+05 4.84E+05 4.94E+05 6.40E+05 8.73E+05 7.17E+05 6.26E+05 5.95E+05 1.02E+06 6.19E+05 
Uric acid 1.08E+04 3.11E+04 1.46E+04 2.21E+04 2.17E+04 2.31E+04 1.99E+04 2.81E+04 1.98E+04 4.20E+04 1.16E+04 
Uridine 6.54E+05 4.11E+05 1.66E+05 2.30E+05 1.78E+05 4.43E+05 3.83E+05 2.34E+05 2.43E+05 3.76E+05 2.34E+05 
Valine 3.59E+05 5.12E+05 1.77E+05 1.63E+05 2.57E+05 3.13E+05 3.66E+05 2.44E+05 1.73E+05 3.25E+05 2.85E+05 




CHAPTER 2: NEUROMETABOLOMICS OF ACUTE SLEEP 





Upon arriving to the University of Tennessee, Knoxville, I had the pleasure of 
collaborating with Drs. Ralph Lydic and Helen Baghdoyan. These two neuroscientists are 
highly-recognized researchers within the field of sleep regulation and function. A primary 
goal of their research was to gain a higher-level understanding of how neurochemicals 
fluctuate during various states of consciousness, which was accomplished by combing 
the well-established sampling technique of microdialysis with the versatility of LC-HRMS 
untargeted metabolomics. 
While quantitative and qualitative analysis of neurotransmitters has been studied 
for decades, analytical limitations had prevented a holistic approach. Using HPLC-UV/Vis 
or electrochemical detection (e.g. voltammetry), researchers were able to analyze one, 
or two, neurotransmitters simultaneously from a single sample. Although the information 
gained from these studies are integral to the understanding of neurochemistry, the 
dynamic changes observed from the entire metabolome would provide a snapshot of how 
neurons are chemically changing for communication across the interstitial space. 
Microdialysis is a proficient sampling technique used by neuroscientists to obtain 
information about temporal neurochemical changes. Through minimally invasive surgery, 
a small probe can be strategically implanted into a specific region of the brain. Following 
probe conditioning, dialysate is collected in small fractions that contain neurochemicals 
from the extracellular space. The result of this analysis can provide valuable information 
about the release and reuptake of specific neurotransmitters, and other small molecules 
that are used for the regulation of neuronal synapses. This sampling technique was the 
perfect tool for analyzing states of consciousness, as a single subject can be analyzed 
across time to determine how neurochemicals change during natural states of sleep and 
wake, through perturbed states, such as sleep deprivation or under the effects of 
anesthesia. 
Samples were collected with assistance from Dr. Chiara Cirelli et al., University of 
Wisconsin, simultaneously from the prefrontal cortex and motor cortex of B6 mice at 15-
minute intervals. Experimental conditions included mice during natural sleep followed by 
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enforced wakefulness (S6-W3; N = 7), natural wake followed by enforced wakefulness 
(W6-W3; N = 6), and sleep deprivation followed by natural sleep (SD6-S3; N = 6). 
Untreated dialysate were diluted to 50 µL to provide repeat injections. Our untargeted 
metabolomics method, using LC-HRMS, analyzed over 1,200 samples across 14 days. 
Following peak identification with MAVEN software, raw ion intensity data was normalized 
with assistance from Dr. William Marshall, University of Wisconsin. 
 This research provided insight about the current state of analytical technology and 
advanced the field of sleep regulation and consciousness. Our results revealed that an 
untargeted metabolomics technique could successfully identify 30+ known metabolites 
from our current standard list of ~300 metabolites and thousands of unidentified spectral 
features. This analysis marks the first time a global metabolic snapshot was observed 
from microdialysate samples, which provided the challenge of small sample volume and 
reduced metabolite concentration. By analyze metabolism in a temporal fashion, we were 
able to observe how neurochemicals fluctuate during various states of consciousness. 
With access to literature that identifies changes to neurotransmitters during these states, 
we can now begin piecing together how these small water-soluble metabolites are related. 
Additionally, we are providing the neuroscience community with a large set of unexplored 
territory in the form of the unidentified spectral features.  
 Small molecule discovery can identify new, safe targets for the treatment or 
prevention of sleep-related illnesses. Across the globe, irregular sleeping habits are 
becoming common, and the medical consequences of these habits are well documented. 
Sleep deprivation has been shown to effect both cardiac and respiratory function, 
increase work-related injury due to drowsiness, and cause weight loss or gain. With the 
completion of this research project, we have provided a new set of small molecules for 
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Cerebral metabolism plays an essential role in sleep-waking states, yet the primary 
information available involves the analysis of a subset of small molecules known as 
neurotransmitters. To date, most neurochemical analyses have involved the detection of 
one, or two metabolites simultaneously. The lack of breadth knowledge has limited 
neuroscientists from developing a greater understanding of how global metabolism 
regulates these states of consciousness. This study has focused on developing a deeper 
understanding of how central carbon metabolites fluctuate across sleep-waking states, 
as well as expanding our knowledge about how sleep deprivation can impact 
homeostasis. Using an untargeted UPLC-HRMS metabolomics method and sequential 
statistical analyses resulted in 11 significant metabolites that fluctuated between the 
sleep-waking cycle and sleep deprivation. 
 
2.2 INTRODUCTION 
Genome-wide transcriptomic studies have identified hundreds of mRNAs with 
expression changes in neurons and glia that are associated with sleep and wakefulness, 
independent of circadian time (Bellesi et al., 2015; Bellesi et al., 2013; Cirelli et al., 2004; 
Mackiewicz et al., 2007; Maret et al., 2007; Mongrain et al., 2010). These studies have 
suggested new hypotheses about the restorative functions of sleep, from synaptic 
homeostasis to the synthesis of cellular components and membranes (Mackiewicz et al., 
2007; Maret et al., 2007; Tononi and Cirelli, 2014). Proteomic approaches also have been 
used, although they are difficult to apply to brain homogenates (e.g.(Basheer et al., 2005; 
Cirelli et al., 2009; Kim et al., 2014; Pawlyk et al., 2007; Poirrier et al., 2008)).  
Metabolomics, or the study of small-molecule metabolites, is a powerful approach 
for identifying endogenous molecules in brain extracellular fluid. Because metabolomics 
provides functional information about cellular physiology, measuring the cortical 
metabolome may help to clarify how changes in neurochemistry contribute to the 
generation of sleep and wakefulness (Baghdoyan and Lydic, 2012). Metabolomics also 
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has the potential to provide insights about the functions of sleep. New detection methods 
are now available to analyze brain microdialysis samples with high sensitivity and 
specificity (Dunn et al., 2011; Snyder et al., 2013). According to the human metabolome 
database, 440 compounds have been detected (quantified or not) in the cerebrospinal 
fluid (Wishart et al., 2013). How these metabolites relate to metabolites present in the 
brain extracellular fluid is unknown. The goal of the present study was to characterize 
changes in the composition of the extracellular fluid that were associated with states of 
sleep and wakefulness, independent of circadian time or stress caused by sleep 
deprivation. To accomplish this aim we used Ultra Performance Liquid Chromatography-
High Resolution Mass Spectrometry (UPLC-HRMS) to identify and quantify molecules 
comprising metabolomics profiles in mouse medial prefrontal cortex (mPFC) and primary 
motor cortex (M1). In vivo microdialysis was used to collect samples from mice during 
electrographically identified states of sleep and wakefulness during times when mice are 
normally asleep (light period), normally awake (dark period), and during sleep deprivation. 
We focused on mPFC and M1 because we recently found that noradrenaline levels 
increased during waking and decreased during sleep in both regions, but they started 
declining by the end of 6 hours of sleep deprivation only in mPFC. This decline correlated 
with an increase in low EEG frequencies, suggesting that the build-up of sleep pressure 
during waking may occur faster in mPFC (Bellesi et al., 2016).  
 
2.3 MATERIALS AND METHODS 
2.3.1 Animals 
Adult, male C57BL/6J (B6, wild type) mice (25 to 30 g; n = 19) were used. All 
animal procedures and experimental protocols followed the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals (2011) and were approved by the 
University of Wisconsin-Madison licensing committee. Animal facilities were reviewed 
and approved by the institutional animal care and use committee (IACUC) of the 
University of Wisconsin-Madison and were inspected and accredited by association for 
assessment and accreditation of laboratory animal care (AAALAC).  
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2.3.2 Stereotaxic Surgery 
Implantation of recording electrodes and microdialysis guide tubes was performed 
under isoflurane anesthesia (2% for induction, 1 to 1.5% for maintenance). Each mouse 
was implanted with two microdialysis guide cannulae (Figure 1A). One cannula was 
aimed for the left medial prefrontal cortex (mPFC) using stereotaxic coordinates Bregma 
AP +1.94, ML -0.3; (Bicks et al., 2015).  A second cannula was aimed for the right primary 
motor cortex (M1) with stereotaxic coordinates of AP +1.5, ML +2 (Franklin and Paxinos, 
2008). For electroencephalographic (EEG) recordings, screw electrodes were implanted 
over left and right parietal cortex (AP -2, ML +/-2) and cerebellum (reference electrode). 
To record the electromyogram (EMG), two stainless steel wires were implanted into the 
nuchal muscles. Cannulae and electrodes were fixed to the skull with dental cement. After 
surgery, mice were individually housed in transparent Plexiglas cages. Environmental 
lighting provided a 12h:12h light/dark cycle (lights on at 8 am; 23 ± 1 °C) with food and 
water available ad libitum and replaced daily at 8 am. Approximately one week was 
allowed for recovery from surgery, and microdialysis experiments started only after the 
temporal organization of sleep and wakefulness had normalized.  
2.3.3 Quantifying States of Sleep and Wakefulness 
For one week after surgery the mice were conditioned for sleep studies by 
connecting them via a flexible cable to a multichannel neurophysiology recording and 
stimulation system that enabled EEG and EMG recordings (Figure 1B) (Tucker-Davis 
Technologies Inc.). EEG and EMG signals were amplified and filtered as follows: EEG, 
high-pass filter at 0.1 Hz; low-pass filter at 100 Hz; EMG, high-pass filter at 10 Hz; low-
pass filter at 100 Hz). All signals were sampled and stored at 256 Hz. States of sleep and 
wakefulness were scored off-line in 4-sec epochs using standard criteria. 
2.3.4 Microdialysis Experiments 
The day before the experiment, each mouse was briefly anesthetized with 
isoflurane and the microdialysis probes (15 KDa pore size) were inserted into the guide 
cannulae (Bellesi et al., 2016). Microdialysis probes in the mouse homologue of 
prefmPFC and M1 were connected to the microfluidic circuit (Figure 1B) and perfused 
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with artificial extracellular fluid (aECF) comprised of mM concentrations of: NaCL 147, 
KCl 2.7, CaCl2 1.2, MgCl2 0.85. The microperfusion pump (CMA/400, CMA Microdialysis), 
maintained aECF flow rate of 1.1 µL / min. Experiments were conducted from 7am until 
6pm or from 9pm until 6am, during which time microdialysis samples from each cortical 
probe were collected every 15 min in 250 μL plastic vials (ESA, PN 70-1695; ESA, Inc.). 
At the conclusion of each dialysis experiment, microdialysis sites were histologically 
confirmed to be located in the targeted brain area. Dialysis samples were stored at -80ºC 
until they were shipped to the University of Tennessee to be analyzed using Ultra 
Performance Liquid Chromatography-High Resolution Mass Spectrometry (UPLC-
HRMS) and an established metabolomics method (Lu et al., 2010). At the University of 
Tennessee samples were also maintained at -80ºC until they were thawed and measured. 
2.3.5 Experimental Groups 
Three different experimental groups were used (Figure 1C). In all cases mice were 
first placed on a slowly rotating treadmill that kept them awake for 2h, and in statistical 
analysis 2 (see below) dialysis samples collected during the second hour served as 
reference to compare samples collected during the following 9h of the light period (first 
two groups) or of the dark period (third group). Figure 1D shows the percent of time mice 
in each of the three groups spent awake during each 15-min sampling bin. 
Group 1: Sleep for 6h followed by wakefulness on treadmill for 3h (S6-W3; n=7 mice) 
At 7am, one hour before lights-on, each mouse was placed on a slowly moving 
treadmill (speed ≈ 0.7 cm/sec) and the flow for microdialysis probe was activated (1.1 µL 
/ min). The mouse was awake while slowly moving on the platform, and four microdialysis 
samples were collected during the second hour to serve as reference. The mouse was 
then returned to its cage and allowed to sleep for 6h. After ad libitum sleep, at 3pm the 
mouse was placed back on the slowly moving treadmill for 3h, to obtain EEG recordings 
and microdialysis samples during a “standardized” period of wakefulness, in which the 
mouse behavior was as homogenous as possible.  
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Group 2: Sleep deprivation for 6h followed by sleep for 3h (SD6-S3; n = 6 mice)  
As described above, mice were placed on the slowly moving treadmill starting at 
7am and the second hour was used as reference. Mice were then returned to their cage 
and kept awake by exposure to novel objects for 6h, followed at 3pm by ad libitum sleep 
for 3h.  
Group 3: Spontaneous wakefulness for 6h followed by wakefulness on treadmill for 3h 
(W6-W3; n = 6 mice) 
Mice were placed on the slowly moving treadmill for 2h starting at 7pm, one hour 
before lights-off, and the second hour served as reference. At 9pm mice returned to their 
cage and as expected, were spontaneously awake for most of the time. A novel object 
was placed in the cage every ~30 min to help maintain a sustained period of wake, but if 
the mouse slept, it was allowed to do so and microdialysis samples were not used for 
subsequent analyses. At 3am mice were placed back on the treadmill for 3h.  
2.3.6 Untargeted Metabolomics using UPLC-HRMS 
Mass spectrometry (MS) is a key approach for metabolic profiling of the brain by 
making possible the simultaneous measurement of thousands of molecules from a small 
volume sample (Patti et al., 2012). The present study used an untargeted approach to 
determine how many metabolites could be identified in each dialysis sample, and a 
targeted approach to query the structure of some unidentified spectral features. Prior to 
untargeted analyses, a 15-μL aliquot of each microdialysis sample was diluted to 50 μL 
of total volume using Ringer’s solution. Instrumentation for untargeted metabolomics 
analysis included an Ultimate 3000 LC pump in line with an Exactive Plus Orbitrap™ 
mass spectrometer (Thermo Scientific). Ultra-performance liquid chromatography 
(UPLC) was accomplished under previously established chromatography (Stough et al., 
2016) using a Synergi Hydro-RP column (100 mm x 2.1 mm, 2.5 μm, 100 Å). Metabolites 
were detected using high-resolution mass spectrometry (HRMS) in negative mode with 
an electrospray ionization (ESI) source. 
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Following detection, raw data were compiled using the Metabolomic Analysis and 
Visualization Engine (MAVEN) software package (Melamud et al., 2010). Known 
metabolites were selected from a pre-existing list of ~300 compounds based on exact 
mass and previously determined retention times (Lu et al., 2010). Metabolite selection 
resulted in the reliable identification of more than 40 small molecules in more than 80% 
of subjects; Group 1 (31 ± 16, mean ± SD), Group 2 (47 ± 8), and Group 3 (45 ± 5).   
Additionally, MAVEN enabled the extraction of all spectral features detected during 
analysis. Each spectral feature refers to a potential metabolite with an exact parent mass 
detected at a specific retention time. After removal of “known” metabolites and carbon-13 
isomers, the remaining spectral features were classified as “unknown”. Total unknown 
features: Group 1 (2436 ± 850, mean ± SD; range, 998 - 3755), Group 2 (2388 ± 1529; 
range, 388 - 5016), and Group 3 (2297 ± 846; range, 947 - 2899).  
2.3.7 Statistical Analysis 
Pre-processing normalization 
Known metabolites were filtered independently of brain region and must be 
observed in at least three mice per treatment condition. This selection criteria provided a 
list of 36 and 33 metabolites in mPFC and M1, respectively. It should be noted that 2/3 of 
the missing data is accounted for by 3 mice from the sleep treatment condition. Samples 
from these subjects were collected without error, analyzed without technical 
complications, and statistically provided no evidence as significant outliers. For these 
reasons, these subjects were included in the final data analyses. Raw ion intensities were 
normalized to the baseline samples collected during the first hour of analysis. To generate 
a z-score normalized matrix, raw values were subtracted from the per 
mouse/location/metabolite mean, then divided by the standard deviation. To minimize the 
number of missing data points, the time domain was coarse-grained into 1-hour segments 
(i.e. 4, 15-minute sample collections), reducing the data set to 9-time points. To complete 
multivariate analysis, a full dataset was required, and the remaining missing data points 
were replaced in the following manner. For metabolites that were not detected in a mouse, 
these values were replaced with the metabolites within treatment/location/time average. 




Partial least squares discriminant analysis (PLSDA) was used as a classification 
model. This analysis included the combined data from mPFC and M1 comparing the 6-
hour metabolic profiles of sleep (S6; blue), wake (W6; green), and sleep deprivation (SD6; 
red). PLSDA computation was accomplished using the DiscriMiner package and plsDA() 
function in R. Figures were generated using the ggbiplot package. Model predictive 
accuracy was performed to validate the results using a repeated, stratified k-fold (k = 3) 
cross validation. This approach applied a learning set to prevent over-fitting of the data. 
A unique function of this technique is the feature classification model that produces a list 
of variable importance of projection (VIP) scores for each metabolite. VIP scores were 
extracted from the plsDA() function and plotted in Excel. 
Heatmap Analysis 
Heatmap analysis allows for facile interpretation of metabolic changes across 
treatment conditions by converting a numerical value to a defined color scale. Treatment 
group differences were calculated from the normalized z-score data (i.e. Δ z-score) and 
expressed temporally using the 9-hour coarse-grained data. The first 9-hour segment 
compares 9am to 3pm (i.e. 1 thru 6) of S6 and SD6, then 3pm to 6pm (i.e. 7 thru 9) of S6-
W3 and SD6-S3; second segment, 9am to 3pm of S6 and 9pm to 3am of W6, then 3pm 
to 6pm of S6-W3 and 3am to 6am of W6-W3; and third segment, 9am to 3pm of SD6 and 
9pm to 3am of W6, then 3pm to 6pm of SD6-S3 and 3am to 6am of W6-W3. The saturated 
color scale ranges from ±3, where the metabolites concentration is blue when higher in 
sleep, red when higher in sleep deprivation, or green when higher in wake. Heatmaps 
were generated in R with the ggplot2 and colorspace packages. 
Linear Mixed Effects Model 
Statistical analyses of the microdialysis samples were performed using LME 
models (Laird and Ware, 1982; Lindstrom and Bates, 1988). LME models are one of the 
few statistical techniques that are appropriate for analyzing repeated measures data, as 
most traditional parametric statistical techniques rely on the assumption of independence 
between data points. The other common approach for this type of data is a repeated 
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measures ANOVA, but the LME analysis is more flexible with respect to missing data, 
and our analysis included many missing values, due to the absence of a compound at a 
specific time point or brain region, and/or due to a mouse that did not meet the criteria for 
sleep or wake at a given time point.  
A linear mixed effect model includes both “fixed” and “random” effects, allowing to 
determine the effect of a variable with a fixed number of states (in our case, the 3 
behavioral conditions of either sleep, spontaneous wake or sleep deprivation), while 
simultaneously controlling for the effects of another variable for which only a random 
sample of possible values are observed (e.g., a random sample of mice). A mixed effect 
model has the form 








𝑏𝑖,𝑞 ∼ 𝑁(0, 𝜎𝑞
2), 
and 
𝜖𝑖,𝑡 ∼ 𝑁(0, 𝜎
2). 
In this model, Yi,t is the response variable, in our case the compound sample of the ith 
mouse at the tth time point. The residuals ϵi,t were assumed to be independent and 
normally distributed with constant variance. To ensure the assumptions of normality and 
constant variance were satisfied, response values for some compounds were 
transformed using a log or square root transformation. The βp values correspond to the 
fixed effects in the model and b0,q are the random effects, which are assumed to be 
normally distributed, with mean zero and constant variance. The design matrices X and 
Z contain the values for each fixed and random explanatory variable respectively. 
Parameters for the LME models were estimated numerically using the lme4 library for the 
R software package (Bates et al., 2015). 
 
146 
All data were baseline corrected before modeling by subtracting out the average 
value of the compound in the second baseline hour on the treadmill. A model selection 
procedure was applied separately for each analysis. Following (Bolker et al., 2008), we 
included as many random effects terms in each model as the data supported; when the 
variance of a random effect went to zero or two random effects became perfectly 
correlated then the model was over parameterized. Once the structure of the random 
effects was determined, the Akaike Information Criterion (Akaike, 1974) was used to 
select the set of fixed effects in the model.  
Statistical analysis of the LMEs was performed using likelihood ratio tests, 
comparing the full model as identified by the model selection procedure with a reduced 
model with the effect of condition removed. Depending on the specific form of the fixed 
effects in the model, this could result in a test for a main effect of condition, a condition x 
time interaction, a condition x brain region interaction, or a condition x time x brain region 
three-way interaction.  
Classification Analysis 
Microdialysis samples were further analyzed using machine learning algorithms in 
an effort to determine whether behavioral state sampling epochs could be accurately 
classified as sleep, spontaneous wake or enforced wake. Baseline correction was applied 
before classification, as with the above LME analysis. Because the number of explanatory 
variables was so much greater than the number of mice in the study, we applied the 
LASSO to fit a sparse model and prevent over-fitting the data (Tibshirani, 1996). 
Classification accuracy was assessed using a 4-fold stratified cross-validation. Briefly, the 
population was divided into 4 groups, with the number of mice from each condition 
approximately equal for each group. Three of the groups were used to train the model 
(training set) and the remaining group was used to test the accuracy (test set).  This 
process was repeated, so that every group (and thus every mouse) was used as the test 




Significance testing for the classifiers was performed using a nonparametric 
permutation test. The condition labels for the mice were randomly permutated to remove 
any distinctions between the groups, and then the classifiers were reapplied, capturing 
the expected accuracy under the hypothesis of no differences. This method captures both 
the fact that chance levels of accuracy are 50% (33% for 3-way classification) and the 
structure of the design matrix, i.e., the number of predictor variables compared to the 
number of observations. The structure of the design matrix is important to consider 
because with so many predictors, one might expect to do better than chance, even in the 
absence of a true difference between groups. 
 
2.4 RESULTS 
 Microdialysis samples were collected simultaneously in the mPFC and M1 of B6 
mice over a 10-hour time period in 15-minute increments, resulting in a total of 1, 571 
dialysate samples for analysis (Figure 2.1A, B). Experiments were performed in 3 
separate groups of animals, all of which well entrained to the light/dark cycle. All mice 
spent the first 2 hours awake, slowly moving on a treadmill, and were then studied during 
the following 9 hours in different sleep/wake conditions (Figure 2.1C). The first 2 groups 
were studied during the light phase, one group during a sustained period (~6h) of sleep 
followed by 3h of wake on the treadmill (S6-W3), and the other group during 6h of sleep 
deprivation enforced by exposure to novel objects, followed by 3h of sleep (SD6-S3). 
Thus, these two groups of animals were studied at the same time of day and in the same 
lighting conditions (lights on) but on average, they spent each of the last 9 hours of the 
experiment in opposite behavioral states (sleep or wake). The third group of mice was 
studied at the opposite circadian time, during the dark phase, and spent the last 9 hours 
awake, the first 6 hours in their cages, and the last 3 hours on the treadmill (W6-W3). In 
each mouse microdialysis samples were collected every 15 minutes (Figure 2.1D). The 
combination of these 3 groups, including enforced wake during the day and spontaneous 
wakefulness at night, allowed us to assess the effects of sleep and wakefulness 




Figure 2.1 Experimental design 
(A) schematic diagram showing the placement of the microdialysis probes, EEG 
electrodes and EMG wires; (B) set-up for EEG recording and microdialysis; (C) the 3 
experimental groups. (D) mean % of wake for each group in 15-min intervals. For each 
group, time points in black indicate the first two hours of the experiment, when all mice 
were on the treadmill, to obtain a “reference” condition of standardized wakefulness. Blue 
time points indicate the periods when mice had the opportunity to sleep. Time points in 
red indicate the period of sleep deprivation using novel objects. Time points in orange 
show when mice were either spontaneous awake at night or placed on the treadmill for 
the last 3 hours of the experiment. 
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stimulation (novel objects) used to enforce wakefulness during the day, when mice would 
spontaneously sleep.  
From the mPFC and M1, respectively, of each experimental group, the following 
microdialysis samples totals were collected; 286 and 290 from Group 1 (N = 7), 242 and 
251 from Group 2 (N = 6), and 249 and 252 from Group 3 (N = 6). Following collection, a 
10 µL injection of each sample was analyzed by an untargeted metabolomics method 
using UPLC-HRMS.  
2.4.1 Temporal Fluctuation of Identified Metabolites 
First, known metabolites were compared in a pairwise fashion between treatment 
groups using Δz-score of metabolite intensities as a proxy for relative metabolite 
concentrations (Figure 2.1). To visualize these data, heatmaps (Saldanha, 2004) were 
constructed that compared metabolite levels across each possible pair of experimental 
groups in mPFC and M1. This visualization, shown in Figure 2, conserves the temporal 
sampling provided by in vivo microdialysis while allowing for the interpretation of 
metabolic trends between treatment conditions. The saturated color scale ranges from 
±3, and the heatmaps were generated in R with the ggplot2 and colorspace packages. 
Metabolites have been organized into their respective metabolic pathways and changes 
in both brain regions have been aligned to assist in visual comparison of metabolic 
changes. Note that the heatmap is designed to help visualize the temporal patterns of 
metabolite levels but does not capture the statistical reliability of such patterns, which was 
done using LME models (see below). Metabolites identified as statistically significant by 
the LME models have been marked with an asterisk and bold text.  
2.4.2 Results of LME Analysis 
We applied 3 linear mixed effect models to each metabolite, one “between groups” 
model that compared the levels of the compound during the first 6 consecutive hours of 
either sleep, spontaneous wakefulness or enforced wakefulness (S6, SW6, EW6), and 
two “within group” models that compared the levels of each metabolite during 9 
consecutive hours (S6-EW3, EW6-S3). To be considered as state-dependent, a known 





Figure 2.1 Heatmap analysis of mPFC and M1 
Graphical representation of the Δ z-score metabolite levels between microdialysis samples collected from mPFC and M1 
during 6 hours of sleep (S6), sleep deprivation (SD6), and spontaneous wakefulness (W6), and 3 hours of post-sleep 
wakefulness (S6-W3), post-sleep deprivation sleep (SD6-S3), and post-wake wakefulness (W6-W3). Each cell represents 
1-hour coarse grained average ion intensity. Array comparisons are labeled above each panel, and a ±3 color legend is 
found on the right (S6 and S6-S3, blue; SD6 and SD6-S3, red; W6 and W6-W3, green).  To facilitate interpretation, 
metabolites have been organized by metabolic pathway (pathway names down the middle of respective heatmaps) and text 
was made bold, with an asterix (*) when identified as significant by LME analyses.
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criteria:  1) show a statistically significant change in at least one model (p < 0.05); 2) 
show biologically consistent changes, even if they did not reach significance, in the 
other models.  
Among the known metabolites (36 in mPFC and 33 in M1) 11 of them (11/36, 30%) 
were modulated by sleep and wakefulness according to the strict criteria discussed 
above, i.e. consistently across the 3 comparisons (Table 2.1): D-gluconate, glutamate, 
homovanillic acid, lactate, N-acetyl-beta-alanine, N-acetylglutamine, orotate, pyruvate, 
succinate/methylmalonate, tryptophan, and uridine. All analytes decreased throughout 
the sleep period relative to both wake conditions (Figure 2.2A and B). One analyte 
(homovanillc acid) had a significant condition by brain region interaction, showing state-
dependent changes primarily in mPFC. Several other metabolites, including 
homoserine/threonine, uracil, and valine, showed highly significant temporal effects in all 
3 behavioral states, with levels decreasing from hour 1 to hour 9. We assume this profile 
likely reflects some form of “depletion” during prolonged sampling and these analytes are 
not further discussed. 
2.4.3 Classification Analysis 
Next, we used partial least squares discriminant analyses (PLSDA) to determine 
whether global metabolic profiles during the first 6 hours of sleep, enforced wakefulness, 
and spontaneous wakefulness could be used to accurately distinguish between the 3 
behavioral states. PLSDA is a commonly used statistical approach in metabolomics 
because is properly suited for an uneven design matrix, in which the number of dependent 
variables (e.g. detected metabolites) is larger than the number of independent variables 
(e.g. number of samples). Indeed, we found that the metabolite profile from all 3 
experimental groups (S6, EW6, SW6) was sufficient to classify the state of arousal using 
data from both mPFC and M1., The PLSDA model perfectly classifies the mice into their 
respective experimental conditions, As shown in Figure 2.2A plotting the PLSDA score 
values of PLS Component 1 and PLS Component 2 demonstrates visible clustering and 
clear separation between the 3 experimental groups. Additionally, PLSDA identifies the 
metabolites that drive the separation among conditions by ascribing a variable importance 
of projection score (VIP). As the weighted sum of the squared correlations between  
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Table 2.1 Significant Metabolites for Regulation of Behavioral States  
Significance levels of the 11 known metabolites with consistent differences between 
behavioral states. The p-values generally reflect a behavioral state * time interaction, with 
the sleep conditions decreasing while the wake conditions remain constant (or increase). 
Pyruvate (S6-SW6-EW6), Orotate (S6-EW3) were the exceptions, where the reported p-
value represent a main effect of state (no time interaction). (*) p < 0.05, (**) p < 0.01, (***) 








D-Gluconate 0.0032 (**) 0.0007 (***) 0.1291 
Glutamate 0.0253 (*) 0.0965  0.0037 (**) 
Homovanillic acid 0.0051 (**) 0.0125 (*) 0.0000 (***) 
Lactate 0.0020 (**) 0.0386 (*) 0.0000 (***) 
N-acetyl-beta-alanine 0.0013 (**) 0.0264 (*) 0.0169 (*) 
N-acetyl-glutamine 0.0894 0.0336 (*) 0.0554 
Orotate 0.1067 0.0006 (***) 0.0057 (**) 
Pyruvate 0.8409 0.0012 (**) 0.0040 (**) 
Succinate/Methylmalonate 0.0000 (***) 0.2814 0.3415 
Tryptophan 0.4869 0.0000 (***) 0.4829 




Figure 2.2 Observation of z-score fluctuation in LME significant metabolites 
Line graphs represent the absolute z-score values across the 3 treatment conditions; S6-
W3, SD6-S3, and W6-W3, for the 11-significant metabolite, as determined by LME 
analysis. Middle line represents the mean z-score, and outside fill section refer to the 
standard deviation. Data from both (A) mPFC and (B) M1 brain regions. States of 
consciousness are color coded to show states of sleep (S/RS) as blue, spontaneous wake 
(SW) as green, and extended wake (EW) as red. S6-W3; blue, first six hours and red, 
final three hours. SD-S3; red, first 6 hours and blue, final three hours. W6-W3; green, first 





































































































PLSDA components and the original variables, these values represent the percentage of 
variation explained by the component in the model. Generally, a VIP greater than 1.0 is 
considered most significant (i.e., metabolites with VIP > 1 strongly contribute to the 
observed differences among groups). The 15 metabolites with the highest VIP scores are 
listed in Figure 2.3B (mPFC) and 2.3C (M1). 
With so many explanatory variables and a relatively small number of mice, 
overfitting the PLSDA model was a concern. To better understand how the results will 
generalize, a K-fold stratified cross-validation procedure was used to estimate the 
accuracy of the classifier and statistical significance was assessed using non-parametric 
permutations tests. The cross-validation analysis resulted in an estimated accuracy of 
76.4%, which was significantly greater than chance (p < 0.05). We then explored 
alternative classification models to see if we could improve on the accuracy of PLSDA. 
The best accuracy was achieved using a logistic regression classifier with an ℓ2 
regularization penalty with sparsity parameter C = 0.001 (smaller values of C restrict the 
model and promote more sparsity). For this classifier the cross-validation procedure 
resulted in an estimated accuracy of 83%, which was significantly greater than chance (p 
< 0.001). Further exploring the ability for this classifier to pair-wise discriminate between 
conditions, we found that the sleep condition was distinguished from the two wake 
conditions with greater accuracy (S vs. SW accuracy 91.8%, p < 0.01; S vs. EW accuracy 
100%, p < 0.01) than the two wake conditions could be distinguished from each other 
(SW vs. EW accuracy 82.1%, p = 0.003). This is consistent with the visualization of the 
PLSDA model (Figure 2.3A), in which the clusters corresponding to the 2 wake conditions 




Figure 2.3 PLSDA accurately classifies states of arousal and associated VIP 
classification model ascribes significant features 
By combining the mPFC and M1 analyses, data from S6, SD6, and W6 were used in the 
PLSDA to determine the overall variation between treatment conditions. (A) The PLSDA 
plot shows significant separation of SD6 from S6 and W6 in Component 1, and additional 
separation of S6 from W6 and SD6 in Component 2. Ellipses represent a confidence 
interval of 95%. VIP score plots were generated from PLSDA calculation, where a value 
greater than 1.0 is considered most significant for the observed separation. In the mPFC 
(B) and M1 (C), the top-15 metabolites are highlighted as potential points of difference. 
An asterisk (*), and bold text represents metabolites that were significant based on linear 

















Figure 2.3B Continued 













Many previous microdialysis studies measured neurotransmitters, neuropeptides 
and metabolites in the rodent brain across the sleep/wake cycle. In some experiments 
the high temporal resolution of biosensors was used to detect rapid changes in cortical 
levels of glutamate, lactate and glucose during wake, NREM sleep and REM sleep (Dash 
et al., 2013; Dash et al., 2009; Dash et al., 2012; Naylor et al., 2012; Wisor et al., 2013). 
In these reports, however, one or at most a few analytes were measured (Lena et al., 
2005; Watson et al., 2011). A recent study did apply liquid chromatography and online 
mass spectrometry to the mouse prefrontal cortex to test a metabolomics platform of 
almost 300 metabolites, of which approximately 120 were identified in the extracellular 
fluid (Kao et al., 2015), but sleep/waking changes were not studied. Thus, to our 
knowledge, this is the first study providing a broader view of metabolome changes in the 
cortical extracellular space across the sleep/waking cycle and after sleep deprivation.  
We reliably (in at least 50% of mice) detected 33 metabolites in M1 and 36 in 
mPFC. According to the LME model analysis, 11 of these metabolites were present at 
significantly higher levels after wake, in most cases after both spontaneous and forced 
wake and in both cortical regions, while no metabolite was detected at higher levels after 
sleep. A similar trend was present among the 14 differentially regulated unidentified 
spectral features, with 12 upregulated in wake and 2 in sleep. This “imbalance” between 
waking-related and sleep-related compounds is not new. Among the hundreds of 
transcripts modulated by sleep and wake in neurons, astrocytes, and oligodendrocytes of 
rat and mouse cortex, the majority were “wake” transcripts whose expression was higher 
in both spontaneous and forced wake than in sleep (Bellesi et al., 2015; Cirelli et al., 
2004), reflecting either increased transcription and/or decreased degradation of mRNAs 
during waking. In the current study, higher wake levels of analytes could reflect increased 
synthesis, decreased utilization, and/or decreased elimination by the glymphatic system 
that drives exchange of interstitial fluid with cerebrospinal fluid (Iliff et al., 2012; Xie et al., 
2013). Wake-related metabolites reflect different signaling pathways and cellular 
processes and most, but not all, of them were already known to be differentially expressed 
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across behavioral states. Below we first discuss each metabolite, and then summarize 
our results in light of other metabolic studies in peripheral tissues. 
Glutamate is the primary excitatory neurotransmitter released into the 
extrasynaptic space. The extracellular concentrations of glutamate are positively 
correlated to the regulation of sleep-wake states (Dash et al., 2009). The glutamate-
glutamine cycle is primary cellular nitrogen metabolism where glutamate is converted to 
glutamine in the astrocytes, then released into the extracellular matrix for re-uptake into 
a neuron and conversion back to glutamate or to GABA. Additionally, the glutamate-
leucine cycle is essential for the formation of glutamate in the cell because leucine can 
pass the blood brain barrier followed by conversion to glutamate in the astrocyte. In 
combination, these two metabolic cycles are essential for the formation of glutamate and 
proper function of the cell. Our study correlates positively to the research of Dash et al., 
2009 where they found that glutamate levels were increased during periods of wake and 
sleep deprivation. In the SD6-S3 mice, glutamate levels spike as sleep pressure 
increases, then return to normal levels as the subjects move to recovery sleep. A similar 
pattern exists across both brain regions. 
Two other energy metabolites were upregulated in wake relative to sleep, pyruvate 
and lactate, consistent with previous studies in rats and mice (Dash et al., 2012; Naylor 
et al., 2012; Reich et al., 1972; Shram et al., 2002). Lactate is mainly derived from glucose 
and glycogen via aerobic glycolysis inside neurons (Lundgaard et al., 2015) and 
astrocytes (Belanger et al., 2011), although astrocytes can also produce lactate from the 
metabolism of glutamate via the Krebs cycle (McKenna, 2012). The sleep-related drop in 
lactate levels, which depends on the activity of the glymphatic system (Lundgaard et al., 
2015), is correlated with changes in SWA, a marker of sleep pressure (Dash et al., 2012). 
These findings suggest that the regulation of sleep need is linked to glycolytic processes 
(Wigren et al., 2009) and astrocytic functions (Haydon, 2017; Magistretti, 2009, 2011), 
but the underlying mechanisms remain unclear. The oxygen to glucose ratio in the brain 
is 5.1-5.4:1, below what would be expected from the full oxidation of glucose (6 mol of 
oxygen are needed to fully oxidize 1 mol of glucose). This ratio further declines with 
neuronal activation (Dienel and Cruz, 2016), indicating that the awake brain relies more 
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on glycolytic processes than the sleeping brain (Dienel and Cruz, 2016; DiNuzzo and 
Nedergaard, 2017). From a purely energetic point of view this seems paradoxical, since 
aerobic glycolysis produces far fewer ATP molecules than oxidative phosphorylation. 
However, aerobic glycolysis is stimulated in conditions of synaptic growth, is blocked by 
inhibition of the noradrenergic system (Dienel and Cruz, 2016), and lactate released from 
astrocytes excites locus coeruleus neurons and increases NA release (Tang et al., 2014). 
Lactate may also serve as a volume transmitter and the G protein coupled lactate receptor 
GPR81 is concentrated in the synaptic membranes of excitatory synapses (Lauritzen et 
al., 2014). Thus, lactate upregulation during wake may reflect more the need for synaptic 
growth and potentiation than increased energy demand. The latter could be met via 
increases in oxidative phosphorylation, and indeed mitochondrial enzymes of the 
respiratory chain are upregulated during waking (Nikonova et al., 2010).  
The gluconate shunt is a less known metabolic pathway that can facilitate the 
breakdown of glucose. It has been studied mainly in plants and microorganisms but key 
enzymes of the shunt, glucose dehydrogenase and gluconate kinase, have been 
identified in mammals (Rohatgi et al., 2014). In this pathway glucose is oxidized by 
glucose dehydrogenase to gluconic acid (or gluconate). Gluconate is then phosphorylated 
by gluconate kinase to produce 6-phosphogluconate, the second intermediate of the 
pentose phosphate pathway, thus bypassing the first rate-limiting step of this pathway 
(Corkins et al., 2017). The main function of the pentose phosphate shunt is anabolic rather 
than catabolic, producing pentose sugars for the synthesis of nucleic acids and amino 
acids. Thus, like lactate, increased gluconate levels during wake may signal the need for 
growth, rather than energy.  
From the pyrimidine pathway, two metabolites were identified as significant. 
Orotate (orotic acid) is an essential intermediate in the de novo pyrimidine pathway that 
provides critical components for the synthesis of DNA, RNA, sugars, glycogen as well as 
phosphatidylcholine and phosphatidylethanolamine, the major phospholipids of the 
cellular membranes (Gerlach et al., 2011; Loffler et al., 2015). Orotate is the product of 
dihydroorotate dehydrogenase, the only enzyme in the pathway directly connected to the 
respiratory chain via its localization to the inner mitochondrial membrane. All genes 
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responsible for the synthesis of pyrimidines are expressed at high levels in cortex and 
other brain regions (Gerlach et al., 2011), suggesting that the brain’s need for pyrimidines 
may be met not only by the uptake of uridine from the blood, as previously believed, but 
also by in situ production. Like lactate and gluconate increased orotate levels during wake 
may signal the need for the synthesis of many essential components, from nucleic acids 
to cellular membranes. Uridine is a pyrimidine-analogue that is one of the five standard 
nucleosides but is only found in ribonucleic acid (RNA). This metabolite is actively 
produced as uridine monophosphate through a de novo synthesis involving the 
decarboxylation of orotidine monophosphate (the primary metabolite of orotate). These 
two metabolites are directly linked in pyrimidine metabolism and exhibit a positive 
correlation from our results, where the highest concentration is found in extended wake 
following natural wake (i.e. W6-W3). 
Two other metabolites upregulated during waking, homovanillic acid (HVA) and 
tryptophan, reflect the activity of two well-known groups of wake-active neurons. HVA is 
one of the major dopamine (DA) metabolites and a valid indicator of DA turnover. DA 
extracellular levels in the mPFC are increased by novelty and higher during waking than 
during sleep (Feenstra et al., 2000; Lena et al., 2005), consistent with the fact that DA 
neurons in the ventral tegmental area, which project to mPFC, are more active during 
wake than during sleep and promote arousal (Eban-Rothschild et al., 2016; Taylor et al., 
2016). Tryptophan is an essential amino acid and the precursor of the neurotransmitter 
serotonin. Like DA neurons in the VTA, serotonin neurons in the dorsal raphe are more 
active during waking than during sleep and extracellular levels of serotonin are higher in 
waking than in sleep in different brain regions, including prefrontal cortex (Ursin, 2002).  
N-acetylglutamine (NAg), commonly referred to as Aceglutamide, is an acetylated 
analogue of glutamine. Sold under the brand name Neuroamina, this compound is 
currently an experimental pharmaceutical used as a psychostimulant and nootropic (class 
of compounds that reportedly improve cognitive function by modulating neurotransmitter 
activity) to improve memory and concentration (Ganellin and Triggle, 1996). Information 
on this compound are challenging to find currently, as research is actively being 
conducted on this compound. In parallel with our results, we see a large increase of NAg 
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across both wake models, and no decrease during recovery sleep. This interpretation 
makes NAg an interesting compound for further analysis as this may play a significant 
role in cognitive awareness during wake. 
N-acetyl-beta-alanine is an endogenous β amino acid that can be converted to 
acetate and β alanine by N-acetyl-β alanine dehydrogenase (Fujimoto et al 1968; 
Chesnoy-Marchais, 2016). In the brain, however, the best characterized pathway leading 
to β-alanine synthesis is the deamination and carboxylation of the pyrimidine uracil 
(Hayaishi et al., 1961; Tiedje et al., 2010), while very little is known about N-acetyl-β 
alanine dehydrogenase. β-alanine is a molecular intermediary of GABA and glycine with 
a very similar mechanism of action, and is considered an inhibitor neurotransmitter (Juge 
et al., 2013). Thus, the upregulation of N-acetyl-beta-alanine during waking is difficult to 
interpret, and it is not clear whether it linked to changes in β-alanine.   
The metabolomics field can establish tremendous insights from the known 
compounds using untargeted techniques, but the investigation of the unexplored space 
of unidentified spectral features offers a unique opportunity. Although annotation of these 
features presents challenges, as the field progresses, the information gained from these 
early untargeted studies could lead to the discovery of major influence from novel 
pathways and metabolites. The unidentified spectral features highlighted in this 
manuscript revealed similar trends to the known metabolites, meaning they had an 
elevated concentration in states of wake when compared to sleep. These trends reveal 
that an unexplored space of metabolomics could lead to new information about various 
states of consciousness. 
2.5.1 Comparisons with Previous Metabolomics Studies 
One study applied both liquid and gas chromatography coupled with mass 
spectrometry to mouse cortical homogenates and identified 226 compounds, of which 20 
changed in mice sleep deprived for 6 hours relative to controls allowed to sleep, mostly 
belonging to the glycolytic pathways (SD increase in alanine and lactate) and to lipid 
metabolism (SD increase in lysolipids due to breakdown of membrane phospholipids) 
(Hinard et al., 2012).  
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In humans, metabolomics analysis of plasma found that the majority of the 
identified compounds (109/171) showed time of day variations, but only 27 of them were 
affected by 24 hours of sleep deprivation. These included tryptophan, serotonin, taurine, 
8 acylcarnitines, 13 glycerophospholipids, and 3 sphingolipids, all of which increased after 
24 hours of sleep deprivation (Davies et al., 2014). In the same subjects, metabolomic 
analysis of urine samples found that out of 32 identified metabolites, 7 (22%) changed 
due to time of day, and 16 due to sleep deprivation, with 8 increasing and 8 decreasing 
due to sleep loss (Giskeodegard et al., 2015).  
Another study used serum from sleep restricted rats from 2 independent 
experiments (5 days; 20h/day): 3,380 unique metabolic species were measured, 407 
identified, and 38 of them changed due to acute (1 day) sleep restriction; of them, 28 were 
identified and were mainly (18/28) lipids, especially phospholipids (Weljie et al., 2015). 
Among the non-lipid metabolites, isocitrate (Krebs/lipogenesis), urocanic acid (histidine 
catabolism) and oxalic acid (glycolate metabolism) were reduced, while valine, leucine, 
N-methyl-alanine were increased. After chronic (5 days) sleep restriction, 18 known 
metabolites changed, including 15 lipids, as well as glycine (decreased) and sucrose and 
malate (increased). Of note, the number of metabolites consistently affected in the 2 
experiments was only ~10% of all analytes found to be changing in each separate 
experiment, stressing the importance of using multiple experimental groups to identify 
biologically significant differences, as we did here by comparing 3 independent groups of 
animals. 
In a parallel study of 5 days of sleep restriction in humans, 92 metabolites were 
identified as potentially significant, 32 of which as lipids or fatty acid related compounds; 
tryptophan and phenylalanine increased, and oxalic acid decreased with sleep loss; 






The completion of this study marks the first global metabolomics experiment from 
a temporal analysis of two brain regions simultaneously comparing the sleep/wake cycle 
to sleep deprivation. We have conclusively shown that many metabolites can be detected 
from a limited sample volume, confirming that a temporal resolution of 15-minutes using 
microdialysis coupled with LC-MS untargeted metabolomics is achievable. In this study, 
the issue of missing data points was exemplified due to small sample volume and 
metabolite concentrations. We have provided a standard protocol for the statistical 
handling of temporal data from microdialysis samples that should be utilized in future 
analyses. 
 The results of this study conclude that sleep deprivation perpetuates a demanding 
strain on the neuronal cellular metabolism. We have provided a list of 11 small molecules 
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In the spring of 2014, I was presented with an opportunity to collaborate with the 
Lӧffler group to elucidate the structure of a novel, biosynthesized cobamide. Dr. Lӧffler 
was a pioneer in the study of reductive dehalogenase microbial cultures, where he 
assisted in the discovery of the first identified species, Dehalococcoides mccartyi. This 
genus has the rare ability to use chlorine for respiration, where they frequently start with 
perchloroethene and reduce this compound to ethene. Given this unique feature, a 
combination of these species are now commonly used at bioremediation sites to remove 
toxic levels of these chlorinated compounds. 
Relative to this study, another unique feature of this genus is that they can 
biosynthetically produce corrinoids, which are prosthetic groups for the enzymatically-
controlled reductive dechlorination. Prior to our study, 16 known cobamides had been 
identified as naturally occurring compounds. The most commonly known cobamide is 
vitamin B12, with all of these structures having an identical corrinoid ring; containing a 
corrin cyclic system coordinated to cobalt, an alpha-ribazole phosphate moiety, and 
accompanied lower base. The structure of the lower is base is commonly the unique 
component of the naturally-occurring cobamide compounds. 
Following the discovery of a novel cobamide compound by the Lӧffler group, I was 
presented with the challenge of confirming the complete structure and identifying the 
connectivity of the lower base. To accomplish the novel structure elucidation, I used high-
resolution mass spectrometry, isotope-labeling mass spectrometry, and nuclear magnetic 
resonance spectroscopy. 
The successful completion of this project marks the discovery of the 17th naturally-
occurring cobamide; the purinyl-cobamide was only the second compound discovered in 
biology to contain unsubstituted purine. This compound was confirmed as a prosthetic 
group for reductive dechlorination and could ultimately have additional biological function. 
Personally, this project has additional meaning for research goals. By completing this 
project, I have proven my skillset in the field of structure elucidation and provided a 
technical set of tools for further analysis of novel cobamides, or other biological 
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compounds. When given a sufficient quantity of purified sample, and the correct set of 
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Cobamides such as vitamin B12 are structurally conserved, cobalt-containing 
tetrapyrrole biomolecules that have essential biochemical functions in all domains of life. 
In organohalide respiration, a vital biological process for the global cycling of natural and 
anthropogenic organohalogens, cobamides are the requisite prosthetic groups for 
carbon–halogen bond-cleaving reductive dehalogenases. This study reports the 
biosynthesis of a new cobamide with unsubstituted purine as the lower base and assigns 
unsubstituted purine a biological function by demonstrating that Coα-purinyl-cobamide 
(purinyl-Cba) is the native prosthetic group in catalytically active tetrachloroethene 
reductive dehalogenases of Desulfitobacterium hafniense. Cobamides featuring different 
lower bases are not functionally equivalent, and purinyl-Cba elicits different physiological 
responses in corrinoid-auxotrophic, organohalide-respiring bacteria. Given that 
cobamide-dependent enzymes catalyze key steps in essential metabolic pathways, the 
discovery of a novel cobamide structure and the realization that lower bases can 
effectively modulate enzyme activities generate opportunities to manipulate 






Corrinoids are the most complicated organometallic cofactors used in biology to 
catalyze essential biochemical reactions including methyl group transfer, carbon skeleton 
rearrangement and reductive dehalogenation1. Complete corrinoids (i.e., cobamides) 
consist of an upper Coβ ligand, a central cobalt-containing corrin ring, and a lower Coα 
base as part of the nucleotide loop that is connected to the corrin ring2. For example, 
vitamin B12 (cyanocobalamin) carries the artificial cyano group as an upper Coβ ligand 
and 5,6-dimethylbenzimidazole (DMB) as the lower base (Figure 3.1). Variations in 
cobamide (Cba) structure exist in the upper ligand, the lower base, and, in one 
documented case, the side chain in the nucleotide loop3. Physiologically functional 
cobamides use a methyl group or a 5′-deoxyadenosyl moiety as the upper ligand and one 
of 16 known lower bases connected to the nucleotide loop2 (Fig. 1). Reductive 
dehalogenation reactions can be mediated abiotically by vitamin B12 and its analogs in 
the presence of a strong reductant capable of generating the cobalt(I) supernucleophile4 
or can be catalyzed by corrinoid-dependent reductive dehalogenases (RDases)5. In either 
case, the cobalt(I) supernucleophile is critical for the initiation of carbon–halogen bond 
cleavage6. 
Recently resolved RDase crystal structures of NpRdhA (PDB ID 4RAS) from 
Nitratireductor pacificus and PceA (PDB ID 4UR0) from Sulfurospirillum multivorans 
demonstrate that their prosthetic groups coenzyme B12 and norpseudo-B12, respectively, 
are in the base-off configurations, indicating that their respective lower bases, DMB and 
adenine, are uncoordinated and distant from the redoxactive cobalt atom7,8. Therefore, 
the lower base is not assigned a direct role in catalysis or electron transfer for restoring 
the reactive cobalt(I) state. Contrary to expectations, lower-base structure does impact 
reductive dechlorination rates and growth of obligate organohalide-respiring, corrinoid-
auxotrophic Dehalococcoides mccartyi (Dhc) strains9,10. Maximum reductive 
dichlorination activity and Dhc growth require the addition of cobamides carrying DMB or 
5-methylbenzimidazole (5-MeBza) as the lower base, and cobamides with other lower-
base structures compromise growth (e.g., 5-methoxybenzimidazole, 5-OMeBza; 
benzimidazole, Bza) or cause complete loss of reductive dechlorination activity (e.g., 5-
 
180 
hydroxybenzimidazole, 5-OHBza; adenine)10,11. The lower base structure also affects 
substrate utilization in the homoacetogen Sporomusa ovata, which uses phenolic 
cobamide-dependent methyltransferases for energy conservation and carbon 
assimilation using the Wood–Ljungdahl pathway12. The addition of 5-Me- Bza or DMB to 
the medium results in the formation of non-native 5-methylbenzimidazolyl-cobamide (5-
MeBza-Cba) or cobalamin, respectively, severely inhibiting growth with methanol or 3,4-
dimethoxybenzoate as substrates12. These findings indicate that the lower bases can 
affect enzyme activity and cause substantial consequences to the host organisms; 
however, the mechanistic understanding is lacking. To date, 16 naturally occurring lower 
bases have been identified, mostly from anaerobic bacteria, with the most recent 
structure, phenol in phenolyl-cobamide of Sporomusa ovata (Figure 3.1), discovered in 
198913.  
Members of the genus Desulfitobacterium (Dsf) are strictly anaerobic, 
metabolically versatile, Gram-positive bacteria common in subsurface environments, 
where they contribute to the reductive dehalogenation of organohalogens, including 
groundwater contaminants such as chlorinated solvents14,15. The tetrachloroethene 
(PCE) RDases have a strict requirement for cobamide as a prosthetic group, and 
generate predominantly cis-1,2-dichloroethene (cDCE) and inorganic chloride as 
products16. The characterized PCE-dehalogenating Dsf pure cultures grow in defined 
medium without exogenous corrinoids, indicating that these Dsf strains are capable of de 
novo corrinoid biosynthesis17. Genome sequence analysis corroborates that Dsf strains 
possess the complete set of genes required for cobinamide biosynthesis and lower base 
activation and attachment, but the identity of the lower base of native Dsf cobamide(s) 
remains elusive18. 
Here we report the discovery and characterization of purinyl-Cba (1) as the native 
cobamide produced in axenic PCE-dechlorinating Dsf cultures and demonstrate its 
distinct functionality in different corrinoid-auxotrophic organohalide-respiring bacteria. 






Figure 3.1 Cobamide general structure and the 16 known lower bases found in 
naturally occurring cobamides 
Variations in cobamide structures are found in the Coβ upper ligand, the side chain at 
position C176, and Coα lower base. 5-OHBza, 5-hydroxybenzimidazole; 5-OMeBza, 5-
methoxybenzimidazole; 5-OMe-6-MeBza, 5-methoxy-6-methylbenzimidazole; DMB, 5,6-
dimethylbenzimidazole; Bza, benzimidazole; 5-MeBza, 5-methylbenzimidazole; 2-
MeAde, 2-methyladenine; 2-SMeAde, 2-methylmercaptoadenine; 2-SOMeAde,2-




electrophoretic separation, illustrating an innovative approach for rapid characterization 
of corrinoid prosthetic groups. The results obtained expand the diversity of naturally 
occurring cobamide structures and assign a biological function to unsubstituted purine. 
 
3.3 RESULTS 
3.3.1 Discovery and structure of a novel cobamide 
HPLC analysis of the cyanated form (for example, a cyano group as the upper β 
ligand) of corrinoid extracts from PCE-grown Dsf pure cultures (i.e., Dsf strains Y51, JH1, 
Viet1 and PCE1) revealed the presence of three candidate corrinoids with retention times 
of 11.79 min (1), 15.74 min (2) and 15.95 min (3) (Figure 3.2A and 3.3A). Integrated peak 
areas at 361 nm of the total fractions eluting between 10 and 18 min (i.e., the range of 
retention times for seven Cba standards, 4–10; Figure 3.2A) showed that the 
predominant corrinoid produced in the Dsf cultures was associated with the 11.79 min 
fraction. This retention time was different from that of cobinamide (Cbi; which eluted at 
8.77 min as monocyano-Cbi and 15.63 min as dicyano-Cbi19; Figure 3.3B) and any of 
the cobamide standards, indicating that the Dsf strains produced a distinct corrinoid. The 
UV-visible (Vis) spectrum of the predominant D. hafniense strain Y51 corrinoid (1) 
substantially overlapped with that of vitamin B12 (10), including the 361 nm absorption 
maximum, but was distinct from the Cbi spectrum with a 355 nm absorption maximum 
(Figure 3.2B). Two minor fractions that eluted after the predominant Dsf corrinoid showed 
absorption spectra and retention times (15.74 and 15.95 min) similar to those of Cbi, 
suggesting that these minor fractions may represent Cbi precursors (Figure 3.4). 
Mass spectra of the D. hafniense strain Y51 corrinoid and of vitamin B12 standard 
obtained using LC–MS displayed strong base peaks with m/z values of 1,329.54 and 
1,355.58, respectively, corresponding to intact corrinoid ions [M+H]+ (Figure 3.5A, B). 
The base peaks with m/z values of 1,351.52 and 1,377.56 represented the [M+Na]+ ion 
form of the strain Y51 corrinoid and vitamin B12, respectively. The mass spectra of the 
predominant corrinoids from Dsf strains JH1, Viet1 and PCE1 matched that of D. 
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hafniense strain Y51, showing base peaks with m/z values of 1,329.54 and 1,351.52 
corresponding to their [M+H]+ and [M+Na]+ ion forms, respectively (Figure 3.5C–E). As 
the molecular mass of the α-ribazole-5′-phosphate (α-RP) moiety in natural cobamides 
ranges from 306.2 (with phenol as the lower base) to 425.31 Da (with 2-
methylsulfonyladenine as the lower base), a mass difference of 312.42 Da between the 
measured molecular mass of the Dsf corrinoid and the calculated molecular mass of Cbi 
(1,016.12 Da in the monocyano form) indicated that the predominant Dsf corrinoid was a 
cobamide carrying an α-RP moiety with a yet-unidentified lower base. Comparison to the 
calculated masses of naturally occurring cobamides in their cyanated form suggested that 
the organohalide-respiring Dsf strains produce a unique cobamide that is distinct from 
any currently known natural cobamide. Based on mass information, a possible molecular 
formula for the Dsf cobamide was deduced as C59H82CoN16O14P. 
In the nor-type corrinoid produced by Sulfurospirillum multivorans, C176 of the side 
chain is demethylated3 (Figure 3.1). To test whether demethylation or any other 
modification exists in the cobinamide structure of this novel Dsf cobamide, we grew D. 
hafniense strain Y51 cultures with PCE as an electron acceptor in the presence of 25 μM 
DMB. The addition of DMB was shown to trigger the synthesis of a non-native 
cobamide12,20. This guided cobamide biosynthesis approach with strain Y51 resulted in 
the formation of cobalamin, as determined by HPLC retention time, UV-Vis spectrum 
(Figure 3.2C, D), and mass spectral features with two strong peaks having m/z values of 
1,355.58 ([M+H]+) and 1,377.56 ([M+Na]+) (Figure 3.5F). Similarly, we detected Bza-Cba 
(5) exclusively in strain Y51 cultures that received Bza (Figure 3.6). Guided cobamide 
biosynthesis does not change the assembly of the cobinic acid skeleton as prior studies 
have suggested20,21. Thus, similar PCE-to-cDCE dechlorination performance in strain 
Y51 cultures producing the Dsf native cobamide, cobalamin, or Bza-Cba indicated that 
the different prosthetic groups supported functionality of the Dsf PceA RDase. 
Collectively, these findings confirmed that the new cobamide natively synthesized in Dsf 
strains did not possess any unusual modifications. Based on this information, the 




Figure 3.2 Spectrophotometric and structural features of Desulfitobacterium native 
corrinoids 
(A) HPLC chromatograms of the native corrinoids produced by D. hafniense strain Y51 
eluted at 11.79 min (1), 15.74 min (2), and 15.94 min (3). The predominant corrinoid peak 
at 11.79 min accounted for 86% of the total corrinoids produced by strain Y51 based on 
361 nm peak area integration. Cobamide standards (5 mg/L each) were norpseudo 
vitamin B12 (4), 11.23 min; Bza-Cba (5), 13.34 min; 5-OMeBza-Cba (6), 13.88 min; p-
cresol-Cba (7), 17.23 min and 17.64 min; 5-OHBza-Cba (8), 13.13 min; 5-MeBza-Cba 
(9), 13.89 min; vitamin B12 (10), 15.02 min. mAU, milli-absorbance units. (B) UV-Vis 
spectra (250–600 nm) of cobinamide (cbi), vitamin B12 and the 11.79-min native Dsf 
corrinoid. (C) HPLC chromatogram and (D) UV-Vis spectrum of the non-native cobamide 
produced in strain Y51 cultures with 25 μM DMB amendment. Dotted lines in B and D 
indicate the maximum absorbance wavelengths (λmax) of a cobinamide or a cobamide, 
respectively. (E) Mass spectra of 15N-labeled and unlabeled native Dsf corrinoid. Mass 
shifts in [M+H]+ and [M+Na]+ values (as shown by red arrows) confirmed that the Dsf 
cobamide contains four N atoms in the lower base structure. (F) The superimposed 1H 
NMR spectra of the Dsf corrinoid (black line) and the vitamin B12 standard (blue line). The 
letters A, B and C in red correlate the protons on the structure to the corresponding 1H 










































































Figure 3.3 The native corrinoids produced by several PCE-dechlorinating 
Desulfitobacterium (Dsf) strains 
(A) HPLC chromatograms of the corrinoids extracted from axenic cultures of Dsf 
hafniense strain JH1, Dsf sp. strain Viet1, and Dsf sp. strain PCE1.  
(B) The HPLC chromatogram of a cobinamide standard (5 mg/L), which was separated 








































Figure 3.4 UV-Vis of novel cobamides 
The UV-Vis spectra (250-600 nm) of the two compounds that eluted after 15.74 min and 
15.94 min showed absorption peaks at 355 nm, distinct from complete cobamides in the 




Figure 3.5 The mass spectra of cobamides produced by different Dsf strains and 
authentic vitamin B12 
(A) The mass spectrum of the predominant Dsf native corrinoid produced by Dsf 
hafniense strain Y51. (B) The mass spectrum of authentic vitamin B12. The mass spectra 
of the predominant corrinoid produced by (C) Dsf hafniense strain JH1, (D) Dsf sp. strain 
Viet1, and (E) Dsf sp. strain PCE1. (F) The mass spectrum of the non-native cobamide 
















































































Figure 3.6 Guided cobamide biosynthesis by Dsf hafniense strain Y51 
(A) HPLC chromatograms of a benzimidazolyl-cobamide (Bza-Cba) standard (5 mg/L) 
and the non-native cobamide formed in strain Y51 cultures amended with 25 μM 
benzimidazole (Bza). (B) UV-Vis spectra (250-600 nm) of the Bza-Cba standard and the 







120.15 (1,329.54 ([M+H]+ of cyanated Dsf cobamide) – [1,355.58 ([M+H]+ of 
cyanocobalamin) – 146.19 (DMB)]), which is suggestive of unsubstituted purine. 
3.3.2 Confirmation of the novel lower base structure 
The cobinic acid skeleton in the cyanated form carries a constant number of 12 
nitrogen atoms. Depending on the lower base, naturally occurring cobamides possess 12 
to 17 nitrogen atoms. Thus, the number of nitrogen atoms distinguishes a cobamide with 
an unsubstituted purine as the lower base (12 + 4 = 16 nitrogen atoms) from cobamides 
that carry nucleobases (for example, adenine or guanine; 12 + 5 = 17 nitrogen atoms), 
Bza (12 + 2 = 14 nitrogen atoms) or phenol derivatives (12 + 0 = 12 nitrogen atoms). 
Based on these structural characteristics, we conducted 15N isotope-labeling experiments 
with D. hafniense strain Y51 to determine the number of nitrogen atoms in the unknown 
lower base structure. The m/z values for the base peaks of the [M+H]+ and [M+Na]+ ion 
forms of the 15N-labeled cobamide shifted from 1,329.54 to 1,344.48 and 1,351.52 to 
1,366.46, respectively, corresponding to a 14.94 Da mass increase (Figure 3.2E). Based 
on this mass shift, we calculated that the total number of nitrogen atoms in the native Dsf 
cobamide is 16 (15 plus one unlabeled nitrogen in the upper CN ligand), indicating that 
the lower base contains 4 nitrogen atoms (i.e., 16–12). Hypoxanthine, a purine derivative 
with 4 N atoms, is the lower base of a native cobamide in Desulfovibrio vulgaris22; 
however, hypoxanthine-Cba in its cyanated form has a calculated molecular mass of 
1,345.29, which is different from the measured [M+H]+ m/z value of 1,329.54 for the Dsf 
cobamide. Collectively, 15N isotope labeling followed by MS analysis provided additional 
evidence that unsubstituted purine served as the lower base in the native Dsf cobamide. 
To confirm unsubstituted purine as a new naturally occurring lower base, we 
conducted 1D and 2D NMR spectroscopy experiments using the native Dsf cobamide. 
The superimposed 1H NMR spectra (Figure 3.2F) of authentic vitamin B12 (10) and the 
purified native Dsf cobamide (1) revealed that the only notable changes (i.e., chemical 
shifts) occurred in the aromatic region (9.0–6.0 ppm.), which was primarily associated 
with the DMB portion of vitamin B12. Homonuclear correlation spectroscopy (COSY) 
experiments with the Dsf cobamide and vitamin B12 (Figure 3.7) revealed spin–spin 
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coupling between neighboring protons, but the spectra differed in the aromatic region. 
The lower base aromatic protons in the Dsf cobamide lacked a correlation with other 
protons in the molecule, suggesting that the aromatic moiety does not have any adjacent 
protons. Hydrogen atoms A, B, and C in Figure 3.2F directly correlate with the three 
hydrogen atoms of purine. In comparison, the vitamin B12 COSY spectrum demonstrated 
direct correlations between the benzyl protons (7.3 and 6.5 ppm) and the adjacent methyl 
group (2.2 ppm) of the DMB moiety. These experiments support the assignment of 
unsubstituted purine as the lower base of native Dsf cobamide. Purine-containing 
compounds can exist as four regioisomers through covalent bonding at each of the N 
heteroatoms, but the limited amount of purinyl-Cba extractable from Dsf cultures did not 
allow stereoisomer confirmation by 13C and/or 15N NMR spectroscopic analyses. Prior 
research has shown that the 9H and 7H purine tautomers of purine are favored over 3H 
and 1H purine because of increased aromaticity (tautomer stability: 9H > 7H > 3H > 1H)23. 
Based on these observations and on precedence for purines to form bonds with an 
imidazole nitrogen24, the N-glycosidic bond was inferred to be analogous to that observed 
in other biomolecules. This combined suite of analytical techniques offers a practical 
approach for lower base characterization and can aid in the discovery of new corrinoids. 
3.3.3 Purinyl-Cba is the prosthetic group of Dsf PceA RDases 
Mature Dsf PceA RDases are in the 50–60 kDa mass range14,16, but maximum 
reductive dechlorination activity is generally associated with bands excised from blue 
native PAGE (BN–PAGE) gels in the 242–480 kDa region, presumably because of 
complexation with other proteins25. Following the nondenaturing separation of D. 
hafniense strain JH1 crude extracts (Figure 3.8), the highest dechlorination activity was 
found to be associated with gel slice #4, whereas the other five gel slices exhibited no 
detectable or negligible (<8%) cDCE production from TCE (Figure 3.9A). Subsequent in-
gel extraction recovered corrinoid from gel slice #4, but not from slices #3 and #5, and 
ultra-performance liquid chromatography-high resolution mass spectrometry (UPLC–
HRMS) revealed that the corrinoid associated with gel slice #4 and the purinyl-Cba 
standard (Figure 3.9B, C) had matching retention times and m/z values. The proteomic 
analysis of gel slices #3, #4, and #5 demonstrated that the Dsf PceA RDase  
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Figure 3.7 Results from homonuclear correlation spectroscopy (COSY) 
experiments 
Gradient-selected COSY nuclear magnetic resonance spectra of (A) the Dsf corrinoid 
(0.7 mg in 250 μL methanol-d4 solution) and (B) a vitamin B12 standard (0.7 mg in 250 













Figure 3.8 BN-PAGE of Dsf hafniense strain JH1 
Representative image of a blue native polyacrylamide gel electrophoresis (BN-PAGE) gel 
used for Dsf hafniense strain JH1 crude protein separation and subsequent in-gel 




Figure 3.9 Identification of purinyl-Cba as the native prosthetic group in Dsf PCE 
RDase following nondenaturing, gel-electrophoretic separation of Dsf crude 
protein extracts using BN–PAGE 
(A) TCE -to-cDCE dechlorination activity of different BN–PAGE gel slices measured using 
dehalogenation enzyme assays.  
(B,C) UPLC separation and MS analysis of the corrinoid recovered from BN–PAGE gel 




























































(WP_011460641.1) was enriched in gel slice #4 along with carbon monoxide 
dehydrogenase (CODH) and flavin adenine dinucleotide (FAD)-dependent fumarate 
reductase, which are both corrinoid-independent enzymes (Table 3.1)26,27. CODH may 
occur in complexes with corrinoid-dependent, Wood–Ljungdahl pathway enzymes (e.g., 
5-methyltetrahydrofolate-homocysteine methyltransferase), but no such proteins were 
detected in gel slice #4. Purinyl-Cba was the only corrinoid detected in this gel slice, 
confirming that the Dsf PceA RDase uses purinyl-Cba as the native prosthetic group. 
3.3.4 Dsf CobT substrate specificity and phylogenetic analysis 
The nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase 
(CobT) activates lower bases to their respective α-RP forms (Figure 3.10A), and the 
CobT substrate specificity determines the type of cobamide produced19. CobT sequences 
encoded in sequenced Dsf genomes are highly conserved (81.3–100% amino acid 
identity) except for Desulfitobacterium metallireducens strain DSM 15288, whose CobT 
shares no more than 58.5% amino acid identity with other available Dsf CobT sequences. 
A broader phylogenetic analysis clustered bacterial CobT sequences into distinct clades 
reflecting the substrate specificities (i.e., lower base type activated) of characterized 
CobT, and provided clues about the native cobamides produced by the respective host 
organisms (Figure 3.10B and Table 3.2). This analysis further revealed that the Dsf CobT 
clade was distinct (<52% amino acid identity) from any other CobT implicated in phenol–
p-cresol, adenine, guanine–hypoxanthine or Bza-type lower base activation. The most 
closely related sequences to the Dsf CobT clade (except for D. metallireducens CobT) 
were found in Dehalobacter (Dhb) and Desulfosporosinus (e.g., Desulfosporosinus 
youngiae strain DSM 17734, CM001441.1; Desulfosporosinus meridiei strain DSM 
13257, CP003629.1; Desulfosporosinus orientis strain DSM 765, CP003108.1) genomes, 
with 57.8–59.3% and 56.6–61.7% amino acid identity, respectively (Figure 3.10B); 
however, the native corrinoids produced in either Dhb or Desulfosporosinus spp. strains 
have not yet been identified. The high CobT sequence identities among these members  
 
204 
Table 3.1 Proteomic analysis of the Desulfitobacterium (Dsf) hafniense strain JH1 

















1 ≥ 720 - - - - 
2 480 - 720 - - - - 




5 18 Acetyl-CoA synthase WP_005812973.1 
4 204 - 346 
6 8 CO dehydrogenase WP_011459977.1 






















6 ≤ 112 - - - - 
 
 
a BN-PAGE lanes were separated into slices based on the position of proteins in a MW 
ladder. The MW ranges were estimated from a standard curve created by interpolating 
the log MW of individual ladder proteins (146, 242, 480, 720 and 1,048 KDa) versus the 
ratio (Rf) of migration distance of each ladder protein to the migration distance of the 
Coomassie Blue dye front. Note that the actual MWs of Dsf proteins do not necessarily 
match the calculated MWs based on BN-PAGE separation. 
b In-gel peptide digestion and proteomic analysis were performed on gel slices # 3, 4, and 




Figure 3.10 Phylogenetic analysis of CobT homologous proteins and substrate 
specificity of Dsf CobT 
(A) The Dsf CobT activated DMB or purine to their respective α-ribazole-5′-phosphate (α-
RP) forms. NaMN, nicotinic acid mononucleotide.  
(B) Phylogenetic relationship of 40 CobT and homologous proteins from phylogenetically 
diverse corrinoid-auxotrophic and prototrophic bacteria. Solid black dots indicate CobT 
enzymes with biochemically determined substrate specificities. CobT enzymes of other 
members of the Peptococcaceae may share catalytic features with the Dsf CobT and 
activate purine as a lower base for cobamide biosynthesis (indicated by the dashed line–
enclosed pink area).  
(C) HPLC analysis demonstrating purified CobT activity with NaMN and a lower base as 
the substrates. The small peak to the left of nicotinic acid in the bottom trace (Dhc CobT 
assay with purine) has a retention time similar to that of α-RP [purine] shown in the panel 
above, but spectral analysis revealed distinct absorbance features.  
(D) The formation of α-RP [DMB] or α-RP [purine] in CobT assays with DMB or purine 
provided as a lower base substrate. The α-RP concentrations were calculated on the 
basis of the concentration decreases of the respective lower base substrates. Data are 
averages of measurements from duplicate assays. The (*) indicates that no α-RP [purine] 
production was observed in Dhc CobT assays with purine as the lower base.  

































Table 3.2 Information about CobT and homologous proteins used for phylogenetic 
tree construction (Figure 4.4B in main text)  
Indicated are the host organisms, the designations of the CobT homologous proteins, the 
experimentally determined or inferred (based on the native types lower bases produced 
in the respective host organisms) substrate specificity, the locus tag numbers of the 












woodii                
DSM 1030 
CobT Bza type Awo_c14620 AFA48245.1 1 
Eubacterium 
limosum                       
strain KIST612 
CobT Bza type ELI_4217 ADO39159.1 1 
Geobacter 
sulfurreducens                      
strain PCA 
CobT Bza type GSU3009 AAR36401.1 1 
Geobacter 
lovleyi                            
strain SZ 
CobT Bza type Glov_3678 ACD97377.1 1 
Pelobacter 
propionicus                           
DSM 2379 
CobT Bza type Ppro_2806 ABL00406.1 2 
Moorella 
thermoacetica                       
ATCC 39073 
CobT Bza type Moth_1721 ABC20023.1 3 
Dehalococcoide
s mccartyi                      
strain 195 
CobT Bza type DET0657 AAW40094.1 4 
Clostridium 





CLOST_0282 CBH20412.1 5 
Sulfurospirillum 





SMUL_1547 AHJ12807.1 6 
Clostridium 














Vpar_1602 ACZ25278.1 4 
Lactobacillus 





Lreu_1695 ABQ83934.1 4 
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DVU_3279 AAS97749.1 10 
Desulfobacterium 
sp. strain PCE1 
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Dehlaobacter sp.                            
strain CF 
CobT Unknown DCF50_p694 AFV04701.1 
This 
study 
Dehlaobacter sp.                            
strain DCA 




restrictus               
strain PER-K23 
CobT Unknown DEHRE_07530 AHF09955.1 
This 
study 
Dehlaobacter sp.                            
strain UNSWDHB 
CobT Unknown N/A WP_015042707.1 
This 
study 
Dehlaobacter sp.                            
strain E1 




orientis                                    
DSM 765 




meridiei                                    
DSM 13257 



















sp. strain I2 




sp. strain HMP52 








of the Peptococcaceae suggested that purine activation to the α-RP derivative is a shared 
feature of this family (Figure 3.10B). 
Cultivation work indicates that Dhc CobT utilizes a variety of benzimidazole-type 
lower bases with a preference for DMB10,11. In vitro enzyme assays with purified Dsf CobT 
and Dhc CobT (Figure 3.11A) with nicotinic acid mononucleotide (NaMN) and purine or 
DMB as substrates verified that Dsf CobT and Dhc CobT both activated DMB to the α-
RP form of DMB (α-RP [DMB]; Figure 3.10C), consistent with the observation that 
exogenous DMB guided Dsf to produce cobalamin as a non-native prosthetic group of 
the PceA RDase. The Dsf and Dhc CobT enzymes activated DMB (250 μM), and 166.9 
± 2.70 and 159.4 ± 1.13 μM α-RP [DMB], respectively, were produced following a 30-min 
incubation period (Figure 3.10D). In Dsf CobT assays in which purine (250 µM) replaced 
DMB, the conversion yield to α-RP [purine] exceeded 99% after a 30-min incubation 
period (Figure 3.10C, D). In assays with Dhc CobT, purine was not consumed, α-RP 
[purine] was not produced, and only small amounts of nicotinate were observed, 
indicating that Dhc CobT was unable to activate unsubstituted purine (Figure 3.10C, D). 
No α-RP formation occurred in controls lacking NaMN, a lower base, or CobT, 
corroborating that Dsf CobT catalyzed the activation of unsubstituted purine to α-RP 
[purine] (Figure 3.11B). MS analysis performed on fractions containing CobT enzyme 
assay products showed strong adducts with m/z ([M+H]+) values of 359.10 and 333.06 
matching the calculated molecular mass of α-RP [DMB] and α-RP [purine], respectively 
(Figure 3.10E). These findings demonstrated an unprecedented Dsf CobT specificity for 
unsubstituted purine, consistent with the discovery of purinyl-Cba as the native prosthetic 
group of Dsf PceA. 
3.3.5 Effects of purinyl-Cba on dechlorinating activity 
To test whether purinyl-Cba supports corrinoid-dependent reductive dechlorination 
in corrinoid-auxotrophic organohalide-respiring bacteria, we grew axenic Dehalobacter 
restrictus strain PER-K23 and Dhc cultures with purinyl-Cba. Strain PER-K23 harbors a 
PceA RDase with 98.7% amino acid identity to the PceA of D. hafniense strain Y51. Strain  
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Figure 3.11 Heterologous expression of Dsf CobT and Dhc CobT in E. coli and 
requirements for lower base activation 
(A) SDS-PAGE image of Dsf CobT and Dhc CobT carrying an N-terminal hexa-histidine 
tag purified from recombinant E. coli cells.  
(B) HPLC chromatograms of CobT enzyme assay controls demonstrating that the 
formation of alpha-ribazole-5’-phosphate requires nicotinic acid mononucleotide (NaMN), 











PER-K23 cultures that received 36.9 nM of vitamin B12 (positive control) or purinyl-Cba 
completely dechlorinated the initial amount of 64.4 ± 2.3 μmol of PCE to cDCE within 6 d 
at statistically indifferent rates of 427 ± 25 and 471 ± 39 μM Cl− released per day, 
respectively (Figure 3.12A). Much lower dechlorination rates of 23.7 ± 9.3 μM Cl− 
released per day, resulting in the formation of small amounts of trichloroethene (TCE; 8.2 
± 2.5 μmol) and cDCE (5.4 ± 2.5 μmol), occurred in control incubations without exogenous 
corrinoid (Figure 3.12A). Strain PER-K23 cell numbers increased about 50-fold in purinyl-
Cba- and vitamin B12-amended cultures, whereas growth was negligible in control 
cultures without corrinoid addition (Table 3.3). Biomass from purinyl-Cba- and vitamin 
B12-fed Dhb cultures exclusively contained purinyl-Cba and vitamin B12, respectively, 
indicating that cobamide or lower base modifications did not occur (Figure 3.12B). These 
findings demonstrated that both D. restrictus strain PER-K23 and D. hafniense strain Y51 
PceA RDases were fully functional with either purinyl-Cba or cobalamin as the prosthetic 
group. 
Corrinoid-auxotrophic Dhc pure cultures demonstrated a different response to 
purinyl-Cba. Dhc strains BAV1 and GT express the BvcA and VcrA RDase, respectively, 
which share less than 20% amino acid identity with the Dsf and Dhb PceA RDases. 
Complete reductive dechlorination of cDCE to ethene occurred in vitamin B12-amended 
Dhc strain BAV1 and strain GT cultures at rates of 201 ± 11 and 197 ± 10 μM Cl− released 
per day, respectively (Figure 3.12C and 3.13). Strain BAV1 and strain GT cultures with 
purinyl-Cba as the sole corrinoid amendment exhibited much slower cDCE dechlorination 
rates of 17.6 ± 1.2 and 11.7 ± 0.7 μM Cl− released per day, respectively (Figure 3.12C 
and 3.13). After a 32-d incubation period, the cultures dechlorinated about half of the 
initially supplied cDCE (83 μmol) but produced no ethene. In control cultures without 
exogenous corrinoid, strain BAV1 and strain GT dechlorinated no more than 22% and 
7.3%, respectively, of the initial cDCE to vinyl chloride (presumably enabled by corrinoid 
carryover with the inoculum), and formed no ethene (Figure 3.12C and 3.13). Consistent 
with the observed reductive dechlorination activity, 16S rRNA gene enumeration indicated 
robust Dhc growth in cultures amended with vitamin B12 but not in cultures that received 
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Figure 3.12 Effects of purinyl-Cba substitution for vitamin B12 on the activity of 
corrinoid-auxotrophic, organohalide-respiring bacteria. 
(A) Reductive dechlorination activity in D. restrictus cultures supplied with PCE as the 
electron acceptor and 36.9 nM vitamin B12 (positive control), 36.9 nM purinyl-Cba, or no 
corrinoid addition (negative control).  
(B) HPLC chromatograms of the total intracellular corrinoids extracted from vitamin B12- 
or purinyl-Cba-amended Dhb cultures. Purinyl-Cba was the only cobamide recovered 
from purinyl-Cba-amended Dhb cultures.  
(C) Reductive dehalogenation of cDCE to ethene in Dhc strain BAV1 cultures amended 
with 36.9 nM vitamin B12 (positive control), 36.9 nM purinyl-Cba, or no corrinoid addition 
(negative control). Unfilled squares, PCE; filled diamonds, TCE; filled triangles, cDCE; 
inverted unfilled triangles, vinyl chloride; filled circles, ethene. Error bars represent mean 















































































Table 3.3 Growth of corrinoid-auxotrophic organohalide-respiring Dehalobacter 
restrictus (Dhb) and Dehlaococcoides mccartyi (Dhc) pure cultures with different 
cobamides 
 
Organism               
(e- acceptor) 
Cobamide 
Dhc 16S rRNA or Dhb pceA gene copies 
per mL culturea 
Average 
fold 
increase Initial Final 
Dhb                     
(PCE) 
Vitamin B12 7.52 ± 0.25 x 106 3.89 ± 0.49 x 108 51.7 
Purinyl-Cba 7.52 ± 0.25 x 106 3.75 ± 0.47 x 108 49.9 
None 7.52 ± 0.25 x 106 1.70 ± 0.85 x 107 2.3 
Dhc strain BAV1 
(cDCE) 
Vitamin B12 4.63 ± 0.22 x 106 1.83 ± 0.09 x 108 39.5 
Purinyl-Cba 4.63 ± 0.22 x 106 1.29 ± 0.15 x 107 2.8 
None 4.63 ± 0.22 x 106 6.26 ± 1.62 x 106 1.4 
Dhc strain GT 
(cDCE) 
Vitamin B12 3.88 ± 0.70 x 106 1.68 ± 0.14 x 108 43.3 
Purinyl-Cba 3.88 ± 0.70 x 106 2.00 ± 0.31 x 107 5.2 
None 3.88 ± 0.70 x 106 4.62 ± 0.51 x 106 1.2 
 
a Based on the available genome information, Dhc possess a single copy of the 16S rRNA 
gene and Dhb possess a single copy of the pceA gene. Average and standard deviation 







Figure 3.13 Reductive dechlorination of cDCE to ethene in Dhc strain GT cultures 
Reductive dechlorination of cDCE to ethene in Dhc strain GT cultures receiving vitamin 
B12 (36.9 nM, top panel), purinyl-Cba (36.9 nM, middle panel), or no corrinoid addition 
(negative control, bottom panel). Solid triangles, cDCE; open, inverted triangles, vinyl 
chloride; solid circles, ethene. Error bars represent the mean values ± standard deviation 




purinyl-Cba (Table 3.3). In contrast to the PceA RDases, the Dhc RDases BvcA and VcrA 
had a pronounced preference for DMB over unsubstituted purine as the lower base, 




The purine structure is the most widely distributed nitrogen-containing heterocycle 
in nature, and purine derivatives fulfill many essential functions in biological systems28. 
Obvious examples of purine derivatives include adenine and guanine, which are essential 
building blocks of nucleic acids, and ubiquitous molecules such as adenosine 5′ 
triphosphate (ATP), nicotinamide adenine dinucleotide (NAD+ and NADH), and flavin 
adenine dinucleotide (FAD and FADH2)28. Remarkably, compounds containing an 
unsubstituted purine moiety are rare, and a specific biological function has never been 
assigned to purine itself. To date, nebularine (purine nucleoside) is the only known 
biological compound that contains unsubstituted purine. Nebularine was first isolated from 
the fungus Clitocybe nebularis29 and is also produced by Streptomyces yokosukanensis30 
and a Microbispora isolate31. Nebularine is a potent antibiotic against various 
Mycobacterium species, exhibits cytotoxic effects in cell cultures and plants32,33, and is 
toxic to the schistosomiasis (bilharzia) parasite34; however, its biological functions in the 
hosts are unclear. In S. yokosukanensis, nebularine biosynthesis involves catalysis of the 
reductive deamination of adenosine by a single enzyme35. Apparently, at least some 
members of the domains Bacteria and Eukaryota synthesize unsubstituted purine, 
indicating that purine is not a xenobiotic, a finding that has potential human health 
implications. Purinergic membrane receptors, which include the adenosine-responsive 
P1 purinoceptors, are found in almost all mammalian tissues, wherein they fulfill crucial 
functions that can affect disease progression36–38. Although the occurrence of 
unsubstituted purine in mammals is not established, the simple enzymatic conversion of 
adenosine to nebularine has been demonstrated35, and enzymatic hydrolysis of the N-
glycosidic bond catalyzed by common nucleoside hydrolases (i.e., purine nucleosidases) 
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releases the corresponding free bases24. Thus, the formation of unsubstituted purine (or 
purine nucleoside) could affect the regulation of cellular functions (purinergic signaling), 
potentially enabling new disease therapies. Purinyl-Cba synthesis using Dsf CobT will 
facilitate detailed investigations of its therapeutic potentials. 
Corrinoid-dependent enzyme systems fulfill essential metabolic functions for 
organisms in all branches of life, but only some members of Bacteria and Archaea have 
the machinery for de novo corrinoid biosynthesis1,2,39–42. The discovery of a new member 
of the corrinoid family of molecules, purinyl-Cba in organohaliderespiring members of the 
Peptococcaceae, expands the number of naturally occurring, functional lower base 
structures and assigns a function to unsubstituted purine in biological systems. From this 
study and from recent reports, a concept emerges that lower base structures are 
modulators of corrinoid-dependent enzyme function10,12,20,21. This concept applies to the 
Dhc RDases, but may possibly expand to many other corrinoid-dependent enzyme 
systems, emphasizing that enzyme-specific corrinoid cofactor requirements must be 
understood to predict, and possibly manipulate, catalytic activity (for example, Dhc 
reductive dechlorination rates and extents)43. The exact role(s) of the lower base in 
RDase function is not resolved, but recent findings reveal a base-off configuration during 
catalysis7,8. If not directly involved in catalysis, the lower base structures may affect 
holoenzyme maturation, or, in the case of periplasmic enzymes such as respiratory 
RDases, export through the cytoplasmic membrane. Cobamides fulfill essential metabolic 
functions for the majority of organisms, including mammals, and the principle of lower 
base-controlled activity of key corrinoid-dependent enzyme systems may provide new 
avenues to manipulate environmental (for example, bioremediation) and biotechnological 
(for example, anaerobic digestion, biogas production) processes and to expand treatment 





Vitamin B12 (≥98%), dicyanocobinamide (Cbi; ≥93%), 5,6-dimethylbenzimidazole 
(DMB) (99%), 5-methylbenzimidazole (5-MeBza; 98%), 5-methoxybenzimidazole (5-
OMeBza) (97%), benzimidazole (Bza; 98%), and purine (98%) were purchased from 
Sigma-Aldrich. 15NH4Cl (99%) was obtained from Cambridge Isotope Laboratories. Yeast 
extract and peptone were purchased from Becton, Dickinson and Company. Bza-Cba, 5-
MeBza-Cba and 5-OMeBza-Cba were prepared via guided cobamide biosynthesis10. 
Factor III (5-OHBza-Cba), norpseudo vitamin B12 and phenolic cobamides (i.e., Phenol-
Cba and p-Cresol-Cba) were extracted and purified from Methanosarcina barkeri strain 
Fusaro (DSM 804), Sulfurospirillum multivorans (DSM 12446) and Sporomusa sp. strain 
KB-1 (16S rRNA gene GenBank accession number AY780559.1) cells, respectively. 
Concentrations of purified cobamides were determined at 361 nm with a Lambda 35 UV-
Vis spectrometer (PerkinElmer) using a molar extinction coefficient of 28,060 mol−1 cm−1 
(ref. 12). Ethene (≥99.9%) and vinyl chloride (≥99.5%) were purchased from Sigma-
Aldrich. All other chemicals used were reagent grade or higher. 
3.5.2 Cultures 
Pure cultures were grown in 160 ml glass serum bottles containing 100 ml of 
bicarbonate (30 mM) or phosphate (50 mM) buffered, defined mineral salts medium, the 
Wolin vitamin mix excluding vitamin B12, and a N2/CO2 (80/20; v/v) headspace. D. 
hafniense strains Y51 and JH1 and Dsf sp. Strains Viet1 and PCE1 cultures were 
supplemented with pyruvate (10 mM) as fermentable substrate and with PCE (68 μmol 
per bottle, 0.48 mM aqueous concentration) as electron acceptor44. Dhc strain BAV1 and 
strain GT cultures were amended with 5 mM acetate as a carbon source, 10 ml hydrogen 
as an electron donor, neat cDCE (79 μmol per bottle, 0.60 mM aqueous concentration) 
as an electron acceptor, and a cobamide (for example, vitamin B12) as described10. 
Geobacter sulfurreducens strain PCA cultures received 5 mM acetate as an electron 
donor and 10 mM fumarate as an electron acceptor as described45. Sulfurospirillum 
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multivorans strain DSM 12446 cultures were grown with pyruvate (10 mM) and neat PCE 
(0.48 mM) as electron acceptor as described21. D. restrictus strain PER-K23 cultures were 
amended with 5 mM acetate as carbon source, 10 ml hydrogen as an electron donor, 
neat PCE (0.48 mM) as electron acceptor, and peptone (0.5 g/L) as source of required 
amino acids46. Sporomusa sp. strain KB-1 cultures were amended with betaine (50 mM) 
as the sole substrate20. Methanosarcina barkeri strain Fusaro was grown with 123 mM 
methanol as the sole substrate20. All vessels were incubated without agitation in the dark 
at 30 °C. For 15N isotope experiments, 15NH4Cl (0.3 g/L) replaced unlabeled NH4Cl as the 
nitrogen source. L-cysteine, a reductant added to the medium, is a potential nitrogen 
source and was omitted in the labeling experiments. 15NH4Cl grown cultures were 
transferred (1% inoculum; v/v) twice in 160 ml serum bottles containing 100 ml of medium 
before scaling up to a 2.2 L vessel containing 1.8 L of medium to extract sufficient 15N-
labeled corrinoid for LC–MS analysis. Initial experiments with Geobacter sulfurreducens 
strain PCA, a bacterium that natively produces 5-OHBza-Cba (14 N atoms in the cyano 
form)47, demonstrated the utility of the 15N isotope labeling approach to determine the 
number of N atoms in the lower base structure. We found that the mass spectra of 15N-
labeled versus unlabeled 5-OHBza-Cba produced in G. sulfurreducens cultures amended 
with 15NH4Cl versus NH4Cl returned a mass shift of 12.96 Da, close to the expected value 
of 13 total N atoms (14 minus one unlabeled N in the upper CN ligand, which was added 
during the KCN extraction process) (Figure 3.14). 
3.5.3 Corrinoid extraction 
Cells were harvested from 0.3–1.8 L culture suspensions by centrifugation at 
15,000 × g for 15 min at 4 °C, or by filtration onto 47-mm diameter 0.22-μm pore size 
polyethersulfone membrane filters (Pall Life Sciences). The intracellular corrinoids were 
extracted from the biomass following an established KCN extraction protocol and purified 
using a C18 Sep-Pak cartridge (Waters Corp)10. To extract corrinoids from proteins 
separated by BN–PAGE, gel slices were excised and transferred to individual 2 ml plastic 
tubes with 1 ml of 90% (v/v) methanol containing 50 mM acetic acid and 10 mM KCN 
(final pH 5.5) for corrinoid extraction. The closed tubes were incubated at 60 °C for 2 h to 





Figure 3.14 Demonstration of the utility of stable isotope 15N-labeling to obtain 
lower base compositional information 
Mass spectra of (A) unlabeled and (B) 15N-labeled 5-OHBza-Cba (i.e., factor III) produced 
by Geobacter sulfurreducens strain PCA. The 15N-labeled 5-OHBza-Cba was purified 
from Geobacter sulfurreducens cells grown with 15N-NH4Cl as the sole nitrogen source. 
Mass shifts of 12.95 Dalton in the m/z values of [M+H]+ and [M+Na]+ base peaks matched 
the predicted mass increase based on the total number of two N atoms in the Bza lower 





vacuum dried using a rotary evaporator at 45 °C for 2 h. The dry residues were suspended 
in 75 μL ice-cold ammonium acetate (20 mM, pH 6.0), and centrifugation at 13,000 × g 
for 5 min at 4 °C removed insoluble Coomassie Blue dye and gel residuals. 
3.5.4 Corrinoid analysis 
Intracellular corrrinoids were analyzed by HPLC, UV-Vis spectroscopy, and 
UPLC–HRMS. HPLC analysis was performed with an Eclipse XDB-C18 column (Agilent 
Technologies, 5 μm pore size, 4.6 mm inner diameter × 250 mm length) operated at a 
flow rate of 1 ml per min at 30 °C using 0.1% (v/v) formic acid (≥88%, w/v; Thermo Fisher, 
Waltham, MA, USA) in water as eluent A and 0.1% (v/v) formic acid in methanol as eluent 
B. The initial mobile phase composition was 82% eluent A and 18% eluent B, before the 
fraction of eluent B increased linearly to 25% over a 12-min and further to 75% over an 
additional 3-min time period, held at 75% B for 5 min before being restored to initial 
column conditions. UV-Vis spectra between 250 to 600 nm were collected using a diode 
array detector. The upper ligand, cobalt oxidation state, and lower base coordination 
influence the corrinoid absorbance spectrum in the UV region42. All corrinoid samples and 
standards in this study carried the cobalt atom in the fully oxidized +3 state and a cyano 
group as the upper ligand. Cbi lacks the entire α-ribazole-5′-phosphate (α-RP) moiety and 
exhibited an UV-Vis spectrum with an absorption peak at 355 nm, distinct from the 361 
nm absorption peak of vitamin B12 (Figure 3.2B). The corrinoids extracted from BN–
PAGE gels were analyzed using an UltiMate 3000 UPLC system in tandem with a high-
resolution Exactive Plus Orbitrap mass spectrometer (Thermo Fisher) and a UV-Vis 
detector set to 361 nm as described48. Corrinoids were separated on a Hypersil Gold C18 
column (Thermo Fisher; 1.9 μm pore size, 2.1 mm inner diameter × 50 mm length) at a 
flow rate of 0.2 ml min−1 at 30 °C using 2.5 mM ammonium acetate in water as eluent A 
and 100% methanol as eluent B. The mobile phase was 100% eluent A and 0% eluent B 
for 0.46 min, followed by linear increases to 15% eluent B after 0.81 min, 50% eluent B 
after 3.32 min, and 90% eluent B after 5.56 min with a 0.3-min hold before equilibration 
to initial column conditions. Corrinoid mass spectra were collected in positive ionization 
mode using a HESI II electrospray ionization source (Thermo Fisher) with a m/z scan 
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ranging from 1,000–1,500 and a resolution of 140,000. The detection limit for this LC–MS 
method was 2.5 ng of corrinoid. 
3.5.5 NMR spectroscopy 
Growth of D. hafniense strain Y51 in twelve 2.2 L vessels yielded approximately 
22 L of cell culture suspension. Each vessel received neat TCE (400 μL; 2.3 mM aqueous 
concentration), yeast extract (2 g/L) and Cbi (0.5 μM) to enhance corrinoid production. 
Cells were harvested after three TCE amendments (a total of 1,200 μL) were completely 
dechlorinated to cDCE. Total intracellular corrinoids were extracted, and the predominant 
corrinoid containing fraction was obtained following HPLC separation and manual 
collection from the detector outlet informed by the detector response at 361 nm. 
Approximately 0.7 mg of purified corrinoid was dissolved in methanol-d4 (250 μL) to 
conduct 1H and COSY NMR experiments using an INOVA 600 MHz NMR spectroscopy 
system (Varian). The 1H NMR experiments consisted of 1,024 scans, using PRESAT 
solvent suppression multiple peak selection and a total measuring time of 1 h. The 
gradient-selected COSY NMR experiments consisted of 256 scans per increment at 96 
increments. The delay time between scans was 1.5 s, and the total measuring time was 
1 h. 
3.5.6 Blue native PAGE (BN–PAGE), enzyme assays and proteomic analysis 
D. hafniense strain JH1 cells were harvested from 100 ml cultures and the crude 
protein extracts were prepared as described49. BN–PAGE using pre-cast 4 to 16% 
gradient Bis–Tris gel (Thermo Fisher) stained with Coomassie Blue was performed 
following the NativePAGE Bis–Tris Gel Protocol49. Gel lanes were loaded with 25 μL of 
protein standards or crude protein extracts containing approximately 6 μg of total protein 
as estimated with the Bradford assay50. Electrophoresis was done using chilled buffers 
and a BN–PAGE chamber placed in an ice bath, and separation occurred for 60 min at 
150 V and then for another 45 min at 200 V. The blank, ladder and sample lanes were 
separated and stained according to the fast Coomassie G-250 staining protocol (Thermo 
Fisher). The gel slices were cut based on molecular mass ranges as visualized by the 
protein standards in the ladder lane. Enzyme assays to detect dechlorinating activity were 
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conducted with D. hafniense strain JH1 cell lysate (positive control) and individual gel 
slices inside an anoxic chamber (Coy Laboratory) as described49. The assays (1 ml) were 
conducted in 2 ml sealed glass vials containing 100 mM Tris–HCl buffer (pH 7.4) 
amended with 2 mM titanium citrate, 2 mM methyl viologen, and 2 mM TCE. Each assay 
mixture was incubated in an anoxic chamber for 24 h and analyzed for cDCE formation 
using gas chromatography49. In-gel digestion and MS analysis were performed at the 
BioZone Mass Spectrometry Facility (University of Toronto, Toronto, Canada) using X! 
Tandem for peptide/protein identification (The GPM, thegpm.org; version X! Tandem 
Vengeance (2015.12.15.2))49. X! Tandem was set up to search for tryptic peptides based 
on the D. hafniense strain Y51 genome, all characterized RDases, other Dsf proteins in 
the NCBI database, as well as common contaminants such as human keratins and trypsin 
(total of 33,950 proteins) using a fragment ion mass tolerance of 0.40 Da and a parent 
ion tolerance of 2.5 Da. Deamidation of asparagine and glutamine, oxidation of 
methionine and tryptophan, N-terminal ammonia loss, or cyclization of glutamine or 
glutamic acid to pyroglutamine or pyroglutamic acid were allowed in X! Tandem as 
possible peptide modifications. Further validation and refinement was performed using 
Scaffold software version 4.5.3 (Proteome Software, Inc.) with a reverse decoy database 
to establish a false discovery rate. Peptide identifications were accepted as valid at a 
Peptide Prophet probability of greater than 95%51. Subsequent protein identifications 
were considered valid at a Protein Prophet probability of greater than 99%52, which were 
filtered to include those that had at least two unique peptide identifications. 
3.5.7 Primer and probe design 
Primers and TaqMan probe targeting the pceA gene in D. hafniense strain Y51 
(locus # DSY2839), D. restrictus strain PERK23 (locus # DEHRE_12145), and pceA 
homologs (>95% sequence identity) identified in other Dsf and Dhb strains (GenBank 
accession numbers CAD28792.1, CDX02974.1, AAO60101.1 and AIA58680.1) were 
designed using Primer Express software (Applied Biosystems). A consensus region of 
the Dsf and Dhb pceA gene sequences was selected to meet the quantitative PCR 
(qPCR) design criteria of (i) an amplicon size between 50–150 bp, (ii) a primer melting 
temperature (Tm) of 58–60 °C, and (iii) a probe Tm of 68–70 °C53. The G+C content of the 
 
232 
primers and probe was between 30 to 80 mol %, with no more than three consecutive G 
or C bases in either the primer or the probe sequences. The specificity of the forward 
primer Df_pceA_1223F (5′-CGGACAAGCCGAGAAAATTC-3′), the reverse primer 
Df_pceA_1286R (5′-GCATCCGCACATTTTTTGC-3′) and the probe Df_pceA_1247 
probe (5′-6FAM-TACGCGAGTTCTGCCG-MGB-3′) to pceA genes was verified by using 
BLAST search against the NCBI database. 
3.5.8 Chemical and molecular analyses 
Ethene and chlorinated compounds were quantified in triplicate cultures using an 
Agilent 7890 gas chromatograph as described10. The two-step dechlorination processes 
PCE-to-cDCE (Dhb) and cDCE-to-ethene (Dhc) were measured based on the 
quantification of daughter and end products, TCE/cDCE and VC/ethene, respectively. 
Each dichlorination step is associated with the release of one chloride ion and the PCE-
to-cDCE and cDCE-to-ethene dechlorination rates were reported as micromolar Cl− 
released per day. The list of potential molecular formulas for the lower base of the Dsf 
cobamide was generated using the web-based platform ChemCalc54. To obtain genomic 
DNA, cells from 1 ml culture suspension were harvested via vacuum filtration onto a 0.22 
μm polyvinylidene difluoride membrane filter (Merck Millipore Ltd.) and processed using 
the MO BIO Soil DNA Isolation kit (MO BIO) as described45. Dhc 16S rRNA gene-targeted 
qPCR was performed following established protocols using primer set 
Dhc1200F/Dhc1271R and TaqMan probe Dhc1240probe53. The qPCR assay targeting 
the Dhb pceA gene with the newly designed primers and probe used identical qPCR 
conditions. Standard curves were generated using a serial dilution of plasmid pMK-RQ 
(Life Technologies) with a D. hafniense strain Y51 pceA fragment (1,656 bp) insertion. 
The pceA qPCR assay standard curve had a slope of −3.785, a y-intercept of 40.41, a R2 
of 0.999, and a PCR amplification efficiency of 83.8%. The assay spanned a linear range 
from 4.64 × 101 to 4.64 × 108 pceA gene copies per reaction, with 4.6 pceA gene copies 
per reaction as the detection limit. All qPCR assays used template DNA samples 
extracted from triplicate cultures, and standard curves were generated from three 
independently prepared serial dilutions of the respective plasmid DNA standards. 
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3.5.9 Statistical analysis 
The PCE-to-cDCE dechlorination rates from three independent Dhb cultures 
grown with purinyl-Cba or vitamin B12 were statistically compared. The two-sample t-test 
was carried out using the data analysis tool provided in Microsoft Excel 2016. 
3.5.10 Bioinformatics and phylogenetic analyses 
RDase sequence alignments and identity comparisons were performed with 
Clustal Omega (www.ebi.ac.uk/Tools/msa/clustalo)55. Reciprocal BLAST analysis was 
used to query the sequenced Dsf genomes and search for orthologous bza genes 
implicated in anaerobic DMB biosynthesis47. Twenty CobT amino acid sequences from 
the genomes of nine Dsf strains, five Dhb strains and six Desulfosporosinus strains, along 
with 20 CobT and homologous protein (i.e., ArsA and ArsB) sequences from other 
bacteria (Table 3.2) were retrieved from GenBank, and aligned using the MUSCLE plug-
in in Geneious 8.1.7 with 10 iterations. The phylogenetic tree of CobT and homologous 
proteins was constructed using the PHMYL maximum likelihood tree builder plug-in in 
Geneious 8.1.7 with 100 bootstraps and the Le and Gascuel substitution model56. 
3.5.11 Heterologous expression and purification of CobT 
The pET-28a(+) vector (EMD Millipore) was used to clone and express cobT 
carrying an N-terminal hexa-histidine tag. Dsf cobT (locus # DSY2114) and Dhc cobT 
(locus # DehaBAV1_0626) were amplified using Phusion Flash High-Fidelity PCR Master 
Mix (Thermo Fisher) and primer sets NJ459-NJ460 and NJ461-NJ462 (Table 3.4), 
respectively, using genomic DNA from Dsf strain Y51 and Dhc strain BAV1 axenic 
cultures. PCR products were cleaned using the UltraClean PCR Clean-Up Kit (MO BIO). 
The pET-28a(+) vector backbone was digested with EcoRI and NdeI, dephosphorylated 
with rSAP, and gel extracted to remove remaining supercoiled constructs. The prepared 
plasmids pNJ050 and pNJ049 (Table 3.5), which contain Dsf cobT and Dhc cobT inserts, 
respectively, were then transformed into BW25113 electrocompetent cells with pre-
induced λ Red recombinase from plasmid pKD46 for homologous recombination57. 
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Following sequence verification, recombinant vectors were introduced into E. coli strain 
BL21(DE3) (New England BioLabs) for overexpression and purification. 
Enzyme expression and purification were performed as described with 
modifications58. In brief, E. coli strain BL21(DE3) carrying a cobT expression plasmid was 
grown in 1 L of Terrific Broth (Thermo Fisher) with 50 μg/mL kanamycin at 37 °C and 180 
rpm to an optical density at 600 nm (OD600) of 0.8. Cultures were induced with 0.4 mM 
isopropyl β-D-1-thiogalactopyranoside (Thermo Fisher) and incubated overnight at 16 °C 
and 180 rpm. Cells were collected by centrifugation at 9,000 × g for 20 min, suspended 
in HEPES buffer (50 mM HEPES, 300 mM NaCl and 10 mM imidazole, pH 7.5), and 
sonicated in an ice bath for 45 min (3-s on and 4-s off). The lysate was centrifuged at 
38,000 × g for 20 min and the supernatant was passed through a 25 ml glass column 
containing about 0.5 ml Ni-NTA resin (Qiagen). After washing with HEPES buffer (20 mM 
imidazole), proteins were eluted with 5–7 mL of HEPES buffer containing 250 mM 
imidazole and 5% (w/v) glycerol. Protein concentrations were estimated using the 
Bradford assay50 and protein purity was examined by SDS–PAGE and Coomassie Blue 
staining. The protein stock solutions (Dsf Y51 CobT, 15 mg/mL; Dhc BAV1 CobT, 10 
mg/mL) were frozen in liquid nitrogen and stored at −80 °C. The N-terminal hexa-histidine 
tag was retained for all experiments. 
3.5.12 In vitro CobT activity 
CobT assays were performed as described59. Briefly, each reaction (300 μL) 
contained 30 μg CobT (corresponding to a final enzyme concentration of ~2.6 μM), 2 mM 
NaMN, 10 mM MgCl2, and 0.25 mM of either purine or DMB in 50 mM pH 7.5 Tris–HCl 
buffer. The assay vials were incubated at 30 °C for 30 min before the reactions were 
terminated by the addition of 15 μL formic acid (≥88%; w/v) and then transferred to a 
boiling water bath for 1 min. Following neutralizing the pH with 5 M NaOH, precipitated 
protein was removed by centrifugation at 13,000 × g for 5 min. Lower bases and their 
respective α-RPs were analyzed by injecting 10 μL samples into an Agilent Technologies 
1200 series HPLC system equipped with a diode array detector set to 262 nm. Separation 
was performed with an Eclipse XDB-C18 column (5 μm pore size; 4.6 mm inner diameter 
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× 250 mm length) at a flow rate of 1 ml per min at 30 °C using 0.1% (v/v) formic acid in 
water as eluent A and 0.1% (v/v) formic acid in methanol as eluent B. The initial mobile 
phase and time parameters for the gradient elution were as follows: t = 0, 15% eluent B; 
t = 5 min, 25% eluent B; t = 11 min, 85% eluent B; t = 11.1 to 15 min, 15% eluent B. To 
obtain material for subsequent MS analysis, semi-preparative HPLC was performed using 
the method outlined above with minor modification as follows. The injection volume was 
increased to 100 μL, and a 1 ml fraction containing α-RP [DMB] or α-RP [purine] was 
manually collected from the detector outlet once the target peak was detected. Three 
such injections were performed and the α-RP fractions from each were combined, and 
then concentrated 10-fold from 3 mL to 300 μL using a Savant ISS110 vacuum dryer 
(Thermo Fisher). Aliquots (10 μL) of the concentrated α-RP solutions were introduced into 
an Exactive Plus Orbitrap MS via direct injection. The analytes were ionized using 
electrospray ionization operated in positive mode and detected via high-resolution MS 




Table 3.4 Nucleotide sequences of the primers designed for PCR amplification of 
the cobT genes to construct overexpression plasmids. 
Primer set NJ459/NJ460 was used to amplify the Dsf cobT gene (locus # DSY2114) from 
Dsf strain Y51 genomic DNA. Primer set NJ461/NJ462 was used to amplify the Dhc cobT 
gene (locus # DehaBAV1_0626) from Dhc strain BAV1 genomic DNA. The homology 
regions for vector recombination are in red color font. 
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While spearheading the development of our neuroscience collaborations at the 
University of Tennessee-Knoxville, I was able to advance the field of small molecule 
detection and identification. These projects stretched the boundaries of our analytical 
technologies and bolstered our current understanding of the true capabilities of high-
resolution mass spectrometry. Through our analyses, we established that a vast amount 
of information can be gained from sub-milligram quantities of brain tissue or even from 
dilute, small volume dialysate samples. Additionally, we have identified standard 
statistical protocols for proper pre-processing normalization procedures and the 
identification of significant metabolites through multiple statistical analyses. Through 
literature research, we have tentatively interpreted the observed metabolic changes for 
identified small molecules that will be studied in detail during future experimental 
endeavors. Lastly, several unidentified features were ambiguously classified, and 
represent the unique advantage of using an untargeted approach. 
  The analysis of stress-related changes to global metabolism provides the field of 
behavioral psychology with a novel toolset to promote the research of new small molecule 
targets. In the future, the results of our analyses may well lead to a therapeutic lead 
discovery compound that could treat, or even prevent post-traumatic stress related 
symptoms. This mental health condition is known to affect our war veterans, but it 
stretches far beyond the military as ~10% of the population exhibits symptoms related to 
PTSD. Unique to our study, future researchers can refer to our unidentified spectral 
features list to determine if a compound of interest was detected in our study. This aspect 
demonstrates the dynamic nature of untargeted metabolomics because even after the 
research has been published, new discoveries could always be related back to our initial 
discovery-based experiment. 
 The identification of thousands of small molecules from a 15-microliter sample of 
dialysate represents the unparalleled qualities of a high-resolution mass spectrometer. 
By detecting the global metabolism during various states of consciousness, we have 
provided sleep researchers with comparable tools that will facilitate the expansion of 
current neurochemical analyses within the field. It is foreseeable that future experiments 
will be conducted based on our results. This is a simple prediction to make because the 
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function and regulation of the sleep-wake cycle is still generally unknown. The analysis 
of native (underivatized) small molecules from dialysate of the extracellular matrix 
reduces sample convolution and increases sample throughput. Although the true 
understanding of neuronal function will forever be a complicated maze, this progression 
of research brings us closer to full comprehension. 
 After analyzing thousands of known and unknown metabolites, the ability to 
successfully characterize a novel compound was refreshing. The successful 
characterization of purinyl-cobamide is a significant advancement within the fields of 
microbiology and structure elucidation. In future studies of novel cobamides, we have 
provided a strategy for the characterization of future cobamide species. This will be 
essential for the continued research involving bioremediation. Microbial cultures are the 
ideal biological system for the characterization of novel compounds. We can grow them 
in large quantities with minimal biosafety regulation and relatively low costs, then following 
analyte purification, we are left with a clean sample. The only limiting factor for cell 
cultures are growth rates and the amount of analyte produced per cell. 
 The expansion of metabolomics for pharmacological development and clinical 
practices is crucial for the treatment, or prevention of various health related 
diseases/disorders. More specifically, the areas of neurological disorders and oncology 
could benefit the most from continued development of small molecule analysis. From my 
point-of-view, the study of small molecules needs to become a cross-functional ‘omics’ 
technique that is easily interpreted when combined with genomics, or even proteomics. 
The disconnect from systems biology to the real-time snapshot analyses of metabolomics 
is an issue that will be resolved over the next decade. Additionally, researchers need to 
begin utilizing the true power of mass spectrometry by analyzing complex multicellular 
organisms, such as rodents and humans, through flux analysis. Flux studies involve the 
labeling of one, or more atoms using a heavy isotope, such as 13-carbon or 15-nitrogen. 
These analyses provide a rate of metabolism because you can observe the appearance, 
and disappearance of labeled metabolites. This process is commonly used in bacterial 
and microbial cultures, and I think would greatly benefit the health research community if 
we could begin using 13-carbon labeled glucose in a food or drink supplement to study 
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the rate of metabolism. Who knows, maybe mass spectrometry imaging or even magnetic 
resonance could be used to show where the labeled material is being consumed fastest. 
This could lead to a non-invasive technique for the identification of tumorous cells. In the 
meantime, small molecule researchers need to continue conducting discovery-based 
research projects, then use those results to begin performing targeted experiments. This 
could include the administration of a small molecule of interest, or even the genetic 
engineering of a knockout strain, given that your research is using rodents. These follow-
up studies would lead to the development of a single, or multiple small molecule targets 
that could lead to the treatment of disease. 
 In closing, my research has all been focused on the study of small molecules and 
the development of new technologies, or techniques for the identification of novel 
compounds. I truly believe that the global biochemical community has only discovered 
less than 5% of all biologically active compounds. As instrumentation becomes more 
accurate and sensitive, as computers and related software enhances, and our ability to 
analyze, comprehend, and learn develops, we can expand our current understanding of 
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